
<html lang="en"     class="pb-page"  data-request-id="9c960a4b-5f50-4ac9-ad6f-7e687e25c4bc"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.9b01462;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2019.62.issue-23"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="4-(3-Aminoazetidin-1-yl)pyrimidin-2-amines as High-Affinity Non-imidazole Histamine H3 Receptor Agonists with in Vivo Central Nervous System Activity" /></meta><meta name="dc.Creator" content="Gábor  Wágner" /></meta><meta name="dc.Creator" content="Tamara A. M.  Mocking" /></meta><meta name="dc.Creator" content="Marta  Arimont" /></meta><meta name="dc.Creator" content="Gustavo  Provensi" /></meta><meta name="dc.Creator" content="Barbara  Rani" /></meta><meta name="dc.Creator" content="Bruna  Silva-Marques" /></meta><meta name="dc.Creator" content="Gniewomir  Latacz" /></meta><meta name="dc.Creator" content="Daniel  Da Costa Pereira" /></meta><meta name="dc.Creator" content="Christina  Karatzidou" /></meta><meta name="dc.Creator" content="Henry F.  Vischer" /></meta><meta name="dc.Creator" content="Maikel  Wijtmans" /></meta><meta name="dc.Creator" content="Katarzyna  Kieć-Kononowicz" /></meta><meta name="dc.Creator" content="Iwan J. P.  de Esch" /></meta><meta name="dc.Creator" content="Rob  Leurs" /></meta><meta name="dc.Description" content="Despite the high diversity of histamine H3 receptor (H3R) antagonist/inverse agonist structures, partial or full H3R agonists have typically been imidazole derivatives. An in-house screening campai..." /></meta><meta name="Description" content="Despite the high diversity of histamine H3 receptor (H3R) antagonist/inverse agonist structures, partial or full H3R agonists have typically been imidazole derivatives. An in-house screening campai..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 1, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01462" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01462" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01462" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01462" /></link>
        
    
    

<title>4-(3-Aminoazetidin-1-yl)pyrimidin-2-amines as High-Affinity Non-imidazole Histamine H3 Receptor Agonists with in Vivo Central Nervous System Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01462" /></meta><meta property="og:title" content="4-(3-Aminoazetidin-1-yl)pyrimidin-2-amines as High-Affinity Non-imidazole Histamine H3 Receptor Agonists with in Vivo Central Nervous System Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/large/jm9b01462_0008.jpeg" /></meta><meta property="og:description" content="Despite the high diversity of histamine H3 receptor (H3R) antagonist/inverse agonist structures, partial or full H3R agonists have typically been imidazole derivatives. An in-house screening campaign intriguingly afforded the non-imidazole 4-(3-azetidin-1-yl)pyrimidin-2-amine 11b as a partial H3R agonist. Here, the design, synthesis, and structure–activity relationships of 11b analogues are described. This series yields several non-imidazole full agonists with potencies varying with the alkyl substitution pattern on the basic amine following the in vitro evaluation of H3R agonism using a cyclic adenosine monophosphate response element-luciferase reporter gene assay. The key compound VUF16839 (14d) combines nanomolar on-target activity (pKi = 8.5, pEC50 = 9.5) with weak activity on cytochrome P450 enzymes and good metabolic stability. The proposed H3R binding mode of 14d indicates key interactions similar to those attained by histamine. In vivo evaluation of 14d in a social recognition test in mice revealed an amnesic effect at 5 mg/kg intraperitoneally. The excellent in vitro and in vivo pharmacological profiles and the non-imidazole structure of 14d make it a promising tool compound in H3R research." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01462"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01462">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01462&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01462&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01462&amp;href=/doi/10.1021/acs.jmedchem.9b01462" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 10848-10866</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01416" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b01405" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">4-(3-Aminoazetidin-1-yl)pyrimidin-2-amines as High-Affinity Non-imidazole Histamine H<sub>3</sub> Receptor Agonists with in Vivo Central Nervous System Activity</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Gábor Wágner</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gábor Wágner</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Division of Medicinal Chemistry, Faculty of Science, Vrije Universiteit Amsterdam, De Boelelaan 1108, 1081 HZ Amsterdam, The Netherlands</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=G%C3%A1bor++W%C3%A1gner">Gábor Wágner</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5111-6749" title="Orcid link">http://orcid.org/0000-0001-5111-6749</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tamara A. M. Mocking</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tamara A. M. Mocking</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Division of Medicinal Chemistry, Faculty of Science, Vrije Universiteit Amsterdam, De Boelelaan 1108, 1081 HZ Amsterdam, The Netherlands</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tamara+A.+M.++Mocking">Tamara A. M. Mocking</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marta Arimont</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marta Arimont</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Division of Medicinal Chemistry, Faculty of Science, Vrije Universiteit Amsterdam, De Boelelaan 1108, 1081 HZ Amsterdam, The Netherlands</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marta++Arimont">Marta Arimont</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9367-5298" title="Orcid link">http://orcid.org/0000-0002-9367-5298</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gustavo Provensi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gustavo Provensi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Neuroscience, Psychology, Drug Research and Child Health, Section of Pharmacology and Toxicology, University of Florence, Viale G. Pieraccini 6, CAP 50139 Florence, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gustavo++Provensi">Gustavo Provensi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Barbara Rani</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Barbara Rani</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Health Sciences, University of Florence, Viale G. Pieraccini 6, CAP 50139 Florence, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Barbara++Rani">Barbara Rani</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bruna Silva-Marques</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bruna Silva-Marques</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Neuroscience, Psychology, Drug Research and Child Health, Section of Pharmacology and Toxicology, University of Florence, Viale G. Pieraccini 6, CAP 50139 Florence, Italy</div><div class="loa-info-affiliations-info">Department of Physiotherapy, Federal University of São Carlos, Washington Luís, km 235, SP-310 São Carlos, Brazil</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bruna++Silva-Marques">Bruna Silva-Marques</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gniewomir Latacz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gniewomir Latacz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Technology and Biotechnology of Drugs, Medical College, Jagiellonian University, Medyczna 9, PL 30-688 Cracow, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gniewomir++Latacz">Gniewomir Latacz</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daniel Da Costa Pereira</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniel Da Costa Pereira</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Division of Medicinal Chemistry, Faculty of Science, Vrije Universiteit Amsterdam, De Boelelaan 1108, 1081 HZ Amsterdam, The Netherlands</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Da+Costa+Pereira">Daniel Da Costa Pereira</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christina Karatzidou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christina Karatzidou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Division of Medicinal Chemistry, Faculty of Science, Vrije Universiteit Amsterdam, De Boelelaan 1108, 1081 HZ Amsterdam, The Netherlands</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christina++Karatzidou">Christina Karatzidou</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Henry F. Vischer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Henry F. Vischer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Division of Medicinal Chemistry, Faculty of Science, Vrije Universiteit Amsterdam, De Boelelaan 1108, 1081 HZ Amsterdam, The Netherlands</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Henry+F.++Vischer">Henry F. Vischer</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0184-6337" title="Orcid link">http://orcid.org/0000-0002-0184-6337</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Maikel Wijtmans</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Maikel Wijtmans</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Division of Medicinal Chemistry, Faculty of Science, Vrije Universiteit Amsterdam, De Boelelaan 1108, 1081 HZ Amsterdam, The Netherlands</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Maikel++Wijtmans">Maikel Wijtmans</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8955-8016" title="Orcid link">http://orcid.org/0000-0001-8955-8016</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Katarzyna Kieć-Kononowicz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Katarzyna Kieć-Kononowicz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Technology and Biotechnology of Drugs, Medical College, Jagiellonian University, Medyczna 9, PL 30-688 Cracow, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Katarzyna++Kie%C4%87-Kononowicz">Katarzyna Kieć-Kononowicz</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Iwan J. P. de Esch</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Iwan J. P. de Esch</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Division of Medicinal Chemistry, Faculty of Science, Vrije Universiteit Amsterdam, De Boelelaan 1108, 1081 HZ Amsterdam, The Netherlands</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Iwan+J.+P.++de+Esch">Iwan J. P. de Esch</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Rob Leurs</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rob Leurs</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Division of Medicinal Chemistry, Faculty of Science, Vrije Universiteit Amsterdam, De Boelelaan 1108, 1081 HZ Amsterdam, The Netherlands</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#f785d99b92828584b78182d9999b"><span class="__cf_email__" data-cfemail="691b47050c1c1b1a291f1c470705">[email protected]</span></a>. Phone: +31 20 59 87579.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rob++Leurs">Rob Leurs</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1354-2848" title="Orcid link">http://orcid.org/0000-0003-1354-2848</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01462&amp;href=/doi/10.1021%2Facs.jmedchem.9b01462" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 10848–10866</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 1, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 September 2019</li><li><span class="item_label"><b>Published</b> online</span>1 November 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 December 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01462" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01462</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice/index.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by-nc text">with CC-BY-NC-ND<a href="/page/policy/authorchoice_ccbyncnd_termsofuse.html" title="License">license</a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01462"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1966</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">4</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01462" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;4-(3-Aminoazetidin-1-yl)pyrimidin-2-amines as High-Affinity Non-imidazole Histamine H3 Receptor Agonists with in Vivo Central Nervous System Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Gábor&quot;,&quot;last_name&quot;:&quot;Wágner&quot;},{&quot;first_name&quot;:&quot;Tamara&quot;,&quot;last_name&quot;:&quot;A. M. Mocking&quot;},{&quot;first_name&quot;:&quot;Marta&quot;,&quot;last_name&quot;:&quot;Arimont&quot;},{&quot;first_name&quot;:&quot;Gustavo&quot;,&quot;last_name&quot;:&quot;Provensi&quot;},{&quot;first_name&quot;:&quot;Barbara&quot;,&quot;last_name&quot;:&quot;Rani&quot;},{&quot;first_name&quot;:&quot;Bruna&quot;,&quot;last_name&quot;:&quot;Silva-Marques&quot;},{&quot;first_name&quot;:&quot;Gniewomir&quot;,&quot;last_name&quot;:&quot;Latacz&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Da Costa Pereira&quot;},{&quot;first_name&quot;:&quot;Christina&quot;,&quot;last_name&quot;:&quot;Karatzidou&quot;},{&quot;first_name&quot;:&quot;Henry&quot;,&quot;last_name&quot;:&quot;F. Vischer&quot;},{&quot;first_name&quot;:&quot;Maikel&quot;,&quot;last_name&quot;:&quot;Wijtmans&quot;},{&quot;first_name&quot;:&quot;Katarzyna&quot;,&quot;last_name&quot;:&quot;Kieć-Kononowicz&quot;},{&quot;first_name&quot;:&quot;Iwan&quot;,&quot;last_name&quot;:&quot;J. P. de Esch&quot;},{&quot;first_name&quot;:&quot;Rob&quot;,&quot;last_name&quot;:&quot;Leurs&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;01&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;10848-10866&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01462&quot;},&quot;abstract&quot;:&quot;Despite the high diversity of histamine H3 receptor (H3R) antagonist/inverse agonist structures, partial or full H3R agonists have typically been imidazole derivatives. An in-house screening campaign intriguingly afforded the non-imidazole 4-(3-azetidin-1-yl)pyrimidin-2-amine 11b as a partial H3R agonist. Here, the design, synthesis, and structure–activity relationships of 11b analogues are described. This series yields several non-imidazole full agonists with potencies varying with the alkyl substitution pattern on the basic amine following the in vitro evaluation of H3R agonism using a cyclic adenosine monophosphate response element-luciferase reporter gene assay. The key compound VUF16839 (14d) combines nanomolar on-target activity (pKi = 8.5, pEC50 = 9.5) with weak activity on cytochrome P450 enzymes and good metabolic stability. The proposed H3R binding mode of 14d indicates key interactions similar to those attained by histamine. In vivo evaluation of 14d in a social recognition test in mice revealed an&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01462&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01462" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01462&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01462" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01462&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01462" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01462&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01462&amp;href=/doi/10.1021/acs.jmedchem.9b01462" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01462" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01462" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01462%26sid%3Dliteratum%253Aachs%26pmid%3D31675226%26genre%3Darticle%26aulast%3DW%25C3%25A1gner%26date%3D2019%26atitle%3D4-%25283-Aminoazetidin-1-yl%2529pyrimidin-2-amines%2Bas%2BHigh-Affinity%2BNon-imidazole%2BHistamine%2BH3%2BReceptor%2BAgonists%2Bwith%2Bin%2BVivo%2BCentral%2BNervous%2BSystem%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D23%26spage%3D10848%26epage%3D10866%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (5)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/jmcmar.2019.62.issue-23/20191212/jmcmar.2019.62.issue-23.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/medium/jm9b01462_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/large/jm9b01462_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01462&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Despite the high diversity of histamine H<sub>3</sub> receptor (H<sub>3</sub>R) antagonist/inverse agonist structures, partial or full H<sub>3</sub>R agonists have typically been imidazole derivatives. An in-house screening campaign intriguingly afforded the non-imidazole 4-(3-azetidin-1-yl)pyrimidin-2-amine <b>11b</b> as a partial H<sub>3</sub>R agonist. Here, the design, synthesis, and structure–activity relationships of <b>11b</b> analogues are described. This series yields several non-imidazole full agonists with potencies varying with the alkyl substitution pattern on the basic amine following the in vitro evaluation of H<sub>3</sub>R agonism using a cyclic adenosine monophosphate response element-luciferase reporter gene assay. The key compound VUF16839 (<b>14d</b>) combines nanomolar on-target activity (p<i>K</i><sub>i</sub> = 8.5, pEC<sub>50</sub> = 9.5) with weak activity on cytochrome P450 enzymes and good metabolic stability. The proposed H<sub>3</sub>R binding mode of <b>14d</b> indicates key interactions similar to those attained by histamine. In vivo evaluation of <b>14d</b> in a social recognition test in mice revealed an amnesic effect at 5 mg/kg intraperitoneally. The excellent in vitro and in vivo pharmacological profiles and the non-imidazole structure of <b>14d</b> make it a promising tool compound in H<sub>3</sub>R research.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23141" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23141" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The four histamine receptors (H<sub>1</sub>R, H<sub>2</sub>R, H<sub>3</sub>R, H<sub>4</sub>R) belong to class A of the G protein-coupled receptor (GPCR) family.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The histamine H<sub>3</sub> receptor (H<sub>3</sub>R) was discovered in 1983 by Arrang et al.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> and regulates the release of several neurotransmitters such as histamine (<b>1</b>), acetylcholine, serotonin, noradrenaline, and dopamine, as both auto- and heteroreceptor.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Due to its expression in the cortex, striatum, and hippocampus, H<sub>3</sub>R regulates several physiological processes such as sleep–wake regulation, cognition, and food intake.<a onclick="showRef(event, 'ref1 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref3">(1,3)</a></div><div class="NLM_p">During the early years of discovery of H<sub>3</sub>R ligands, the natural ligand histamine served as an initial structure for drug design, leading to a plethora of imidazole-containing ligands. However, imidazole-containing ligands are associated with drug–drug interactions due to the propensity for cytochrome P450 (CYP) inhibition and having poor brain penetration.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> Therefore, research toward therapeutically relevant H<sub>3</sub>R antagonists focused on druglike non-imidazole structures,<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> and these efforts have led to numerous clinical candidates for different indications connected to central nervous system diseases, for example, Alzheimer′s disease, attention deficit hyperactivity disorders, sleep disorders, schizophrenia, obesity, epilepsy, and neuropathic pain and narcolepsy.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> For the latter condition, the H<sub>3</sub>R ligand pitolisant (Wakix) was approved by the European Medicines Agency in 2016<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and, most recently, by the Food and Drug Administration in 2019.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">In sharp contrast, developing non-imidazole H<sub>3</sub>R agonists has not been very successful. The best agonists contain an imidazole ring<a onclick="showRef(event, 'ref12 ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20 ref21 ref22 ref23">(12−23)</a> and, compared to the endogenous ligand histamine (<b>1</b>), these derivatives show similar [e.g., imbutamine (<b>2</b>)] or significantly higher affinity (p<i>K</i><sub>i</sub>) and/or functional activity (pEC<sub>50</sub>) on H<sub>3</sub>R [e.g., imetit (<b>3</b>), methimepip (<b>4</b>), and (1<i>S</i>,2<i>S</i>)-2-(2-aminoethyl)-1-(1<i>H</i>-imidazol-4-yl)cyclopropane (<b>5</b>)] (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A). Imidazole-containing agonists have shown some potential application in different therapeutic areas, such as mechanical nociception,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> obesity, and diabetes mellitus (diet-induced obesity mice test)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and stress (rodent-intruder mice test).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Some data also support the hypothesis of cardioprotective effect of H<sub>3</sub>R receptor activation.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> However, it is fair to say that imidazole-containing agonists may suffer from the same imidazole-related drawbacks that were associated with the first generation of imidazole-containing H<sub>3</sub>R antagonists (vide supra). Future studies on the pharmacological and therapeutic roles of H<sub>3</sub>R agonists can therefore be helped by having non-imidazole H<sub>3</sub>R agonists available.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/medium/jm9b01462_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/large/jm9b01462_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Representative imidazole H<sub>3</sub>R agonists. Activities are extracted from Igel et al.,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Govoni et al.,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and Kazuta et al.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> (B) Published non-imidazole H<sub>3</sub>R (partial) agonists.<a onclick="showRef(event, 'ref27 ref28 ref29 ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30 ref31 ref32">(27−32)</a> Unless mentioned otherwise, compounds were tested on the human receptor. α, intrinsic activity compared to histamine; β-gal, cyclic adenosine monophosphate (cAMP) response element (CRE)-β-galactosidase reporter gene assay; cAMP, forskolin-stimulated cAMP accumulation assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/large/jm9b01462_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01462&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">A very limited number of non-imidazole agonists have been published to date (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B). VUF8430 (<b>6</b>) was designed as an H<sub>4</sub>R agonist based on the H<sub>2</sub>R agonist dimaprit and shows micromolar affinity and full H<sub>3</sub>R agonism as well.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The histamine analogues amthamine (<b>7a</b>) and amselamine (<b>7b</b>) were identified as H<sub>2</sub>R agonists, but both show weak H<sub>3</sub>R agonist activity in an electrically stimulated guinea-pig jejunum model.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a> Three pentacyclic spiroindolinone derivatives were isolated from <i>Penicillium waksmanii</i>, of which PF1270A (<b>8</b>) shows the best affinity for H<sub>3</sub>R and moderate functional H<sub>3</sub>R activity in a guanosine 5′-<i>O</i>-[γ-thio]triphosphate (GTPγS) accumulation assay.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> ZEL-H16 (<b>9</b>) has been reported to have nanomolar binding affinity to the H<sub>3</sub>R, partial H<sub>3</sub>R agonism in forskolin-stimulated cAMP accumulation and ERK1/2 signaling assays, and full H<sub>3</sub>R agonism in a guinea-pig ileum contraction assay.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Finally, a compound set with 94 examples in four compound families with either a β-lactam or a pyrrolidinone central core without basic amino moiety was published recently and surprisingly included compounds with nanomolar functional H<sub>3</sub>R agonist activities (e.g., compound <b>10</b>).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The fungal isolates and the multicomponent reaction product <b>10</b> are large and complex molecules, which are difficult to align with known H<sub>3</sub>R pharmacophores or H<sub>3</sub>R binding modes for agonists and antagonists. We therefore started a search for novel high-affinity non-imidazole H<sub>3</sub>R full agonists with simpler structures to generate fundamental knowledge on ligand recognition and signaling of the H<sub>3</sub>R.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23726" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23726" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Design</h3><div class="NLM_p">During an in-house compound screen aimed at identifying agonist activities in a set of ligands using a H<sub>3</sub>R-driven reporter gene assay in HEK293T cells, diaminopyrimidine <b>11b</b> emerged as a H<sub>3</sub>R partial agonist hit (α = 0.7), while its close derivative <b>11i</b> showed only weak agonist activity (α = 0.4) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). Interestingly, a set of four diaminopyrimidine compounds has been tested before by others on H<sub>3</sub>R en route to imbutamine (<b>2</b>) analogues, but the majority of these diaminopyrimidines were rather inactive and, where applicable, all were shown to be antagonists/inverse agonists.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Intrigued by the agonist activity of the diaminopyrimidine <b>11b</b> and recognizing its core as a thoroughly explored heterocycle in the H<sub>4</sub>R area,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> we decided to perform an in-depth patent search on this scaffold in an effort to capture the full array of industrial contributions. This resulted in the identification of <b>14a</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B) as the closest derivative with data associated with H<sub>3</sub>R (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Remarkably, <b>14a</b> was claimed as a H<sub>3</sub>R agonist by Abbott, although its actual synthesis was not included and only the potential synthetic route was described.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> In the same patent, 25 related examples have been prepared, and partial agonism at the human H<sub>3</sub>R is reported.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/medium/jm9b01462_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/large/jm9b01462_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Initial functional data of compounds <b>11b</b> and <b>11i</b> compared to histamine, as obtained by ligand-induced activation of hH<sub>3</sub>R expressed on HEK293T cells measured by the CRE-luc reporter gene assay. Shown is a representative graph of at least three experiments performed in triplicate. Data are mean ± standard deviation (S.D.). (B) Structures of <b>11b</b> and <b>11i</b>, the closest relevant structure (<b>14a</b>) resulting from a subsequent extensive patent search and the compound set designed for the current study.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/large/jm9b01462_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01462&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Based on <b>11b</b> and <b>14a</b>, we designed a focused series of compounds to explore the H<sub>3</sub>R affinity and activity in the chemical space between <b>14a</b> and <b>11b</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). The design strategy targets four series with <i>i</i>Pr, Et, Me, or H as the R<sup>1</sup> group at position 6 (<b>11</b>–<b>14</b>). These R<sup>1</sup> groups were combined with different substituents on the basic amino groups (R<sup>2</sup> and R<sup>3</sup>). Beyond the evident H (<b>a</b>) and Me (<b>b</b>) substituents, dimethyl derivatives (<b>i</b>) were synthesized due to the potential functional switch that appears to reside in the cases of <b>11b</b> and <b>11i</b>. Based on the initial results of the designed compound set (vide infra), the R<sup>1</sup> = H series was extended with elongated (<b>d</b> and <b>f</b>), branched (<b>e</b>, <b>g</b>, <b>h</b>), and disubstituted (<b>j</b>, <b>k</b>) amino derivatives. This second design iteration was also inspired by previous work from our labs on the imidazole-containing agonist imbutamine (<b>2</b>), which harbors a functional switch on the basic amine.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Beyond <b>14a</b>, some exact compounds from this designed set are known but none in a context of H<sub>3</sub>R. That is, <b>11a</b>, <b>11b</b>, and <b>12b</b> have been claimed as H<sub>4</sub>R ligands,<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37,38)</a> while <b>12i</b>, <b>13i</b>, <b>14i</b>, <b>14j</b>, and <b>14k</b> were offered in chemical catalogs (April 2019) without any synthesis description and analytical or pharmacological data.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Chemistry</h3><div class="NLM_p">The designed compound set shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B was synthesized as outlined in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The key step of the synthetic route was a nucleophilic aromatic substitution on the appropriate aromatic cores with aminoazetidine moieties (step ii). The 4-chloro-2-aminopyrimidines were commercially available (<b>19</b> and <b>20</b>) or were synthesized (<b>17</b> and <b>18</b>) from the appropriate pyrimidin-4(3<i>H</i>)-one derivatives (<b>15</b> and <b>16</b>) with POCl<sub>3</sub>. The R<sup>2</sup> = H or Me derivatives of the Boc-protected 3-aminoazetidines (<b>28a</b> and <b>28b</b>) were commercially available, while the R<sup>2</sup> = Et, <i>n</i>Pr, and <i>n</i>Bu derivatives were synthesized. These intermediates were built from benzhydryl-protected 3-aminoazetidine (<b>25</b>) with Boc protection of the primary amino group to give <b>26</b>, followed by alkylation with the corresponding iodoalkyl reagents resulting in the orthogonally protected intermediates (<b>27c</b>, <b>27d</b>, <b>27f</b>) and the removal of the benzhydryl group with hydrogenation. The resulting mixtures of unprotected azetidine intermediate and diphenylmethane were used directly for the ensuing nucleophilic substitution with <b>17</b>–<b>20</b>. The key nucleophilic aromatic substitution of the appropriate Boc-protected intermediates was performed in a microwave at 120–150 °C to give <b>21</b>–<b>24</b>. This was followed by the deprotection under acidic condition to afford the majority of monosubstituted (R<sup>2</sup> = H or linear alkyl, R<sup>3</sup> = H) products <b>11</b>–<b>14</b>. Although the Boc protection was necessary at the precursor stage to avoid overalkylation in the case of linear alkyl derivatives, overalkylation was not a problem in the case of the branched-alkyl derivatives as a result of steric hindrance. Therefore, the branched-alkyl derivatives <b>14e</b>, <b>g</b>, and <b>h</b> as well as the dialkylated derivatives <b>12i</b>, <b>13i</b>, <b>14i</b>, and <b>14j</b> were synthesized from <b>14a</b> with a reductive amination. Last, <b>11i</b> was synthesized directly from <b>17</b> and <i>N</i>,<i>N</i>-dimethylazetidin-3-amine with a nucleophilic substitution, while the pyrrolidine ring of <b>14k</b> was obtained from 1,4-diiodobutane and <b>14a</b>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/medium/jm9b01462_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/large/jm9b01462_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Syntheses Routes for Final Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/large/jm9b01462_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01462&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) POCl<sub>3</sub>, 110 °C, 3 h, 26–52%; (ii) <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA), dioxane or <i>N</i>-methyl-2-pyrrolidone (NMP), microwave (μW), 120–150 °C, 0.5–2 h, 27–50% (<b>a</b>, <b>b</b>) or 35–71% (<b>c</b>, <b>d</b>, <b>f</b>, two steps from benzhydryl deprotection); (iii) HCl, dichloromethane (DCM), MeOH, room temperature (rt) to 50 °C, 3 h to overnight, 10% to quant.; (iv) aldehyde/ketone, AcOH, NaHB(OAc)<sub>3</sub>, DCM, MeOH, rt, 3 h to overnight, 16–44%; or 1,4-diiodobutane, K<sub>2</sub>CO<sub>3</sub>, MeCN, reflux, 16 h, 9%; (v) <i>N</i>,<i>N</i>-dimethylazetidin-3-amine dihydrochloride, DIPEA, dioxane, μW, 150 °C, 30 min, 65%; (vi) di-<i>tert</i>-butyl dicarbonate, triethylamine (TEA), tetrahydrofuran (THF), rt, overnight, 63%; (vii) NaH, R<sup>2</sup>I, THF, 0 °C to rt, overnight, 28–58%; (viii) H<sub>2</sub>, Pd/C, MeOH, EtOH, rt to 60 °C, 1 h to overnight, not purified and used crude.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Pharmacological Evaluation</h3><div class="NLM_p">The synthesized compound set was tested for its activity at the human H<sub>3</sub>R transiently expressed in HEK293T cells. Binding affinity (<i>K</i><sub>i</sub>) was evaluated using a [<sup>3</sup>H]NAMH displacement assay, while potency (EC<sub>50</sub>) and intrinsic activity (α) were determined as the H<sub>3</sub>R-mediated inhibition of forskolin-induced CRE-driven luciferase reporter gene activity with histamine as the control (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). During the first iteration, the isopropyl group of <b>11b</b> was gradually decreased in size to give <b>11</b>–<b>14</b>, which were all combined with small-size R<sup>2</sup>/R<sup>3</sup> amino substituents (<b>a</b>, <b>b</b>, <b>c</b>, <b>i</b>). The affinities of the unsubstituted derivatives (<b>14</b>) stand out especially within the monomethylated (<b>b</b>) and monoethylated series (<b>c</b>), with both <b>14b</b> and <b>14c</b> exceeding the affinity of histamine. Although monomethylated (<b>b</b>) derivatives generally show the highest affinities in each R<sup>1</sup> subseries <b>11</b>–<b>14</b>, the most notable variation was observed in the case of the monoethylated series <b>c</b>, with affinities of Me/Et/<i>i</i>Pr derivatives <b>11c</b>, <b>12c</b>, and <b>13c</b> being considerably reduced compared with that of <b>14c</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). A more indicative trend was observed in the case of the functional results of this <b>c</b> series. Compound <b>14c</b> has a higher potency than <b>14b</b> and produces the same intrinsic activity (α) as histamine but with higher potency (EC<sub>50</sub>), while <b>12c</b> and <b>13c</b> show >1 log unit weaker EC<sub>50</sub> albeit with maintained full agonism (α ∼ 1.0). Interestingly, isopropyl substitution on the R<sup>1</sup> position (<b>11c</b>) turns this full agonism to partial agonism (α = 0.3) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). A similar trend was observed in the other three series, with the pyrimidine derivatives bearing R<sup>1</sup> = H (<b>14a</b>–<b>c</b> and <b>14i</b>) reaching or exceeding the affinity (<i>K</i><sub>i</sub>) and potency (EC<sub>50</sub>) of histamine, while any alkyl substituent at position 6 (R<sup>1</sup>) on the pyrimidine leads to inferior results. The intrinsic activity (α) indicates full or almost full agonism (α ≥ 0.8) in the methyl (<b>12a</b>, <b>12b</b>, <b>12i</b>) and ethyl (<b>13a</b>, <b>13b</b>, <b>13i</b>) series, while it drops to partial agonism in the isopropyl series (<b>11a</b>, <b>11b</b>, <b>11i</b>) (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/medium/jm9b01462_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/large/jm9b01462_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Representative structure–affinity relationship (A, C) and structure–function relationship (SFR) (B, D) effects selected from <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. (A, B) Different R<sup>1</sup> substituents with R<sup>2</sup> = Et and R<sup>3</sup> = H (<b>11c</b>, <b>12c</b>, <b>13c</b>, <b>14c</b>), (C, D) Different R<sup>2</sup> and R<sup>3</sup> substituents with R<sup>1</sup> = H (<b>14b</b>, <b>14d</b>, <b>14e</b>, <b>14f</b>, <b>14i</b>). Shown is a representative graph of at least three experiments performed in triplicate. Data are mean ± S.D.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/large/jm9b01462_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01462&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Pharmacological Evaluation of Designed Compound Set</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/medium/jm9b01462_0005.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center" char="±">pK<sub>i</sub><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="±">pEC<sub>50</sub><a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char="±">α</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">histamine</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">7.9 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">8.6 ± 0.0</td><td class="colsep0 rowsep0" align="char" char="±">1.0 ± 0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11a</b></td><td class="colsep0 rowsep0" align="left"><i>i</i>Pr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">6.7 ± 0.0</td><td class="colsep0 rowsep0" align="char" char="±">7.1 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">0.7 ± 0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11b</b></td><td class="colsep0 rowsep0" align="left"><i>i</i>Pr</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">7.0 ± 0.0</td><td class="colsep0 rowsep0" align="char" char="±">7.9 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">0.7 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11c</b></td><td class="colsep0 rowsep0" align="left"><i>i</i>Pr</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">7.0 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">6.8 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">0.3 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11i</b></td><td class="colsep0 rowsep0" align="left"><i>i</i>Pr</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char="±">6.9 ± 0.0</td><td class="colsep0 rowsep0" align="char" char="±">7.0 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">0.4 ± 0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">7.1 ± 0.0</td><td class="colsep0 rowsep0" align="char" char="±">7.5 ± 0.0</td><td class="colsep0 rowsep0" align="char" char="±">0.9 ± 0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">7.3 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">7.6 ± 0.0</td><td class="colsep0 rowsep0" align="char" char="±">0.8 ± 0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12c</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">6.9 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">7.5 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">0.9 ± 0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12i</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char="±">6.6 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">7.2 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">0.8 ± 0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13a</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">7.3 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">7.8 ± 0.0</td><td class="colsep0 rowsep0" align="char" char="±">0.9 ± 0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13b</b><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">7.5 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">8.0 ± 0.0</td><td class="colsep0 rowsep0" align="char" char="±">0.8 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13c</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">7.1 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">7.9 ± 0.0</td><td class="colsep0 rowsep0" align="char" char="±">1.0 ± 0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13i</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char="±">6.5 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">7.4 ± 0.0</td><td class="colsep0 rowsep0" align="char" char="±">0.9 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14a</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">7.8 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">8.3 ± 0.0</td><td class="colsep0 rowsep0" align="char" char="±">1.1 ± 0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14b</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">8.2 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">8.9 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">1.1 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14c</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">8.0 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">9.2 ± 0.0</td><td class="colsep0 rowsep0" align="char" char="±">1.0 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14d</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>Pr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">8.5 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">9.5 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">1.2 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14e</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>i</i>Pr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">7.4 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">8.5 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">1.2 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14f</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>Bu</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">7.8 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">9.1 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">1.2 ± 0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14g</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>rac-s</i>Bu</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">7.9 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">8.7 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">1.1 ± 0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14h</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>i</i>Bu</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">7.4 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">8.3 ± 0.0</td><td class="colsep0 rowsep0" align="char" char="±">1.1 ± 0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14i</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char="±">7.3 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">8.4 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">1.0 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14j</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="char" char="±">7.2 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">8.1 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">1.2 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14k</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" colspan="2" align="left">-(CH<sub>2</sub>)<sub>4</sub>-</td><td class="colsep0 rowsep0" align="char" char="±">7.4 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">8.1 ± 0.0</td><td class="colsep0 rowsep0" align="char" char="±">1.3 ± 0.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Measured as fumarate salt.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Measured as dihydrochloride salt.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Affinity values (p<i>K</i><sub>i</sub>) were determined by [<sup>3</sup>H]NAMH displacement assay on hH<sub>3</sub>R expressed on HEK293T cell homogenates.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">Potency (pEC<sub>50</sub>) and intrinsic activity (α) were determined by ligand induced activation of hH<sub>3</sub>R expressed on HEK293T cells as measured by a CRE-luciferase reporter gene assay. Data are mean ± standard error of the mean (S.E.M.) of at least three experiments performed in triplicate.</p></div></div></div><div class="NLM_p last">Due to the better results of the pyrimidines lacking an R<sup>1</sup> substituent (<b>14</b>), in a subsequent iteration the amine NHR<sup>2</sup> substituent was replaced with longer linear groups (<b>14d</b>, <b>14f</b>), branched groups (<b>14e</b>, <b>14g</b>, <b>14h</b>), or dialkylamino (<b>14j</b>, <b>14k</b>) moieties. Representative curves illustrate the structure–activity relationship (SAR) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C) and SFR (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D) of this series. The <i>n</i>Pr derivative <b>14d</b> shows the highest affinity (p<i>K</i><sub>i</sub> = 8.5) from all linear monoalkyl substituents. Although both shorter and longer R<sup>2</sup> moieties resulted in lower binding affinities (e.g., <b>14c</b>: p<i>K</i><sub>i</sub> = 8.0 or <b>14f</b>: p<i>K</i><sub>i</sub> = 7.8), all derivatives remained in the same affinity range (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C). The branched-alkyl moieties as well as the dialkylated derivatives display loss of affinity (compare, e.g., <b>14d</b> vs <b>14e</b>, or <b>14b</b> vs <b>14i</b>). The potencies (EC<sub>50</sub>) show almost the same trends as observed for the affinities (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D). Highly noteworthy, the potency of <b>14d</b> (pEC<sub>50</sub> = 9.5) is almost a log unit higher than that of histamine (pEC<sub>50</sub> = 8.6), while chain shortening (e.g., <b>14b</b>, <b>14c</b>), chain lengthening (<b>14f</b>), chain branching (e.g., <b>14e</b>), or dialkylation (e.g., <b>14i</b>) results in lower potencies. In contrast to the observed differences in affinity and potency, the intrinsic activities indicate that all derivatives of <b>14</b> remain full agonists (α ≥ 1.0) (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). A combination of highest affinity (p<i>K</i><sub>i</sub> = 8.5), highest potency (pEC<sub>50</sub> = 9.5), and full agonism resides in <b>14d</b>. The potential aggregation of GPCR ligands might cause nonspecific effect on the receptor activity,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> but nephelometry revealed no microprecipitation of <b>14d</b> up to 100 mM concentration (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01462/suppl_file/jm9b01462_si_001.pdf" class="ext-link">Figure S1</a>) and underscores the high aqueous (aq) solubility of <b>14d</b> (soluble up to at least 100 mM in 50 mM Tris–HCl, pH 7.4). All this led to identification of <b>14d</b> as a key compound (VUF16839) in this study.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Computational Studies on <b>14d</b></h3><div class="NLM_p">A combination of molecular docking and molecular dynamics (MD) simulations was used to evaluate the potential binding mode of the key compound <b>14d</b> and to compare it to the binding mode of the endogenous ligand histamine. A homology model of H<sub>3</sub>R based on the available crystal structure of H<sub>1</sub>R was used (see the <a class="ref internalNav" href="#sec2_3" aria-label="Experimental section">Experimental section</a>). This model was validated by its ability to retrospectively discriminate between known H<sub>3</sub>R fragmentlike ligands and true inactives.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Histamine was docked in the receptor model using PLANTS 1.1 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). The best-scored docking pose showing interactions with both D114<sup>3.32</sup> and E206<sup>5.461</sup> (residues known to be involved in H<sub>3</sub>R ligand binding<a onclick="showRef(event, 'ref40 ref41 ref42 ref43 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42 ref43 ref44 ref45">(40−45)</a>) was selected. During 100 ns of molecular dynamics (MD) simulations, histamine is able to maintain stable interactions with residues D114<sup>3.32</sup> and E206<sup>5.461</sup> as well as with Y374<sup>6.51</sup> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B,E). Using similar procedures, compound <b>14d</b> was also docked into the same homology model using PLANTS 1.1 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A), and the best-scored docking results show similar interactions of <b>14d</b> with D114<sup>3.32</sup> and E206<sup>5.461</sup>. The basic amine of <b>14d</b> forms an ionic interaction with the negatively charged side chain of D114<sup>3.32</sup>, and the amino group in the pyrimidine ring makes a hydrogen bond with E206<sup>5.461</sup>. Different docking poses maintain these key interactions but show a different positioning of the linear <i>n</i>Pr moiety at the R<sup>2</sup> position: toward the extracellular surface of the receptor or toward the intracellular side (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01462/suppl_file/jm9b01462_si_001.pdf" class="ext-link">Figure S2A,B</a>, respectively). MD simulations of the two alternative models were performed (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01462/suppl_file/jm9b01462_si_005.mpg" class="ext-link">Movies 1 and 2</a>, Supporting Information). The model in which the <i>n</i>Pr group of <b>14d</b> is directed toward the intracellular half of the receptor was not stable along 100 ns of MD simulations (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01462/suppl_file/jm9b01462_si_001.pdf" class="ext-link">Figure S2D</a>, <a href="/doi/suppl/10.1021/acs.jmedchem.9b01462/suppl_file/jm9b01462_si_006.mpg" class="ext-link">Movie 2</a>, Supporting Information), while the model where the <i>n</i>Pr group of <b>14d</b> is pointing toward the extracellular vestibule remained stable throughout the entire simulation time (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01462/suppl_file/jm9b01462_si_001.pdf" class="ext-link">Figure S2C</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.9b01462/suppl_file/jm9b01462_si_005.mpg" class="ext-link">Movie 1</a>, Supporting Information). This binding mode is shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D, and the interactions that remained stable during the simulations are depicted in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C and the interaction fingerprints (IFPs) in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>E. It can be concluded that the non-imidazole H<sub>3</sub>R ligand <b>14d</b> exerts its unusual agonist H<sub>3</sub>R activity by showing a similar pharmacophore as the endogenous H<sub>3</sub>R ligand. That is, it may achieve its agonist activity by forming similar interactions with the same residues as histamine.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/medium/jm9b01462_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/large/jm9b01462_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Predicted binding mode of <b>14d</b>. (A) Overview of the H<sub>3</sub>R homology model based on the H<sub>1</sub>R crystal structure (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RZE">3RZE</a>).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The experimentally validated binding mode of histamine (magenta) is shown in more detail in (B), and the predicted binding mode of <b>14d</b> (green) is schematically represented in (C) and shown in more detail in (D). Interaction fingerprint representations of histamine and compound <b>14d</b> are shown in (E), where a one represents the presence of an interaction according to the color coding: blue for apolar, olive green for face-to-face aromatic, green for edge-to-face aromatic, red for protein hydrogen bond donor, purple for ligand hydrogen bond donor, gray for ligand-negative charge, and orange for protein-negative charge.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/large/jm9b01462_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01462&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Pharmacological and Pharmacokinetic Characterization of <b>14d</b></h3><div class="NLM_p">Functional characterization of key compound <b>14d</b> in a direct G protein activation assay, that is, the [<sup>35</sup>S]-GTPγS accumulation assay on hH<sub>3</sub>R expressing cell homogenates (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A), results in potent but partial agonism (pEC<sub>50</sub> = 8.4 ± 0.3, α = 0.5 ± 0.05) compared with histamine (pEC<sub>50</sub> = 7.2 ± 0.3, α = 1.0 ± 0.0).</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/medium/jm9b01462_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/large/jm9b01462_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Dose-dependent Gα<sub>i</sub> activation by <b>14d</b> and histamine as measured by [<sup>35</sup>S]GTPγS accumulation on HEK293T cell homogenates expressing the hH<sub>3</sub>R. (B, C) Dose–response curves of <b>14d</b> and histamine for ligand-induced activation of mH<sub>3</sub>R (B) and mH<sub>4</sub>R (C) expressed on HEK293T cells as measured by the CRE-luciferase reporter gene assay. Representative graphs of at least three experiments performed in triplicate are shown. Data are mean ± S.D.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/large/jm9b01462_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01462&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Due to the high homology of the hH<sub>3</sub>R with hH<sub><span class="strike">4</span></sub>R (43% full sequence identity, 58% predicted transmembrane region identity),<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> several, mainly imidazole-containing, hH<sub>3</sub>R ligands are known to possess high affinity to hH<sub>4</sub>R as well,<a onclick="showRef(event, 'ref33 ref44'); return false;" href="javascript:void(0);" class="ref ref33 ref44">(33,44)</a> although there are examples of imidazole-containing H<sub>3</sub>R agonists with high H<sub>3</sub>R/H<sub>4</sub>R selectivity as well (e.g., <b>4</b> and <b>5</b>).<a onclick="showRef(event, 'ref12 ref33'); return false;" href="javascript:void(0);" class="ref ref12 ref33">(12,33)</a> Therefore, <b>14d</b> was tested for its H<sub>3</sub>R/H<sub>4</sub>R selectivity. The pyrimidine shows only marginal selectivity with respect to binding hH<sub>3</sub>R or hH<sub>4</sub>R (hH<sub>3</sub>R p<i>K</i><sub>i</sub> = 8.5 ± 0.1 vs hH<sub>4</sub>R p<i>K</i><sub>i</sub> = 8.1 ± 0.0), but encouragingly a 10-fold selectivity in potency is observed in favor of the hH<sub>3</sub>R (hH<sub>3</sub>R pEC<sub>50</sub> = 9.5 ± 0.1 vs hH<sub>4</sub>R pEC<sub>50</sub> = 8.5 ± 0.2) with full agonism on hH<sub>4</sub>R (α = 1.1 ± 0.1) in a CRE-luc reporter gene assay. Moreover, <b>14d</b> does not activate the H<sub>1</sub>R and H<sub>2</sub>R up to 10 μM (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01462/suppl_file/jm9b01462_si_001.pdf" class="ext-link">Figure S3</a>).</div><div class="NLM_p">Equally encouragingly, the binding affinity of <b>14d</b> is increased for mH<sub>3</sub>R (p<i>K</i><sub>i</sub> = 9.0 ± 0.1) compared with hH<sub>3</sub>R, while for mH<sub>4</sub>R, the p<i>K</i><sub>i</sub> value is decreased to 7.8 ± 0.0, thus yielding a substantial H<sub>3</sub>R/H<sub>4</sub>R binding selectivity for mouse receptors. Compound <b>14d</b> was also functionally evaluated as an agonist on the mH<sub>3</sub>R and mH<sub>4</sub>R using the CRE-luciferase reporter gene assay. In these experiments, <b>14d</b> displays a 10-fold selectivity in potency (mH<sub>3</sub>R pEC<sub>50</sub> = 10.0 ± 0.1 vs mH<sub>4</sub>R pEC<sub>50</sub> = 9.0 ± 0.1), while it acts as a full agonist on both murine receptors (mH<sub>3</sub>R α = 1.2 ± 0.1 and mH<sub>4</sub>R α = 1.1 ± 0.1) (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B,C).</div><div class="NLM_p">The metabolic stability of <b>14d</b> was determined in vitro by incubation with rodent liver microsomes (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The pharmacokinetic properties for mouse [<i>t</i><sub>1/2</sub> = 130.8 min; Cl<sub>int</sub> = 20.7 mL/(min*kg)] indicate more than 2 times slower elimination compared with the reference control verapamil.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> For rats, this difference between <b>14d</b> and verapamil is even more pronounced.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Pharmacokinetic Properties of <b>14d</b> and the Reference Drug Verapamil</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">rat liver microsomes</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">mouse liver microsomes</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (min)</th><th class="colsep0 rowsep0" align="center" char=".">Cl<sub>int</sub> [mL/(min*kg)]</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (min)</th><th class="colsep0 rowsep0" align="center" char=".">Cl<sub>int</sub> [mL/(min*kg)]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14d</b></td><td class="colsep0 rowsep0" align="char" char=".">239.0</td><td class="colsep0 rowsep0" align="char" char=".">7.9</td><td class="colsep0 rowsep0" align="char" char=".">130.8</td><td class="colsep0 rowsep0" align="char" char=".">20.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">verapamil</td><td class="colsep0 rowsep0" align="char" char=".">50.9</td><td class="colsep0 rowsep0" align="char" char=".">37.3</td><td class="colsep0 rowsep0" align="char" char=".">57.3</td><td class="colsep0 rowsep0" align="char" char=".">47.3</td></tr></tbody></table></div></div><div class="NLM_p last">The imidazole ring is known to generally be able to interact with CYP enzymes via coordination of the imidazole with the prosthetic heme iron, which can cause unwanted drug–drug interaction.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Since the 2-aminopyrimidine core contains a pattern of adjacent nitrogen atoms, we measured its propensity for CYP inhibition. Compound <b>14d</b> shows only weak activity on three key CYP enzymes (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01462/suppl_file/jm9b01462_si_001.pdf" class="ext-link">Figure S4</a>) with IC<sub>50</sub> values for binding to CYP3A4, CYP2C9, and CYP2D6 all being larger than 25 μM.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Effect of <b>14d</b> on Social Recognition in Mice</h3><div class="NLM_p">Given the notion that CNS penetration of H<sub>3</sub>R agonists,<a onclick="showRef(event, 'ref1 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref5">(1,5)</a> including <b>14d</b>, is not evident, we evaluated the in vivo CNS effects of <b>14d</b> in a standard paradigm for H<sub>3</sub>R action. It is well known that histamine, acting in different brain sites, is an important regulator of memory consolidation and retrieval in various learning paradigms, including the social recognition test.<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50,51)</a> We used this behavioral paradigm to investigate the H<sub>3</sub>R-related CNS activity of compound <b>14d</b> in vivo. The social recognition memory investigates the ability to remember the identity of a conspecific, which is crucial to the building of social relationships and survival. Twenty-four hours after animals’ habituation to the apparatus, the subject mouse was placed in an open-field arena with an empty cage and another one containing a juvenile mouse. Mice tend to spend more time in the proximity of the cage containing the juvenile mouse than the empty one, offering an indication of sociability. One hour later, the experimental mouse was placed again in the same arena, but this time one cage contained the familiar mouse and the second one a novel juvenile mouse. The exploration times of the familiar and the novel mouse were recorded separately. Compound <b>14d</b> at a dose of 5 mg/kg or vehicle was given intraperitoneally (i.p.) 30 min before the training session (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). Compound <b>14d</b> did not affect animals’ sociability as revealed by the longer time that they spent exploring the cage containing the social stimulus compared with the empty cage (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01462/suppl_file/jm9b01462_si_001.pdf" class="ext-link">Figure S5</a>). In this respect, mice treated with compound <b>14d</b> behaved like controls. During the test session, control mice recognized the familiar juvenile, since they spent more time exploring the novel one. Conversely, mice treated with <b>14d</b> did not discriminate between the novel and the familiar mouse (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). This result clearly suggests a social memory impairment, further confirmed by the negative discrimination index (DI) calculated for the group of animals receiving injections of <b>14d</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C).</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/medium/jm9b01462_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/large/jm9b01462_0009.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>14d</b> impairs social recognition in mice. (A) Schematic drawings showing the sequence of procedures and treatment administrations. (B) Results are calculated as means of individual percentage of time spent exploring familiar (white columns) and novel (black columns) social stimuli. ***<i>P</i> < 0.001 vs the respective familiar subject [two-way analysis of variance (ANOVA) and Bonferroni’s MCT]. (C) Discrimination index calculated according to the formula tN – tF/tN + tF. **<i>P</i> < 0.01 vs vehicle (unpaired <i>t</i>-test). Shown are means ± S.E.M. of 10–11 animals per experimental group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/large/jm9b01462_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01462&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15358" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15358" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We present 2-aminopyrimidine derivatives with an alkylated 3-amino-azetidine moiety showing low nanomolar affinities for the H<sub>3</sub>R. Based on the non-imidazole partial agonist <b>11b</b> identified as an in-house hit, a 23-membered compound set was synthesized and tested on H<sub>3</sub>R. The reduction of the substituent size at position 6 of the pyrimidine ring (R<sup>1</sup>) improved both affinity (p<i>K</i><sub>i</sub>) and potency (pEC<sub>50</sub>) on hH<sub>3</sub>R. Each member of the extended R<sup>1</sup> = H series (<b>14</b>) shows full agonism in a CRE-luciferase reporter gene assay, with three derivatives (<b>14b</b>–<b>d</b>) improving upon the endogenous ligand histamine, combining full H<sub>3</sub>R agonism with high (sub)nanomolar potencies. Most notably, the key non-imidazole H<sub>3</sub>R agonist <b>14d</b> (VUF16839) combines high affinity to the H<sub>3</sub>R (p<i>K</i><sub>i</sub> = 8.5) with full agonism at the H<sub>3</sub>R and a subnanomolar potency (pEC<sub>50</sub> = 9.5) in a CRE-luciferase reporter gene assay. However, <b>14d</b> acts as a partial agonist in an [<sup>35</sup>S]GTPγS accumulation assay with a 13-fold lower potency as compared with the more downstream CRE-luciferase reporter gene assay, which is most likely the consequence of signal amplification as suggested by a 25-fold higher potency of the full agonist histamine in the CRE-luciferase reporter gene assay as compared with an [<sup>35</sup>S]GTPγS accumulation assay.</div><div class="NLM_p">From the recent development of numerous series of H<sub>4</sub>R antagonists, it is known that 2-aminopyrimidine is a privileged scaffold for H<sub>4</sub>R antagonism.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> As such, it is not surprising that <b>14d</b> also binds with relatively high affinity to the H<sub>4</sub>R (p<i>K</i><sub>i</sub> = 8.1). It acts as an agonist at H<sub>4</sub>R, but it is 10-fold less potent than at H<sub>3</sub>R, while <b>14d</b> is not active at H<sub>1</sub>R and H<sub>2</sub>R.</div><div class="NLM_p">The subnanomolar potency of the non-imidazole compound <b>14d</b> as an agonist at H<sub>3</sub>R is remarkable, as so far only a few low-potency and/or complex non-imidazole ligands have been reported as agonists at H<sub>3</sub>R.<a onclick="showRef(event, 'ref27 ref28 ref29 ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30 ref31 ref32">(27−32)</a> Indeed, replacements of the imidazole ring while maintaining agonism have so far yielded little success. To illustrate, several imbutamine (<b>2</b>) analogues in which the imidazole moiety was replaced with an aminopyrimidine, aminopyridine or aminotriazole ring studied were not effective as H<sub>3</sub>R agonists.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Comparing the activities of the aminopyrimidine analog of <b>2</b> with <b>14d</b>, the effective activation of H<sub>3</sub>R by <b>14d</b> suggests a very important role of its azetidine side chain. Molecular docking combined with MD studies affords a predicted binding mode (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) in which <b>14d</b> interacts with the same key amino acids (D114<sup>3.32</sup>, E206<sup>5.461</sup>, Y374<sup>6.51</sup>) as histamine (<b>1</b>) (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>E), suggesting that the 2-aminopyrimidine moiety mimics the imidazole ring. The computational studies also suggest that the azetidine side chain makes an ionic interaction with the same amino acid (D114<sup>3.32</sup>) as the amine group in the ethylamine side chain of histamine. Clearly, both <b>14d</b> and histamine are able to interact with the same key amino acids of H<sub>3</sub>R, despite the fact that the binding modes of <b>14d</b> and histamine do not substantially overlap.</div><div class="NLM_p">The alkyl substitution of the basic amino moiety of <b>2</b> was studied previously in our group,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and subtle differences in alkyl substituents on the basic amine strongly influence the functional activity of such imbutamine analogs. Based on this SAR, we hypothesize that the basic amine of the 2-aminopyrimidine compound series <b>11</b>–<b>14</b> might be a functional “hot spot” as well. In the case of the R<sup>1</sup> = <i>i</i>Pr series (<b>11</b>), this appears to partially pan out as the chain elongation and dialkylation show moderate drops in intrinsic activity (α) (compare <b>11b</b> vs <b>11c</b> and <b>11i</b> in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). However, such a trend was not observed within the other series <b>12</b>–<b>14</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D).</div><div class="NLM_p">The analysis of additional properties for key compound <b>14d</b> underscores its suitability for in vivo characterization in mice. That is, mouse potency data (mH<sub>3</sub>R: pEC<sub>50</sub> = 10.0, mH<sub>4</sub>R: pEC<sub>50</sub> = 9.0) and in vitro elimination parameters in mouse [<i>t</i><sub>1/2</sub> = 130.8 min; Cl<sub>int</sub> = 20.7 mL/(min*kg)] all bode well. The inhibition of CYP enzymes is a general issue of imidazole-containing ligands.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Although the diaminopyrimidine core might conceivably also be prone to CYP inhibition, <b>14d</b> only weakly (IC<sub>50</sub> > 25 μM) interacts with selected key CYP enzymes (CYP3A4, CYP2D6, CYP2C9).</div><div class="NLM_p">Poor brain penetration is a known problem of some imidazole-containing ligands,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> limiting their potential administration routes in CNS-related experiments. As indicated by the effects in the in vivo social memory test, the 2-aminopyrimidine <b>14d</b> (5 mg/kg i.p.) is clearly penetrating the CNS. Histamine is a known modulator of different types of memory.<a onclick="showRef(event, 'ref3 ref52'); return false;" href="javascript:void(0);" class="ref ref3 ref52">(3,52)</a> H<sub>3</sub>R antagonists, such as thioperamide, improve short-term memory, while H<sub>3</sub>R agonists such as immepip (<b>4</b>) cause amnesia in the social recognition test.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> The results shown here confirm and expand these observations, since a memory impairment was observed also for systemic treatment with compound <b>14d</b> in the same paradigm (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). It should be noted that H<sub>3</sub>R activation affects the circadian rhythm by increasing slow wave sleep and dose-dependently attenuates ciproxifan-induced waking effects.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Also, H<sub>3</sub>R agonists reduce stress-induced behavior in preclinical models.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> These observations suggest that H<sub>3</sub>R activation may affect exploratory activity, which could negatively impact arousal and cognition. We did not specifically measure <b>14d</b>-induced alterations of the sleep–wake cycle; however, <b>14d</b>-associated social memory impairment does not seem to be related to sedative effects, as there were no statistically significant differences between the control group and <b>14d</b>-treated mice in exploration time of the cage in the presence or absence of the social stimulus (during training: vehicle = 144.0 ± 60.0 s; <b>14d</b> = 136.2 ± 44.1 s; during test: vehicle = 150.5 ± 42.4 s; <b>14d</b> = 148.3 ± 69.4 s). Moreover, based on the mH<sub>3</sub>R/mH<sub>4</sub>R selectivity profile of <b>14d</b> (vide supra), available literature on H<sub>4</sub>R expression, H<sub>4</sub>R agonist actions in the CNS, and the behavioral profile of H<sub>4</sub>R-deficient mice excluding a relevant role of this receptor on the histaminergic modulation of memory processing, it is highly unlikely that the in vivo amnesic effects of <b>14d</b> are confounded by its H<sub>4</sub>R activity.<a onclick="showRef(event, 'ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref55 ref56">(55,56)</a> Indeed, the amnesic effects of <b>14d</b> are consistent with the memory impairments observed following treatment with different H<sub>3</sub>R agonists [imetit (<b>3</b>) and (<i>R</i>)-α-methylhistamine] in the object recognition and passive avoidance tests in rats.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a></div><div class="NLM_p last">To conclude, in this study, 2-aminopyrimidine derivatives with an alkylated 3-amino-azetidine side chain are presented as highly potent, non-imidazole agonists for the H<sub>3</sub>R. The key <i>n</i>-propyl derivative (<b>14d</b>, VUF16839) shows attractive in vitro pharmacological properties on human H<sub>3</sub>R (p<i>K</i><sub>i</sub> = 8.5, pEC<sub>50</sub> = 9.5, α ≥ 1.0 in a CRE-luciferase reporter gene assay with a 10-fold lower potency at H<sub>4</sub>R) and mouse H<sub>3</sub>R (p<i>K</i><sub>i</sub> = 9.0, pEC<sub>50</sub> = 10.0, with a >10-fold lower potency at mH<sub>4</sub>R). It exerts reasonable metabolic stability in rodent liver microsomes and weak activity on CYP enzymes. Moreover, <b>14d</b> causes amnesic effects in social recognition tests in mice at 5 mg/kg, which is in line with the reported memory loss after administration of other H<sub>3</sub>R agonists.<a onclick="showRef(event, 'ref51 ref57'); return false;" href="javascript:void(0);" class="ref ref51 ref57">(51,57)</a> The observed in vivo H<sub>3</sub>R effects also indicate appreciable brain penetration of <b>14d</b>. Compound <b>14d</b> can serve as a useful tool compound for fundamental studies concerning H<sub>3</sub>R, given its excellent affinity and potency, H<sub>3</sub>R agonism, and effective brain penetration.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73403" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73403" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Pharmacology and ADME</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Materials</h4><div class="NLM_p last">[<sup>3</sup>H]NAMH (specific activity: 79.7 Ci/mmol) and [<sup>3</sup>H]histamine (specific activity: 17.5 Ci/mmol) were purchased from PerkinElmer (Groningen, the Netherlands). Human embryonic kidney 293T cells (HEK293T cells) were obtained from ATCC. Ketoconazole, quinidine, sulfaphenazole, and verapamil were obtained from Sigma-Aldrich (St. Louis, MO).</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Cell Culture and Transfection</h4><div class="NLM_p last">HEK293T cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum and 1% penicillin and 1% streptomycin. Two million cells per 10 cm<sup>2</sup> dishes were plated 24 h prior to transfection. Cells were transfected using the polyethylenimine (PEI) method.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> For radioligand displacement assays, HEK293T cells were transfected with 2500 ng of complementary DNA (cDNA) encoding the hH<sub>3</sub>R (genbank: <a href="https://www.ncbi.nlm.nih.gov/gquery?Term=AF140538">AF140538</a>), mH<sub>3</sub>R (genbank: <a href="https://www.ncbi.nlm.nih.gov/gquery?Term=NM_133849.3">NM_133849.3</a>), hH<sub>4</sub>R (genbank: <a href="https://www.ncbi.nlm.nih.gov/gquery?Term=AY136745">AY136745</a>), or mH<sub>4</sub>R (genbank: <a href="https://www.ncbi.nlm.nih.gov/gquery?Term=NM_153087.2">NM_153087.2</a>) and 2500 ng of empty plasmid pcDEF3. The DNA/PEI mixture (ratio 1:4) was incubated for 20 min at 22 °C before addition to the cells.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Preparation of Cell Homogenates</h4><div class="NLM_p last">Cell homogenates expressing the hH<sub>3</sub>R were harvested 48 h after transfection as reported previously.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Radioligand Displacement Assays</h4><div class="NLM_p last">[<sup>3</sup>H]NAMH and [<sup>3</sup>H]histamine displacement assays were performed in a binding buffer (50 mM Tris–HCl pH 7.4, 25 °C) by coincubation of 2 nM [<sup>3</sup>H]NAMH or 10 nM [<sup>3</sup>H]histamine, increasing concentrations of unlabeled ligand and cell homogenates expressing the hH<sub>3</sub>R/mH<sub>3</sub>R or hH<sub>4</sub>R, respectively. For mH<sub>4</sub>R displacement, similar studies were performed but with 30 nM [<sup>3</sup>H]histamine. The assay mixture was incubated for 2 h at 25 °C before rapid filtration over a 0.5% PEI-coated GF/C filter with a PerkinElmer filtermate harvester. The filter plate was dried, and 300 min after 25 μL of Microsint O was added, filter-bound radioactivity was measured with a Microbeta scintillation counter (PerkinElmer).</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> [<sup>35</sup>S]GTPγS Accumulation Assay</h4><div class="NLM_p last">[<sup>35</sup>S]GTPγS accumulation experiments on hH<sub>3</sub>R were performed as described previously.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Reporter Gene Assay</h4><div class="NLM_p last">HEK293T cells were transfected in suspension with cDNA encoding hH<sub>3</sub>R, mH<sub>3</sub>R, hH<sub>4</sub>R, mH<sub>4</sub>R, H<sub>1</sub>R (1000 ng) or H<sub>2</sub>R (2500 ng), CRE-luciferase (2500 ng) or NFAT-luciferase (2000 ng) for H<sub>1</sub>R, and empty pcDEF3 plasmid, and 50.000 cells per well were plated on a poly-<span class="smallcaps smallerCapital">l</span>-lysine-coated white 96-well plate and grown for an additional 24 h. Cells were stimulated with increasing ligand concentrations for H<sub>3</sub>R and H<sub>4</sub>R in the presence of 1 μM forskolin at 37 °C and 5% CO<sub>2</sub>. After 6 h, the medium was aspirated and 25 μL of luciferase assay reagent [0.83 mM adenosine 5′-triphosphate, 0.83 mM <span class="smallcaps smallerCapital">d</span>-luciferin, 18.7 mM MgCl<sub>2</sub>, 0.78 μM Na<sub>2</sub>PO<sub>4</sub>, 38.9 mM Tris–HCl (pH 7.8), 0.39% glycerol, 0.03% Triton-X-100, and 2.6 μM dithiothreitol] was added to each well. After 30 min of incubation at 37 °C, luminescence was measured with a Mithras plate reader (Berthold, Germany).</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Data Analysis</h4><div class="NLM_p last">Data were analyzed using GraphPad prism 7.02 (GraphPad Software Inc., San Diego). Shown data are mean ± S.E.M. of three individual experiments performed in triplicate unless stated otherwise. Competition binding curves were fitted to a one-site binding model. Obtained IC<sub>50</sub> values were converted into p<i>K</i><sub>i</sub> values using the Cheng–Prusoff equation.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Dose–response curves were fitted using nonlinear regression.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Metabolic Stability</h4><div class="NLM_p">The pharmacokinetic parameters of <b>14d</b> and the reference drug verapamil were estimated by using rat liver microsomes (RLMs) or mouse liver microsomes (MLMs) obtained from Sigma-Aldrich (St. Louis, MO). The tested compounds (50 μM) were incubated in the presence of microsomes (1 mg/mL) for 5, 15, 30, and 45 min in 10 mM Tris–HCl buffer (pH = 7.4) at 37 °C. Cold methanol with an internal standard (IS) was added to terminate each reaction. Next, the reaction mixtures were centrifuged at 14 500 rpm. The disappearance of the tested compounds in time was calculated by the UPLC/MS Waters ACQUITY TQD system with a TQ Detector (Waters, Milford). The course of the reaction was followed by using the analyte/IS peak height ratio values. For the determination of the <i>t</i><sub>1/2</sub> value, the slope of linear regression from log concentration remaining versus time relationships (−<i>k</i>) was used according to Obach<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> (<a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a>)<span class="NLM_disp-formula" id="eq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/medium/jm9b01462_m001.gif" alt="" id="_i24" /></img><span class="labelSpan">(1)</span></span></div><div class="NLM_p last">Conversion of <i>t</i><sub>1/2</sub> to intrinsic clearance Cl<sub>int</sub> [in units of mL/(min*kg)] was done by using <a class="ref internalNav" href="#eq2" aria-label="eq 2">eq 2</a><span class="NLM_disp-formula" id="eq2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/medium/jm9b01462_m002.gif" alt="" id="_i25" /></img><span class="labelSpan">(2)</span></span>where 45 mg of microsomal protein per gram of liver tissue (g liver) and 87 g of liver per kilogram of body weight (kg b.w.) were applied to calculate Cl<sub>int</sub> in mice, whereas 61 mg of microsomal protein per g liver and 45 g of liver per kg b.w. were applied to calculate Cl<sub>int</sub> in rats, according to Huang et al.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> and Smith et al.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Effect on CYP</h4><div class="NLM_p last">Luminescent CYP3A4, CYP2D6, and CYP2C9 P450-Glo assays and protocols were obtained from Promega (Madison, WI). Compound <b>14d</b> was tested in triplicate at the final concentrations in range from 0.01 to 25 μM. The luminescent signal was measured by using a microplate reader EnSpire PerkinElmer (Waltham, MA).</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Social Recognition Test</h4><div class="NLM_p last">Male C57Bl6 mice (8–9 weeks old) behavior was assessed in a test apparatus comprising an open-field plexiglass arena (45 × 25 cm<sup>2</sup> and 20 cm high) placed in a sound-attenuated room. The assay paradigm comprises three sessions. In the first session, mice were placed in the arena containing two empty pencil-wire cups placed on opposing sides and left free to explore for 10 min. Twenty-four hours after this session, a juvenile mouse (stimulus, 4–5 weeks old), which had no prior contact with the subject mice, was placed under one of the wire cups while the other cup remained empty. The subject mouse was then placed in the arena and was left free to explore for 10 min. During the third session, performed 1 h later, the same stimulus animal was again placed under the wire cup and a novel unfamiliar juvenile mouse was placed under the opposing cup. Subject mice were then placed again in the arena and tested for discrimination between novel and familiar mice in a 10 min session. Each mouse was subjected to the procedure separately, and care was taken to remove any olfactory/taste cues by cleaning carefully the arena and wire cups between trials. The positions of the social stimuli (empty × social; familiar × novel) were counterbalanced across subjects and trials to prevent bias from place preference. Stimulus mice were habituated to remain under the wire cups several days before behavioral testing. Vehicle or <b>14d</b> (5 mg/kg) was injected systemically (i.p.) 30 min before the second session. The animal’s behavior during all sessions was videotaped, and the time spent actively exploring the stimuli was analyzed by experienced observers unaware of the experimental groups. Exploration was defined as direct snout-to-cup contact, and the time spent climbing on the cups was not considered. Data are expressed as a percentage of time spent exploring each cup (social × nonsocial during the second session or familiar × novel during the third session), and statistical significance was determined by the two-way ANOVA followed by Bonferroni’s test. We also determined a sociability index, calculated according to the formula [time exploring social cup (tS) – time exploring nonsocial cup (tNS)]/[total exploration time (tS + tNS)], and a discrimination index (DI), which was calculated according to the formula [time exploring the novel mouse (tN) – time exploring the familiar mouse (tS)]/[total exploration time (tN + tF)], both analyzed using unpaired <i>t</i>-tests.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Computational Studies</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Residue Numbering</h4><div class="NLM_p last">Residue numbering is displayed throughout the manuscript as absolute sequence numbers and with generic numbering from GPCRdb<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> also in superscript, in which the first number denotes the helix, 1–8, and the second number denotes the residue position relative to the most-conserved residue, defined as number 50, in a gapped sequence alignment.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Homology Modeling</h4><div class="NLM_p last">A three-dimensional model of the H<sub>3</sub>R was constructed on Modeller v.9.15<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> based on the crystal structure of H<sub>1</sub>R (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RZE">3RZE</a>).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The sequence of H<sub>3</sub>R was obtained from UniProt<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> and aligned to the crystal structure sequence based on the structure-based alignment of GPCRdb. An optimal structure was selected based on its ability to retrospectively discriminate between known H<sub>3</sub>R fragmentlike ligands and true inactives as described elsewhere.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Docking</h4><div class="NLM_p last">A conformational library of all of the compounds was obtained with Corina v3.49<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> and protonated in ChemAxon Calculator.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> The most energetically favorable conformations were docked using PLANTS v1.1.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Hundred docking poses were generated per conformation and postprocessed with interaction fingerprints (IFPs) inferred from OpenEye’s OChem 1.3 library.<a onclick="showRef(event, 'ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref70 ref71">(70,71)</a> IFPs are bit vectors that are switched off (0) or on (1) depending on the occurrence of predefined intermolecular interactions [apolar, face-to-face, and face-to-edge aromatic interactions, hydrogen bonds (acceptor or donor), and ionic interactions (cationic or anionic)].</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Molecular Dynamics Simulations and Analysis</h4><div class="NLM_p last">Ligands were parametrized using the AM1-BCC charges in Antechamber.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> The selected models were energy minimized to optimize protein–ligand interactions and used to run membrane-embedded MD simulations in GROMACS.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Each system was simulated for 100 ns after an equilibration of 5 ns, with the parameters and conditions described elsewhere.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Potential energy, root-mean-square deviation, root-mean-square fluctuation, and dihedrals of the simulations were analyzed with GROMACS tools, and residue interactions were analyzed with IFPs.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Nephelometry</h3><div class="NLM_p last">In transparent flat-bottom 96-well plates, <b>14d</b> was placed at different concentrations in triplicate (10<sup>–1</sup>, 10<sup>–1.5</sup>, 10<sup>–2</sup>, 10<sup>–2.5</sup>, 10<sup>–3</sup>, 10<sup>–3.5</sup>, 10<sup>–4</sup>, and 10<sup>–4.5</sup> M) in Tris–HCl binding buffer (50 mM Tris–HCl, pH 7.4) at least 1 h before the measurement. A Kaolin dispersion was used as a positive control<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> in each plate at different concentrations (10<sup>–2.5</sup>, 10<sup>–3</sup>, 10<sup>–3.5</sup>, 10<sup>–4</sup>, 10<sup>–4.5</sup>, 10<sup>–5</sup>, and 10<sup>–5.5</sup> M) under the same conditions as with compound <b>14d</b>. Nephelometry measurements were performed with a NEPHELO star Plus (BMG Labtech, Germany) with the following settings: one cycle, measurement start time 0.1 s, measurement interval time 0.1 s, laser intensity 80%, beam focus 2.0 mm, orbital shaking mode at 200 rpm with an additional shaking time of 10 s before each cycle. Results were analyzed using Matlab R2014A (8.3.0.532) software, plotting all available data points and plotting mean and standard deviation values in a line chart compared to the Kaolin control. The linear fit (<i>R</i><sup>2</sup>) of the Kaolin control was above 0.985 in all cases.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Chemistry</h3><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> General Information</h4><div class="NLM_p">Chemicals and solvents were obtained from commercial suppliers and were used without further purification. THF was dried by passing through the PureSolv solvent purification system by Inert. All reactions were carried out under an inert N<sub>2</sub> atmosphere. Hydrogenation experiments were performed with routine batch technology or the H-cube Mini Plus flow reactor. Microwave reactions were performed with the Biotage Initiator microwave system. Thin-layer chromatography analyses were performed with Merck F254 alumina silica plates using UV visualization or staining. Column purifications were carried out automatically using Biotage Isolera or Teledyne Isco CombiFlash equipment using Silicycle Ultra Pure silica gel. Melting point (mp) for final compounds was determined using a Büchi M-565 melting point apparatus at a rate of 1 °C/min. NMR spectra were recorded on a Bruker 250, 300, 500, or 600 MHz spectrometer. Chemical shifts are reported in ppm (δ), and the residual solvent was used as the internal standard (δ <sup>1</sup>H NMR: CDCl<sub>3</sub> 7.26; CD<sub>3</sub>OD 4.87; D<sub>2</sub>O 4.79; <sup>13</sup>C NMR: CDCl<sub>3</sub> 77.16; CD<sub>3</sub>OD 49.00). Data are reported as follows: chemical shift, multiplicity (s, singlet; d, doublet; t, triplet; q, quartet; p, pentet; sext, sextet; hept, heptet; br, broad signal; m, multiplet; app, apparent), coupling constant(s) (Hz), and integration. High-resolution mass spectra (HRMS) were recorded on a Bruker microTOF mass spectrometer using electrospray ionization in the positive ion mode. Analytical high-performance liquid chromatography (HPLC)-mass spectrometry (MS) analyses were conducted using a Shimadzu LC-20AD liquid chromatograph pump system connected to a Shimadzu SPDM20A diode array detector with MS detection using a Shimadzu HPLC-MS 2010EV mass spectrometer. The column used is an Xbridge C18 5 mm column (50 mm × 4.6 mm). Acidic mode: solvent B (MeCN/0.1% formic acid) and solvent A (water/0.1% formic acid), flow rate of 1.0 mL/min with a run time of 8 min. For compounds whose retention time (<i>t</i><sub>R</sub>) was less than 1.5 min with the acidic solvent system, a basic solvent system was used. Basic mode: solvent B (MeCN/10% buffer), solvent A (water/10% buffer). The buffer is a 0.4% (w/v) NH<sub>4</sub>HCO<sub>3</sub> solution in water, adjusted to pH 8.0 with NH<sub>4</sub>OH. The analysis was conducted using a flow rate of 1.0 mL/min with a total run time of 8 min. Gradient settings (basic and acidic system): start 5% B, linear gradient to 90% B in 4.5 min, then isocratic for 1.5 min at 90% B, then linear gradient to 5% B in 0.5 min, then isocratic for 1.5 min at 5% B. All compounds (except <b>14c</b> and <b>14f</b>) have a purity of ≥95% calculated as the percentage peak area of the target compound by UV detection at 254 nm using the analytical HPLC-MS method listed above. Yields reported are not optimized. The compounds described in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> were checked for the presence of pan assay interference compounds (PAINS) substructures as described by Baell and Holloway,<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> and no PAINS substructures were identified.</div><div id="sec4_4_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> 4-(3-Aminoazetidin-1-yl)-6-isopropylpyrimidin-2-amine (<b>11a</b>)</h5><div class="NLM_p last">To a solution of carbamate <b>21a</b> (351 mg, 1.14 mmol) in MeOH (20 mL) was added aq HCl (37%, 0.35 mL, 4.23 mmol). The reaction mixture was stirred at rt overnight. The solvents were removed under reduced pressure. The residue was dissolved in DCM/MeOH (10:1, 10 mL). The pH was adjusted to above 10 with NH<sub>3</sub> solution (7 N) in MeOH. The suspension was filtered. The solvents were removed under reduced pressure. The crude product was dissolved in hot EtOH (5 mL), and after addition of EtOAc (5 mL), a precipitate formed. The formed solid was collected by filtration, washed, and dried in vacuo. Purification by flash chromatography (DCM/MeOH/TEA 100:0:0–90:9:1) gave the title compound as a white solid (53 mg, 22%). mp: 157.0–157.6 °C. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 5.58 (s, 1H), 4.25 (t, <i>J</i> = 8.1 Hz, 2H), 3.95–3.85 (m, 1H), 3.72 (dd, <i>J</i> = 9.0, 5.2 Hz, 2H), 2.64 (hept, <i>J</i> = 7.0 Hz, 1H), 1.21 (d, <i>J</i> = 6.9 Hz, 6H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD) δ 175.4, 165.7, 164.0, 89.8, 59.9, 44.1, 36.6, 22.0. HPLC-MS (basic mode): <i>t</i><sub>R</sub> = 2.6 min, purity: >99%, [M + H]<sup>+</sup>: 208. HR-MS [M + H]<sup>+</sup> calcd for C<sub>10</sub>H<sub>18</sub>N<sub>5</sub><sup>+</sup>: 208.1557, found 208.1564.</div></div><div id="sec4_4_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> 4-Isopropyl-6-(3-(methylamino)azetidin-1-yl)pyrimidin-2-amine (<b>11b</b>)</h5><div class="NLM_p last">To a solution of carbamate <b>21b</b> (96 mg, 0.30 mmol) in DCM (5 mL) was added HCl in dioxane (4 N, 1.0 mL, 4.0 mmol). The reaction mixture was stirred for 3 h at rt. The reaction mixture was diluted with satd. aq Na<sub>2</sub>CO<sub>3</sub> (10 mL) and extracted with DCM (3 × 5 mL). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash chromatography (DCM/MeOH/TEA 100:0:0–90:9:1) gave the title compound as a white solid (45 mg, 68%). mp: 81.8–82.4 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 5.47 (s, 1H), 5.05 (br, 2H), 4.23–4.15 (m, 2H), 3.76–3.63 (m, 3H), 2.65 (hept, <i>J</i> = 6.9 Hz, 1H), 2.42 (s, 3H), 1.19 (d, <i>J</i> = 6.9 Hz, 6H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 173.8, 164.4, 162.0, 89.1, 56.7, 50.5, 35.4, 33.3, 21.6. HPLC-MS (basic mode): <i>t</i><sub>R</sub> = 3.1 min, purity: 97.3%, [M + H]<sup>+</sup>: 222. HR-MS [M + H]<sup>+</sup> calcd for C<sub>11</sub>H<sub>20</sub>N<sub>5</sub><sup>+</sup>: 222.1713, found 222.1718.</div></div><div id="sec4_4_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> 4-(3-(Ethylamino)azetidin-1-yl)-6-isopropylpyrimidin-2-amine (<b>11c</b>)</h5><div class="NLM_p last">To a solution of carbamate <b>21c</b> (79 mg, 0.24 mmol) in MeOH (4 mL) was added aq HCl (37%, 0.19 mL, 2.29 mmol). The reaction mixture was stirred at rt overnight. The solvents were removed under reduced pressure. The residue was dissolved in DCM/MeOH (4:1, 8 mL). The pH was adjusted to above 10 with NH<sub>3</sub> solution (7 N) in MeOH. The inorganic salts were filtered off and washed with DCM/MeOH (4:1, 12 mL). The filtrate was concentrated under reduced pressure. The crude product was dissolved in hot EtOH (1 mL), and after addition of EtOAc (5 mL), a precipitate formed. The formed solid was collected by filtration, washed, and dried in vacuo. The title compound was obtained as a white solid (25 mg, 45%). mp: 226.2–227.3 °C. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 5.97 (s, 1H), 4.63 (br, 1H), 4.57 (br, 1H), 4.46 (br, 1H), 4.37 (br, 1H), 4.35–4.27 (m, 1H), 3.13 (q, <i>J</i> = 7.2 Hz, 2H), 2.87 (hept, <i>J</i> = 6.8 Hz, 1H), 1.38 (t, <i>J</i> = 7.2 Hz, 3H), 1.32 (d, <i>J</i> = 6.9 Hz, 6H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD) δ 164.2, 163.6, 157.0, 91.5, 54.8, 54.4, 48.2, 42.4, 33.3, 20.9, 11.7. HPLC-MS (basic mode): <i>t</i><sub>R</sub> = 3.2 min, purity: >99%, [M + H]<sup>+</sup>: 236. HR-MS [M + H]<sup>+</sup> calcd for C<sub>12</sub>H<sub>22</sub>N<sub>5</sub><sup>+</sup>: 236.1870, found 236.1868.</div></div><div id="sec4_4_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> 4-(3-(Dimethylamino)azetidin-1-yl)-6-isopropylpyrimidin-2-amine (<b>11i</b>)</h5><div class="NLM_p last">A microwave vial charged with amine <b>17</b> (248 mg, 1.44 mmol), <i>N</i>,<i>N</i>-dimethylazetidin-3-amine dihydrochloride (250 mg, 1.44 mmol), DIPEA (0.76 mL, 4.33 mmol), and dioxane (10 mL) was heated for 30 min at 150 °C under microwave irradiation. The reaction mixture was diluted with water (20 mL) and extracted with DCM (3 × 20 mL). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash chromatography (DCM/MeOH/TEA 100:0:0–90:9:1) gave the title compound as a white solid (220 mg, 65%). mp: 123.6–123.8 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 5.49 (s, 1H), 4.87 (br, 2H), 4.04 (t, <i>J</i> = 7.8 Hz, 2H), 3.94–3.81 (m, 2H), 3.21 (p, <i>J</i> = 5.6 Hz, 1H), 2.65 (hept, <i>J</i> = 6.8 Hz, 1H), 2.20 (s, 6H), 1.20 (d, <i>J</i> = 6.8 Hz, 6H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 174.0, 164.6, 162.1, 89.1, 56.2, 53.9, 41.8, 35.5, 21.7. HPLC-MS (basic mode): <i>t</i><sub>R</sub> = 3.4 min, purity: 97.8%, [M + H]<sup>+</sup>: 236. HR-MS [M + H]<sup>+</sup> calcd for C<sub>12</sub>H<sub>22</sub>N<sub>5</sub><sup>+</sup>: 236.1870, found 236.1878.</div></div><div id="sec4_4_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> 4-(3-Aminoazetidin-1-yl)-6-ethylpyrimidin-2-amine (<b>12a</b>)</h5><div class="NLM_p last">To a solution of carbamate <b>22a</b> (250 mg, 0.85 mmol) in MeOH (20 mL) was added aq HCl (37%, 0.21 mL, 2.54 mmol). The reaction mixture was stirred at rt overnight. The solvents were removed under reduced pressure. The residue was dissolved in DCM/MeOH (10:1, 40 mL). The pH was adjusted to above 10 with NH<sub>3</sub> solution (7 N) in MeOH. The suspension was filtered. The solvents were removed under reduced pressure. The crude product was dissolved in hot EtOH (5 mL), and after addition of EtOAc (15 mL), a precipitate formed. The formed solid was collected by filtration, washed, and dried in vacuo. Dissolving in H<sub>2</sub>O (5 mL) and freeze-drying gave the title compound as a white fluffy solid (95 mg, 58%). mp: 224.7–225.9 °C. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 5.83 (s, 1H), 4.51–4.37 (m, 2H), 4.16–4.02 (m, 3H), 2.50 (q, <i>J</i> = 7.6 Hz, 2H), 1.18 (t, <i>J</i> = 7.6 Hz, 3H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD) δ 164.1, 160.2, 157.4, 92.7, 56.5, 42.6, 27.1, 12.2. HPLC-MS (basic mode): <i>t</i><sub>R</sub> = 2.3 min, purity: >99%, [M + H]<sup>+</sup>: 194. HR-MS [M + H]<sup>+</sup> calcd for C<sub>9</sub>H<sub>16</sub>N<sub>5</sub><sup>+</sup>: 194.1400, found 194.1410.</div></div><div id="sec4_4_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> 4-Ethyl-6-(3-(methylamino)azetidin-1-yl)pyrimidin-2-amine (<b>12b</b>)</h5><div class="NLM_p last">To a solution of carbamate <b>22b</b> (450 mg, 1.46 mmol) in MeOH (20 mL) was added aq HCl (37%, 0.36 mL, 4.35 mmol). The reaction mixture was stirred at rt overnight. The solvents were removed under reduced pressure. The residue was dissolved in DCM/MeOH (10:1, 20 mL). The pH was adjusted to above 10 with NH<sub>3</sub> solution (7 N) in MeOH. The suspension was filtered. The solvents were removed under reduced pressure. The crude product was dissolved in hot EtOH (5 mL), and after addition of EtOAc (15 mL), a precipitate formed. The formed solid was collected by filtration, washed, and dried in vacuo. Dissolving in H<sub>2</sub>O (5 mL) and freeze-drying gave the title compound as a white fluffy solid (150 mg, 50%). mp: 202.8–203.3 °C. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 5.89 (s, 1H), 4.51–4.39 (m, 2H), 4.11 (dd, <i>J</i> = 10.1, 3.5 Hz, 2H), 3.96 (br, 1H), 2.58 (q, <i>J</i> = 7.9 Hz, 2H), 2.55 (s, 3H), 1.27 (t, <i>J</i> = 7.6 Hz, 3H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD) δ 164.1, 160.4, 157.6, 92.6, 55.9, 50.4, 32.3, 27.2, 12.2. HPLC-MS (basic mode): <i>t</i><sub>R</sub> = 2.6 min, purity: >99%, [M + H]<sup>+</sup>: 208. HR-MS [M + H]<sup>+</sup> calcd for C<sub>10</sub>H<sub>18</sub>N<sub>5</sub><sup>+</sup>: 208.1557, found 208.1566.</div></div><div id="sec4_4_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> 4-Ethyl-6-(3-(ethylamino)azetidin-1-yl)pyrimidin-2-amine (<b>12c</b>)</h5><div class="NLM_p last">To a solution of carbamate <b>22c</b> (117 mg, 0.36 mmol) in MeOH (4 mL) was added aq HCl (37%, 0.30 mL, 3.62 mmol). The reaction mixture was stirred at rt overnight. The solvents were removed under reduced pressure. The residue was dissolved in DCM/MeOH (9:1, 3 mL). The pH was adjusted to above 10 with NH<sub>3</sub> solution (7 N) in MeOH. The inorganic salts were filtered off and washed with DCM/MeOH (9:1, 8 mL). The filtrate was concentrated under reduced pressure. The crude product was dissolved in hot EtOH (1.5 mL), and after addition of EtOAc (7 mL), a precipitate formed. The formed solid was collected by filtration, washed, and dried in vacuo. The title compound was obtained as a white solid (8 mg, 10%). mp: 236.6–236.9 °C. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 5.99 (s, 1H), 4.60 (br, 2H), 4.48–4.26 (m, 3H), 3.13 (q, <i>J</i> = 7.3 Hz, 2H), 2.64 (q, <i>J</i> = 7.6 Hz, 2H), 1.38 (t, <i>J</i> = 7.2 Hz, 3H), 1.31 (t, <i>J</i> = 7.6 Hz, 3H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD) δ 164.2, 159.8, 157.0, 92.8, 54.8, 54.4, 48.2, 42.4, 26.8, 12.0, 11.7. HPLC-MS (basic mode): <i>t</i><sub>R</sub> = 2.9 min, purity: >99%, [M + H]<sup>+</sup>: 222. HR-MS [M + H]<sup>+</sup> calcd for C<sub>11</sub>H<sub>20</sub>N<sub>5</sub><sup>+</sup>: 222.1713, found 222.1703.</div></div><div id="sec4_4_1_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> 4-(3-(Dimethylamino)azetidin-1-yl-6-ethyl)pyrimidin-2-amine (<b>12i</b>)</h5><div class="NLM_p last">To a solution of amine <b>12b</b> (110 mg, 0.53 mmol) in MeOH (5 mL) were added formaline (37%, 47 μL, 0.64 mmol) and AcOH (30 μL, 0.53 mmol). After 10 min of stirring at rt, NaBH(OAc)<sub>3</sub> (169 mg, 0.80 mmol) was added, and the resulting mixture was stirred for 3 h at rt. The reaction mixture was quenched with 5 M aq NaOH (two drops). The solvents were removed under reduced pressure. The residue was dissolved in DCM/MeOH (4:1, 8 mL). The pH was adjusted to above 10 with NH<sub>3</sub> solution (7 N) in MeOH. The inorganic salts were filtered and washed with DCM/MeOH (4:1, 12 mL). The filtrate was concentrated under reduced pressure. The crude product was purified by flash chromatography (DCM/MeOH/TEA 100:0:0–90:9:1). The selected fractions were collected, and the solvents were removed under reduced pressure. The residue was dissolved in DCM (5 mL) and washed with satd. aq Na<sub>2</sub>CO<sub>3</sub> (10 mL). The aqueous phase was extracted with DCM (2 × 5 mL). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was dissolved in MeOH (10 mL) and washed with <i>c</i>-hexane (20 mL). The <i>c</i>-hexane layer was extracted with MeOH (2 × 5 mL). The combined MeOH layers were concentrated in vacuo to give the title compound as a white solid (34 mg, 29%). mp: 128.7–128.9 °C. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 5.63 (s, 1H), 4.15–4.05 (m, 2H), 3.85 (dd, <i>J</i> = 9.0, 5.1 Hz, 2H), 3.30–3.23 (m, 1H), 2.43 (q, <i>J</i> = 7.6 Hz, 2H), 2.23 (s, 6H), 1.20 (t, <i>J</i> = 7.6 Hz, 3H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD) δ 171.6, 165.6, 164.0, 91.3, 57.4, 54.7, 41.9, 31.2, 13.4. HPLC-MS (basic mode): <i>t</i><sub>R</sub> = 2.9 min, purity: >99%, [M + H]<sup>+</sup>: 222. HR-MS [M + H]<sup>+</sup> calcd for C<sub>11</sub>H<sub>20</sub>N<sub>5</sub><sup>+</sup>: 222.1713, found 222.1705.</div></div><div id="sec4_4_1_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> 4-(3-Aminoazetidin-1-yl)-6-methylpyrimidin-2-amine (<b>13a</b>)</h5><div class="NLM_p last">To a solution of carbamate <b>23a</b> (723 mg, 2.59 mmol) in MeOH (25 mL) was added aq HCl (37%, 3.26 mL, 39.4 mmol). The reaction mixture was stirred at rt overnight. The solvents were removed under reduced pressure. The residue was dissolved in DCM/MeOH (10:1, 40 mL). The pH was adjusted to above 10 with NH<sub>3</sub> solution (7 N) in MeOH. The suspension was filtered. The solvents were removed under reduced pressure. The crude product was recrystallized from EtOH. The crystals were collected by filtration, washed, and dried in vacuo. Dissolving in H<sub>2</sub>O (5 mL) and freeze-drying gave the title compound as a white fluffy solid (189 mg, 43%). mp: 204.7–206.5 °C. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 5.89 (s, 1H), 4.50–4.43 (m, 2H), 4.17–4.11 (m, 1H), 4.06 (dd, <i>J</i> = 10.6, 4.8 Hz, 2H), 2.28 (s, 3H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD) δ 164.0, 157.8, 155.9, 94.0, 57.4, 43.0, 19.3. HPLC-MS (basic mode): <i>t</i><sub>R</sub> = 2.0 min, purity: >99%, [M + H]<sup>+</sup>: 180. HR-MS [M + H]<sup>+</sup> calcd for C<sub>8</sub>H<sub>14</sub>N<sub>5</sub><sup>+</sup>: 180.1244, found 180.1244.</div></div><div id="sec4_4_1_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> 4-Methyl-6-(3-(methylamino)azetidin-1-yl)pyrimidin-2-amine Dihydrochloride (<b>13b</b>)</h5><div class="NLM_p last">To a solution of carbamate <b>23b</b> (193 mg, 0.66 mmol) in dioxane (2 mL) was added HCl in dioxane (4 N, 2.0 mL, 8.0 mmol). The reaction mixture was stirred at rt overnight. The solvents were removed under reduced pressure. The title compound was obtained as an off-white solid (176 mg, quant.). mp: 220.1–220.5 °C. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD/D<sub>2</sub>O) δ 6.01 (s, 1H), 4.69–4.56 (m, 2H), 4.46–4.29 (m, 3H), 2.82 (s, 3H), 2.36 (s, 3H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD/D<sub>2</sub>O) δ 163.4, 156.2, 154.8, 94.3, 54.1, 53.7, 49.3, 31.6, 18.8. HPLC-MS (basic mode): <i>t</i><sub>R</sub> = 2.3 min, purity: >99%, [M + H]<sup>+</sup>: 194. HR-MS [M + H]<sup>+</sup> calcd for C<sub>9</sub>H<sub>16</sub>N<sub>5</sub><sup>+</sup>: 194.1400, found 194.1401.</div></div><div id="sec4_4_1_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> 4-(3-(Ethylamino)azetidin-1-yl)-6-methylpyrimidin-2-amine (<b>13c</b>)</h5><div class="NLM_p last">To a solution of carbamate <b>23c</b> (124 mg, 0.40 mmol) in MeOH (4 mL) was added aq HCl (37%, 0.33 mL, 3.99 mmol). The reaction mixture was stirred for 3 h at rt. The solvents were removed under reduced pressure. The residue was dissolved in DCM/MeOH (9:1, 8 mL). The pH was adjusted to above 10 with NH<sub>3</sub> solution (7 N) in MeOH. The inorganic salts were filtered off and washed with DCM/MeOH (4:1, 12 mL). The filtrate was concentrated under reduced pressure. The title compound was obtained as a white solid (70 mg, 84%). mp: 218.1–219.2 °C. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 5.85 (s, 1H), 4.44–4.34 (m, 2H), 4.03 (dd, <i>J</i> = 10.6, 4.8 Hz, 2H), 3.98–3.91 (m, 1H), 2.78 (q, <i>J</i> = 7.2 Hz, 2H), 2.26 (s, 3H), 1.20 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD) δ 164.0, 158.2, 156.4, 93.9, 56.6, 48.9, 42.2, 19.6, 13.8. HPLC-MS (basic mode): <i>t</i><sub>R</sub> = 2.7 min, purity: 96.4%, [M + H]<sup>+</sup>: 208. HR-MS [M + H]<sup>+</sup> calcd for C<sub>10</sub>H<sub>18</sub>N<sub>5</sub><sup>+</sup>: 208.1557, found 208.1549.</div></div><div id="sec4_4_1_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> 4-(3-(Dimethylamino)azetidin-1-yl-6-methyl)pyrimidin-2-amine (<b>13i</b>)</h5><div class="NLM_p last">Free base 4-methyl-6-(3-(methylamino)azetidin-1-yl)pyrimidin-2-amine (160 mg, 0.83 mmol) was obtained from <b>13b</b> by neutralization with NH<sub>3</sub> solution (7 N) in MeOH and filtration of the inorganic salt, followed by evaporation of the solvent. The residue was dissolved in MeOH (5 mL). To this were added formaline (37%, 74 μL, 0.99 mmol) and AcOH (47 μL, 0.83 mmol). After 10 min of stirring at rt, NaBH(OAc)<sub>3</sub> (263 mg, 1.24 mmol) was added, and the resulting mixture was stirred for 3 h at rt. The reaction mixture was quenched with 5 M aq NaOH (two drops). The solvents were removed under reduced pressure. The residue was dissolved in DCM/MeOH (4:1, 8 mL). The pH was adjusted to above 10 with NH<sub>3</sub> solution (7 N) in MeOH. The inorganic salts were filtered off and washed with DCM/MeOH (4:1, 12 mL). The filtrate was concentrated under reduced pressure. The crude product was purified by flash chromatography (DCM/MeOH/TEA 100:0:0–90:9:1). The selected fractions were collected, and the solvents were removed under reduced pressure. The residue was dissolved in DCM (5 mL) and washed with satd. aq Na<sub>2</sub>CO<sub>3</sub> (10 mL). The aqueous phase was extracted with DCM (2 × 5 mL). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was dissolved in MeOH (10 mL) and washed with <i>c</i>-hexane (20 mL). The <i>c</i>-hexane layer was extracted with MeOH (2 × 5 mL). The combined MeOH layers were concentrated in vacuo to give the title compound as a white solid (65 mg, 38%). mp: 171.5–172.7 °C. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 5.63 (app d, <i>J</i> = 3.2 Hz, 1H), 4.15–4.04 (m, 2H), 3.91–3.80 (m, 2H), 3.30–3.23 (m, 1H), 2.23 (d, <i>J</i> = 2.5 Hz, 6H), 2.16 (s, 3H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD) δ 166.2, 165.5, 163.9, 92.6, 57.4, 54.7, 41.9, 23.3. HPLC-MS (basic mode): <i>t</i><sub>R</sub> = 2.6 min, purity: >99%, [M + H]<sup>+</sup>: 208. HR-MS [M + H]<sup>+</sup> calcd for C<sub>10</sub>H<sub>18</sub>N<sub>5</sub><sup>+</sup>: 208.1557, found 208.1550.</div></div><div id="sec4_4_1_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> 4-(3-Aminoazetidin-1-yl)pyrimidin-2-amine Fumarate (<b>14a</b>)</h5><div class="NLM_p last">To a solution of carbamate <b>24a</b> (433 mg, 1.63 mmol) in MeOH (25 mL) was added aq HCl (37%, 0.74 mL, 8.94 mmol). The reaction mixture was stirred at rt overnight. The solvents were removed under reduced pressure. The residue was dissolved in DCM/MeOH (4:1, 25 mL). The pH was adjusted to above 10 with NH<sub>3</sub> solution (7 N) in MeOH. The suspension was filtered. The solvents were removed under reduced pressure. The free base (248 mg, 1.50 mmol) was dissolved in MeOH (4 mL), and fumaric acid (88 mg, 0.75 mmol) in MeOH (1 mL) was added. The clear solution was concentrated until a suspension formed. The suspension was cooled overnight at 5 °C. The formed solid was collected by filtration, washed, and dried in vacuo. Dissolving in H<sub>2</sub>O (5 mL) and freeze-drying gave the title compound as a white fluffy solid (134 mg, 37%). The base-to-fumaric-acid ratio was 1:0.5 based on the <sup>1</sup>H NMR peak integration. mp: 222.7–224.1 °C. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD/D<sub>2</sub>O) δ 7.62 (d, <i>J</i> = 7.3 Hz, 1H), 6.45 (s, 1H), 6.01 (d, <i>J</i> = 7.3 Hz, 1H), 4.57 (br, 2H), 4.38–4.15 (m, 3H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD/D<sub>2</sub>O) δ 174.7, 162.9, 155.8, 142.4, 136.3, 95.8, 55.4, 54.9, 41.7. HPLC-MS (basic mode): <i>t</i><sub>R</sub> = 1.7 min, purity: 96.1%, [M + H]<sup>+</sup>: 166. HR-MS [M + H]<sup>+</sup> calcd for C<sub>7</sub>H<sub>12</sub>N<sub>5</sub><sup>+</sup>: 166.1087, found 166.1082.</div></div><div id="sec4_4_1_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> 4-(3-(Methylamino)azetidin-1-yl)pyrimidin-2-amine Fumarate (<b>14b</b>)</h5><div class="NLM_p last">To a solution of carbamate <b>24b</b> (501 mg, 1.79 mmol) in MeOH (8 mL) was added aq HCl (37%, 0.54 mL, 6.52 mmol). The reaction mixture was stirred at rt overnight. The solvents were removed under reduced pressure. The residue was dissolved in DCM/MeOH (9:1, 25 mL). The pH was adjusted to above 10 with NH<sub>3</sub> solution (7 N) in MeOH. The suspension was filtered. The solvents were removed under reduced pressure. The crude free base (205 mg, 1.13 mmol) was dissolved in MeOH (25 mL), and fumaric acid (131 mg, 1.13 mmol) in MeOH (10 mL) was added. The clear solution was concentrated until a suspension formed. The suspension was cooled for 1 h at 5 °C. The formed solid was collected by filtration, washed, and dried in vacuo. Dissolving in H<sub>2</sub>O (5 mL) and freeze-drying gave the title compound as a white fluffy solid (250 mg, 53%). The base-to-fumaric-acid ratio was 1:0.7 based on the <sup>1</sup>H NMR peak integration. mp: 230.1–230.5 °C. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD/D<sub>2</sub>O) δ 7.64 (d, <i>J</i> = 7.0 Hz, 1H), 6.43 (s, 1H), 5.96 (d, <i>J</i> = 7.1 Hz, 1H), 4.46 (dd, <i>J</i> = 11.1, 7.6 Hz, 2H), 4.18 (dd, <i>J</i> = 11.2, 4.5 Hz, 2H), 4.13–4.06 (m, 1H), 2.62 (s, 3H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD/D<sub>2</sub>O) δ 175.2, 163.3, 157.7, 146.0, 136.5, 95.5, 54.5, 49.5, 31.8. HPLC-MS (basic mode): <i>t</i><sub>R</sub> = 2.1 min, purity: 95.6%, [M + H]<sup>+</sup>: 180. HR-MS [M + H]<sup>+</sup> calcd for C<sub>8</sub>H<sub>14</sub>N<sub>5</sub><sup>+</sup>: 180.1244, found 180.1238.</div></div><div id="sec4_4_1_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> 4-(3-(Ethylamino)azetidin-1-yl)pyrimidin-2-amine Fumarate (<b>14c</b>)</h5><div class="NLM_p last">To a solution of carbamate <b>24c</b> (117 mg, 0.40 mmol) in MeOH (4 mL) was added aq HCl (37%, 0.30 mL, 3.62 mmol). The reaction mixture was stirred at rt overnight. The solvents were removed under reduced pressure. The residue was dissolved in DCM/MeOH (9:1, 4 mL). The pH was adjusted to above 10 with NH<sub>3</sub> solution (7 N) in MeOH. The suspension was filtered. The solvents were removed under reduced pressure. The crude free base (54 mg, 0.28 mmol) was dissolved in MeOH (8 mL), and fumaric acid (32 mg, 0.28 mmol) in MeOH (3 mL) was added. After partial evaporation of MeOH and addition of EtOAc (3 mL), a precipitate was formed. The suspension was cooled for 3 h at 5 °C. The formed solid was collected by filtration, washed, and dried in vacuo. Dissolving in H<sub>2</sub>O (5 mL) and freeze-drying gave the title compound as a white fluffy solid (18 mg, 17%). The base-to-fumaric-acid ratio was 1:0.6 based on the <sup>1</sup>H NMR peak integration. mp: 206.8–208.5 °C. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD/D<sub>2</sub>O) δ 7.76 (d, <i>J</i> = 7.3 Hz, 1H), 6.70 (s, 1H), 6.16 (d, <i>J</i> = 7.3 Hz, 1H), 4.68 (br, 2H), 4.55–4.31 (m, 3H), 3.19 (q, <i>J</i> = 7.3 Hz, 2H), 1.41 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD/D<sub>2</sub>O) δ 171.9, 163.2, 156.0, 142.7, 136.0, 95.7, 54.5, 54.1, 47.7, 42.3, 11.6. HPLC-MS (basic mode): <i>t</i><sub>R</sub> = 2.2 min, purity: 91.8%, [M + H]<sup>+</sup>: 194. HR-MS [M + H]<sup>+</sup> calcd for C<sub>9</sub>H<sub>16</sub>N<sub>5</sub><sup>+</sup>: 194.1400, found 194.1393.</div></div><div id="sec4_4_1_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> 4-(3-(Propylamino)azetidin-1-yl)pyrimidin-2-amine Fumarate Hydrate (<b>14d</b>, VUF16839)</h5><div class="NLM_p last">To a solution of carbamate <b>24d</b> (1.19 g, 3.87 mmol) in MeOH (20 mL) was added aq HCl (37%, 3.2 mL, 38.6 mmol). The reaction mixture was stirred at rt overnight and subsequently at 50 °C for 30 min. The solvents were removed under reduced pressure. The residue was dissolved in DCM/MeOH (4:1, 20 mL). The pH was adjusted to above 10 with NH<sub>3</sub> solution (7 N) in MeOH. The suspension was filtered. The solvents were removed under reduced pressure. The crude free base (871 mg, 3.87 mmol) was dissolved in MeOH (10 mL), and fumaric acid (453 mg, 3.90 mmol) in MeOH (10 mL) was added. The solvent was removed under reduced pressure, and the residue was recrystallized from EtOH. The suspension was cooled for 1 h at 5 °C. The crystals were filtered, washed with EtOH, and dried in vacuo. Dissolving in H<sub>2</sub>O (20 mL) and freeze-drying gave the title compound as a white fluffy solid (803 mg, 58%). The base-to-fumaric-acid ratio was 1:1 based on the <sup>1</sup>H NMR peak integration. mp: 213.8–214.2 °C. <sup>1</sup>H NMR (500 MHz, D<sub>2</sub>O) δ 7.61 (d, <i>J</i> = 7.3 Hz, 1H), 6.43 (s, 2H), 5.99 (d, <i>J</i> = 7.3 Hz, 1H), 4.56 (br, 2H), 4.40–4.19 (m, 3H), 3.06–2.92 (m, 2H), 1.68 (sext, <i>J</i> = 7.5 Hz, 2H), 0.94 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD/D<sub>2</sub>O) δ 175.2, 162.9, 155.8, 142.7, 136.3, 95.7, 54.4 53.9, 48.4, 47.9, 20.2, 11.1. HPLC-MS (basic mode): <i>t</i><sub>R</sub> = 2.7 min, purity: 97.9%, [M + H]<sup>+</sup>: 208. HR-MS [M + H]<sup>+</sup> calcd for C<sub>10</sub>H<sub>18</sub>N<sub>5</sub><sup>+</sup>: 208.1557, found 208.1566. Anal. calcd for C<sub>10</sub>H<sub>17</sub>N<sub>5</sub>·C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>·1.75H<sub>2</sub>O: C, 47.38; H, 6.96; N, 19.73; O, 25.92; Cl, 0.00. Found: C, 47.07; H, 6.97; N, 19.43; O, 25.60; Cl, <0.1.</div></div><div id="sec4_4_1_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> 4-(3-(Isopropylamino)azetidin-1-yl)pyrimidin-2-amine Fumarate (<b>14e</b>)</h5><div class="NLM_p last">To a solution of free base <b>14a</b> (100 mg, 0.60 mmol) in DCM (4 mL) and MeOH (1 mL) were added acetone (48 μL, 0.66 mmol) and AcOH (34 μL, 0.60 mmol). After 10 min of stirring at rt, NaBH(OAc)<sub>3</sub> (201 mg, 0.90 mmol) was added, and the resulting mixture was stirred at rt overnight. The reaction mixture was quenched with 5 M aq NaOH (two drops). The solvents were removed under reduced pressure. The residue was purified by column chromatography (DCM/MeOH/TEA 100:0:0–80:18:2). The selected fractions were collected, and the solvents were removed under reduced pressure. The residue was dissolved in DCM/MeOH (9:1, 10 mL) and washed with satd. aq Na<sub>2</sub>CO<sub>3</sub> solution (10 mL). The aqueous layer was extracted with DCM/MeOH (9:1, 2 × 5 mL). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The free base (32 mg, 0.154 mmol) was dissolved in MeOH (1 mL), and fumaric acid (18 mg, 0.154 mmol) in MeOH (1 mL) was added. After partial evaporation of MeOH and addition of EtOAc (5 mL), a precipitate was formed. The suspension was cooled for 1 h at 5 °C. The formed solid was collected by filtration, washed, and dried in vacuo. Dissolving in H<sub>2</sub>O (5 mL) and freeze-drying gave the title compound as a white fluffy solid (42 mg, 22%). The base-to-fumaric-acid ratio was 1:1 based on the <sup>1</sup>H NMR peak integration. mp: 219.0–219.3 °C. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD/D<sub>2</sub>O) δ 7.76 (d, <i>J</i> = 7.1 Hz, 1H), 6.68–6.55 (m, 2H), 6.14–6.03 (m, 1H), 4.67–4.56 (m, 2H), 4.43–4.29 (m, 3H), 3.51–3.39 (m, 1H), 1.43–1.34 (m, 6H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD/D<sub>2</sub>O) δ 174.2, 174.0, 163.4, 157.4, 157.1, 144.9, 144.5, 136.7, 95.5, 95.4, 55.3, 55.1, 50.9, 50.6, 46.2, 46.1, 20.0, 19.8 (multiple sets observed). HPLC-MS (basic mode): <i>t</i><sub>R</sub> = 2.7 min, purity: >99%, [M + H]<sup>+</sup>: 208. HR-MS [M + H]<sup>+</sup> calcd for C<sub>10</sub>H<sub>18</sub>N<sub>5</sub><sup>+</sup>: 208.1557, found 208.1566.</div></div><div id="sec4_4_1_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> 4-(3-(Butylamino)azetidin-1-yl)pyrimidin-2-amine Fumarate (<b>14f</b>)</h5><div class="NLM_p last">To a solution of carbamate <b>24f</b> (32 mg, 0.19 mmol) in MeOH (3 mL) was added aq HCl (37%, 0.158 mL, 1.19 mmol). The reaction mixture was stirred at rt overnight. The solvents were removed under reduced pressure. The residue was dissolved in DCM/MeOH (4:1, 5 mL). The pH was adjusted to above 10 with NH<sub>3</sub> solution (7 N) in MeOH. The suspension was filtered. The solvents were removed under reduced pressure. The free base (48 mg, 0.19 mmol) was dissolved in MeOH (1 mL), and fumaric acid (22 mg, 0.19 mmol) in MeOH (1 mL) was added. After partial evaporation of MeOH and addition of EtOAc (5 mL), a precipitate formed. The suspension was cooled for 1 h at 5 °C. The formed solid was collected by filtration, washed, and dried in vacuo. The title compound was obtained as a white solid (34 mg, 58%). The base-to-fumaric-acid ratio was 1:0.75 based on the <sup>1</sup>H NMR peak integration. mp: 169.6–169.9 °C. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD/D<sub>2</sub>O) δ 7.72–7.66 (m, 1H), 6.66 (s, 1H), 6.06 (d, <i>J</i> = 7.2 Hz, 1H), 4.54 (br, 2H), 4.34 (br, 2H), 4.27–4.21 (m, 1H), 3.02–2.95 (m, 2H), 1.72–1.64 (m, 2H), 1.43 (sext, <i>J</i> = 7.4 Hz, 2H), 0.97 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD/D<sub>2</sub>O) δ 170.0, 163.6, 156.7, 143.1, 135.8, 95.5, 54.7, 48.6, 47.0, 29.6, 20.9, 13.9. HPLC-MS (basic mode): <i>t</i><sub>R</sub> = 3.1 min, purity: 94.6%, [M + H]<sup>+</sup>: 222. HR-MS [M + H]<sup>+</sup> calcd for C<sub>11</sub>H<sub>20</sub>N<sub>5</sub><sup>+</sup>: 222.1713, found 222.1705.</div></div><div id="sec4_4_1_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> (<i>rac</i>)-4-(3-(<i>sec</i>-Butylamino)azetidin-1-yl)pyrimidin-2-amine Fumarate (<b>14g</b>)</h5><div class="NLM_p last">To a solution of free base <b>14a</b> (100 mg, 0.60 mmol) in DCM (4 mL) and MeOH (1 mL) were added butane-2-one (64 μL, 0.66 mmol) and AcOH (34 μL, 0.60 mmol). After 10 min of stirring at rt, NaBH(OAc)<sub>3</sub> (201 mg, 0.90 mmol) was added, and the resulting mixture was stirred at rt overnight. The reaction mixture was quenched with 5 M aq NaOH (two drops). The solvents were removed under reduced pressure. The residue was purified by column chromatography (DCM/MeOH/TEA 100:0:0–80:18:2). The selected fractions were collected, and the solvents were removed under reduced pressure. The residue was dissolved in DCM/MeOH (9:1, 10 mL) and washed with satd. aq Na<sub>2</sub>CO<sub>3</sub> solution (10 mL). The aqueous layer was extracted with DCM/MeOH (9:1, 2 × 5 mL). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The free base (25 mg, 0.113 mmol) was dissolved in MeOH (1 mL), and fumaric acid (13 mg, 0.113 mmol) in MeOH (1 mL) was added. After partial evaporation of MeOH and addition of EtOAc (5 mL), a precipitate formed. The suspension was cooled for 1 h at 5 °C. The formed solid was collected by filtration, washed, and dried in vacuo. Dissolving in H<sub>2</sub>O (5 mL) and freeze-drying gave the title compound as a white fluffy solid (32 mg, 16%). The base-to-fumaric-acid ratio was 1:1 based on the <sup>1</sup>H NMR peak integration. mp: 214.6–215.4 °C. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD/D<sub>2</sub>O) δ 7.74 (d, <i>J</i> = 7.1 Hz, 1H), 6.64–6.53 (m, 2H), 6.12–6.05 (m, 1H), 4.62 (br, 2H), 4.47–4.30 (m, 3H), 3.28 (br, 1H), 1.90–1.80 (m, 1H), 1.69–1.57 (m, 1H), 1.38–1.30 (m, 3H), 1.05 (t, <i>J</i> = 7.5 Hz, 3H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD/D<sub>2</sub>O) δ 174.5, 174.1, 163.2, 156.9, 156.8, 144.3, 143.8, 136.7, 95.6, 95.5, 56.1, 56.0, 55.0, 46.1, 46.0, 27.4, 27.2, 16.3, 16.2, 9.8 (multiple sets observed). HPLC-MS (basic mode): <i>t</i><sub>R</sub> = 3.0 min, purity: 95.6%, [M + H]<sup>+</sup>: 222. HR-MS [M + H]<sup>+</sup> calcd for C<sub>11</sub>H<sub>20</sub>N<sub>5</sub><sup>+</sup>: 222.1713, found 222.1715.</div></div><div id="sec4_4_1_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> 4-(3-(Isobutylamino)azetidin-1-yl)pyrimidin-2-amine Fumarate (<b>14h</b>)</h5><div class="NLM_p last">To a solution of free base <b>14a</b> (100 mg, 0.60 mmol) in DCM (4 mL) and MeOH (1 mL) were added isobutyraldehyde (66 μL, 0.66 mmol) and AcOH (34 μL, 0.60 mmol). After 10 min of stirring at rt, NaBH(OAc)<sub>3</sub> (201 mg, 0.90 mmol) was added, and the resulting mixture was stirred at rt overnight. The reaction mixture was quenched with 5 M aq NaOH (two drops). The solvents were removed under reduced pressure. The residue was purified by column chromatography (DCM/MeOH/TEA 100:0:0–80:18:2). The selected fractions were collected, and the solvents were removed under reduced pressure. The residue was dissolved in DCM/MeOH (9:1, 10 mL) and washed with satd. aq Na<sub>2</sub>CO<sub>3</sub> solution (10 mL). The aqueous layer was extracted with DCM/MeOH (9:1, 2 × 5 mL). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The free base (59 mg, 0.267 mmol) was dissolved in MeOH (1 mL), and fumaric acid (31 mg, 0.267 mmol) in MeOH (1 mL) was added. After partial evaporation of MeOH and addition of EtOAc (5 mL), a precipitate formed. The suspension was cooled for 1 h at 5 °C. The formed solid was collected by filtration, washed, and dried in vacuo. Dissolving in H<sub>2</sub>O (5 mL) and freeze-drying gave the title compound as a white fluffy solid (78 mg, 38%). The base-to-fumaric-acid ratio was 1:1 based on the <sup>1</sup>H NMR peak integration. mp: 230.9–231.3 °C. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD/D<sub>2</sub>O) δ 7.73 (d, <i>J</i> = 7.2 Hz, 1H), 6.59–6.55 (m, 2H), 6.09 (d, <i>J</i> = 7.2 Hz, 1H), 4.59 (t, <i>J</i> = 9.5 Hz, 2H), 4.37 (br app d, 2H), 4.30–4.23 (m, 1H), 2.88 (dd, <i>J</i> = 7.2, 3.6 Hz, 2H), 2.11–2.03 (m, 1H), 1.08 (d, <i>J</i> = 6.7 Hz, 6H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>ODD<sub>2</sub>O) δ 174.3, 174.2, 163.2, 156.7, 156.7, 143.7, 143.7, 136.6, 95.6, 95.5, 54.6, 54.0, 48.6, 27.3, 27.2, 20.3 (multiple sets observed). HPLC-MS (basic mode): <i>t</i><sub>R</sub> = 3.1 min, purity: >99%, [M + H]<sup>+</sup>: 222. HR-MS [M + H]<sup>+</sup> calcd for C<sub>11</sub>H<sub>20</sub>N<sub>5</sub><sup>+</sup>: 222.1713, found 222.1716.</div></div><div id="sec4_4_1_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> 4-(3-(Dimethylamino)azetidin-1-yl)pyrimidin-2-amine Fumarate (<b>14i</b>)</h5><div class="NLM_p last">To a solution of amine fumarate <b>14b</b> (100 mg, 0.34 mmol) in MeOH (25 mL) were added formaline (37%, 70 μL, 0.94 mmol) and AcOH (20 μL, 0.34 mmol). After 10 min of stirring at rt, NaBH(OAc)<sub>3</sub> (108 mg, 0.68 mmol) was added, and the resulting mixture was stirred at rt overnight. The reaction mixture was quenched with 5 M aq NaOH (two drops). The solvents were removed under reduced pressure. The residue was purified by column chromatography (DCM/MeOH/TEA 100:0:0–90:9:1). The selected fractions were collected, and the solvents were removed under reduced pressure. The residue was dissolved in DCM/MeOH (9:1, 20 mL). The pH was adjusted to above 10 with NH<sub>3</sub> solution (7 N) in MeOH. The suspension was filtered. The solvents were removed under reduced pressure. The crude free base (25 mg, 0.130 mmol) was dissolved in MeOH (5 mL), and fumaric acid (7.5 mg, 0.065 mmol) in MeOH (2.5 mL) was added. The solvent was evaporated until a suspension formed. The suspension was cooled overnight at 5 °C. The formed solid was collected by filtration, washed, and dried in vacuo. Dissolving in H<sub>2</sub>O (5 mL) and freeze-drying gave the title compound as a white fluffy solid (31 mg, 36%). The base-to-fumaric-acid ratio was 1:0.5 based on the <sup>1</sup>H NMR peak integration. mp: 224.0–224.4 °C. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD/D<sub>2</sub>O) δ 7.66 (d, <i>J</i> = 7.0 Hz, 1H), 6.50 (s, 1H), 5.98 (d, <i>J</i> = 7.0 Hz, 1H), 4.35–4.27 (m, 2H), 4.08 (dd, <i>J</i> = 10.8, 4.9 Hz, 2H), 3.62–3.53 (m, 1H), 2.36 (s, 6H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD/D<sub>2</sub>O) δ 175.0, 163.2, 157.8, 145.6, 136.7, 95.4, 56.4, 54.4, 41.5. HPLC-MS (basic mode): <i>t</i><sub>R</sub> = 2.4 min, purity: >99%, [M + H]<sup>+</sup>: 194. HR-MS [M + H]<sup>+</sup> calcd for C<sub>9</sub>H<sub>16</sub>N<sub>5</sub><sup>+</sup>: 194.1400, found 194.1395.</div></div><div id="sec4_4_1_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> 4-(3-(Diethylamino)azetidin-1-yl)pyrimidin-2-amine Fumarate (<b>14j</b>)</h5><div class="NLM_p last">To a solution of free base <b>14a</b> (100 mg, 0.60 mmol) in DCM (4 mL) and MeOH (1 mL) were added acetaldehyde (0.34 mL, 6 mmol) and AcOH (34 μL, 0.60 mmol). After 10 min of stirring at rt, NaBH(OAc)<sub>3</sub> (402 mg, 1.80 mmol) was added, and the resulting mixture was stirred at rt overnight. The reaction mixture was quenched with 5 M aq NaOH (two drops). The solvents were removed under reduced pressure. The residue was purified by column chromatography (DCM/MeOH/TEA 100:0:0–80:18:2). The selected fractions were collected, and the solvents were removed under reduced pressure. The residue was dissolved in DCM/MeOH (9:1, 10 mL) and washed with satd. aq Na<sub>2</sub>CO<sub>3</sub> solution (10 mL). The aqueous layer was extracted with DCM/MeOH (9:1, 2 × 5 mL). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The free base (82 mg, 0.37 mmol) was dissolved in MeOH (1 mL), and fumaric acid (43 mg, 0.37 mmol) in MeOH (1 mL) was added. After partial evaporation of MeOH and addition of EtOAc (5 mL), a precipitate formed. The suspension was cooled for 1 h at 5 °C. The formed solid was collected by filtration, washed, and dried in vacuo. Dissolving in H<sub>2</sub>O (5 mL) and freeze-drying gave the title compound as a white fluffy solid (90 mg, 44%). The base-to-fumaric-acid ratio was 1:1 based on the <sup>1</sup>H NMR peak integration. mp: 229.6–229.8 °C. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD/D<sub>2</sub>O) δ 7.74 (d, <i>J</i> = 7.1 Hz, 1H), 6.64–6.55 (m, 2H), 6.10 (dd, <i>J</i> = 7.2, 4.0 Hz, 1H), 4.62–4.51 (m, 2H), 4.50–4.41 (m, 2H), 4.41–4.29 (m, 1H), 3.28–3.13 (m, 4H), 1.40–1.27 (m, 6H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD/D<sub>2</sub>O) δ 174.1, 173.8, 163.3, 157.0, 156.9, 144.1, 144.0, 136.6, 95.6, 95.5, 53.9, 52.7, 45.6, 45.4, 9.3, 9.2 (multiple sets observed). HPLC-MS (basic mode): <i>t</i><sub>R</sub> = 3.0 min, purity: 97.3%, [M + H]<sup>+</sup>: 222. HR-MS [M + H]<sup>+</sup> calcd for C<sub>11</sub>H<sub>20</sub>N<sub>5</sub><sup>+</sup>: 222.1713, found 222.1722.</div></div><div id="sec4_4_1_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> 4-(3-(Pyrrolidin-1-yl)azetidin-1-yl)pyrimidin-2-amine Fumarate (<b>14k</b>)</h5><div class="NLM_p last">To a solution of free base <b>14a</b> (100 mg, 0.60 mmol) in MeCN (20 mL) were added 1,4-diiodobutane (0.095 mL, 0.72 mmol) and K<sub>2</sub>CO<sub>3</sub> (166 mg, 1.20 mmol). The resulting mixture was heated at reflux for 16 h. The solvent was removed under reduced pressure. The residue was purified by column chromatography (DCM/MeOH/TEA 100:0:0–80:18:2). The selected fractions were collected, and the solvents were removed under reduced pressure. The residue was dissolved in DCM/MeOH (9:1, 10 mL) and washed with satd. aq Na<sub>2</sub>CO<sub>3</sub> solution (10 mL). The aqueous layer was extracted with DCM/MeOH (9:1, 2 × 5 mL). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The free base (32 mg, 0.146 mmol) was dissolved in MeOH (1 mL), and fumaric acid (17 mg, 0.146 mmol) in MeOH (1 mL) was added. After partial evaporation of MeOH and addition of EtOAc (5 mL), a precipitate formed. The suspension was cooled for 1 h at 5 °C. The formed solid was collected by filtration, washed, and dried in vacuo. Dissolving in H<sub>2</sub>O (5 mL) and freeze-drying gave the title compound as a white fluffy solid (20 mg, 9%). The base-to-fumaric-acid ratio was 1:1.15 based on the <sup>1</sup>H NMR peak integration. mp: 228.3–228.6 °C. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD/D<sub>2</sub>O) δ 7.74 (d, <i>J</i> = 7.2 Hz, 1H), 6.58 (s, 2H), 6.12 (d, <i>J</i> = 7.2 Hz, 1H), 4.63 (br, 2H), 4.46 (br, 2H), 4.39–4.31 (m, 1H), 3.42 (br, 4H), 2.24–2.11 (m, 4H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD/D<sub>2</sub>O) δ 173.8, 163.2, 156.3, 143.2, 136.4, 95.6, 54.6, 54.1, 53.3, 24.2. HPLC-MS (basic mode): <i>t</i><sub>R</sub> = 2.8 min, purity: >99%, [M + H]<sup>+</sup>: 220. HR-MS [M + H]<sup>+</sup> calcd for C<sub>11</sub>H<sub>18</sub>N<sub>5</sub><sup>+</sup>: 220.1557, found 220.1563.</div></div><div id="sec4_4_1_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> 4-Chloro-6-isopropylpyrimidin-2-amine (<b>17</b>)</h5><div class="NLM_p last">Pyrimidin-4(3<i>H</i>)-one <b>15</b> (4.87 g, 31.8 mmol) was dissolved in POCl<sub>3</sub> (40 mL, 0.43 mol). The mixture was heated to reflux for 3 h. The solvent was removed under reduced pressure. Ice (150 g) was carefully added to the residue. The pH of the mixture was adjusted to 9–10 with aq NaOH (2.5 M). The mixture was extracted with DCM (3 × 100 mL). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash chromatography (DCM/MeOH 10:0–9:1) gave the title compound as an off-white solid (1.41 g, 26%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 6.53 (s, 1H), 5.33 (br, 2H), 2.77 (hept, <i>J</i> = 6.9 Hz, 1H), 1.22 (d, <i>J</i> = 6.9 Hz, 6H). HPLC-MS (acidic mode): <i>t</i><sub>R</sub> = 3.5 min, purity: 96.8%, [M + H]<sup>+</sup>: 172.</div></div><div id="sec4_4_1_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> 4-Chloro-6-ethylpyrimidin-2-amine (<b>18</b>)</h5><div class="NLM_p last">Pyrimidin-4(3<i>H</i>)-one <b>16</b> (6.13 g, 44.1 mmol) was dissolved in POCl<sub>3</sub> (50 mL, 0.54 mol). The mixture was heated to reflux for 3 h. The solvent was removed under reduced pressure. Ice (150 g) was carefully added to the residue. The pH of the mixture was adjusted to 9–10 with aq NaOH (2.5 M). The mixture was extracted with DCM (3 × 10 mL). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash chromatography (DCM/MeOH 10:0–9:1) gave the title compound as an off-white solid (3.63 g, 52%). <sup>1</sup>H (500 MHz, CDCl<sub>3</sub>) δ 6.53 (s, 1H), 5.43 (br, 2H), 2.57 (q, <i>J</i> = 7.6 Hz, 2H), 1.23 (t, <i>J</i> = 7.6 Hz, 3H). HPLC-MS (acidic mode): <i>t</i><sub>R</sub> = 3.0 min, purity: >99%, [M + H]<sup>+</sup>: 158.</div></div><div id="sec4_4_1_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> <i>tert</i>-Butyl (1-(2-Amino-6-isopropylpyrimidin-4-yl)azetidin-3-yl)carbamate (<b>21a</b>)</h5><div class="NLM_p last">A microwave vial charged with chloride <b>17</b> (400 g, 2.33 mmol), carbamate <b>28a</b> (402 mg, 2.33 mmol), DIPEA (0.41 mL, 2.33 mmol), and dioxane (10 mL) was heated for 120 min at 150 °C under microwave irradiation. The reaction mixture was diluted with water (20 mL) and extracted with DCM (3 × 20 mL). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash chromatography (DCM/MeOH/TEA 100:0:0–90:9:1) gave the title compound as a colorless oil (351 mg, 49%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 5.48 (s, 1H), 5.01 (br, 1H), 4.80 (br, 2H), 4.57 (br, 1H), 4.31 (t, <i>J</i> = 8.3 Hz, 2H), 3.89–3.74 (m, 2H), 2.65 (hept, <i>J</i> = 6.9 Hz, 1H), 1.45 (s, 9H), 1.19 (d, <i>J</i> = 6.9 Hz, 6H). HPLC-MS (acidic mode): <i>t</i><sub>R</sub> = 3.1 min, purity: >99%, [M + H]<sup>+</sup>: 308.</div></div><div id="sec4_4_1_27" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> <i>tert</i>-Butyl (1-(2-Amino-6-isopropylpyrimidin-4-yl)azetidin-3-yl)(methyl)carbamate (<b>21b</b>)</h5><div class="NLM_p last">A microwave vial charged with chloride <b>17</b> (300 mg, 1.75 mmol), carbamate hydrochloride <b>28b</b> (389 mg, 1.75 mmol), DIPEA (0.61 mL, 3.50 mmol), and dioxane (10 mL) was heated for 30 min at 150 °C under microwave irradiation. The reaction mixture was diluted with water (20 mL) and extracted with DCM (3 × 15 mL). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash chromatography (DCM/MeOH 10:0–9:1) gave the title compound as a yellow oil (280 mg, 50%). <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>) δ 5.50 (s, 1H), 5.03 (br, 1H), 4.79 (br, 2H), 4.20 (t, <i>J</i> = 8.6 Hz, 2H), 4.07–3.95 (m, 2H), 2.93 (s, 3H), 2.65 (hept, <i>J</i> = 6.9 Hz, 1H), 1.46 (s, 9H), 1.20 (d, <i>J</i> = 6.9 Hz, 6H). HPLC-MS (acidic mode): <i>t</i><sub>R</sub> = 3.4 min, purity: >99%, [M + H]<sup>+</sup>: 322.</div></div><div id="sec4_4_1_28" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> <i>tert</i>-Butyl (1-(2-Amino-6-isopropylpyrimidin-4-yl)azetidin-3-yl)(ethyl)carbamate (<b>21c</b>)</h5><div class="NLM_p last">Carbamate <b>27c</b> (1.02 g, 2.78 mmol) was dissolved in MeOH/EtOH (10:10 mL) and reacted with H<sub>2</sub> gas under atmospheric pressure using Pd/C (5%, 0.60 g) overnight at rt. The mixture was filtered over Celite, and the filtrate was concentrated in vacuo. The resulting yellowish oil (900 mg, a mixture of intermediate and diphenylmethane) was used in the next step without further purification. A microwave vial charged with chloride <b>17</b> (103 mg, 0.60 mmol), crude intermediate (221 mg), DIPEA (0.105 mL, 0.60 mmol), and dioxane (5 mL) was heated for 90 min at 150 °C under microwave irradiation. The reaction mixture was diluted with water (10 mL) and extracted with DCM (3 × 10 mL). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash chromatography (DCM/MeOH 10:0–9:1) gave the title compound as a yellowish oil (79 mg, 35% over two steps, extrapolated). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 6.03 (br, 2H), 5.46 (s, 1H), 5.06 (br, 1H), 4.73 (br, 1H), 4.25 (t, <i>J</i> = 8.7 Hz, 2H), 4.17–4.05 (m, 2H), 3.33 (q, <i>J</i> = 7.0 Hz, 2H), 2.76 (hept, <i>J</i> = 6.9 Hz, 1H), 1.46 (s, 9H), 1.23 (d, <i>J</i> = 6.9 Hz, 6H), 1.14 (t, <i>J</i> = 7.0 Hz, 3H). HPLC-MS (acidic mode): <i>t</i><sub>R</sub> = 3.6 min, purity: >99%, [M + H]<sup>+</sup>: 336.</div></div><div id="sec4_4_1_29" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64"> <i>tert</i>-Butyl (1-(2-Amino-6-ethylpyrimidin-4-yl)azetidin-3-yl)carbamate (<b>22a</b>)</h5><div class="NLM_p last">A microwave vial charged with chloride <b>18</b> (500 mg, 3.17 mmol), carbamate <b>28a</b> (546 mg, 3.17 mmol), DIPEA (0.55 mL, 3.17 mmol), and dioxane (11 mL) was heated for 45 min at 150 °C under microwave irradiation. The reaction mixture was diluted with water (50 mL) and extracted with DCM (3 × 50 mL). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash chromatography (DCM/MeOH 10:0–9:1) gave the title compound as a colorless oil (250 mg, 27%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 5.49 (s, 1H), 4.99 (br, 1H), 4.78 (br, 2H), 4.58 (br, 1H), 4.31 (t, <i>J</i> = 8.3 Hz, 2H), 3.85–3.73 (m, 2H), 2.46 (q, <i>J</i> = 7.6 Hz, 2H), 1.45 (s, 9H), 1.20 (t, <i>J</i> = 7.6 Hz, 3H). HPLC-MS (acidic mode): <i>t</i><sub>R</sub> = 3.0 min, purity: 94.5%, [M + H]<sup>+</sup>: 294.</div></div><div id="sec4_4_1_30" class="NLM_sec NLM_sec_level_4"><div id="ac_i65" class="anchor-spacer"></div><h5 class="article-section__title" id="_i65"> <i>tert</i>-Butyl (1-(2-Amino-6-ethylpyrimidin-4-yl)azetidin-3-yl)(methyl)carbamate (<b>22b</b>)</h5><div class="NLM_p last">A microwave vial charged with chloride <b>18</b> (500 mg, 3.17 mmol), carbamate hydrochloride <b>28b</b> (707 mg, 3.17 mmol), DIPEA (1.11 mL, 6.35 mmol), and dioxane (11 mL) was heated for 45 min at 150 °C under microwave irradiation. The reaction mixture was diluted with water (15 mL) and extracted with DCM (3 × 10 mL). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash chromatography (DCM/MeOH 10:0–9:1) gave the title compound as a colorless oil (450 mg, 46%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 5.52 (s, 1H), 5.00 (br, 1H), 4.77 (br, 2H), 4.20 (t, <i>J</i> = 8.6 Hz, 2H), 4.07–3.94 (m, 2H), 2.92 (s, 3H), 2.47 (q, <i>J</i> = 7.6 Hz, 2H), 1.46 (s, 9H), 1.20 (t, <i>J</i> = 7.6 Hz, 3H). HPLC-MS (acidic mode): <i>t</i><sub>R</sub> = 3.1 min, purity: >99%, [M + H]<sup>+</sup>: 308.</div></div><div id="sec4_4_1_31" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66"> <i>tert</i>-Butyl (1-(2-Amino-6-ethylpyrimidin-4-yl)azetidin-3-yl)(ethyl)carbamate (<b>22c</b>)</h5><div class="NLM_p last">Carbamate <b>27c</b> (1.02 g, 2.78 mmol) was dissolved in MeOH/EtOH (10:10 mL) and reacted with H<sub>2</sub> gas under atmospheric pressure using Pd/C (5%, 0.60 g) overnight at rt. The mixture was filtered over Celite, and the filtrate was concentrated in vacuo. The resulting yellowish oil (900 mg, a mixture of intermediate and diphenylmethane) was used in the next step without further purification. A microwave vial charged with chloride <b>18</b> (95 mg, 0.60 mmol), crude intermediate (221 mg), DIPEA (0.105 mL, 0.60 mmol), and dioxane (5 mL) was heated for 90 min at 150 °C under microwave irradiation. The reaction mixture was diluted with water (10 mL) and extracted with DCM (3 × 10 mL). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash chromatography (DCM/MeOH 10:0–9:1) gave the title compound as a yellowish oil (92 mg, 42% over two steps, extrapolated). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 5.54 (s, 1H), 4.83 (br, 3H), 4.24 (t, <i>J</i> = 8.5 Hz, 2H), 4.12–3.96 (m, 2H), 3.36 (q, <i>J</i> = 7.1 Hz, 2H), 2.49 (q, <i>J</i> = 7.6 Hz, 2H), 1.48 (s, 9H), 1.29–1.11 (m, 6H). HPLC-MS (acidic mode): <i>t</i><sub>R</sub> = 3.3 min, purity: >99% %, [M + H]<sup>+</sup>: 322.</div></div><div id="sec4_4_1_32" class="NLM_sec NLM_sec_level_4"><div id="ac_i67" class="anchor-spacer"></div><h5 class="article-section__title" id="_i67"> <i>tert</i>-Butyl (1-(2-Amino-6-methylpyrimidin-4-yl)azetidin-3-yl)carbamate (<b>23a</b>)</h5><div class="NLM_p last">A microwave vial charged with chloride <b>19</b> (1.00 g, 6.97 mmol), carbamate <b>28a</b> (1.20 g, 6.97 mmol), DIPEA (1.22 mL, 6.99 mmol), and dioxane (20 mL) was heated for 60 min at 150 °C under microwave irradiation. The reaction mixture was diluted with water (40 mL) and extracted with DCM (3 × 40 mL). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash chromatography (DCM/MeOH 10:0–9:1) gave the title compound as a yellowish solid (726 mg, 36%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 5.50 (s, 1H), 4.99 (br, 1H), 4.78 (br, 2H), 4.58 (br, 1H), 4.30 (t, <i>J</i> = 8.3 Hz, 2H), 3.83–3.73 (m, 2H), 2.20 (s, 3H), 1.45 (s, 9H). HPLC-MS (acidic mode): <i>t</i><sub>R</sub> = 2.7 min, purity: 95.5%, [M + H]<sup>+</sup>: 280.</div></div><div id="sec4_4_1_33" class="NLM_sec NLM_sec_level_4"><div id="ac_i68" class="anchor-spacer"></div><h5 class="article-section__title" id="_i68"> <i>tert</i>-Butyl (1-(2-Amino-6-methylpyrimidin-4-yl)azetidin-3-yl)(methyl)carbamate (<b>23b</b>)</h5><div class="NLM_p last">A microwave vial charged with chloride <b>19</b> (287 mg, 2.00 mmol), carbamate hydrochloride <b>28b</b> (445 mg, 2.00 mmol), DIPEA (0.70 mL, 4.00 mmol), and dioxane (4 mL) was heated for 60 min at 150 °C under microwave irradiation. The reaction mixture was diluted with water (15 mL) and extracted with DCM (3 × 10 mL). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash chromatography (DCM/MeOH 100:0–92:8) gave the title compound as a colorless oil (501 mg, 46%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 5.51 (s, 1H), 4.99 (br, 1H), 4.81 (br, 2H), 4.19 (t, <i>J</i> = 8.6 Hz, 2H), 4.06–3.93 (m, 2H), 2.91 (s, 3H), 2.19 (s, 3H), 1.46 (s, 9H). HPLC-MS (acidic mode): <i>t</i><sub>R</sub> = 2.9 min, purity: 95.9%, [M + H]<sup>+</sup>: 294.</div></div><div id="sec4_4_1_34" class="NLM_sec NLM_sec_level_4"><div id="ac_i69" class="anchor-spacer"></div><h5 class="article-section__title" id="_i69"> <i>tert</i>-Butyl (1-(2-Amino-6-methylpyrimidin-4-yl)azetidin-3-yl)(ethyl)carbamate (<b>23c</b>)</h5><div class="NLM_p last">Carbamate <b>27c</b> (1.02 g, 2.78 mmol) was dissolved in MeOH/EtOH (10:10 mL) and reacted with H<sub>2</sub> gas under atmospheric pressure using Pd/C (5%, 0.60 g) overnight at rt. The mixture was filtered over Celite, and the filtrate was concentrated in vacuo. The resulting yellowish oil (900 mg, a mixture of intermediate and diphenylmethane) was used in the next step without further purification. A microwave vial charged with chloride <b>19</b> (101 mg, 0.71 mmol), crude intermediate (260 mg), DIPEA (0.123 mL, 0.71 mmol), and dioxane (3 mL) was heated for 90 min at 150 °C under microwave irradiation. The reaction mixture was diluted with water (10 mL) and extracted with DCM (3 × 10 mL). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash chromatography (DCM/MeOH 10:0–9:1) gave the title compound as a colorless oil (125 mg, 56% over two steps, extrapolated). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 5.52 (s, 1H), 4.75 (br, 3H), 4.20 (t, <i>J</i> = 8.5 Hz, 2H), 4.07–3.95 (m, 2H), 3.33 (q, <i>J</i> = 7.0 Hz, 2H), 2.20 (s, 3H), 1.46 (s, 9H), 1.15 (t, <i>J</i> = 7.0 Hz, 3H). HPLC-MS (acidic mode): <i>t</i><sub>R</sub> = 3.2 min, purity: >99% %, [M + H]<sup>+</sup>: 308.</div></div><div id="sec4_4_1_35" class="NLM_sec NLM_sec_level_4"><div id="ac_i70" class="anchor-spacer"></div><h5 class="article-section__title" id="_i70"> <i>tert</i>-Butyl (1-(2-Aminopyrimidin-4-yl)azetidin-3-yl)carbamate (<b>24a</b>)</h5><div class="NLM_p last">A microwave vial charged with chloride <b>20</b> (500 mg, 3.86 mmol), carbamate <b>28a</b> (665 mg, 3.86 mmol), DIPEA (0.67 mL, 3.86 mmol), and dioxane (10 mL) was heated for 60 min at 150 °C under microwave irradiation. The reaction mixture was diluted with water (40 mL) and extracted with DCM (3 × 40 mL). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash chromatography (DCM/MeOH 100:0–88:12) gave the title compound as a colorless oil (434 mg, 39%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.83 (d, <i>J</i> = 5.8 Hz, 1H), 5.61 (d, <i>J</i> = 5.8 Hz, 1H), 5.10 (br, 1H), 4.82 (s, 2H), 4.58 (br, 1H), 4.31 (t, <i>J</i> = 8.4 Hz, 2H), 3.86–3.74 (m, 2H), 1.45 (s, 9H). HPLC-MS (acidic mode): <i>t</i><sub>R</sub> = 2.6 min, purity: 91.6%, [M + H]<sup>+</sup>: 266.</div></div><div id="sec4_4_1_36" class="NLM_sec NLM_sec_level_4"><div id="ac_i71" class="anchor-spacer"></div><h5 class="article-section__title" id="_i71"> <i>tert</i>-Butyl (1-(2-Aminopyrimidin-4-yl)azetidin-3-yl)(methyl)carbamate (<b>24b</b>)</h5><div class="NLM_p last">A microwave vial charged with chloride <b>20</b> (500 mg, 3.86 mmol), carbamate hydrochloride <b>28b</b> (723 mg, 3.86 mmol), DIPEA (1.35 mL, 7.72 mmol), and dioxane (10 mL) was heated for 30 min at 150 °C under microwave irradiation. The reaction mixture was diluted with water (40 mL) and extracted with DCM (3 × 40 mL). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash chromatography (DCM/MeOH 100:0–88:12) gave the title compound as a colorless oil (501 mg, 46%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.84 (d, <i>J</i> = 5.9 Hz, 1H), 5.65 (d, <i>J</i> = 5.9 Hz, 1H), 5.21–4.59 (m, 3H), 4.22 (t, <i>J</i> = 8.7 Hz, 2H), 4.09–3.98 (m, 2H), 2.93 (s, 3H), 1.47 (s, 9H). HPLC-MS (acidic mode): <i>t</i><sub>R</sub> = 2.8 min, purity: >99%, [M + H]<sup>+</sup>: 280.</div></div><div id="sec4_4_1_37" class="NLM_sec NLM_sec_level_4"><div id="ac_i72" class="anchor-spacer"></div><h5 class="article-section__title" id="_i72"> <i>tert</i>-Butyl (1-(2-Aminopyrimidin-4-yl)azetidin-3-yl)(ethyl)carbamate (<b>24c</b>)</h5><div class="NLM_p last">Carbamate <b>27c</b> (1.02 g, 2.78 mmol) was dissolved in MeOH/EtOH (10:10 mL) and reacted with H<sub>2</sub> gas under atmospheric pressure using Pd/C (5%, 0.60 g) overnight at rt. The mixture was filtered through Celite. The Celite cake was washed with MeOH (2 × 5 mL), and the combined filtrates were concentrated in vacuo. The resulting yellowish oil (900 mg, a mixture of intermediate and diphenylmethane) was used in the next step without further purification. A microwave vial charged with chloride <b>20</b> (78 mg, 0.60 mmol), crude intermediate (221 mg), DIPEA (0.105 mL, 0.60 mmol), and dioxane (5 mL) was heated for 90 min at 150 °C under microwave irradiation. The reaction mixture was diluted with water (10 mL) and extracted with DCM (3 × 10 mL). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash chromatography (DCM/MeOH 10:0–9:1) gave the title compound as a colorless oil (117 mg, 50% over two steps, extrapolated). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.84 (d, <i>J</i> = 5.8 Hz, 1H), 5.64 (d, <i>J</i> = 5.8 Hz, 1H), 4.77 (br, 3H), 4.22 (t, <i>J</i> = 8.5 Hz, 2H), 4.10–3.97 (m, 2H), 3.33 (q, <i>J</i> = 7.0 Hz, 2H), 1.45 (s, 9H), 1.15 (t, <i>J</i> = 7.0 Hz, 3H). HPLC-MS (acidic mode): <i>t</i><sub>R</sub> = 3.0 min, purity: 95.5%, [M + H]<sup>+</sup>: 294.</div></div><div id="sec4_4_1_38" class="NLM_sec NLM_sec_level_4"><div id="ac_i73" class="anchor-spacer"></div><h5 class="article-section__title" id="_i73"> <i>tert</i>-Butyl (1-(2-Aminopyrimidin-4-yl)azetidin-3-yl)(propyl)carbamate (<b>24d</b>)</h5><div class="NLM_p last">Carbamate <b>27d</b> (2.09 g, 5.49 mmol) in MeOH (100 mL) was passed through an H-cube fitted with a Pd/C (10%) catalyst cartridge at a flow rate of 1 mL/min at 60 °C and at 10 atm H<sub>2</sub> pressure. The solvent was removed in vacuo. The resulting colorless oil (2.03 g, a mixture of intermediate and diphenylmethane) was used in the next step without further purification. A microwave vial charged with chloride <b>20</b> (687 mg, 5.31 mmol), crude intermediate (2.03 g), DIPEA (0.93 mL, 5.27 mmol), and NMP (5 mL) was heated for 30 min at 120 °C under microwave irradiation. The mixture was purified by flash chromatography (DCM/MeOH/TEA 100:0:0–90:9:1). The selected fractions were collected, and the solvents were removed under reduced pressure. The residue was dissolved in DCM (50 mL) and washed with satd. aq Na<sub>2</sub>CO<sub>3</sub> (80 mL). The aqueous phase was extracted with DCM (2 × 50 mL). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The title compound was obtained as a colorless oil (1.19 g, 71% over two steps). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.83 (d, <i>J</i> = 5.8 Hz, 1H), 5.64 (d, <i>J</i> = 5.8 Hz, 1H), 5.06–4.38 (m, 3H), 4.20 (t, <i>J</i> = 8.5 Hz, 2H), 4.07 (t, <i>J</i> = 7.6 Hz, 2H), 3.22 (t, <i>J</i> = 7.6 Hz, 2H), 1.54 (sext, <i>J</i> = 7.4 Hz, 2H), 1.44 (s, 9H), 0.88 (t, <i>J</i> = 7.4 Hz, 3H). HPLC-MS (acidic mode): <i>t</i><sub>R</sub> = 3.3 min, purity: >99%, [M + H]<sup>+</sup>: 308.</div></div><div id="sec4_4_1_39" class="NLM_sec NLM_sec_level_4"><div id="ac_i74" class="anchor-spacer"></div><h5 class="article-section__title" id="_i74"> <i>tert</i>-Butyl (1-(2-Aminopyrimidin-4-yl)azetidin-3-yl)(butyl)carbamate (<b>24f</b>)</h5><div class="NLM_p last">A solution of carbamate <b>27f</b> (178 mg, 0.45 mmol) in MeOH (16 mL) was passed through an H-cube fitted with a Pd/C (10%) catalyst cartridge at a flow rate of 1 mL/min at 60 °C and at 10 atm H<sub>2</sub> pressure. The solvent was removed in vacuo. The resulting colorless oil (136 mg, a mixture of intermediate and diphenylmethane) was used in the next step without further purification. A microwave vial charged with chloride <b>20</b> (44 mg, 0.34 mmol), crude intermediate (136 mg), DIPEA (0.060 mL, 0.34 mmol), and NMP (0.5 mL) was heated for 30 min at 120 °C under microwave irradiation. The mixture was purified by flash chromatography (DCM/MeOH/TEA 100:0:0–80:18:2). The title compound was obtained as an off-white solid (62 mg, 46% over two steps). <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.71 (d, <i>J</i> = 6.2 Hz, 1H), 5.77 (d, <i>J</i> = 6.0 Hz, 1H), 4.54 (s, 1H), 4.32–4.14 (m, 4H), 3.35–3.25 (m, 2H), 1.62–1.47 (m, 2H), 1.44 (s, 9H), 1.38–1.24 (m, 2H), 0.98–0.90 (m, 3H). HPLC-MS (acidic mode): <i>t</i><sub>R</sub> = 3.4 min, purity: 97.5%, [M + H]<sup>+</sup>: 322.</div></div><div id="sec4_4_1_40" class="NLM_sec NLM_sec_level_4"><div id="ac_i75" class="anchor-spacer"></div><h5 class="article-section__title" id="_i75"> <i>tert</i>-Butyl (1-Benzhydrylazetidin-3-yl)carbamate (<b>26</b>)</h5><div class="NLM_p last">To a solution of amine <b>25</b> (5.00 g, 21.0 mmol) in THF (40 mL) at 0 °C was added a solution of di-<i>tert</i>-butyl dicarbonate (5.40, 25.2 mmol) in THF (40 mL) and TEA (3.51 mL, 25.2 mmol). The reaction mixture was warmed to rt and stirred for 2 h. The solvent was evaporated. Purification by flash chromatography (<i>c</i>-hexane/EtOAc/TEA 100:0:0–0:95:5) gave the title compound as a white solid (4.45 g, 63%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.39 (d, <i>J</i> = 7.6 Hz, 4H), 7.32–7.22 (m, 4H), 7.22–7.12 (m, 2H), 4.87 (br, 1H), 4.30 (br, 2H), 3.53 (t, <i>J</i> = 6.3 Hz, 2H), 2.82 (br, 2H), 1.42 (s, 9H). HPLC-MS (acidic mode): <i>t</i><sub>R</sub> = 3.5 min, purity: 97.5%, [M + H]<sup>+</sup>: 339.</div></div><div id="sec4_4_1_41" class="NLM_sec NLM_sec_level_4"><div id="ac_i76" class="anchor-spacer"></div><h5 class="article-section__title" id="_i76"> <i>tert</i>-Butyl (1-Benzhydrylazetidin-3-yl)(ethyl)carbamate (<b>27c</b>)</h5><div class="NLM_p last">To a solution of carbamate <b>26</b> (3.10 g, 9.2 mmol) in THF (30 mL) at 0 °C, NaH (60%, 0.44 g, 11.0 mmol) was added. When the evolution of H<sub>2</sub> gas subsided, iodoethane (0.81 mL, 10.1 mmol) was added dropwise to the reaction mixture. The resulting mixture was stirred overnight at rt. The reaction mixture was diluted with water (60 mL) and extracted with DCM (3 × 40 mL). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash chromatography (<i>c</i>-hexane/EtOAc 10:0–7:3) gave the title compound as a white solid (1.95 g, 58%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.48–7.35 (m, 4H), 7.32–7.23 (m, 4H), 7.23–7.12 (m, 2H), 4.34 (br, 2H), 3.51 (br, 2H), 3.27 (q, <i>J</i> = 7.1 Hz, 2H), 2.95 (br, 2H), 1.42 (s, 9H), 1.05 (t, <i>J</i> = 7.0 Hz, 3H). HPLC-MS (acidic mode): <i>t</i><sub>R</sub> = 3.9 min, purity: 99.6%, [M + H]<sup>+</sup>: 367.</div></div><div id="sec4_4_1_42" class="NLM_sec NLM_sec_level_4"><div id="ac_i77" class="anchor-spacer"></div><h5 class="article-section__title" id="_i77"> <i>tert</i>-Butyl (1-Benzhydrylazetidin-3-yl)(propyl)carbamate (<b>27d</b>)</h5><div class="NLM_p last">To a solution of carbamate <b>26</b> (4.55 g, 13.2 mmol) in THF (30 mL) at 0 °C, NaH (95%, 0.40 g, 10.5 mmol) was added. When the evolution of H<sub>2</sub> gas subsided, iodopropane (1.44 mL, 14.7 mmol) was added dropwise to the reaction mixture. The resulting mixture was stirred overnight at rt. The reaction mixture was diluted with water (200 mL) and extracted with DCM (3 × 120 mL). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash chromatography (<i>c</i>-hexane/EtOAc/TEA 100:0:0–70:28.5:1.5) gave the title compound as a white solid (2.09 g, 42%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.46–7.35 (m, 4H), 7.33–7.23 (m, 4H), 7.23–7.14 (m, 2H), 4.33 (s, 2H), 3.50 (t, <i>J</i> = 7.2 Hz, 2H), 3.22–3.10 (m, 2H), 2.93 (t, <i>J</i> = 6.9 Hz, 2H), 1.51–1.36 (m, 11H), 0.85 (t, <i>J</i> = 7.4 Hz, 3H). HPLC-MS (acidic mode): <i>t</i><sub>R</sub> = 3.9 min, purity: 99.3%, [M + H]<sup>+</sup>: 381.</div></div><div id="sec4_4_1_43" class="NLM_sec NLM_sec_level_4"><div id="ac_i78" class="anchor-spacer"></div><h5 class="article-section__title" id="_i78"> <i>tert</i>-Butyl (1-Benzhydrylazetidin-3-yl)(butyl)carbamate (<b>27f</b>)</h5><div class="NLM_p last">To a solution of carbamate <b>26</b> (552 mg, 1.60 mmol) in THF (50 mL) at 0 °C, NaH (60%, 77 mg, 1.92 mmol) was added. When the evolution of H<sub>2</sub> gas subsided, iodobutane (0.20 mL, 1.76 mmol) was added dropwise to the reaction mixture. The resulting mixture was stirred overnight at rt. The reaction mixture was diluted with water (20 mL) and extracted with DCM (3 × 15 mL). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash chromatography (<i>c</i>-hexane/EtOAc/TEA 100:0:0–0:95:5) gave the title compound as a white solid (178 mg, 28%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.46–7.36 (m, 4H), 7.32–7.23 (m, 4H), 7.23–7.14 (m, 2H), 4.33 (br, 2H), 3.59–3.35 (m, 2H), 3.26–3.12 (m, 2H), 2.93 (br, 2H), 1.50–1.34 (m, 11H, overlaps with residual <i>c</i>-hexane), 1.33–1.17 (m, 2H), 0.90 (t, <i>J</i> = 7.2 Hz, 3H). HPLC-MS (acidic mode): <i>t</i><sub>R</sub> = 4.4 min, purity: 97.8%, [M + H]<sup>+</sup>: 395.</div></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i79"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01462" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13762" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13762" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b01462" class="ext-link">10.1021/acs.jmedchem.9b01462</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Nephelometry results of <b>14d</b>; best-scored docking poses of <b>14d</b>; functional assay on H<sub>1</sub>R and H<sub>2</sub>R; effect of <b>14d</b> on CYP3A4, CYP2D6, and CYP2C9 activities; sociability effect of <b>14d</b> in the social recognition test in mice; HPLC-MS chromatogram and spectra of <b>14d</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01462/suppl_file/jm9b01462_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Biochemical data of <b>1</b>, <b>11a</b> to <b>14k</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01462/suppl_file/jm9b01462_si_003.xls" class="ext-link">XLS</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01462/suppl_file/jm9b01462_si_004.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">MD simulations of the model where the <i>n</i>Pr group of <b>14d</b> is pointing toward the extracellular vestibule (Movie 1) (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01462/suppl_file/jm9b01462_si_005.mpg" class="ext-link">MPG</a>)</p></li><li><p class="inline">MD simulations of the model where the <i>n</i>Pr group of <b>14d</b> is directed toward the intracellular half of the receptor (Movie 2) (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01462/suppl_file/jm9b01462_si_006.mpg" class="ext-link">MPG</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01462/suppl_file/jm9b01462_si_001.pdf">jm9b01462_si_001.pdf (1.47 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01462/suppl_file/jm9b01462_si_003.xls">jm9b01462_si_003.xls (100.0 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01462/suppl_file/jm9b01462_si_004.csv">jm9b01462_si_004.csv (1.85 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01462/suppl_file/jm9b01462_si_005.mpg">jm9b01462_si_005.mpg (2.46 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01462/suppl_file/jm9b01462_si_006.mpg">jm9b01462_si_006.mpg (2.83 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01462" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87482" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87482" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rob Leurs</span> - <span class="hlFld-Affiliation affiliation">Amsterdam Institute for Molecules, Medicines
and Systems (AIMMS), Division of Medicinal Chemistry, Faculty of Science, Vrije Universiteit Amsterdam, De Boelelaan 1108, 1081 HZ Amsterdam, The Netherlands</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1354-2848" title="Orcid link">http://orcid.org/0000-0003-1354-2848</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#295b07454c5c5b5a695f5c074745"><span class="__cf_email__" data-cfemail="f88ad6949d8d8a8bb88e8dd69694">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gábor Wágner</span> - <span class="hlFld-Affiliation affiliation">Amsterdam Institute for Molecules, Medicines
and Systems (AIMMS), Division of Medicinal Chemistry, Faculty of Science, Vrije Universiteit Amsterdam, De Boelelaan 1108, 1081 HZ Amsterdam, The Netherlands</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5111-6749" title="Orcid link">http://orcid.org/0000-0001-5111-6749</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tamara A. M. Mocking</span> - <span class="hlFld-Affiliation affiliation">Amsterdam Institute for Molecules, Medicines
and Systems (AIMMS), Division of Medicinal Chemistry, Faculty of Science, Vrije Universiteit Amsterdam, De Boelelaan 1108, 1081 HZ Amsterdam, The Netherlands</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marta Arimont</span> - <span class="hlFld-Affiliation affiliation">Amsterdam Institute for Molecules, Medicines
and Systems (AIMMS), Division of Medicinal Chemistry, Faculty of Science, Vrije Universiteit Amsterdam, De Boelelaan 1108, 1081 HZ Amsterdam, The Netherlands</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9367-5298" title="Orcid link">http://orcid.org/0000-0002-9367-5298</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gustavo Provensi</span> - <span class="hlFld-Affiliation affiliation">Department of Neuroscience, Psychology,
Drug Research and Child Health,
Section of Pharmacology and Toxicology and , University of Florence, Viale G. Pieraccini 6, CAP 50139 Florence, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barbara Rani</span> - <span class="hlFld-Affiliation affiliation">Department of Health Sciences and , University of Florence, Viale G. Pieraccini 6, CAP 50139 Florence, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bruna Silva-Marques</span> - <span class="hlFld-Affiliation affiliation">Department of Neuroscience, Psychology,
Drug Research and Child Health,
Section of Pharmacology and Toxicology, 
     and , University of Florence, Viale G. Pieraccini 6, CAP 50139 Florence, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Physiotherapy, Federal University of
São Carlos, Washington
Luís, km 235, SP-310 São Carlos, Brazil</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gniewomir Latacz</span> - <span class="hlFld-Affiliation affiliation">Department
of Technology and Biotechnology of Drugs, Medical College, Jagiellonian University, Medyczna 9, PL 30-688 Cracow, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Da Costa Pereira</span> - <span class="hlFld-Affiliation affiliation">Amsterdam Institute for Molecules, Medicines
and Systems (AIMMS), Division of Medicinal Chemistry, Faculty of Science, Vrije Universiteit Amsterdam, De Boelelaan 1108, 1081 HZ Amsterdam, The Netherlands</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christina Karatzidou</span> - <span class="hlFld-Affiliation affiliation">Amsterdam Institute for Molecules, Medicines
and Systems (AIMMS), Division of Medicinal Chemistry, Faculty of Science, Vrije Universiteit Amsterdam, De Boelelaan 1108, 1081 HZ Amsterdam, The Netherlands</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Henry F. Vischer</span> - <span class="hlFld-Affiliation affiliation">Amsterdam Institute for Molecules, Medicines
and Systems (AIMMS), Division of Medicinal Chemistry, Faculty of Science, Vrije Universiteit Amsterdam, De Boelelaan 1108, 1081 HZ Amsterdam, The Netherlands</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0184-6337" title="Orcid link">http://orcid.org/0000-0002-0184-6337</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maikel Wijtmans</span> - <span class="hlFld-Affiliation affiliation">Amsterdam Institute for Molecules, Medicines
and Systems (AIMMS), Division of Medicinal Chemistry, Faculty of Science, Vrije Universiteit Amsterdam, De Boelelaan 1108, 1081 HZ Amsterdam, The Netherlands</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8955-8016" title="Orcid link">http://orcid.org/0000-0001-8955-8016</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katarzyna Kieć-Kononowicz</span> - <span class="hlFld-Affiliation affiliation">Department
of Technology and Biotechnology of Drugs, Medical College, Jagiellonian University, Medyczna 9, PL 30-688 Cracow, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Iwan J. P. de Esch</span> - <span class="hlFld-Affiliation affiliation">Amsterdam Institute for Molecules, Medicines
and Systems (AIMMS), Division of Medicinal Chemistry, Faculty of Science, Vrije Universiteit Amsterdam, De Boelelaan 1108, 1081 HZ Amsterdam, The Netherlands</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e6499-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i80">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68580" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68580" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Irma Hoekstra, Jasmina Elsayed, Mohamed Ibrahim, and Alex de Waal are acknowledged for their assistance in synthesis. We thank Hans Custers for HRMS measurements, Niels Hauwert for nephelometry measurements, Inna Slynko for her contribution to docking studies, and Jasper W. van de Sande for pharmacological support. Profs. Beatrice Passani and Patrizio Blandina are thanked for their discussions on the in vivo work. This work was supported by The Netherlands Organization for Scientific Research (NWO) TOPPUNT [“7 ways to 7TMR modulation (7-to-7)”] [Grant 718.014.002]. G.P. was supported by the Brazilian National Council for Scientific and Technological Development fellowship (CNPq; 201511/2014-2). The contribution of Prof. Katarzyna Kieć-Kononowicz and Dr. Gniewomir Latacz was financially supported by the Jagiellonian University Medical College, Poland Grant no. N42/DBS/000039.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">α</td><td class="NLM_def"><p class="first last">intrinsic activity compared to histamine</p></td></tr><tr><td class="NLM_term">cAMP</td><td class="NLM_def"><p class="first last">cyclic adenosine monophosphate</p></td></tr><tr><td class="NLM_term">CRE</td><td class="NLM_def"><p class="first last"><i>c</i>AMP response element</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">FLIPR</td><td class="NLM_def"><p class="first last">fluorometric imaging plate reader</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G protein-coupled receptor</p></td></tr><tr><td class="NLM_term">GTPγS</td><td class="NLM_def"><p class="first last">guanosine 5′-<i>O</i>-[γ-thio]triphosphate</p></td></tr><tr><td class="NLM_term">IFP</td><td class="NLM_def"><p class="first last">interaction fingerprint</p></td></tr><tr><td class="NLM_term">i.p.</td><td class="NLM_def"><p class="first last">intraperitoneal</p></td></tr><tr><td class="NLM_term">mp</td><td class="NLM_def"><p class="first last">melting point</p></td></tr><tr><td class="NLM_term">MD</td><td class="NLM_def"><p class="first last">molecular dynamics</p></td></tr><tr><td class="NLM_term">NAMH</td><td class="NLM_def"><p class="first last"><i>N</i>-α-methylhistamine</p></td></tr><tr><td class="NLM_term">NMP</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-2-pyrrolidone</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">satd. aq</td><td class="NLM_def"><p class="first last">saturated aqueous</p></td></tr><tr><td class="NLM_term">S.D.</td><td class="NLM_def"><p class="first last">standard deviation</p></td></tr><tr><td class="NLM_term">S.E.M.</td><td class="NLM_def"><p class="first last">standard error of mean</p></td></tr><tr><td class="NLM_term">SFR</td><td class="NLM_def"><p class="first last">structure–function relationship</p></td></tr><tr><td class="NLM_term">rt</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">μW</td><td class="NLM_def"><p class="first last">microwave reaction</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73820" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73820" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 76 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panula, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chazot, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowart, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutzmer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W. L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thurmond, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haas, H. L.</span></span> <span> </span><span class="NLM_article-title">International Union of Basic and <tep-common:author-query>AQ9: Please check whether the updated information in ref 1 is correct.</tep-common:author-query>Clinical Pharmacology. XCVIII. Histamine receptors</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">601</span>– <span class="NLM_lpage">655</span>, <span class="refDoi"> DOI: 10.1124/pr.114.010249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1124%2Fpr.114.010249" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2014&pages=601-655&author=P.+Panulaauthor=P.+L.+Chazotauthor=M.+Cowartauthor=R.+Gutzmerauthor=R.+Leursauthor=W.+L.+S.+Liuauthor=H.+Starkauthor=R.+L.+Thurmondauthor=H.+L.+Haas&title=International+Union+of+Basic+and+%3Ctep-common%3Aauthor-query%3EAQ9%3A+Please+check+whether+the+updated+information+in+ref+1+is+correct.%3C%2Ftep-common%3Aauthor-query%3EClinical+Pharmacology.+XCVIII.+Histamine+receptors&doi=10.1124%2Fpr.114.010249"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1124%2Fpr.114.010249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.114.010249%26sid%3Dliteratum%253Aachs%26aulast%3DPanula%26aufirst%3DP.%26aulast%3DChazot%26aufirst%3DP.%2BL.%26aulast%3DCowart%26aufirst%3DM.%26aulast%3DGutzmer%26aufirst%3DR.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DW.%2BL.%2BS.%26aulast%3DStark%26aufirst%3DH.%26aulast%3DThurmond%26aufirst%3DR.%2BL.%26aulast%3DHaas%26aufirst%3DH.%2BL.%26atitle%3DInternational%2520Union%2520of%2520Basic%2520and%2520%253Ctep-common%253Aauthor-query%253EAQ9%253A%2520Please%2520check%2520whether%2520the%2520updated%2520information%2520in%2520ref%25201%2520is%2520correct.%253C%252Ftep-common%253Aauthor-query%253EClinical%2520Pharmacology.%2520XCVIII.%2520Histamine%2520receptors%26jtitle%3DPharmacol.%2520Rev.%26date%3D2014%26volume%3D67%26spage%3D601%26epage%3D655%26doi%3D10.1124%2Fpr.114.010249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arrang, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garbarg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, J. C.</span></span> <span> </span><span class="NLM_article-title">Auto-inhibition of brain histamine release mediated by a novel class (H<sub>3</sub>) of histamine receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>302</i></span>,  <span class="NLM_fpage">832</span>– <span class="NLM_lpage">837</span>, <span class="refDoi"> DOI: 10.1038/302832a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1038%2F302832a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=6188956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADyaL3sXitFSmsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=1983&pages=832-837&author=J.+M.+Arrangauthor=M.+Garbargauthor=J.+C.+Schwartz&title=Auto-inhibition+of+brain+histamine+release+mediated+by+a+novel+class+%28H3%29+of+histamine+receptor&doi=10.1038%2F302832a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Autoinhibition of brain histamine release mediated by a novel class (H3) of histamine receptor</span></div><div class="casAuthors">Arrang, Jean Michel; Garbarg, Monique; Schwartz, Jean Charles</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">5911</span>),
    <span class="NLM_cas:pages">832-7</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The K+-induced release of 3H-labeled histamine (I)  [51-45-6] from rat cerebral cortex slices was inhibited by exogenous I, suggesting the presence of histaminic receptors by which this compd. can control its own release.  Although Nα-methylhistamine  [673-50-7] and Nα,Nα-dimethylhistamine  [673-46-1] also inhibited [3H]-I release, a no. of compds. known to exhibit agonist activities of H1 or H2 receptors had no significant effect.  Consequently, autoinhibition of I release by the brain is apparently mediated by a type of receptor (histaminic H3) that is clearly different from H1 and H2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpu3HYACgLprVg90H21EOLACvtfcHk0ljwDpxdz-GUGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXitFSmsbc%253D&md5=891b1e95467aa9213317c930f12bf3b7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F302832a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F302832a0%26sid%3Dliteratum%253Aachs%26aulast%3DArrang%26aufirst%3DJ.%2BM.%26aulast%3DGarbarg%26aufirst%3DM.%26aulast%3DSchwartz%26aufirst%3DJ.%2BC.%26atitle%3DAuto-inhibition%2520of%2520brain%2520histamine%2520release%2520mediated%2520by%2520a%2520novel%2520class%2520%2528H3%2529%2520of%2520histamine%2520receptor%26jtitle%3DNature%26date%3D1983%26volume%3D302%26spage%3D832%26epage%3D837%26doi%3D10.1038%2F302832a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schlicker, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kathmann, M.</span></span> <span> </span><span class="NLM_article-title">Role of the histamine H<sub>3</sub> receptor in the central nervous system</span>. <i>Handb. Exp. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>241</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">299</span>, <span class="refDoi"> DOI: 10.1007/164_2016_12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1007%2F164_2016_12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=27787717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVGkt7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=241&publication_year=2017&pages=277-299&author=E.+Schlickerauthor=M.+Kathmann&title=Role+of+the+histamine+H3+receptor+in+the+central+nervous+system&doi=10.1007%2F164_2016_12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the histamine H3 receptor in the central nervous system</span></div><div class="casAuthors">Schlicker, Eberhard; Kathmann, Markus</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">241</span>
        (<span class="NLM_cas:issue">Histamine and Histamine Receptors in Health and Disease</span>),
    <span class="NLM_cas:pages">277-299</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">1865-0325</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">The Gi/o protein-coupled histamine H3 receptor is distributed throughout the central nervous system including areas like cerebral cortex, hippocampus and striatum with the d. being highest in the posterior hypothalamus, i.e. the area in which the histaminergic cell bodies are located.  In contrast to the other histamine receptor subtypes (H1, H2 and H4), the H3 receptor is located presynaptically and shows a constitutive activity.  In detail, H3 receptors are involved in the inhibition of histamine release (presynaptic autoreceptor), impulse flow along the histaminergic neurons (somadendritic autoreceptor) and histamine synthesis.  Moreover, they occur as inhibitory presynaptic heteroreceptors on serotoninergic, noradrenergic, dopaminergic, glutamatergic, GABAergic and perhaps cholinergic neurons.  This review shows for four functions of the brain that the H3 receptor represents a brake against the wake-promoting, anticonvulsant and anorectic effect of histamine (via postsynaptic H1 receptors) and its procognitive activity (via postsynaptic H1 and H2 receptors).  Indeed, H1 agonists and H3 inverse agonists elicit essentially the same effects, at least in rodents; these effects are opposite in direction to those elicited by brain-penetrating H1 receptor antagonists in humans.  Although the benefit for H3 inverse agonists for the symptomatic treatment of dementias is inconclusive, several members of this group have shown a marked potential for the treatment of disorders assocd. with excessive daytime sleepiness.  In March 2016, the European Commission granted a marketing authorisation for pitolisant (WakixR) (as the first representative of the H3 inverse agonists) for the treatment of narcolepsy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRxj_MzY8jbLVg90H21EOLACvtfcHk0liDBU7H5mILmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVGkt7vO&md5=a13d674516616afba34b4029cd4885bd</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2F164_2016_12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F164_2016_12%26sid%3Dliteratum%253Aachs%26aulast%3DSchlicker%26aufirst%3DE.%26aulast%3DKathmann%26aufirst%3DM.%26atitle%3DRole%2520of%2520the%2520histamine%2520H3%2520receptor%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2017%26volume%3D241%26spage%3D277%26epage%3D299%26doi%3D10.1007%2F164_2016_12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stark, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kathmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlicker, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schunack, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlegel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sippl, W.</span></span> <span> </span><span class="NLM_article-title">Medicinal chemical and pharmacological aspects of imidazole-containing histamine H3 receptor antagonists</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">965</span>– <span class="NLM_lpage">977</span>, <span class="refDoi"> DOI: 10.2174/1389557043403107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.2174%2F1389557043403107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=15544557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosFyhtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=965-977&author=H.+Starkauthor=M.+Kathmannauthor=E.+Schlickerauthor=W.+Schunackauthor=B.+Schlegelauthor=W.+Sippl&title=Medicinal+chemical+and+pharmacological+aspects+of+imidazole-containing+histamine+H3+receptor+antagonists&doi=10.2174%2F1389557043403107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemical and pharmacological aspects of imidazole-containing histamine H3 receptor antagonists</span></div><div class="casAuthors">Stark, Holger; Kathmann, Markus; Schlicker, Eberhard; Schunack, Walter; Schlegel, Birgit; Sippl, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">965-977</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The 1st antagonists known for the histamine H3 receptor were mono-substituted imidazole-contg. compds. like thioperamide.  Meanwhile numerous novel leads were developed possessing improved affinities, selectivities, specificities, and pharmacokinetic properties.  Scope and limitations of this promising class are discussed concerning their structure-activity relationships as well as pharmacol. and potential therapeutic aspects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBGlF2FqscGrVg90H21EOLACvtfcHk0liDBU7H5mILmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosFyhtLg%253D&md5=942bb2726669c4457f673ec996a88251</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F1389557043403107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557043403107%26sid%3Dliteratum%253Aachs%26aulast%3DStark%26aufirst%3DH.%26aulast%3DKathmann%26aufirst%3DM.%26aulast%3DSchlicker%26aufirst%3DE.%26aulast%3DSchunack%26aufirst%3DW.%26aulast%3DSchlegel%26aufirst%3DB.%26aulast%3DSippl%26aufirst%3DW.%26atitle%3DMedicinal%2520chemical%2520and%2520pharmacological%2520aspects%2520of%2520imidazole-containing%2520histamine%2520H3%2520receptor%2520antagonists%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2004%26volume%3D4%26spage%3D965%26epage%3D977%26doi%3D10.2174%2F1389557043403107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ganellin, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurquin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piripitsi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrang, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garbarg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligneau, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schunack, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, J.-C.</span></span> <span> </span><span class="NLM_article-title">Synthesis of potent non-imidazole histamine H<sub>3</sub>-receptor antagonists</span>. <i>Arch. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>331</i></span>,  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">404</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1521-4184(199812)331:12<395::AID-ARDP395>3.0.CO;2-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1002%2F%28SICI%291521-4184%28199812%29331%3A12%3C395%3A%3AAID-ARDP395%3E3.0.CO%3B2-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=9923195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADyaK1MXivFWkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=1998&pages=395-404&author=C.+R.+Ganellinauthor=F.+Leurquinauthor=A.+Piripitsiauthor=J.+M.+Arrangauthor=M.+Garbargauthor=X.+Ligneauauthor=W.+Schunackauthor=J.-C.+Schwartz&title=Synthesis+of+potent+non-imidazole+histamine+H3-receptor+antagonists&doi=10.1002%2F%28SICI%291521-4184%28199812%29331%3A12%3C395%3A%3AAID-ARDP395%3E3.0.CO%3B2-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of potent non-imidazole histamine H3-receptor antagonists</span></div><div class="casAuthors">Ganellin, C. Robin; Leurquin, Fabien; Piripitsi, Antonia; Arrang, Jean-Michel; Garbarg, Monique; Ligneau, Xavier; Schunack, Walter; Schwartz, Jean-Charles</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">331</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">395-404</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">Histamine was converted into a non-imidazole H3-receptor histamine antagonist by addn. of a 4-phenylbutyl group at the Nα-position followed by removal of the imidazole ring.  The resulting compd., N-ethyl-N-(4-phenylbutyl)amine, had a Ki = 1.3 μM as an H3 antagonist.  Using this as a lead compd., a series of homologous O and S isosteric tertiary amines was synthesized and structure-activity studies furnished N-(5-phenoxypentyl)pyrrolidine (Ki = 0.18 μM for [3H]histamine release from rat cerebral cortex synaptosomes) which was active in vivo.  Substitution of NO2 into the para position of the phenoxy group gave N-(5-p-nitrophenoxypentyl)pyrrolidine, UCL 1972 (Ki = 39 μM), ED50 = 1.1 mg/kg per os in mice on brain tele-methylhistamine levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNYq84DJ1FlrVg90H21EOLACvtfcHk0liDBU7H5mILmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXivFWkuw%253D%253D&md5=849df6e056508e04d5f3c7ff02cea344</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-4184%28199812%29331%3A12%3C395%3A%3AAID-ARDP395%3E3.0.CO%3B2-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-4184%2528199812%2529331%253A12%253C395%253A%253AAID-ARDP395%253E3.0.CO%253B2-7%26sid%3Dliteratum%253Aachs%26aulast%3DGanellin%26aufirst%3DC.%2BR.%26aulast%3DLeurquin%26aufirst%3DF.%26aulast%3DPiripitsi%26aufirst%3DA.%26aulast%3DArrang%26aufirst%3DJ.%2BM.%26aulast%3DGarbarg%26aufirst%3DM.%26aulast%3DLigneau%26aufirst%3DX.%26aulast%3DSchunack%26aufirst%3DW.%26aulast%3DSchwartz%26aufirst%3DJ.-C.%26atitle%3DSynthesis%2520of%2520potent%2520non-imidazole%2520histamine%2520H3-receptor%2520antagonists%26jtitle%3DArch.%2520Pharm.%26date%3D1998%26volume%3D331%26spage%3D395%26epage%3D404%26doi%3D10.1002%2F%28SICI%291521-4184%28199812%29331%3A12%3C395%3A%3AAID-ARDP395%3E3.0.CO%3B2-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Celanire, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wijtmans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talaga, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Esch, I. J. P.</span></span> <span> </span><span class="NLM_article-title">Keynote review: Histamine H<sub>3</sub> receptor antagonists reach out for the clinic</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1613</span>– <span class="NLM_lpage">1627</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(05)03625-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1016%2FS1359-6446%2805%2903625-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=16376822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlCrtrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=1613-1627&author=S.+Celanireauthor=M.+Wijtmansauthor=P.+Talagaauthor=R.+Leursauthor=I.+J.+P.+de+Esch&title=Keynote+review%3A+Histamine+H3+receptor+antagonists+reach+out+for+the+clinic&doi=10.1016%2FS1359-6446%2805%2903625-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Keynote review: Histamine H3 receptor antagonists reach out for the clinic</span></div><div class="casAuthors">Celanire, Sylvain; Wijtmans, Maikel; Talaga, Patrice; Leurs, Rob; de Esch, Iwan J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">23/24</span>),
    <span class="NLM_cas:pages">1613-1627</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Histamine receptors represent a tried and tested target for the treatments of various conditions including allergic responses, gastric ulcers and dyspepsia.  The eagerly awaited new generation of histamine H3 antagonists looks set to represent a new class of potential blockbuster drugs.  Antagonists of the histamine H1 and H2 receptors have been successful as blockbuster drugs for treating allergic conditions and gastric ulcers, resp.  As such, histamine receptors have made a significant contribution to establishing G-Protein-coupled receptors as the favored drug targets of the industry.  In this light, it can easily be understood that the discovery of a third histamine receptor subtype (H3R) in 1983 was greeted with considerable excitement.  However, characterization of the H3R turned out to be far from trivial.  In the past five years, mol. biol. approaches have given fresh impetus to the H3R research field.  As a result, H3R ligands are where they were anticipated to be 20 years ago: at the center of attention and on the verge of an anticipated breakthrough as the next generation of histaminergic blockbuster drugs.  Here, we assess the status of the H3R medicinal chem. programs of the various players in the field, as far as can be deduced from patent applications and scientific literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUsoQNsCQFFrVg90H21EOLACvtfcHk0ljFM5n8W49M6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlCrtrjJ&md5=3d534a18de31f56df11a5dd5aaf34a66</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2805%2903625-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252805%252903625-1%26sid%3Dliteratum%253Aachs%26aulast%3DCelanire%26aufirst%3DS.%26aulast%3DWijtmans%26aufirst%3DM.%26aulast%3DTalaga%26aufirst%3DP.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26atitle%3DKeynote%2520review%253A%2520Histamine%2520H3%2520receptor%2520antagonists%2520reach%2520out%2520for%2520the%2520clinic%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2005%26volume%3D10%26spage%3D1613%26epage%3D1627%26doi%3D10.1016%2FS1359-6446%2805%2903625-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lebois, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span> <span> </span><span class="NLM_article-title">The evolution of histamine H<sub>3</sub> antagonists/inverse agonists</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">648</span>– <span class="NLM_lpage">660</span>, <span class="refDoi"> DOI: 10.2174/1568026611109060648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.2174%2F1568026611109060648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=21261594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslSmsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=648-660&author=E.+P.+Leboisauthor=C.+K.+Jonesauthor=C.+W.+Lindsley&title=The+evolution+of+histamine+H3+antagonists%2Finverse+agonists&doi=10.2174%2F1568026611109060648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of histamine H3 antagonists/inverse agonists</span></div><div class="casAuthors">Lebois, Evan P.; Jones, Carrie K.; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">648-660</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This article describes our efforts along with recent advances in the development, biol. evaluation and clin. proof of concept of small mol. histamine H3 antagonists/inverse agonists.  The H3 receptor is a presynaptic autoreceptor within the Class A GPCR family, but also functions as a heteroreceptor modulating levels of neurotransmitters such as dopamine, acetylcholine, norepinephrine, serotonin, GABA and glutamate.  Thus, H3R has garnered a great deal of interest from the pharmaceutical industry for the possible treatment of obesity, epilepsy, sleep/wake, schizophrenia, Alzheimer's disease, neuropathic pain and ADHD.  Within the two main classes of H3 ligands, both imidazole and non-imidazole derived, have shown sufficient potency and specificity which culminated with efficacy in preclin. models for various CNS disorders.  Importantly, conserved elements have been identified within the small mol. H3 ligand scaffolds that resulted in a highly predictive pharmacophore model.  Understanding of the pharmacophore model has allowed several groups to dial H3R activity into scaffolds designed for other CNS targets, and engender directed polypharmacol.  Moreover, Abbott, GSK, Pfizer and several others have reported pos. Phase I and/or Phase II data with structurally diverse H3R antagonists/inverse agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpqYa1Cbba9bVg90H21EOLACvtfcHk0ljFM5n8W49M6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslSmsr4%253D&md5=511cdab35b85a73969fecac97896c24d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2174%2F1568026611109060648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026611109060648%26sid%3Dliteratum%253Aachs%26aulast%3DLebois%26aufirst%3DE.%2BP.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DThe%2520evolution%2520of%2520histamine%2520H3%2520antagonists%252Finverse%2520agonists%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D648%26epage%3D660%26doi%3D10.2174%2F1568026611109060648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuhne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wijtmans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Esch, I. J. P.</span></span> <span> </span><span class="NLM_article-title">Several down, a few to go: histamine H<sub>3</sub> receptor ligands making the final push towards the market?</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1629</span>– <span class="NLM_lpage">1648</span>, <span class="refDoi"> DOI: 10.1517/13543784.2011.625010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1517%2F13543784.2011.625010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=21992603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVyltL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=1629-1648&author=S.+Kuhneauthor=M.+Wijtmansauthor=H.+D.+Limauthor=R.+Leursauthor=I.+J.+P.+de+Esch&title=Several+down%2C+a+few+to+go%3A+histamine+H3+receptor+ligands+making+the+final+push+towards+the+market%3F&doi=10.1517%2F13543784.2011.625010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Several down, a few to go: histamine H3 receptor ligands making the final push towards the market?</span></div><div class="casAuthors">Kuhne, Sebastiaan; Wijtmans, Maikel; Lim, Herman D.; Leurs, Rob; de Esch, Iwan J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1629-1648</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction:The histamine H3 receptor (H3R) plays a pivotal role in a plethora of therapeutic areas.  Blocking the H3R with antagonists/inverse agonists has been postulated to be of broad therapeutic use.  Indeed, H3R antagonists/inverse agonists have been extensively evaluated in the clinic.Areas covered:Here, we address new developments, insights obtained and challenges encountered in the clin. evaluations.  For recent H3R clin. candidates, the status and results of the corresponding clin. trial(s) will be discussed along with preclin. data.  Main findings: In all, it becomes evident that clin. evaluation of H3R antagonists/inverse agonists is characterized by mixed results.  On one hand, Pitolisant has successfully passed several Phase II trials and seems to be the most advanced compd. in the clinic now, being in Phase III.  On the other hand, some compds. (e.g., PF-03654647 and MK-0249) failed at Phase II clin. level for several indications.Expert opinion:A challenging feature in H3R research is the multifaceted role of the receptor at a mol./biochem. level, which can complicate targeting by small mols. at several (pre)clin. levels.  Accordingly, H3R antagonists/inverse agonists require further testing to pinpoint the determinants for clin. efficacy and to aid in the final push towards the market.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL4R4cmsASwLVg90H21EOLACvtfcHk0ljFM5n8W49M6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVyltL7N&md5=25d7e80b666a495a039011a83899e36e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1517%2F13543784.2011.625010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2011.625010%26sid%3Dliteratum%253Aachs%26aulast%3DKuhne%26aufirst%3DS.%26aulast%3DWijtmans%26aufirst%3DM.%26aulast%3DLim%26aufirst%3DH.%2BD.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26atitle%3DSeveral%2520down%252C%2520a%2520few%2520to%2520go%253A%2520histamine%2520H3%2520receptor%2520ligands%2520making%2520the%2520final%2520push%2520towards%2520the%2520market%253F%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2011%26volume%3D20%26spage%3D1629%26epage%3D1648%26doi%3D10.1517%2F13543784.2011.625010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sadek, B.</span>; <span class="NLM_string-name">Łażewska, D.</span>; <span class="NLM_string-name">Hagenow, S.</span>; <span class="NLM_string-name">Kieć-Kononowicz, K.</span>; <span class="NLM_string-name">Stark, H.</span></span> <span> </span><span class="NLM_article-title">Histamine H<sub>3</sub>R Antagonists: From Scaffold Hopping to Clinical Candidates</span>. In  <i>Histamine Receptors</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blandina, P.</span>, <span class="NLM_string-name">Passani, M.</span></span>, Eds.; <span class="NLM_series">The Receptors</span>; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">Cham</span>, <span class="NLM_year">2016</span>; Vol.  <span class="NLM_volume">28</span>, pp  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">155</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1007%2F978-3-319-40308-3_5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=109-155&author=B.+Sadek&author=D.+%C5%81a%C5%BCewska&author=S.+Hagenow&author=K.+Kie%C4%87-Kononowicz&author=H.+Starkauthor=P.+Blandina&author=M.+Passani&title=Histamine+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-40308-3_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-319-40308-3_5%26sid%3Dliteratum%253Aachs%26aulast%3DSadek%26aufirst%3DB.%26atitle%3DHistamine%2520H3R%2520Antagonists%253A%2520From%2520Scaffold%2520Hopping%2520to%2520Clinical%2520Candidates%26btitle%3DHistamine%2520Receptors%26aulast%3DBlandina%26aufirst%3DP.%26pub%3DHumana%2520Press%26date%3D2016%26volume%3D28%26spage%3D109%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kollb-Sielecka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demolis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmerich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markey, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmonson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haas, M.</span></span> <span> </span><span class="NLM_article-title">The European Medicines Agency review of pitolisant for treatment of narcolepsy: summary of the scientific assessment by the Committee for Medicinal Products for Human Use</span>. <i>Sleep Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">129</span>, <span class="refDoi"> DOI: 10.1016/j.sleep.2017.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1016%2Fj.sleep.2017.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=28449891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A280%3ADC%252BC1crhvVGnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2017&pages=125-129&author=M.+Kollb-Sieleckaauthor=P.+Demolisauthor=J.+Emmerichauthor=G.+Markeyauthor=T.+Salmonsonauthor=M.+Haas&title=The+European+Medicines+Agency+review+of+pitolisant+for+treatment+of+narcolepsy%3A+summary+of+the+scientific+assessment+by+the+Committee+for+Medicinal+Products+for+Human+Use&doi=10.1016%2Fj.sleep.2017.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The European Medicines Agency review of pitolisant for treatment of narcolepsy: summary of the scientific assessment by the Committee for Medicinal Products for Human Use</span></div><div class="casAuthors">Kollb-Sielecka Marta; Demolis Pierre; Emmerich Joseph; Markey Greg; Salmonson Tomas; Haas Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Sleep medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">125-129</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">On 31 March 2016, the European Commission issued a decision for a marketing authorisation valid throughout the European Union (EU) for pitolisant (Wakix) for the treatment of narcolepsy with or without cataplexy in adults.  Pitolisant is an antagonist/inverse agonist of the human histamine H3 receptor.  The dose should be selected using an up-titration scheme depending on individual patient response and tolerance and should not exceed 36 mg/day.  The main evidence of efficacy of pitolisant was based on two Phase III clinical trials.  The improvement on excessive daytime sleepiness was shown against placebo in the Harmony I study (-3.33 points; 95% confidence interval (CI) [-5.83; -0.83]; p = 0.024) and in Harmony CTP (-3.41 points; 95% CI [-4.95; -1.87]; p < 0.0001).  The daily cataplexy rate in Harmony I improved against placebo with a rate ratio (rR) of 0.38 whilst in the Harmony CTP the ratio of improvement on weekly cataplexy rate against placebo was 0.512.  The most commonly reported adverse reactions were headache, insomnia and nausea.  This article summarizes the scientific review leading to approval of pitolisant in the EU.  The assessment report and product information are available on the European Medicines Agency website (http://www.ema.europa.eu).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQm-VCMMXIrVkNoizSOkG_FfW6udTcc2eazNHIYLwUnk7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1crhvVGnsg%253D%253D&md5=2f820dc747146322af50c191bb0c0f98</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.sleep.2017.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sleep.2017.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DKollb-Sielecka%26aufirst%3DM.%26aulast%3DDemolis%26aufirst%3DP.%26aulast%3DEmmerich%26aufirst%3DJ.%26aulast%3DMarkey%26aufirst%3DG.%26aulast%3DSalmonson%26aufirst%3DT.%26aulast%3DHaas%26aufirst%3DM.%26atitle%3DThe%2520European%2520Medicines%2520Agency%2520review%2520of%2520pitolisant%2520for%2520treatment%2520of%2520narcolepsy%253A%2520summary%2520of%2520the%2520scientific%2520assessment%2520by%2520the%2520Committee%2520for%2520Medicinal%2520Products%2520for%2520Human%2520Use%26jtitle%3DSleep%2520Med.%26date%3D2017%26volume%3D33%26spage%3D125%26epage%3D129%26doi%3D10.1016%2Fj.sleep.2017.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Harmony
Biosciences LLC</span>. <a href="https://www.harmonybiosciences.com/newsroom/harmony-biosciences-announces-fda-approval-of-wakix-r-pitolisant-a-first-in/" class="extLink">https://www.harmonybiosciences.com/newsroom/harmony-biosciences-announces-fda-approval-of-wakix-r-pitolisant-a-first-in/</a> (accessed Aug 15, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Harmony%0ABiosciences+LLC.+https%3A%2F%2Fwww.harmonybiosciences.com%2Fnewsroom%2Fharmony-biosciences-announces-fda-approval-of-wakix-r-pitolisant-a-first-in%2F+%28accessed+Aug+15%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kazuta, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natsume, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furuichi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuto, S.</span></span> <span> </span><span class="NLM_article-title">Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist for the histamine H<sub>3</sub> receptor, having a cis-cyclopropane structure</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1980</span>– <span class="NLM_lpage">1988</span>, <span class="refDoi"> DOI: 10.1021/jm020415q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020415q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitF2qtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1980-1988&author=Y.+Kazutaauthor=K.+Hiranoauthor=K.+Natsumeauthor=S.+Yamadaauthor=R.+Kimuraauthor=S.+I.+Matsumotoauthor=K.+Furuichiauthor=A.+Matsudaauthor=S.+Shuto&title=Cyclopropane-based+conformational+restriction+of+histamine.+%281S%2C2S%29-2-%282-aminoethyl%29-1-%281H-imidazol-4-yl%29cyclopropane%2C+a+highly+selective+agonist+for+the+histamine+H3+receptor%2C+having+a+cis-cyclopropane+structure&doi=10.1021%2Fjm020415q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclopropane-Based Conformational Restriction of Histamine. (1S,2S)-2-(2-Aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a Highly Selective Agonist for the Histamine H3 Receptor, Having a cis-Cyclopropane Structure</span></div><div class="casAuthors">Kazuta, Yuji; Hirano, Kazufumi; Natsume, Kentaro; Yamada, Shizuo; Kimura, Ryohei; Matsumoto, Shunichiro; Furuichi, Kiyoshi; Matsuda, Akira; Shuto, Satoshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1980-1988</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of cyclopropane-based conformationally restricted analogs of histamine, the "folded" cis-analogs, i.e. I (R1 = H2N, H2NCH2, H2NCH2CH2) and their enantiomers, and the "extended" trans-analogs, i.e. II and its enantiomer, were designed as histamine H3 receptor agonists.  The compds. I and II were synthesized from the versatile chiral cyclopropane units III (R2 = H2N, H2NCH2, H2NCH2CH2).  Among the conformationally restricted analogs, the "folded" analog I (R1 = H2NCH2CH2) was identified as a potent H3 receptor agonist, which showed a significant binding affinity (Ki = 1.31 ± 0.16 nM) and had an agonist effect (EC50 value of 10 ± 3 nM) on the receptor.  This compd. owes its importance to being the first highly selective H3 receptor agonist to have virtually no effect on the H4 subtype receptor.  These studies showed that the cis-cyclopropane structure is very effective in the conformational restriction of histamine to improve the specific binding to the histamine H3 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr10ks4Q3LNlbVg90H21EOLACvtfcHk0lgtjxOHWgLXiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitF2qtLk%253D&md5=93b0b6f6c12157c9b1dd581f53222ff1</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm020415q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020415q%26sid%3Dliteratum%253Aachs%26aulast%3DKazuta%26aufirst%3DY.%26aulast%3DHirano%26aufirst%3DK.%26aulast%3DNatsume%26aufirst%3DK.%26aulast%3DYamada%26aufirst%3DS.%26aulast%3DKimura%26aufirst%3DR.%26aulast%3DMatsumoto%26aufirst%3DS.%2BI.%26aulast%3DFuruichi%26aufirst%3DK.%26aulast%3DMatsuda%26aufirst%3DA.%26aulast%3DShuto%26aufirst%3DS.%26atitle%3DCyclopropane-based%2520conformational%2520restriction%2520of%2520histamine.%2520%25281S%252C2S%2529-2-%25282-aminoethyl%2529-1-%25281H-imidazol-4-yl%2529cyclopropane%252C%2520a%2520highly%2520selective%2520agonist%2520for%2520the%2520histamine%2520H3%2520receptor%252C%2520having%2520a%2520cis-cyclopropane%2520structure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1980%26epage%3D1988%26doi%3D10.1021%2Fjm020415q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kitbunnadaj, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuiderveld, O. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Esch, I. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vollinga, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lutz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spek, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavoy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deltent, M.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menge, W. M. P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure–activity relationships of conformationally constrained histamine H<sub>3</sub> receptor agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">5445</span>– <span class="NLM_lpage">5457</span>, <span class="refDoi"> DOI: 10.1021/jm030905y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030905y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD3sXos1SlsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=5445-5457&author=R.+Kitbunnadajauthor=O.+P.+Zuiderveldauthor=I.+J.+P.+de+Eschauthor=R.+C.+Vollingaauthor=R.+Bakkerauthor=M.+Lutzauthor=A.+L.+Spekauthor=E.+Cavoyauthor=M.-F.+Deltentauthor=W.+M.+P.+B.+Mengeauthor=H.+Timmermanauthor=R.+Leurs&title=Synthesis+and+structure%E2%80%93activity+relationships+of+conformationally+constrained+histamine+H3+receptor+agonists&doi=10.1021%2Fjm030905y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure-Activity Relationships of Conformationally Constrained Histamine H3 Receptor Agonists</span></div><div class="casAuthors">Kitbunnadaj, Ruengwit; Zuiderveld, Obbe P.; De Esch, Iwan J. P.; Vollinga, Roeland C.; Bakker, Remko; Lutz, Martin; Spek, Anthony L.; Cavoy, Emile; Deltent, Marie-France; Menge, Wiro M. P. B.; Timmerman, Henk; Leurs, Rob</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">5445-5457</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Immepip, a conformationally constrained analog of the histamine congener imbutamine, shows high affinity and functional activity on the human H3 receptor.  Using histamine and its homologs as prototypes, other rigid analogs contg. either a piperidine or pyrrolidine ring in the side chain were synthesized and tested for their activities at the human H3 receptor and the closely related H4 receptor.  In the series of piperidine contg. analogs, immepip was found to be the most potent H3 receptor agonist, whereas a propylene analog was identified as a high-affinity neutral antagonist for the human H3 receptor.  Moreover, replacement of the piperidine ring of immepip by a pyrrolidine ring led to a pair of enantiomers that show a distinct stereoselectivity at the human H3 and H4 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAbj8TTwbU8bVg90H21EOLACvtfcHk0lgtjxOHWgLXiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXos1SlsL0%253D&md5=c28c9539b49258e59427bc8f37a880b4</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm030905y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030905y%26sid%3Dliteratum%253Aachs%26aulast%3DKitbunnadaj%26aufirst%3DR.%26aulast%3DZuiderveld%26aufirst%3DO.%2BP.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3DVollinga%26aufirst%3DR.%2BC.%26aulast%3DBakker%26aufirst%3DR.%26aulast%3DLutz%26aufirst%3DM.%26aulast%3DSpek%26aufirst%3DA.%2BL.%26aulast%3DCavoy%26aufirst%3DE.%26aulast%3DDeltent%26aufirst%3DM.-F.%26aulast%3DMenge%26aufirst%3DW.%2BM.%2BP.%2BB.%26aulast%3DTimmerman%26aufirst%3DH.%26aulast%3DLeurs%26aufirst%3DR.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520conformationally%2520constrained%2520histamine%2520H3%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D5445%26epage%3D5457%26doi%3D10.1021%2Fjm030905y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kitbunnadaj, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuiderveld, O. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christophe, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulscher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menge, W. M. P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelens, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snip, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakker, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Celanire, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talaga, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span> <span> </span><span class="NLM_article-title">Identification of 4-(1H-Imidazol-4(5)-ylmethyl)pyridine (immethridine) as a novel, potent, and highly selective histamine H<sub>3</sub> receptor agonist</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2414</span>– <span class="NLM_lpage">2417</span>, <span class="refDoi"> DOI: 10.1021/jm049932u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049932u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivFSrsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2414-2417&author=R.+Kitbunnadajauthor=O.+P.+Zuiderveldauthor=B.+Christopheauthor=S.+Hulscherauthor=W.+M.+P.+B.+Mengeauthor=E.+Gelensauthor=E.+Snipauthor=R.+A.+Bakkerauthor=S.+Celanireauthor=M.+Gillardauthor=P.+Talagaauthor=H.+Timmermanauthor=R.+Leurs&title=Identification+of+4-%281H-Imidazol-4%285%29-ylmethyl%29pyridine+%28immethridine%29+as+a+novel%2C+potent%2C+and+highly+selective+histamine+H3+receptor+agonist&doi=10.1021%2Fjm049932u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of 4-(1H-Imidazol-4(5)-ylmethyl)pyridine (immethridine) as a Novel, Potent, and Highly Selective Histamine H3 Receptor Agonist</span></div><div class="casAuthors">Kitbunnadaj, Ruengwit; Zuiderveld, Obbe P.; Christophe, Bernard; Hulscher, Saskia; Menge, Wiro M. P. B.; Gelens, Edith; Snip, Erwin; Bakker, Remko A.; Celanire, Sylvain; Gillard, Michel; Talaga, Patrice; Timmerman, Henk; Leurs, Rob</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2414-2417</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this study, the piperidine ring of immepip and its analogs was replaced by a rigid heterocyclic pyridine ring.  Many compds. in the series exhibit high affinity and agonist activity at the human histamine H3 receptor.  Particularly, the 4-pyridinyl analog of immepip (immethridine) is identified as a novel potent and highly selective histamine H3 receptor agonist (pKi = 9.07, pEC50 = 9.74) with a 300-fold selectivity over the closely related H4 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSB7-YU2AxdLVg90H21EOLACvtfcHk0liEyTiubF70rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivFSrsrw%253D&md5=df8febb3d4f05a616aad9d95b1186a10</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm049932u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049932u%26sid%3Dliteratum%253Aachs%26aulast%3DKitbunnadaj%26aufirst%3DR.%26aulast%3DZuiderveld%26aufirst%3DO.%2BP.%26aulast%3DChristophe%26aufirst%3DB.%26aulast%3DHulscher%26aufirst%3DS.%26aulast%3DMenge%26aufirst%3DW.%2BM.%2BP.%2BB.%26aulast%3DGelens%26aufirst%3DE.%26aulast%3DSnip%26aufirst%3DE.%26aulast%3DBakker%26aufirst%3DR.%2BA.%26aulast%3DCelanire%26aufirst%3DS.%26aulast%3DGillard%26aufirst%3DM.%26aulast%3DTalaga%26aufirst%3DP.%26aulast%3DTimmerman%26aufirst%3DH.%26aulast%3DLeurs%26aufirst%3DR.%26atitle%3DIdentification%2520of%25204-%25281H-Imidazol-4%25285%2529-ylmethyl%2529pyridine%2520%2528immethridine%2529%2520as%2520a%2520novel%252C%2520potent%252C%2520and%2520highly%2520selective%2520histamine%2520H3%2520receptor%2520agonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2414%26epage%3D2417%26doi%3D10.1021%2Fjm049932u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meier, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hüls, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligneau, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertz, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrang, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganellin, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schunack, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, H.</span></span> <span> </span><span class="NLM_article-title">4-(ω-(Alkyloxy)alkyl)-1H-imidazole derivatives as histamine H<sub>3</sub> receptor antagonists/agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2678</span>– <span class="NLM_lpage">2687</span>, <span class="refDoi"> DOI: 10.1021/jm031065q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm031065q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtVSqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2678-2687&author=G.+Meierauthor=M.+Krauseauthor=A.+H%C3%BClsauthor=X.+Ligneauauthor=H.+H.+Pertzauthor=J.+M.+Arrangauthor=C.+R.+Ganellinauthor=J.+C.+Schwartzauthor=W.+Schunackauthor=H.+Stark&title=4-%28%CF%89-%28Alkyloxy%29alkyl%29-1H-imidazole+derivatives+as+histamine+H3+receptor+antagonists%2Fagonists&doi=10.1021%2Fjm031065q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">4-(ω-(Alkyloxy)alkyl)-1H-imidazole Derivatives as Histamine H3 Receptor Antagonists/Agonists</span></div><div class="casAuthors">Meier, Galina; Krause, Michael; Huels, Annette; Ligneau, Xavier; Pertz, Heinz H.; Arrang, Jean-Michel; Ganellin, C. Robin; Schwartz, Jean-Charles; Schunack, Walter; Stark, Holger</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2678-2687</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In an effort to develop new histamine H3 receptor antagonists usable as pharmacol. tools, the authors present here novel unsym. ether derivs.  Etherification of different ω-(1H-imidazol-4-yl)alkyl scaffolds led to compds. contg. alkyl chains of increasing lengths either with or without unsatd. termini, cycloalkyl or arylalkyl moieties, or addnl. heteroatoms.  When investigated in an in vitro assay on rat synaptosomes, the majority of compds. displayed potencies in the low nanomolar concn. range at the H3 receptor, e.g., 4-(3-(3-cyclopentylpropyloxy)propyl)-1H-imidazole (27, Ki = 7 nM).  FUB 465, 4-(3-(ethoxy)propyl)-1H-imidazole, a useful tool for the characterization of constitutive activity of H3 receptors in vivo in rodents, proved to be of high oral in vivo potency in mice (ED50 = 0.26 mg/kg).  Further, the influence of chosen compds. on specific [35S]GTPγS binding was assayed on HEK293 cell membranes expressing the human histamine H3 receptor revealing partial agonism of the compds. in this particular model.  These distinct responses are further hints for "protean agonism" in this class of compds.  Addnl., selected compds. were functionally investigated in vitro on isolated organs of the guinea-pig at H3, H1, and H2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwkkTfmYqSHLVg90H21EOLACvtfcHk0liEyTiubF70rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtVSqurc%253D&md5=351d3efdb766bc08951912ee6c9f8d89</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm031065q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm031065q%26sid%3Dliteratum%253Aachs%26aulast%3DMeier%26aufirst%3DG.%26aulast%3DKrause%26aufirst%3DM.%26aulast%3DH%25C3%25BCls%26aufirst%3DA.%26aulast%3DLigneau%26aufirst%3DX.%26aulast%3DPertz%26aufirst%3DH.%2BH.%26aulast%3DArrang%26aufirst%3DJ.%2BM.%26aulast%3DGanellin%26aufirst%3DC.%2BR.%26aulast%3DSchwartz%26aufirst%3DJ.%2BC.%26aulast%3DSchunack%26aufirst%3DW.%26aulast%3DStark%26aufirst%3DH.%26atitle%3D4-%2528%25CF%2589-%2528Alkyloxy%2529alkyl%2529-1H-imidazole%2520derivatives%2520as%2520histamine%2520H3%2520receptor%2520antagonists%252Fagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2678%26epage%3D2687%26doi%3D10.1021%2Fjm031065q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pelloux-Léon, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fkyerat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piripitsi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tertiuk, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schunack, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garbarg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligneau, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrang, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganellin, C. R.</span></span> <span> </span><span class="NLM_article-title">Meta-substituted aryl(thio)ethers as potent partial agonists (or antagonists) for the histamine H<sub>3</sub> receptor lacking a nitrogen atom in the side chain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">3264</span>– <span class="NLM_lpage">3274</span>, <span class="refDoi"> DOI: 10.1021/jm031141p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm031141p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjslOitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=3264-3274&author=N.+Pelloux-L%C3%A9onauthor=A.+Fkyeratauthor=A.+Piripitsiauthor=W.+Tertiukauthor=W.+Schunackauthor=H.+Starkauthor=M.+Garbargauthor=X.+Ligneauauthor=J.-M.+Arrangauthor=J.-C.+Schwartzauthor=C.+R.+Ganellin&title=Meta-substituted+aryl%28thio%29ethers+as+potent+partial+agonists+%28or+antagonists%29+for+the+histamine+H3+receptor+lacking+a+nitrogen+atom+in+the+side+chain&doi=10.1021%2Fjm031141p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Meta-Substituted Aryl(thio)ethers as Potent Partial Agonists (or Antagonists) for the Histamine H3 Receptor Lacking a Nitrogen Atom in the Side Chain</span></div><div class="casAuthors">Pelloux-Leon, Nadia; Fkyerat, Abdellatif; Piripitsi, Antonia; Tertiuk, Wasyl; Schunack, Walter; Stark, Holger; Garbarg, Monique; Ligneau, Xavier; Arrang, Jean-Michel; Schwartz, Jean-Charles; Ganellin, C. Robin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3264-3274</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">4-(3-Aryloxypropyl)-1H-imidazoles, which possess a meta-positioned substituent in the aryl ring, have been synthesized and tested for activity at histamine H3 receptors.  The compds. having a CN, Me, or Br substituent were found to be antagonists, whereas CF3, Et, i-Pr, t-Bu, COCH3, or NO2 substituents remarkably afforded partial agonists when tested in vitro on rat cerebral cortex synaptosomes for inhibition of [3H]histamine release.  The compds. were also active in vivo, and furthermore, the CF3-substituted compd. trifluproxim acted as a potent full agonist in vivo, having ED50 = 0.6 ± 0.3 mg/kg per os in mice for inhibition of brain Nτ-methylhistamine formation.  Related structures have also been investigated; homologs 4-[4-(3-(trifluoromethyl)phenoxy)butyl]-1H-imidazole and 4-[2-(3-(trifluoromethyl)phenylthio)ethyl]-1H-imidazole are shown to be partial agonists, whereas the O isostere 4-[2-(3-(trifluoromethyl)phenoxy)ethyl]-1H-imidazole is an antagonist as is the S homolog 4-[3-(3-(trifluoromethyl)phenylthio)propyl]-1H-imidazole and its CH2 isostere 4-[4-(3-(trifluoromethyl)phenyl)butyl]-1H-imidazole.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgZUL5F4JuELVg90H21EOLACvtfcHk0ljChdIfFmpLng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjslOitrg%253D&md5=02cf3df40ee3a3b032defa81747128cd</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm031141p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm031141p%26sid%3Dliteratum%253Aachs%26aulast%3DPelloux-L%25C3%25A9on%26aufirst%3DN.%26aulast%3DFkyerat%26aufirst%3DA.%26aulast%3DPiripitsi%26aufirst%3DA.%26aulast%3DTertiuk%26aufirst%3DW.%26aulast%3DSchunack%26aufirst%3DW.%26aulast%3DStark%26aufirst%3DH.%26aulast%3DGarbarg%26aufirst%3DM.%26aulast%3DLigneau%26aufirst%3DX.%26aulast%3DArrang%26aufirst%3DJ.-M.%26aulast%3DSchwartz%26aufirst%3DJ.-C.%26aulast%3DGanellin%26aufirst%3DC.%2BR.%26atitle%3DMeta-substituted%2520aryl%2528thio%2529ethers%2520as%2520potent%2520partial%2520agonists%2520%2528or%2520antagonists%2529%2520for%2520the%2520histamine%2520H3%2520receptor%2520lacking%2520a%2520nitrogen%2520atom%2520in%2520the%2520side%2520chain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D3264%26epage%3D3274%26doi%3D10.1021%2Fjm031141p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kitbunnadaj, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuiderveld, O. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menozzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hidaka, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Esch, I. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakker, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menge, W. M. P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamatodani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coruzzi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span> <span> </span><span class="NLM_article-title">N-Substituted Piperidinyl Alkyl Imidazoles: Discovery of methimepip as a potent and selective histamine H<sub>3</sub> receptor agonist</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">2100</span>– <span class="NLM_lpage">2107</span>, <span class="refDoi"> DOI: 10.1021/jm049475h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049475h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVagtLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2100-2107&author=R.+Kitbunnadajauthor=T.+Hashimotoauthor=E.+Poliauthor=O.+P.+Zuiderveldauthor=A.+Menozziauthor=R.+Hidakaauthor=I.+J.+P.+de+Eschauthor=R.+A.+Bakkerauthor=W.+M.+P.+B.+Mengeauthor=A.+Yamatodaniauthor=G.+Coruzziauthor=H.+Timmermanauthor=R.+Leurs&title=N-Substituted+Piperidinyl+Alkyl+Imidazoles%3A+Discovery+of+methimepip+as+a+potent+and+selective+histamine+H3+receptor+agonist&doi=10.1021%2Fjm049475h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">N-Substituted Piperidinyl Alkyl Imidazoles: Discovery of Methimepip as a Potent and Selective Histamine H3 Receptor Agonist</span></div><div class="casAuthors">Kitbunnadaj, Ruengwit; Hashimoto, Takeshi; Poli, Enzo; Zuiderveld, Obbe P.; Menozzi, Alessandro; Hidaka, Ryoko; de Esch, Iwan J. P.; Bakker, Remko A.; Menge, Wiro M. P. B.; Yamatodani, Atsushi; Coruzzi, Gabriella; Timmerman, Henk; Leurs, Rob</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2100-2107</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this study, we continue our efforts toward the development of potent and highly selective histamine H3 receptor agonists.  We introduced various alkyl or aryl alkyl groups on the piperidine nitrogen of the known H3/H4 agonist immepip and its analogs.  We obsd. that N-methyl-substituted immepip (methimepip) exhibits high affinity and agonist activity at the human histamine H3 receptor (pKi = 9.0 and pEC50 = 9.5) with a 2000-fold selectivity at the human H3 receptor over the human H4 receptor and more than a 10000-fold selectivity over the human histamine H1 and H2 receptors.  Methimepip was also very effective as an H3 receptor agonist at the guinea pig ileum (pD2 = 8.26).  Moreover, in vivo microdialysis (in rat brain) showed that methimepip reduces the basal level of brain histamine to about 25% after a 5 mg/kg i.p. administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDAeujcwlOm7Vg90H21EOLACvtfcHk0ljChdIfFmpLng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVagtLvK&md5=587438743f4482608254162eb50da570</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm049475h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049475h%26sid%3Dliteratum%253Aachs%26aulast%3DKitbunnadaj%26aufirst%3DR.%26aulast%3DHashimoto%26aufirst%3DT.%26aulast%3DPoli%26aufirst%3DE.%26aulast%3DZuiderveld%26aufirst%3DO.%2BP.%26aulast%3DMenozzi%26aufirst%3DA.%26aulast%3DHidaka%26aufirst%3DR.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3DBakker%26aufirst%3DR.%2BA.%26aulast%3DMenge%26aufirst%3DW.%2BM.%2BP.%2BB.%26aulast%3DYamatodani%26aufirst%3DA.%26aulast%3DCoruzzi%26aufirst%3DG.%26aulast%3DTimmerman%26aufirst%3DH.%26aulast%3DLeurs%26aufirst%3DR.%26atitle%3DN-Substituted%2520Piperidinyl%2520Alkyl%2520Imidazoles%253A%2520Discovery%2520of%2520methimepip%2520as%2520a%2520potent%2520and%2520selective%2520histamine%2520H3%2520receptor%2520agonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2100%26epage%3D2107%26doi%3D10.1021%2Fjm049475h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Govoni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Atmioui, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menge, W. M. P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakker, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Esch, I. J. P.</span></span> <span> </span><span class="NLM_article-title">A chemical switch for the modulation of the functional activity of higher homologues of histamine on the human histamine H<sub>3</sub> receptor: effect of various substitutions at the primary amino function</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">2549</span>– <span class="NLM_lpage">2557</span>, <span class="refDoi"> DOI: 10.1021/jm0504353</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0504353" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1Khs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2549-2557&author=M.+Govoniauthor=H.+D.+Limauthor=D.+El-Atmiouiauthor=W.+M.+P.+B.+Mengeauthor=H.+Timmermanauthor=R.+A.+Bakkerauthor=R.+Leursauthor=I.+J.+P.+de+Esch&title=A+chemical+switch+for+the+modulation+of+the+functional+activity+of+higher+homologues+of+histamine+on+the+human+histamine+H3+receptor%3A+effect+of+various+substitutions+at+the+primary+amino+function&doi=10.1021%2Fjm0504353"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A Chemical Switch for the Modulation of the Functional Activity of Higher Homologues of Histamine on the Human Histamine H3 Receptor: Effect of Various Substitutions at the Primary Amino Function</span></div><div class="casAuthors">Govoni, Marinella; Lim, Herman D.; El-Atmioui, Dris; Menge, Wiro M. P. B.; Timmerman, Henk; Bakker, Remko A.; Leurs, Rob; De Esch, Iwan J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2549-2557</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In an effort to establish the structural requirements for agonism, neutral antagonism, and inverse agonism at the human histamine H3 receptor (H3R) we have prepd. a series of higher homologs of histamine in which the terminal nitrogen of the side chain has been either mono- or disubstituted with several aliph., alicyclic, and arom. moieties or incorporated in cyclic systems.  The novel ligands have been pharmacol. investigated in vitro for their affinities on the human H3R and H4R subtypes by radioligand displacement expts. and for their intrinsic H3R activities via a CRE-mediated β-galactosidase reporter gene assay.  Subtle changes of the substitution pattern at the side chain nitrogen alter enormously the pharmacol. activity of the ligands, resulting in a series of compds. with a wide spectrum of pharmacol. activities.  Among the several neutral H3R antagonists identified within this series, aminoalkylimidazoles I (n = 5, R1 = H, R2 = Et; n = 5, R1 = H, R2 = cyclopentyl), display an H3R affinity in the low nanomolar concn. range (pKi values of 8.1 and 8.4, resp.).  A very potent and selective H3R agonist I (n = 4, R1 = R2 = Me) with pEC50 = 8.9, α = 0.94, and a very potent, though not highly selective, H3R inverse agonist I (n = 5, R1 = H, R2 = CH2C6H4Cl-4) with pIC50 = 8.9, α = -0.97 have been identified as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3uk9mr0H8e7Vg90H21EOLACvtfcHk0liK1QiRAVmEdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1Khs7s%253D&md5=92d454d4de364b332b53c10f9d0b9ef2</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm0504353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0504353%26sid%3Dliteratum%253Aachs%26aulast%3DGovoni%26aufirst%3DM.%26aulast%3DLim%26aufirst%3DH.%2BD.%26aulast%3DEl-Atmioui%26aufirst%3DD.%26aulast%3DMenge%26aufirst%3DW.%2BM.%2BP.%2BB.%26aulast%3DTimmerman%26aufirst%3DH.%26aulast%3DBakker%26aufirst%3DR.%2BA.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26atitle%3DA%2520chemical%2520switch%2520for%2520the%2520modulation%2520of%2520the%2520functional%2520activity%2520of%2520higher%2520homologues%2520of%2520histamine%2520on%2520the%2520human%2520histamine%2520H3%2520receptor%253A%2520effect%2520of%2520various%2520substitutions%2520at%2520the%2520primary%2520amino%2520function%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2549%26epage%3D2557%26doi%3D10.1021%2Fjm0504353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wijtmans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Celanire, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snip, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillard, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelens, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collart, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venhuis, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christophe, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulscher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Goot, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakker, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lallemand, B. I. L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talaga, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Esch, I. J. P.</span></span> <span> </span><span class="NLM_article-title">4-Benzyl-1H-imidazoles with oxazoline termini as histamine H<sub>3</sub> receptor agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">2944</span>– <span class="NLM_lpage">2953</span>, <span class="refDoi"> DOI: 10.1021/jm7014149</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm7014149" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvF2mu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2944-2953&author=M.+Wijtmansauthor=S.+Celanireauthor=E.+Snipauthor=M.+R.+Gillardauthor=E.+Gelensauthor=P.+P.+Collartauthor=B.+J.+Venhuisauthor=B.+Christopheauthor=S.+Hulscherauthor=H.+van+der+Gootauthor=F.+Lebonauthor=H.+Timmermanauthor=R.+A.+Bakkerauthor=B.+I.+L.+F.+Lallemandauthor=R.+Leursauthor=P.+E.+Talagaauthor=I.+J.+P.+de+Esch&title=4-Benzyl-1H-imidazoles+with+oxazoline+termini+as+histamine+H3+receptor+agonists&doi=10.1021%2Fjm7014149"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">4-Benzyl-1H-imidazoles with Oxazoline Termini as Histamine H3 Receptor Agonists</span></div><div class="casAuthors">Wijtmans, Maikel; Celanire, Sylvain; Snip, Erwin; Gillard, Michel R.; Gelens, Edith; Collart, Philippe P.; Venhuis, Bastiaan J.; Christophe, Bernard; Hulscher, Saskia; van der Goot, Henk; Lebon, Florence; Timmerman, Henk; Bakker, Remko A.; Lallemand, Benedicte I. L. F.; Leurs, Rob; Talaga, Patrice E.; de Esch, Iwan J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2944-2953</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Research on the therapeutic applications of the histamine H3 receptor (H3R) has traditionally focused on antagonists/inverse agonists.  In contrast, H3R agonists have received less attention despite their potential use in several disease areas.  The lower availability of H3R agonists not only hampers their full therapeutic exploration, it also prevents an unequivocal understanding of the structural requirements for H3R activation.  In the light of these important issues, we present our findings on 4-benzyl-1H-imidazole-based H3R agonists.  Starting from two high throughput screen hits (10 and 11), the benzyl side chain was altered with lipophilic groups using combinatorial and classical chem. approaches (compds. 12-31).  Alkyne- or oxazolino-substituents gave excellent affinities and agonist activities up to the single digit nM range.  Our findings further substantiate the growing notion that basic ligand sidechains are not necessary for H3R activation and reveal the oxazolino group as a hitherto unexplored functional group in H3R research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrL9RayBsEIiLVg90H21EOLACvtfcHk0liK1QiRAVmEdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvF2mu7g%253D&md5=5e18898562a1eeb50921ff5e17270ded</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm7014149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7014149%26sid%3Dliteratum%253Aachs%26aulast%3DWijtmans%26aufirst%3DM.%26aulast%3DCelanire%26aufirst%3DS.%26aulast%3DSnip%26aufirst%3DE.%26aulast%3DGillard%26aufirst%3DM.%2BR.%26aulast%3DGelens%26aufirst%3DE.%26aulast%3DCollart%26aufirst%3DP.%2BP.%26aulast%3DVenhuis%26aufirst%3DB.%2BJ.%26aulast%3DChristophe%26aufirst%3DB.%26aulast%3DHulscher%26aufirst%3DS.%26aulast%3Dvan%2Bder%2BGoot%26aufirst%3DH.%26aulast%3DLebon%26aufirst%3DF.%26aulast%3DTimmerman%26aufirst%3DH.%26aulast%3DBakker%26aufirst%3DR.%2BA.%26aulast%3DLallemand%26aufirst%3DB.%2BI.%2BL.%2BF.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DTalaga%26aufirst%3DP.%2BE.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26atitle%3D4-Benzyl-1H-imidazoles%2520with%2520oxazoline%2520termini%2520as%2520histamine%2520H3%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2944%26epage%3D2953%26doi%3D10.1021%2Fjm7014149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furuuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamauchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakui, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships of N-aryl-piperidine derivatives as potent (partial) agonists for human histamine H<sub>3</sub> receptor</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">5441</span>– <span class="NLM_lpage">5448</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.04.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1016%2Fj.bmc.2010.04.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=20541426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC3cXoslans70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=5441-5448&author=M.+Ishikawaauthor=T.+Furuuchiauthor=M.+Yamauchiauthor=F.+Yokoyamaauthor=N.+Kakuiauthor=Y.+Sato&title=Synthesis+and+structure-activity+relationships+of+N-aryl-piperidine+derivatives+as+potent+%28partial%29+agonists+for+human+histamine+H3+receptor&doi=10.1016%2Fj.bmc.2010.04.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and structure-activity relationships of N-aryl-piperidine derivatives as potent (partial) agonists for human histamine H3 receptor</span></div><div class="casAuthors">Ishikawa, Makoto; Furuuchi, Takeshi; Yamauchi, Miki; Yokoyama, Fumikazu; Kakui, Nobukazu; Sato, Yasuo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5441-5448</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">4-((1H-Imidazol-4-yl)methyl)-1-aryl-piperazine and piperidine derivs. were designed and synthesized as candidate human histamine type 3 agonists.  The piperazine derivs. were found to have low (or no) affinity for human histamine H3 receptor, whereas the piperidine derivs. showed moderate to high affinity, and their agonistic activity was greatly influenced by substituents on the arom. ring.  Among the piperidine-contg. compds., 17d (I) and 17h (II) were potent human histamine H3 receptor agonists with high selectivity over the closely related human H4 receptor.  Our results indicate that appropriate conformational restriction, i.e., by the piperidine spacer moiety, favors specific binding to the human histamine H3 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTot9cyE1ZdbVg90H21EOLACvtfcHk0liK1QiRAVmEdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXoslans70%253D&md5=f261ddec809b349032e3a09d8ea725a5</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.04.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.04.052%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DFuruuchi%26aufirst%3DT.%26aulast%3DYamauchi%26aufirst%3DM.%26aulast%3DYokoyama%26aufirst%3DF.%26aulast%3DKakui%26aufirst%3DN.%26aulast%3DSato%26aufirst%3DY.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520of%2520N-aryl-piperidine%2520derivatives%2520as%2520potent%2520%2528partial%2529%2520agonists%2520for%2520human%2520histamine%2520H3%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D5441%26epage%3D5448%26doi%3D10.1016%2Fj.bmc.2010.04.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinei, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamauchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuma, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagayama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakui, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, Y.</span></span> <span> </span><span class="NLM_article-title">Role of hydrophobic substituents on the terminal nitrogen of histamine in receptor binding and agonist activity: development of an orally active histamine type 3 receptor agonist and evaluation of its antistress activity in mice</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3840</span>– <span class="NLM_lpage">3844</span>, <span class="refDoi"> DOI: 10.1021/jm901890s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901890s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksF2ls70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3840-3844&author=M.+Ishikawaauthor=R.+Shineiauthor=F.+Yokoyamaauthor=M.+Yamauchiauthor=M.+Oyamaauthor=K.+Okumaauthor=T.+Nagayamaauthor=K.+Katoauthor=N.+Kakuiauthor=Y.+Sato&title=Role+of+hydrophobic+substituents+on+the+terminal+nitrogen+of+histamine+in+receptor+binding+and+agonist+activity%3A+development+of+an+orally+active+histamine+type+3+receptor+agonist+and+evaluation+of+its+antistress+activity+in+mice&doi=10.1021%2Fjm901890s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Hydrophobic Substituents on the Terminal Nitrogen of Histamine in Receptor Binding and Agonist Activity: Development of an Orally Active Histamine Type 3 Receptor Agonist and Evaluation of Its Antistress Activity in Mice</span></div><div class="casAuthors">Ishikawa, Makoto; Shinei, Rie; Yokoyama, Fumikazu; Yamauchi, Miki; Oyama, Masayo; Okuma, Kunihiro; Nagayama, Takako; Kato, Kazuhiko; Kakui, Nobukazu; Sato, Yasuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3840-3844</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The terminal nitrogen atom of histamine was modified with lipophilic substituents to investigate the structure-activity relationship of histamine type 3 receptor (H3R) agonists.  The introduction of an alkylated benzene rings maintained or increased the H3R binding affinity.  The most potent compd., 4-(2-(4-tert-butylphenylthio)ethyl)-1H-imidazole (I), possessed in vivo agonistic activity, decreasing brain Nτ-methylhistamine levels in mice after oral administration.  It also exhibited antistress activity in the mouse resident-intruder test.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs9ig3rdlsc7Vg90H21EOLACvtfcHk0lhBLOf46fW4lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksF2ls70%253D&md5=d3d868bf617fa577565b9be9b48a1155</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm901890s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901890s%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DShinei%26aufirst%3DR.%26aulast%3DYokoyama%26aufirst%3DF.%26aulast%3DYamauchi%26aufirst%3DM.%26aulast%3DOyama%26aufirst%3DM.%26aulast%3DOkuma%26aufirst%3DK.%26aulast%3DNagayama%26aufirst%3DT.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DKakui%26aufirst%3DN.%26aulast%3DSato%26aufirst%3DY.%26atitle%3DRole%2520of%2520hydrophobic%2520substituents%2520on%2520the%2520terminal%2520nitrogen%2520of%2520histamine%2520in%2520receptor%2520binding%2520and%2520agonist%2520activity%253A%2520development%2520of%2520an%2520orally%2520active%2520histamine%2520type%25203%2520receptor%2520agonist%2520and%2520evaluation%2520of%2520its%2520antistress%2520activity%2520in%2520mice%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3840%26epage%3D3844%26doi%3D10.1021%2Fjm901890s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamauchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kudo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakui, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span> <span> </span><span class="NLM_article-title">Investigation of the histamine H<sub>3</sub> receptor binding site. Design and synthesis of hybrid agonists with a lipophilic side chain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">6445</span>– <span class="NLM_lpage">6456</span>, <span class="refDoi"> DOI: 10.1021/jm100643t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100643t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvVaru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6445-6456&author=M.+Ishikawaauthor=M.+Yamauchiauthor=F.+Yokoyamaauthor=T.+Kudoauthor=Y.+Satoauthor=N.+Kakuiauthor=K.+Katoauthor=T.+Watanabe&title=Investigation+of+the+histamine+H3+receptor+binding+site.+Design+and+synthesis+of+hybrid+agonists+with+a+lipophilic+side+chain&doi=10.1021%2Fjm100643t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of the Histamine H3 Receptor Binding Site. Design and Synthesis of Hybrid Agonists with a Lipophilic Side Chain</span></div><div class="casAuthors">Ishikawa, Makoto; Watanabe, Takashi; Kudo, Toshiaki; Yokoyama, Fumikazu; Yamauchi, Miki; Kato, Kazuhiko; Kakui, Nobukazu; Sato, Yasuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6445-6456</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As a part of our search for novel histamine H3 receptor agonists, we designed and synthesized hybrid compds. in which the lipophilic (4'-alkylphenylthio)ethyl moiety of a novel H3 receptor agonist, 4-(2-(4'-tert-butylphenylthio)ethyl)-1H-imidazole (I), was incorporated into Nα-methylhistamine, immepip, and immethridine derivs.  These hybrid compds. were expected to interact concurrently with the histamine-binding site and a putative hydrophobic region in the H3 receptor.  Among them, piperidine- and pyridine-type derivs. displayed partial agonist activity, and (S)-4-(1-(1H-imidazol-4-yl)-2-(4-(trifluoromethyl)phenylthio)ethyl)piperidine (II) was identified as a potent H3 agonist.  We performed computational docking studies to examine the binding mode of the agonists.  The results indicated that immepip interacts with the key residues, Asp114 and Glu206, in a different manner from histamine.  The binding mode of II to these residues is similar to that of immepip, and the lipophilic tail of II has an addnl. interaction with a hydrophobic region in transmembrane helix 6 of the receptor.  These results indicated that II served as a useful tool for studies on receptor-agonist interactions and drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCmdYERfiu-LVg90H21EOLACvtfcHk0lhBLOf46fW4lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvVaru7k%253D&md5=3c7dd7af7ff0535517015ed33ac07700</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm100643t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100643t%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DYamauchi%26aufirst%3DM.%26aulast%3DYokoyama%26aufirst%3DF.%26aulast%3DKudo%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DKakui%26aufirst%3DN.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DWatanabe%26aufirst%3DT.%26atitle%3DInvestigation%2520of%2520the%2520histamine%2520H3%2520receptor%2520binding%2520site.%2520Design%2520and%2520synthesis%2520of%2520hybrid%2520agonists%2520with%2520a%2520lipophilic%2520side%2520chain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6445%26epage%3D6456%26doi%3D10.1021%2Fjm100643t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cannon, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nalwalk, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stadel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silos-Santiago, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hough, L. B.</span></span> <span> </span><span class="NLM_article-title">Activation of spinal histamine H<sub>3</sub> receptors inhibits mechanical nociception</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>470</i></span>,  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1016/S0014-2999(03)01737-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1016%2FS0014-2999%2803%2901737-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=12798951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksVegsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=470&publication_year=2003&pages=139-147&author=K.+E.+Cannonauthor=J.+W.+Nalwalkauthor=R.+Stadelauthor=P.+Geauthor=D.+Lawsonauthor=I.+Silos-Santiagoauthor=L.+B.+Hough&title=Activation+of+spinal+histamine+H3+receptors+inhibits+mechanical+nociception&doi=10.1016%2FS0014-2999%2803%2901737-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of spinal histamine H3 receptors inhibits mechanical nociception</span></div><div class="casAuthors">Cannon, Keri E.; Nalwalk, Julia W.; Stadel, Rebecca; Ge, P.; Lawson, D.; Silos-Santiago, I.; Hough, Lindsay B.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">470</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">139-147</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Previous studies have suggested a possible pain-modulatory role for histamine H3 receptors, but the localization of these receptors and nature of this modulation is not clear.  To explore the role of spinal histamine H3 receptors in the inhibition of nociception, the effects of systemically (s.c.) and intrathecally (i.t.) administered histamine H3 receptor agonists were studied in rats and mice.  Immepip (5 mg/kg, s.c.) produced robust antinociception in rats on a mech. (tail pinch) test but did not alter nociceptive responses on a thermal (tail flick) test.  In contrast, this treatment in mice (immepip, 5 and 30 mg/kg, s.c.) did not change either mech. or thermally evoked nociceptive responses.  When administered directly into the spinal subarachnoid space, immepip (15-50 μg, i.t.) and R-α-methylhistamine (50 μg, i.t.) had no effect in rats on the tail flick and hot plate tests, but produced a dose- and time-dependent inhibition (90-100%) of nociceptive responses on the tail pinch test.  This attenuation was blocked by administration of thioperamide (10 mg/kg, s.c.), a histamine H3 receptor antagonist.  Intrathecally administered thioperamide also reversed antinociceptive responses induced by systemically administered immepip, which demonstrates a spinal site of action for the histamine H3 receptor agonist.  In addn., intrathecally administered immepip (25 μg) produced maximal antinociception on the tail pinch test in wild type, but not in histamine H3 receptor knockout (H3KO) mice.  These findings demonstrate an antinociceptive role for spinal histamine H3 receptors.  Further studies are needed to confirm the existence of modality-specific (i.e., mech. vs. thermal) inhibition of nociception by these receptors, and to assess the efficacy of spinally delivered histamine H3 receptor agonists for the treatment for pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphNOgDFX3yIrVg90H21EOLACvtfcHk0lhBLOf46fW4lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksVegsbs%253D&md5=e6e518b53e8cbabdfecbe1b1f6082193</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2803%2901737-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252803%252901737-0%26sid%3Dliteratum%253Aachs%26aulast%3DCannon%26aufirst%3DK.%2BE.%26aulast%3DNalwalk%26aufirst%3DJ.%2BW.%26aulast%3DStadel%26aufirst%3DR.%26aulast%3DGe%26aufirst%3DP.%26aulast%3DLawson%26aufirst%3DD.%26aulast%3DSilos-Santiago%26aufirst%3DI.%26aulast%3DHough%26aufirst%3DL.%2BB.%26atitle%3DActivation%2520of%2520spinal%2520histamine%2520H3%2520receptors%2520inhibits%2520mechanical%2520nociception%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D470%26spage%3D139%26epage%3D147%26doi%3D10.1016%2FS0014-2999%2803%2901737-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishihara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacNeil, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanatani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokita, S.</span></span> <span> </span><span class="NLM_article-title">Therapeutic potential of histamine H<sub>3</sub> receptor agonist for the treatment of obesity and diabetes mellitus</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">13866</span>– <span class="NLM_lpage">13871</span>, <span class="refDoi"> DOI: 10.1073/pnas.0506104103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1073%2Fpnas.0506104103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=16954192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvFSkt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=13866-13871&author=R.+Yoshimotoauthor=Y.+Miyamotoauthor=K.+Shimamuraauthor=A.+Ishiharaauthor=K.+Takahashiauthor=H.+Kotaniauthor=A.+S.+Chenauthor=H.+Y.+Chenauthor=D.+J.+MacNeilauthor=A.+Kanataniauthor=S.+Tokita&title=Therapeutic+potential+of+histamine+H3+receptor+agonist+for+the+treatment+of+obesity+and+diabetes+mellitus&doi=10.1073%2Fpnas.0506104103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of histamine H3 receptor agonist for the treatment of obesity and diabetes mellitus</span></div><div class="casAuthors">Yoshimoto, Ryo; Miyamoto, Yasuhisa; Shimamura, Ken; Ishihara, Akane; Takahashi, Kazuhiko; Kotani, Hidehito; Chen, Airu S.; Chen, Howard Y.; MacNeil, Douglas J.; Kanatani, Akio; Tokita, Shigeru</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">13866-13871</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Histamine H3 receptors (H3Rs) are located on the presynaptic membranes and cell soma of histamine neurons, where they neg. regulate the synthesis and release of histamine.  In addn., H3Rs are also located on nonhistaminergic neurons, acting as heteroreceptors to regulate the releases of other amines such as dopamine, serotonin, and norepinephrine.  The present study investigated the effects of H3R ligands on appetite and body-wt. regulation by using WT and H3R-deficient mice (H3RKO), because brain histamine plays a pivotal role in energy homeostasis.  The results showed that thioperamide, an H3R inverse agonist, increases, whereas imetit, an H3R agonist, decreases appetite and body wt. in diet-induced obese (DiO) WT mice.  Moreover, in DiO WT mice, but not in DiO H3RKO mice, imetit reduced fat mass, plasma concns. of leptin and insulin, and hepatic triglyceride content.  The anorexigenic effects of imetit were assocd. with a redn. in histamine release, but a comparable redn. in histamine release with α-fluoromethylhistidine, an inhibitor of histamine synthesis, increased appetite.  Moreover, the anorexigenic effects of imetit were independent of the melanocortin system, because imetit comparably reduced appetite in melanocortin 3 and 4 receptor-deficient mice.  The results provide roles of H3Rs in energy homeostasis and suggest a therapeutic potential for H3R agonists in the treatment of obesity and diabetes mellitus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofkNzoZkv1HrVg90H21EOLACvtfcHk0lhBLOf46fW4lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvFSkt74%253D&md5=b47c382e0252442f05001a839d6e6577</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0506104103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0506104103%26sid%3Dliteratum%253Aachs%26aulast%3DYoshimoto%26aufirst%3DR.%26aulast%3DMiyamoto%26aufirst%3DY.%26aulast%3DShimamura%26aufirst%3DK.%26aulast%3DIshihara%26aufirst%3DA.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DKotani%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DA.%2BS.%26aulast%3DChen%26aufirst%3DH.%2BY.%26aulast%3DMacNeil%26aufirst%3DD.%2BJ.%26aulast%3DKanatani%26aufirst%3DA.%26aulast%3DTokita%26aufirst%3DS.%26atitle%3DTherapeutic%2520potential%2520of%2520histamine%2520H3%2520receptor%2520agonist%2520for%2520the%2520treatment%2520of%2520obesity%2520and%2520diabetes%2520mellitus%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D13866%26epage%3D13871%26doi%3D10.1073%2Fpnas.0506104103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reid, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brazin, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrey, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silver, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levi, R.</span></span> <span> </span><span class="NLM_article-title">Targeting Cardiac Mast Cells: Pharmacological modulation of the local renin-angiotensin system</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3744</span>– <span class="NLM_lpage">3752</span>, <span class="refDoi"> DOI: 10.2174/138161211798357908</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.2174%2F138161211798357908" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=22103845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC38XovVyrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=3744-3752&author=A.+C.+Reidauthor=J.+A.+Brazinauthor=C.+Morreyauthor=R.+B.+Silverauthor=R.+Levi&title=Targeting+Cardiac+Mast+Cells%3A+Pharmacological+modulation+of+the+local+renin-angiotensin+system&doi=10.2174%2F138161211798357908"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cardiac mast cells: pharmacological modulation of the local renin-angiotensin system</span></div><div class="casAuthors">Reid, Alicia C.; Brazin, Jacqueline A.; Morrey, Christopher; Silver, Randi B.; Levi, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">3744-3752</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Enhanced prodn. of angiotensin II and excessive release of norepinephrine in the ischemic heart are major causes of arrhythmias and sudden cardiac death.  Mast cell-dependent mechanisms are pivotal in the local formation of angiotensin II and modulation of norepinephrine release in cardiac pathophysiol.  Cardiac mast cells increase in no. in myocardial ischemia and are located in close proximity to sympathetic neurons expressing angiotensin AT1- and histamine H3-receptors.  Once activated, cardiac mast cells release a host of potent pro-inflammatory and pro-fibrotic cytokines, chemokines, preformed mediators (e.g., histamine) and proteases (e.g., renin).  In myocardial ischemia, angiotensin II (formed locally from mast cell-derived renin) and histamine (also released from local mast cells) resp. activate AT1- and H3-receptors on sympathetic nerve endings.  Stimulation of angiotensin AT1-receptors is arrhythmogenic whereas H3-receptor activation is cardioprotective.  It is likely that in ischemia/reperfusion the balance may be tipped toward the deleterious effects of mast cell renin, as demonstrated in mast cell-deficient mice, lacking mast cell renin and histamine in the heart.  In these mice, no ventricular fibrillation occurs at reperfusion following ischemia, as opposed to wild-type hearts which all fibrillate.  Preventing mast cell degranulation in the heart and inhibiting the activation of a local renin-angiotensin system, hence abolishing its detrimental effects on cardiac rhythmicity, appears to be more significant than the loss of histamine-induced cardioprotection.  This suggests that therapeutic targets in the treatment of myocardial ischemia, and potentially congestive heart failure and hypertension, should include prevention of mast cell degranulation, mast cell renin inhibition, local ACE inhibition, ANG II antagonism and H3-receptor activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSYFqvdj1nm7Vg90H21EOLACvtfcHk0lhA35bsQ-FV7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovVyrtw%253D%253D&md5=6e0851d9351bd6ffc09ba1fac67977c6</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.2174%2F138161211798357908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161211798357908%26sid%3Dliteratum%253Aachs%26aulast%3DReid%26aufirst%3DA.%2BC.%26aulast%3DBrazin%26aufirst%3DJ.%2BA.%26aulast%3DMorrey%26aufirst%3DC.%26aulast%3DSilver%26aufirst%3DR.%2BB.%26aulast%3DLevi%26aufirst%3DR.%26atitle%3DTargeting%2520Cardiac%2520Mast%2520Cells%253A%2520Pharmacological%2520modulation%2520of%2520the%2520local%2520renin-angiotensin%2520system%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2011%26volume%3D17%26spage%3D3744%26epage%3D3752%26doi%3D10.2174%2F138161211798357908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hashikawa-Hobara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, N. Y.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levi, R.</span></span> <span> </span><span class="NLM_article-title">Histamine 3 receptor activation reduces the expression of neuronal angiotensin II type 1 receptors in the heart</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>340</i></span>,  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.1124/jpet.111.187765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1124%2Fjpet.111.187765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=22011436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtVSlsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=2012&pages=185-191&author=N.+Hashikawa-Hobaraauthor=N.+Y.-K.+Chanauthor=R.+Levi&title=Histamine+3+receptor+activation+reduces+the+expression+of+neuronal+angiotensin+II+type+1+receptors+in+the+heart&doi=10.1124%2Fjpet.111.187765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Histamine 3 receptor activation reduces the expression of neuronal angiotensin II type 1 receptors in the heart</span></div><div class="casAuthors">Hashikawa-Hobara, Narumi; Chan, Noel Yan-Ki; Levi, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">185-191</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">In severe myocardial ischemia, histamine 3 (H3) receptor activation affords cardioprotection by preventing excessive norepinephrine release and arrhythmias; pivotal to this action is the inhibition of neuronal Na+/H+ exchanger (NHE).  Conversely, angiotensin II, formed locally by mast cell-derived renin, stimulates NHE via angiotensin II type 1 (AT1) receptors, facilitating norepinephrine release and arrhythmias.  Thus, ischemic dysfunction may depend on a balance between the NHE-modulating effects of H3 receptors and AT1 receptors.  The purpose of this investigation was therefore to elucidate the H3/AT1 receptor interaction in myocardial ischemia/reperfusion.  We found that H3 receptor blockade with clobenpropit increased norepinephrine overflow and arrhythmias in Langendorff-perfused guinea pig hearts subjected to ischemia/reperfusion.  This coincided with increased neuronal AT1 receptor expression.  NHE inhibition with cariporide prevented both increases in norepinephrine release and AT1 receptor expression.  Moreover, norepinephrine release and AT1 receptor expression were increased by the nitric oxide (NO) synthase inhibitor NG-methyl-L-arginine and the protein kinase C activator phorbol myristate acetate.  H3 receptor activation in differentiated sympathetic neuron-like PC12 cells permanently transfected with H3 receptor cDNA caused a decrease in protein kinase C activity and AT1 receptor protein abundance.  Collectively, our findings suggest that neuronal H3 receptor activation inhibits NHE by diminishing protein kinase C activity.  Reduced NHE activity sequentially causes intracellular acidification, increased NO synthesis, and diminished AT1 receptor expression.  Thus, H3 receptor-mediated NHE inhibition in ischemia/reperfusion not only opposes the angiotensin II-induced stimulation of NHE in cardiac sympathetic neurons, but also down-regulates AT1 receptor expression.  Cardioprotection ultimately results from the combined attenuation of angiotensin II and norepinephrine effects and alleviation of arrhythmias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvf26mG2Ts2rVg90H21EOLACvtfcHk0lhA35bsQ-FV7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtVSlsb8%253D&md5=3d2452ae305ff804015fce1eb131ebd1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.187765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.187765%26sid%3Dliteratum%253Aachs%26aulast%3DHashikawa-Hobara%26aufirst%3DN.%26aulast%3DChan%26aufirst%3DN.%2BY.-K.%26aulast%3DLevi%26aufirst%3DR.%26atitle%3DHistamine%25203%2520receptor%2520activation%2520reduces%2520the%2520expression%2520of%2520neuronal%2520angiotensin%2520II%2520type%25201%2520receptors%2520in%2520the%2520heart%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D340%26spage%3D185%26epage%3D191%26doi%3D10.1124%2Fjpet.111.187765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smits, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakker, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Dam, C. M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de
Esch, I. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span> <span> </span><span class="NLM_article-title">Discovery of S-(2-Guanidylethyl)-isothiourea (VUF 8430) as a potent nonimidazole histamine H4 receptor agonist</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6650</span>– <span class="NLM_lpage">6651</span>, <span class="refDoi"> DOI: 10.1021/jm060880d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060880d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFeltrbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6650-6651&author=H.+D.+Limauthor=R.+A.+Smitsauthor=R.+A.+Bakkerauthor=C.+M.+E.+van+Damauthor=I.+J.+P.+de%0AEschauthor=R.+Leurs&title=Discovery+of+S-%282-Guanidylethyl%29-isothiourea+%28VUF+8430%29+as+a+potent+nonimidazole+histamine+H4+receptor+agonist&doi=10.1021%2Fjm060880d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of S-(2-Guanidylethyl)-isothiourea (VUF 8430) as a Potent Nonimidazole Histamine H4 Receptor Agonist</span></div><div class="casAuthors">Lim, Herman D.; Smits, Rogier A.; Bakker, Remko A.; van Dam, Cindy M. E.; de Esch, Iwan J. P.; Leurs, Rob</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6650-6651</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">During an inhouse database screen, the authors identified S-(2-guanidylethyl)-isothiourea as a high affinity agonist for the histamine H4 receptor, with a 33-fold selectivity over the histamine H3 receptor and negligible affinity for the other histamine receptor subtypes.  This nonimidazole ligand is introduced as a useful and complementary pharmacol. tool that enables further unraveling of the physiol. roles of the H4 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6omakaVFWBbVg90H21EOLACvtfcHk0lhA35bsQ-FV7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFeltrbK&md5=90e02342cb4d1814907a6a5f523ccef2</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm060880d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060880d%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DH.%2BD.%26aulast%3DSmits%26aufirst%3DR.%2BA.%26aulast%3DBakker%26aufirst%3DR.%2BA.%26aulast%3Dvan%2BDam%26aufirst%3DC.%2BM.%2BE.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3DLeurs%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520S-%25282-Guanidylethyl%2529-isothiourea%2520%2528VUF%25208430%2529%2520as%2520a%2520potent%2520nonimidazole%2520histamine%2520H4%2520receptor%2520agonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6650%26epage%3D6651%26doi%3D10.1021%2Fjm060880d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smit, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, H.</span></span> <span> </span><span class="NLM_article-title">Molecular Pharmacological Aspects of Histamine Receptors</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">413</span>– <span class="NLM_lpage">463</span>, <span class="refDoi"> DOI: 10.1016/0163-7258(95)00006-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1016%2F0163-7258%2895%2900006-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=7494855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADyaK2MXnt1alsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1995&pages=413-463&author=R.+Leursauthor=M.+J.+Smitauthor=H.+Timmerman&title=Molecular+Pharmacological+Aspects+of+Histamine+Receptors&doi=10.1016%2F0163-7258%2895%2900006-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular pharmacological aspects of histamine receptors</span></div><div class="casAuthors">Leurs, R.; Smit, M. J.; Timmerman, H.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">413-63</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review, with 375 refs., on the recent developments in the field of histamine research.  Besides the description of pharmacol. tools for the H1, H2 and H3 receptors, specific attention is paid to both the mol. aspects of the receptor proteins, including the recent cloning of the receptor genes, and their resp. signal transduction mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW6tWKRg5EybVg90H21EOLACvtfcHk0ljhSrk3xYcDqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnt1alsLg%253D&md5=edff7f323b90872c084fdcd9139b53f9</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2F0163-7258%2895%2900006-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0163-7258%252895%252900006-3%26sid%3Dliteratum%253Aachs%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DSmit%26aufirst%3DM.%2BJ.%26aulast%3DTimmerman%26aufirst%3DH.%26atitle%3DMolecular%2520Pharmacological%2520Aspects%2520of%2520Histamine%2520Receptors%26jtitle%3DPharmacol.%2520Ther.%26date%3D1995%26volume%3D66%26spage%3D413%26epage%3D463%26doi%3D10.1016%2F0163-7258%2895%2900006-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
der Goot, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriks, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, H.</span></span> <span> </span><span class="NLM_article-title">Amselamine, a new selective histamine H<sub>2</sub>-receptor agonist</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1913</span>– <span class="NLM_lpage">1916</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(01)80533-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1016%2FS0960-894X%2801%2980533-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1994&pages=1913-1916&author=H.+van%0Ader+Gootauthor=J.+C.+Eriksauthor=R.+Leursauthor=H.+Timmerman&title=Amselamine%2C+a+new+selective+histamine+H2-receptor+agonist&doi=10.1016%2FS0960-894X%2801%2980533-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2801%2980533-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252801%252980533-3%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BGoot%26aufirst%3DH.%26aulast%3DEriks%26aufirst%3DJ.%2BC.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DTimmerman%26aufirst%3DH.%26atitle%3DAmselamine%252C%2520a%2520new%2520selective%2520histamine%2520H2-receptor%2520agonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1994%26volume%3D4%26spage%3D1913%26epage%3D1916%26doi%3D10.1016%2FS0960-894X%2801%2980533-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kushida, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gyobu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaguchi, T.</span></span> <span> </span><span class="NLM_article-title">PF1270A, B and C, novel histamine H3 receptor ligands produced by <i>Penicillium waksmanii</i> PF1270</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">667</span>– <span class="NLM_lpage">673</span>, <span class="refDoi"> DOI: 10.1038/ja.2007.85</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1038%2Fja.2007.85" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=18057695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVWitL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2007&pages=667-673&author=N.+Kushidaauthor=N.+Watanabeauthor=T.+Okudaauthor=F.+Yokoyamaauthor=Y.+Gyobuauthor=T.+Yaguchi&title=PF1270A%2C+B+and+C%2C+novel+histamine+H3+receptor+ligands+produced+by+Penicillium+waksmanii+PF1270&doi=10.1038%2Fja.2007.85"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">PF1270A, B and C, novel histamine H3 receptor ligands produced by Penicillium waksmanii PF1270</span></div><div class="casAuthors">Kushida, Nobuaki; Watanabe, Naoko; Okuda, Takako; Yokoyama, Fumikazu; Gyobu, Yasuhiro; Yaguchi, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">667-673</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    
            (<span class="NLM_cas:orgname">Japan Antibiotics Research Association</span>)
        </div><div class="casAbstract">Three novel histamine H3 receptor (H3R) ligands, PF1270A, PF1270B, and PF1270C were isolated from the culture broth of the fungal strain PF1270.  The strain was identified as Penicillium waksmanii on the basis of morphol. characteristics.  These compds. were obtained from the culture broth by solvent extn. and chromatog. purifn.  Their structures were established by spectroscopic methods and x-ray crystallog. anal.  They possess pentacyclic spiroindolinone skeletons.  PF1270A, B and C displayed high affinity for the rat H3R (Ki = 0.058, 0.17 and 0.19 μM, resp.) and human H3R (Ki = 0.047, 0.12 and 0.22 μM, resp.).  Moreover, PF1270A, B and C acted as potent agonists with the EC50 values of 0.12, 0.15 and 0.20 μM, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0vhpWIoKJHLVg90H21EOLACvtfcHk0ljhSrk3xYcDqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVWitL%252FK&md5=60478c33c1872826274b4ba0b0acbb84</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fja.2007.85&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fja.2007.85%26sid%3Dliteratum%253Aachs%26aulast%3DKushida%26aufirst%3DN.%26aulast%3DWatanabe%26aufirst%3DN.%26aulast%3DOkuda%26aufirst%3DT.%26aulast%3DYokoyama%26aufirst%3DF.%26aulast%3DGyobu%26aufirst%3DY.%26aulast%3DYaguchi%26aufirst%3DT.%26atitle%3DPF1270A%252C%2520B%2520and%2520C%252C%2520novel%2520histamine%2520H3%2520receptor%2520ligands%2520produced%2520by%2520Penicillium%2520waksmanii%2520PF1270%26jtitle%3DJ.%2520Antibiot.%26date%3D2007%26volume%3D60%26spage%3D667%26epage%3D673%26doi%3D10.1038%2Fja.2007.85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, N.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of ZEL-H16 as a novel agonist of the histamine H<sub>3</sub> receptor</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e42185</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0042185</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1371%2Fjournal.pone.0042185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=22870296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFKhtrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=Y.+Shiauthor=R.+Shengauthor=T.+Zhongauthor=Y.+Xuauthor=X.+Chenauthor=D.+Yangauthor=Y.+Sunauthor=F.+Yangauthor=Y.+Huauthor=N.+Zhou&title=Identification+and+characterization+of+ZEL-H16+as+a+novel+agonist+of+the+histamine+H3+receptor&doi=10.1371%2Fjournal.pone.0042185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of ZEL-H16 as a novel agonist of the histamine H3 receptor</span></div><div class="casAuthors">Shi, Ying; Sheng, Rong; Zhong, Tingting; Xu, Yu; Chen, Xiaopan; Yang, Dong; Sun, Yi; Yang, Fenyan; Hu, Yongzhou; Zhou, Naiming</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e42185</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The histamine H3 receptor (H3R) has been recognized as a promising target for the treatment of various central and peripheral nervous system diseases.  In this study, a non-imidazole compd., ZEL-H16, was identified as a novel histamine H3 receptor agonist.  ZEL-H16 was found to bind to human H3R with a Ki value of approx. 2.07 nM and 4.36 nM to rat H3R.  Further characterization indicated that ZEL-H16 behaved as a partial agonist on the inhibition of forskolin-stimulated cAMP accumulation (the efficacy was 60% of that of histamine) and activation of ERK1/2 signaling (the efficacy was 50% of that of histamine) at H3 receptors, but acted as a full agonist just like histamin in the guinea-pig ileum contraction assay.  These effects were blocked by pertussis toxin and H3 receptor specific antagonist thioperamide.  ZEL-H16 showed no agonist or antagonist activities at the cloned human histamine H1, H2, and H4 receptors and other biogenic amine GPCRs in the CRE-driven reporter assay.  Furthermore, our present data demonstrated that treatment of ZEL-H16 resulted in intensive H3 receptor internalization and delayed recycling to the cell surface as compared to that of control with treatment of histamine.  Thus, ZEL-H16 is a novel and potent nonimidazole agonist of H3R, which might serve as a pharmacol. tool for future investigations or as possible therapeutic agent of H3R.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVABJX6rPEbbVg90H21EOLACvtfcHk0ljhSrk3xYcDqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFKhtrbI&md5=b2372e83fabf74b00466450061446dee</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0042185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0042185%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DY.%26aulast%3DSheng%26aufirst%3DR.%26aulast%3DZhong%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DN.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520ZEL-H16%2520as%2520a%2520novel%2520agonist%2520of%2520the%2520histamine%2520H3%2520receptor%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0042185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghoshal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yugandhar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sona, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuriakose, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagesh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rashid, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahajuddin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, A. K.</span></span> <span> </span><span class="NLM_article-title">Identification of novel β-lactams and pyrrolidinone derivatives as selective histamine-3 receptor (H3R) modulators as possible anti-obesity agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>152</i></span>,  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.04.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1016%2Fj.ejmech.2018.04.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=29704723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosFyhsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2018&pages=148-159&author=A.+Ghoshalauthor=A.+Kumarauthor=D.+Yugandharauthor=C.+Sonaauthor=S.+Kuriakoseauthor=K.+Nageshauthor=M.+Rashidauthor=S.+K.+Singhauthor=M.+Wahajuddinauthor=P.+N.+Yadavauthor=A.+K.+Srivastava&title=Identification+of+novel+%CE%B2-lactams+and+pyrrolidinone+derivatives+as+selective+histamine-3+receptor+%28H3R%29+modulators+as+possible+anti-obesity+agents&doi=10.1016%2Fj.ejmech.2018.04.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel β-lactams and pyrrolidinone derivatives as selective Histamine-3 receptor (H3R) modulators as possible anti-obesity agents</span></div><div class="casAuthors">Ghoshal, Anirban; Kumar, Ajeet; Yugandhar, Doddapaneni; Sona, Chandan; Kuriakose, Sunu; Nagesh, Kommu; Rashid, Mamunur; Singh, Sandeep K.; Wahajuddin, Muhammad; Yadav, Prem N.; Srivastava, Ajay K.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">148-159</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Four series of structurally related β-lactams, 2,5-pyrrolidinediones, azaspirodecatrienediones (ASDT) and dihydropyrroloquinoxalinetriones (DPQT) were synthesized by utilizing post-Ugi modifications in one-pot, and their activity towards human histamine-3 receptor (H3R) was evaluated.  Out of 94 compds., screened against histamine-3 receptor (H3R), 21 compds. showed high H3R selective agonist property with EC50 values ranging from 187 nM to 0.1 nM, whereas none of the compd. was found to have the affinity towards other receptors of histamine family such as histamine H1, H2, and H4 receptor.  All active compds. have no assay interference activity as detd. by in-silico anal. and receptor independent luciferase assay and cell cytotoxicity assay.  Given the important role of H3R in hypophagia, we also evaluated the in vivo effect of the representative compd., (E)-4-benzylidene-1-(tert-butyl)-3-(3-chlorophenyl)-3-((3,4,5-trimethoxyphenyl)amino)pyrrolidine-2,5-dione (6k) on the cumulative food intake in diet induce obese C57BL6/J mice.  Interestingly, it was obsd. that single dose administration (20 mg/kg, i.p. injection) of 6k significantly suppressed cumulative food intake, while no significant effect was obsd. at 10 mg/kg.  These results suggest that β-lactams, 2,5-pyrrolidinediones, azaspirodecatrienediones (ASDT) and dihydropyrroloquinoxalinetriones (DPQT) could be useful for the development of anti-obesity candidate drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqTTE9adXDOrVg90H21EOLACvtfcHk0lhcR5zQt2w2mA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosFyhsbg%253D&md5=ad56433384f969c238dff5d81eb65e44</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.04.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.04.020%26sid%3Dliteratum%253Aachs%26aulast%3DGhoshal%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DYugandhar%26aufirst%3DD.%26aulast%3DSona%26aufirst%3DC.%26aulast%3DKuriakose%26aufirst%3DS.%26aulast%3DNagesh%26aufirst%3DK.%26aulast%3DRashid%26aufirst%3DM.%26aulast%3DSingh%26aufirst%3DS.%2BK.%26aulast%3DWahajuddin%26aufirst%3DM.%26aulast%3DYadav%26aufirst%3DP.%2BN.%26aulast%3DSrivastava%26aufirst%3DA.%2BK.%26atitle%3DIdentification%2520of%2520novel%2520%25CE%25B2-lactams%2520and%2520pyrrolidinone%2520derivatives%2520as%2520selective%2520histamine-3%2520receptor%2520%2528H3R%2529%2520modulators%2520as%2520possible%2520anti-obesity%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D152%26spage%3D148%26epage%3D159%26doi%3D10.1016%2Fj.ejmech.2018.04.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Igel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dove, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschauer, A.</span></span> <span> </span><span class="NLM_article-title">Histamine H<sub>4</sub> receptor agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">7191</span>– <span class="NLM_lpage">7199</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.10.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1016%2Fj.bmcl.2010.10.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=21044842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVKjtLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=7191-7199&author=P.+Igelauthor=S.+Doveauthor=A.+Buschauer&title=Histamine+H4+receptor+agonists&doi=10.1016%2Fj.bmcl.2010.10.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Histamine H4 receptor agonists</span></div><div class="casAuthors">Igel, Patrick; Dove, Stefan; Buschauer, Armin</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7191-7199</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Since its discovery 10 years ago the histamine H4 receptor (H4R) has attracted attention as a potential drug target, for instance, for the treatment of inflammatory and allergic diseases.  Potent and selective ligands including agonists are required as pharmacol. tools to study the role of the H4R in vitro and in vivo.  Many H4R agonists, which were identified among already known histamine receptor ligands, show only low or insufficient H4R selectivity.  In addn., the investigation of numerous H4R agonists in animal models is hampered by species-dependent discrepancies regarding potencies and histamine receptor selectivities of the available compds., esp. when comparing human and rodent receptors.  This article gives an overview about structures, potencies, and selectivities of various compds. showing H4R agonistic activity and summarizes the structure-activity relationships of selected compd. classes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq21SpHt6eblLVg90H21EOLACvtfcHk0lhcR5zQt2w2mA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVKjtLbI&md5=038181dce07ea1dc83eebd9d55e12283</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.10.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.10.041%26sid%3Dliteratum%253Aachs%26aulast%3DIgel%26aufirst%3DP.%26aulast%3DDove%26aufirst%3DS.%26aulast%3DBuschauer%26aufirst%3DA.%26atitle%3DHistamine%2520H4%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D7191%26epage%3D7199%26doi%3D10.1016%2Fj.bmcl.2010.10.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geyer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaske, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumeister, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschauer, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and functional characterization of imbutamine analogs as histamine H<sub>3</sub> and H<sub>4</sub> receptor ligands</span>. <i>Arch. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>347</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1002/ardp.201300316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1002%2Fardp.201300316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=24493592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCrtbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2014&pages=77-88&author=R.+Geyerauthor=M.+Kaskeauthor=P.+Baumeisterauthor=A.+Buschauer&title=Synthesis+and+functional+characterization+of+imbutamine+analogs+as+histamine+H3+and+H4+receptor+ligands&doi=10.1002%2Fardp.201300316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Functional Characterization of Imbutamine Analogs as Histamine H3 and H4 Receptor Ligands</span></div><div class="casAuthors">Geyer, Roland; Kaske, Melanie; Baumeister, Paul; Buschauer, Armin</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">77-88</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Imbutamine (4-(1H-imidazol-4-yl)butanamine) is a potent histamine H3 (H3R) and H4 receptor (H4R) agonist (EC50 values: 3 and 66 nM, resp.).  Aiming at improved selectivity for the H4R, the imidazole ring in imbutamine was methyl-substituted or replaced by various differently substituted heterocycles (1,2,3-triazoles, 1,2,4-triazoles, pyridines, pyrimidines) as potential bioisosteres.  Investigations in [35S]GTPγS binding assays using membranes of Sf9 insect cells expressing the resp. human histamine receptor subtype revealed only very weak activity of most of the synthesized hetarylalkylamines at both receptors.  By contrast, the introduction of substituents at the 4-imidazolyl ring was most effective regarding H4R selectivity.  This holds for Me substitution in position 2 and, esp., in position 5.  5-Methylimbutamine (I, H4R: EC50 = 59 nM, α = 0.8) was equipotent with imbutamine at the hH4R, but revealed about 16-fold selectivity for the hH4R compared to the hH3R (EC50 980 nM, α = 0.36), whereas imbutamine preferred the hH3R.  The functional activities were in agreement with radioligand binding data.  The results support the hypothesis that, by analogy with histamine, Me substitution in histamine homologs offers a way to shift the selectivity in favor of the H4R.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxc6e4wvJQi7Vg90H21EOLACvtfcHk0lhcR5zQt2w2mA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCrtbvM&md5=d28791867ecc1367a61f6b9614a318bc</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fardp.201300316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.201300316%26sid%3Dliteratum%253Aachs%26aulast%3DGeyer%26aufirst%3DR.%26aulast%3DKaske%26aufirst%3DM.%26aulast%3DBaumeister%26aufirst%3DP.%26aulast%3DBuschauer%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520functional%2520characterization%2520of%2520imbutamine%2520analogs%2520as%2520histamine%2520H3%2520and%2520H4%2520receptor%2520ligands%26jtitle%3DArch.%2520Pharm.%26date%3D2014%26volume%3D347%26spage%3D77%26epage%3D88%26doi%3D10.1002%2Fardp.201300316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keseru, G. M.</span></span> <span> </span><span class="NLM_article-title">Novel histamine H4 receptor ligands and their potential therapeutic applications: an update</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1517/13543776.2014.959494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1517%2F13543776.2014.959494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=24206261" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=1-13&author=R.+Kissauthor=G.+M.+Keseru&title=Novel+histamine+H4+receptor+ligands+and+their+potential+therapeutic+applications%3A+an+update&doi=10.1517%2F13543776.2014.959494"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1517%2F13543776.2014.959494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2014.959494%26sid%3Dliteratum%253Aachs%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26atitle%3DNovel%2520histamine%2520H4%2520receptor%2520ligands%2520and%2520their%2520potential%2520therapeutic%2520applications%253A%2520an%2520update%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2014%26volume%3D24%26spage%3D1%26epage%3D13%26doi%3D10.1517%2F13543776.2014.959494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Black, L. A.</span>; <span class="NLM_string-name">Gfesser, G. A.</span>; <span class="NLM_string-name">Cowart, M. D.</span></span> <span> </span><span class="NLM_article-title">4-Substituted-2-amino-pyrimidine Derivatives</span>. <span class="NLM_patent">US20100331294</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=L.+A.+Black&author=G.+A.+Gfesser&author=M.+D.+Cowart&title=4-Substituted-2-amino-pyrimidine+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DL.%2BA.%26atitle%3D4-Substituted-2-amino-pyrimidine%2520Derivatives%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carceller
González, E.</span>; <span class="NLM_string-name">Medina Fuentes, E. M.</span>; <span class="NLM_string-name">Martí
Via, J.</span>; <span class="NLM_string-name">Virgili
Barnardó, M.</span></span> <span> </span><span class="NLM_article-title">2-Amino-pyrimidine Derivatives as Histamine H<sub>4</sub> Antagonists</span>. <span class="NLM_patent">WO2009068512</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=E.+Carceller%0AGonz%C3%A1lez&author=E.+M.+Medina+Fuentes&author=J.+Mart%C3%AD%0AVia&author=M.+Virgili%0ABarnard%C3%B3&title=2-Amino-pyrimidine+Derivatives+as+Histamine+H4+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCarceller%2BGonz%25C3%25A1lez%26aufirst%3DE.%26atitle%3D2-Amino-pyrimidine%2520Derivatives%2520as%2520Histamine%2520H4%2520Antagonists%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, H.</span>; <span class="NLM_string-name">Chavez, F.</span>; <span class="NLM_string-name">Edwards, J. P.</span>; <span class="NLM_string-name">Fitzgerald, A. E.</span>; <span class="NLM_string-name">Liu, J.</span>; <span class="NLM_string-name">Mani, N. S.</span>; <span class="NLM_string-name">Neff, D. K.</span>; <span class="NLM_string-name">Rizzolio, M. C.</span>; <span class="NLM_string-name">Savall, B. M.</span>; <span class="NLM_string-name">Smith, D. M.</span>; <span class="NLM_string-name">Venable, J. D.</span>; <span class="NLM_string-name">Jianmei, W.</span>; <span class="NLM_string-name">Wolin, R.</span></span> <span> </span><span class="NLM_article-title">2-Aminopyrimidine Modulators of the Histamine H<sub>4</sub> Receptor</span>. <span class="NLM_patent">WO2008100565</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=H.+Cai&author=F.+Chavez&author=J.+P.+Edwards&author=A.+E.+Fitzgerald&author=J.+Liu&author=N.+S.+Mani&author=D.+K.+Neff&author=M.+C.+Rizzolio&author=B.+M.+Savall&author=D.+M.+Smith&author=J.+D.+Venable&author=W.+Jianmei&author=R.+Wolin&title=2-Aminopyrimidine+Modulators+of+the+Histamine+H4+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DH.%26atitle%3D2-Aminopyrimidine%2520Modulators%2520of%2520the%2520Histamine%2520H4%2520Receptor%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doak, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">Colloidal aggregation causes inhibition of G protein-coupled receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">2406</span>– <span class="NLM_lpage">2414</span>, <span class="refDoi"> DOI: 10.1021/jm301749y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301749y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVCgt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2406-2414&author=M.+F.+Sassanoauthor=A.+K.+Doakauthor=B.+L.+Rothauthor=B.+K.+Shoichet&title=Colloidal+aggregation+causes+inhibition+of+G+protein-coupled+receptors&doi=10.1021%2Fjm301749y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Colloidal aggregation causes inhibition of G protein-coupled receptors</span></div><div class="casAuthors">Sassano, Maria F.; Doak, Allison K.; Roth, Bryan L.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2406-2414</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Colloidal aggregation is the dominant mechanism for artifactual inhibition of sol. proteins, and controls against it are now widely deployed.  Conversely, investigating this mechanism for membrane-bound receptors has proven difficult.  Here, the authors investigated the activity of 4 well-characterized aggregators against 3 G protein-coupled receptors (GPCRs) recognizing peptide and protein ligands.  Each of the aggregators was active at micromolar concns. against the 3 GPCRs in cell-based assays.  This activity could be attenuated by either centrifugation of the inhibitor stock soln. or by the addn. of Tween-80 detergent.  In the absence of agonist, the aggregators acted as inverse agonists, consistent with a direct receptor interaction.  Meanwhile, several literature GPCR ligands that resembled aggregators themselves formed colloids, by both phys. and enzymol. tests.  These observations suggest that some GPCRs may be artifactually antagonized by colloidal aggregates, an effect that merits the attention of investigators in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojG9CcuOYoXrVg90H21EOLACvtfcHk0lh4CGrGDchspw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVCgt7s%253D&md5=84fa59f9635330739bf836f8085be5e0</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm301749y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301749y%26sid%3Dliteratum%253Aachs%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DDoak%26aufirst%3DA.%2BK.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DColloidal%2520aggregation%2520causes%2520inhibition%2520of%2520G%2520protein-coupled%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2406%26epage%3D2414%26doi%3D10.1021%2Fjm301749y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sirci, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Istyastono, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vischer, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kooistra, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nijmeijer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuijer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wijtmans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannhold, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Esch, I. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Graaf, C.</span></span> <span> </span><span class="NLM_article-title">Virtual fragment screening: Discovery of histamine H<sub>3</sub> receptor ligands using ligand-based and protein-based molecular fingerprints</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">3308</span>– <span class="NLM_lpage">3324</span>, <span class="refDoi"> DOI: 10.1021/ci3004094</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci3004094" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1ekt7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=3308-3324&author=F.+Sirciauthor=E.+P.+Istyastonoauthor=H.+F.+Vischerauthor=A.+J.+Kooistraauthor=S.+Nijmeijerauthor=M.+Kuijerauthor=M.+Wijtmansauthor=R.+Mannholdauthor=R.+Leursauthor=I.+J.+P.+de+Eschauthor=C.+de+Graaf&title=Virtual+fragment+screening%3A+Discovery+of+histamine+H3+receptor+ligands+using+ligand-based+and+protein-based+molecular+fingerprints&doi=10.1021%2Fci3004094"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual Fragment Screening: Discovery of Histamine H3 Receptor Ligands Using Ligand-Based and Protein-Based Molecular Fingerprints</span></div><div class="casAuthors">Sirci, Francesco; Istyastono, Enade P.; Vischer, Henry F.; Kooistra, Albert J.; Nijmeijer, Saskia; Kuijer, Martien; Wijtmans, Maikel; Mannhold, Raimund; Leurs, Rob; de Esch, Iwan J. P.; de Graaf, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3308-3324</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Virtual fragment screening (VFS) is a promising new method that uses computer models to identify small, fragment-like biol. active mols. as useful starting points for fragment-based drug discovery (FBDD).  Training sets of true active and inactive fragment-like mols. to construct and validate target customized VFS methods are however lacking.  The authors have for the first time explored the possibilities and challenges of VFS using mol. fingerprints derived from a unique set of fragment affinity data for the histamine H3 receptor (H3R), a pharmaceutically relevant G protein-coupled receptor (GPCR).  Optimized FLAP (Fingerprints of Ligands and Proteins) models contg. essential mol. interaction fields that discriminate known H3R binders from inactive mols. were successfully used for the identification of new H3R ligands.  Prospective virtual screening of 156 090 mols. yielded a high hit rate of 62% (18 of the 29 tested) exptl. confirmed novel fragment-like H3R ligands that offer new potential starting points for the design of H3R targeting drugs.  The first construction and application of customized FLAP models for the discovery of fragment-like biol. active mols. demonstrates that VFS is an efficient way to explore protein-fragment interaction space in silico.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-rcV1LwQDR7Vg90H21EOLACvtfcHk0lh4CGrGDchspw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1ekt7fM&md5=14a4c7d26dd1ba29903259d450f355df</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fci3004094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci3004094%26sid%3Dliteratum%253Aachs%26aulast%3DSirci%26aufirst%3DF.%26aulast%3DIstyastono%26aufirst%3DE.%2BP.%26aulast%3DVischer%26aufirst%3DH.%2BF.%26aulast%3DKooistra%26aufirst%3DA.%2BJ.%26aulast%3DNijmeijer%26aufirst%3DS.%26aulast%3DKuijer%26aufirst%3DM.%26aulast%3DWijtmans%26aufirst%3DM.%26aulast%3DMannhold%26aufirst%3DR.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3Dde%2BGraaf%26aufirst%3DC.%26atitle%3DVirtual%2520fragment%2520screening%253A%2520Discovery%2520of%2520histamine%2520H3%2520receptor%2520ligands%2520using%2520ligand-based%2520and%2520protein-based%2520molecular%2520fingerprints%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D3308%26epage%3D3324%26doi%3D10.1021%2Fci3004094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kooistra, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Esch, I. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Graaf, C.</span></span> <span> </span><span class="NLM_article-title">A structural chemogenomics analysis of aminergic GPCRs: Lessons for histamine receptor ligand design</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>170</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.1111/bph.12248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1111%2Fbph.12248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=23713847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlSgtbnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2013&pages=101-126&author=A.+J.+Kooistraauthor=S.+Kuhneauthor=I.+J.+P.+de+Eschauthor=R.+Leursauthor=C.+de+Graaf&title=A+structural+chemogenomics+analysis+of+aminergic+GPCRs%3A+Lessons+for+histamine+receptor+ligand+design&doi=10.1111%2Fbph.12248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design</span></div><div class="casAuthors">Kooistra, A. J.; Kuhne, S.; de Esch, I. J. P.; Leurs, R.; de Graaf, C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-126</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose Chemogenomics focuses on the discovery of new connections between chem. and biol. space leading to the discovery of new protein targets and biol. active mols.  G-protein coupled receptors (GPCRs) are a particularly interesting protein family for chemogenomics studies because there is an overwhelming amt. of ligand binding affinity data available.  The increasing no. of aminergic GPCR crystal structures now for the first time allows the integration of chemogenomics studies with high-resoln. structural analyses of GPCR-ligand complexes.  Exptl. Approach In this study, we have combined ligand affinity data, receptor mutagenesis studies, and amino acid sequence analyses to high-resoln. structural analyses of (hist)aminergic GPCR-ligand interactions.  This integrated structural chemogenomics anal. is used to more accurately describe the mol. and structural determinants of ligand affinity and selectivity in different key binding regions of the crystd. aminergic GPCRs, and histamine receptors in particular.  Key Results Our investigations highlight interesting correlations and differences between ligand similarity and ligand binding site similarity of different aminergic receptors.  Apparent discrepancies can be explained by combining detailed anal. of crystd. or predicted protein-ligand binding modes, receptor mutation studies, and ligand structure-selectivity relationships that identify local differences in essential pharmacophore features in the ligand binding sites of different receptors.  Conclusions and Implications We have performed structural chemogenomics studies that identify links between (hist)aminergic receptor ligands and their binding sites and binding modes.  This knowledge can be used to identify structure-selectivity relationships that increase our understanding of ligand binding to (hist)aminergic receptors and hence can be used in future GPCR ligand discovery and design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxr6kq48O11rVg90H21EOLACvtfcHk0ljpiJIfbXQ88g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlSgtbnE&md5=08ae55b9565885165e76d98e2db1befa</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1111%2Fbph.12248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12248%26sid%3Dliteratum%253Aachs%26aulast%3DKooistra%26aufirst%3DA.%2BJ.%26aulast%3DKuhne%26aufirst%3DS.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3Dde%2BGraaf%26aufirst%3DC.%26atitle%3DA%2520structural%2520chemogenomics%2520analysis%2520of%2520aminergic%2520GPCRs%253A%2520Lessons%2520for%2520histamine%2520receptor%2520ligand%2520design%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D170%26spage%3D101%26epage%3D126%26doi%3D10.1111%2Fbph.12248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jongejan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smits, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Esch, I. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haaksma, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span> <span> </span><span class="NLM_article-title">Delineation of agonist binding to the human histamine H<sub>4</sub> receptor using mutational analysis, homology modeling, and ab initio calculations</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1455</span>– <span class="NLM_lpage">1463</span>, <span class="refDoi"> DOI: 10.1021/ci700474a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci700474a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntF2rs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=1455-1463&author=A.+Jongejanauthor=H.+D.+Limauthor=R.+A.+Smitsauthor=I.+J.+P.+de+Eschauthor=E.+Haaksmaauthor=R.+Leurs&title=Delineation+of+agonist+binding+to+the+human+histamine+H4+receptor+using+mutational+analysis%2C+homology+modeling%2C+and+ab+initio+calculations&doi=10.1021%2Fci700474a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Delineation of Agonist Binding to the Human Histamine H4 Receptor Using Mutational Analysis, Homology Modeling, and ab Initio Calculations</span></div><div class="casAuthors">Jongejan, Aldo; Lim, Herman D.; Smits, Rogier A.; de Esch, Iwan J. P.; Haaksma, Eric; Leurs, Rob</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1455-1463</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A three-dimensional homol. model of the human histamine H4 receptor was developed to investigate the binding mode of a series of structurally diverse H4-agonists, i.e.  Histamine, clozapine, and the recently described selective, nonimidazole agonist VUF 8430.  Mutagenesis studies and docking of these ligands in a rhodopsin-based homol. model revealed two essential points of interactions in the binding pocket, i.e. Asp3.32 and Glu5.46 (Ballesteros-Weinstein numbering system).  It is postulated that Asp3.32 interacts in its anionic state, whereas Glu5.46 interacts in its neutral form.  The hypothesis was tested with the point mutations D3.32N and E5.46Q.  For the D3.32N no binding affinity toward any of the ligands could be detected.  This is in sharp contrast to the E5.46Q mutant, which discriminates between various ligands.  The affinity of histamine-like ligands was decreased approx. a 1000-fold, whereas the affinity of all other ligands remained virtually unchanged.  The proposed model for agonist binding as well as ab initio calcns. for histamine and VUF 8430 explain the obsd. differences in binding to the H4R mutants.  These studies provide a mol. understanding for the action of a variety of H4 receptor-ligands.  The resulting H4 receptor model will be the basis for the development of new H4 receptor-ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfm0Zxd6C6ArVg90H21EOLACvtfcHk0ljpiJIfbXQ88g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntF2rs7g%253D&md5=28f7e8b852b66da6a537438a905c825d</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fci700474a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci700474a%26sid%3Dliteratum%253Aachs%26aulast%3DJongejan%26aufirst%3DA.%26aulast%3DLim%26aufirst%3DH.%2BD.%26aulast%3DSmits%26aufirst%3DR.%2BA.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3DHaaksma%26aufirst%3DE.%26aulast%3DLeurs%26aufirst%3DR.%26atitle%3DDelineation%2520of%2520agonist%2520binding%2520to%2520the%2520human%2520histamine%2520H4%2520receptor%2520using%2520mutational%2520analysis%252C%2520homology%2520modeling%252C%2520and%2520ab%2520initio%2520calculations%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2008%26volume%3D48%26spage%3D1455%26epage%3D1463%26doi%3D10.1021%2Fci700474a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coates, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murgolo, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morse, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayne, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strader, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monsma, F. J.</span></span> <span> </span><span class="NLM_article-title">Molecular modeling and site-specific mutagenesis of the histamine-binding site of the histamine H<sub>4</sub> receptor</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">38</span>– <span class="NLM_lpage">47</span>, <span class="refDoi"> DOI: 10.1124/mol.62.1.38</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1124%2Fmol.62.1.38" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=12065753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD38Xlt1KqtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=38-47&author=N.+Shinauthor=E.+Coatesauthor=N.+J.+Murgoloauthor=K.+L.+Morseauthor=M.+Bayneauthor=C.+D.+Straderauthor=F.+J.+Monsma&title=Molecular+modeling+and+site-specific+mutagenesis+of+the+histamine-binding+site+of+the+histamine+H4+receptor&doi=10.1124%2Fmol.62.1.38"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular modeling and site-specific mutagenesis of the histamine-binding site of the histamine H4 receptor</span></div><div class="casAuthors">Shin, Niu; Coates, Elizabeth; Murgolo, Nicholas J.; Morse, Kelley L.; Bayne, Marvin; Strader, Catherine D.; Monsma, Frederick J., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-47</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The histamine H4 receptor is a novel G-protein-coupled receptor with a unique pharmacol. profile.  The distribution of H4 mRNA suggests that it may play a role in the regulation of immune function, particularly with respect to allergy and asthma.  To define the histamine-binding site of this receptor, mol. modeling and site-directed mutagenesis were used to predict and alter amino acids residing in the histamine-binding pocket.  The effects of these alterations on histamine binding and receptor activation were then assessed.  The authors' results indicate that Asp94 (3.32) in transmembrane region (TM) 3 and Glu182 (5.46) in TM5 are critically involved in histamine binding.  Asp94 probably serves as a counter-anion to the cationic amino group of histamine, whereas Glu182 (5.46) interacts with the Nτ nitrogen atom of the histamine imidazole ring via an ion pair.  In contrast, Thr178 (5.42) and Ser179 (5.43) in TM5 are not significantly involved in either histamine binding or receptor activation.  These results resemble those for the analogous residues in the H1 histamine receptor but contrast with findings regarding the H2 histamine receptor.  The authors' results also demonstrate that Asn147 (4.57) in TM4 and Ser320 (6.52) in TM6 play a role in receptor activation but are not involved in histamine binding.  Taken together, these data indicate that although histamine seems to bind to the H4 receptor in a fashion similar to that predicted for the other histamine receptor subtypes, there are also important differences that can probably be exploited for the discovery of novel H4-selective compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp04y1YiSqFS7Vg90H21EOLACvtfcHk0ljpiJIfbXQ88g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xlt1KqtLk%253D&md5=13f386f22254209e61e858b14a2f89e6</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1124%2Fmol.62.1.38&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.62.1.38%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DN.%26aulast%3DCoates%26aufirst%3DE.%26aulast%3DMurgolo%26aufirst%3DN.%2BJ.%26aulast%3DMorse%26aufirst%3DK.%2BL.%26aulast%3DBayne%26aufirst%3DM.%26aulast%3DStrader%26aufirst%3DC.%2BD.%26aulast%3DMonsma%26aufirst%3DF.%2BJ.%26atitle%3DMolecular%2520modeling%2520and%2520site-specific%2520mutagenesis%2520of%2520the%2520histamine-binding%2520site%2520of%2520the%2520histamine%2520H4%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2002%26volume%3D62%26spage%3D38%26epage%3D47%26doi%3D10.1124%2Fmol.62.1.38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Istyastono, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nijmeijer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stolpe van de, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roumen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kooistra, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vischer, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Esch, I. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Graaf, C.</span></span> <span> </span><span class="NLM_article-title">Molecular determinants of ligand binding modes in the histamine H<sub>4</sub> receptor: linking ligand-based three-dimensional quantitative structure–activity relationship (3D-QSAR) models to in silico guided receptor mutagenesis studies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">8136</span>– <span class="NLM_lpage">8147</span>, <span class="refDoi"> DOI: 10.1021/jm201042n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201042n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlaksrjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8136-8147&author=E.+P.+Istyastonoauthor=S.+Nijmeijerauthor=H.+D.+Limauthor=A.+Stolpe+van+deauthor=L.+Roumenauthor=A.+J.+Kooistraauthor=H.+F.+Vischerauthor=I.+J.+P.+de+Eschauthor=R.+Leursauthor=C.+de+Graaf&title=Molecular+determinants+of+ligand+binding+modes+in+the+histamine+H4+receptor%3A+linking+ligand-based+three-dimensional+quantitative+structure%E2%80%93activity+relationship+%283D-QSAR%29+models+to+in+silico+guided+receptor+mutagenesis+studies&doi=10.1021%2Fjm201042n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Determinants of Ligand Binding Modes in the Histamine H4 Receptor: Linking Ligand-Based Three-Dimensional Quantitative Structure-Activity Relationship (3D-QSAR) Models to in Silico Guided Receptor Mutagenesis Studies</span></div><div class="casAuthors">Istyastono, Enade P.; Nijmeijer, Saskia; Lim, Herman D.; van de Stolpe, Andrea; Roumen, Luc; Kooistra, Albert J.; Vischer, Henry F.; de Esch, Iwan J. P.; Leurs, Rob; de Graaf, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8136-8147</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The histamine H4 receptor (H4R) is a G protein-coupled receptor (GPCR) that plays an important role in inflammation.  Similar to the homologous histamine H3 receptor (H3R), two acidic residues in the H4R binding pocket, D3.32 and E5.46, act as essential hydrogen bond acceptors of pos. ionizable hydrogen bond donors in H4R ligands.  Given the sym. distribution of these complementary pharmacophore features in H4R and its ligands, different alternative ligand binding mode hypotheses have been proposed.  The current study focuses on the elucidation of the mol. determinants of H4R-ligand binding modes by combining (3D) quant. structure-activity relationship (QSAR), protein homol. modeling, mol. dynamics simulations, and site-directed mutagenesis studies.  We have designed and synthesized a series of clobenpropit (N-(4-chlorobenzyl)-S-[3-(4(5)-imidazolyl)propyl]isothiourea) derivs. to investigate H4R-ligand interactions and ligand binding orientations.  Interestingly, our studies indicate that clobenpropit (2) itself can bind to H4R in two distinct binding modes, while the addn. of a cyclohexyl group to the clobenpropit isothiourea moiety allows VUF5228 (5) to adopt only one specific binding mode in the H4R binding pocket.  Our ligand-steered, exptl. supported protein modeling method gives new insights into ligand recognition by H4R and can be used as a general approach to elucidate the structure of protein-ligand complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhhoHc4I5Ya7Vg90H21EOLACvtfcHk0lhefxddWB9FPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlaksrjO&md5=f4adb3a9dfd4cefaba2ea1cdc56c7e1f</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm201042n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201042n%26sid%3Dliteratum%253Aachs%26aulast%3DIstyastono%26aufirst%3DE.%2BP.%26aulast%3DNijmeijer%26aufirst%3DS.%26aulast%3DLim%26aufirst%3DH.%2BD.%26aulast%3DStolpe%2Bvan%2Bde%26aufirst%3DA.%26aulast%3DRoumen%26aufirst%3DL.%26aulast%3DKooistra%26aufirst%3DA.%2BJ.%26aulast%3DVischer%26aufirst%3DH.%2BF.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3Dde%2BGraaf%26aufirst%3DC.%26atitle%3DMolecular%2520determinants%2520of%2520ligand%2520binding%2520modes%2520in%2520the%2520histamine%2520H4%2520receptor%253A%2520linking%2520ligand-based%2520three-dimensional%2520quantitative%2520structure%25E2%2580%2593activity%2520relationship%2520%25283D-QSAR%2529%2520models%2520to%2520in%2520silico%2520guided%2520receptor%2520mutagenesis%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8136%26epage%3D8147%26doi%3D10.1021%2Fjm201042n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uveges, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spangler, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunlop, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philip, G. J.</span></span> <span> </span><span class="NLM_article-title">The role of transmembrane helix 5 in agonist binding to the human H<sub>3</sub> receptor</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>301</i></span>,  <span class="NLM_fpage">451</span>– <span class="NLM_lpage">458</span>, <span class="refDoi"> DOI: 10.1124/jpet.301.2.451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1124%2Fjpet.301.2.451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=11961043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtlKjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2002&pages=451-458&author=A.+J.+Uvegesauthor=D.+Kowalauthor=Y.+Zhangauthor=T.+B.+Spanglerauthor=J.+Dunlopauthor=S.+Semusauthor=G.+J.+Philip&title=The+role+of+transmembrane+helix+5+in+agonist+binding+to+the+human+H3+receptor&doi=10.1124%2Fjpet.301.2.451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The role of transmembrane helix 5 in agonist binding to the human H3 receptor</span></div><div class="casAuthors">Uveges, Albert J.; Kowal, Dianne; Zhang, Yingxin; Spangler, Taylor B.; Dunlop, John; Semus, Simon; Jones, Philip G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">301</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">451-458</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We have used alanine scanning mutagenesis to identify residues in transmembrane domain 5 of the histamine H3 receptor that are important for agonist binding.  All of the mutants generated were functionally expressed as demonstrated by their ability to bind [125I]iodoproxyfan with comparable affinity to the wild-type receptor and their ability to inhibit forskolin-stimulated cAMP formation when activated by histamine.  Many mutations produced small changes in the potency of histamine, but the most pronounced redn. in potency and affinity of the agonists, histamine, R-α-methylhistamine, imetit, and impentamine, was seen with mutation of glutamate 206.  Our modeling suggests that this residue plays a key role in ligand binding by interacting with the imidazole ring of histamine.  Interestingly, L199A greatly reduced agonist potency in functional assays but had only minor effects on agonist affinity, implicating a role for this residue in the mechanism of receptor activation.  We also studied the functional effects of the mutations by linking the receptor to calcium signaling using a chimeric G protein.  A comparison of the two functional assays demonstrated contrasting effects on agonist activity.  Histamine, imetit, and impentamine were full agonists in the cAMP assay, but imetit exhibited only partial agonist activity through the chimeric G protein.  Furthermore, impentamine, another potent agonist in the cAMP assay, was only able to activate the E206A mutant in the calcium assay despite being inactive at the wild-type receptor.  These observations suggest that the agonist receptor complexes formed by these three different H3 agonists are not conformationally equiv.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQYuVf-QZSLrVg90H21EOLACvtfcHk0lhefxddWB9FPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtlKjurg%253D&md5=1a47a766511d1c6170ca31e5a31dc598</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1124%2Fjpet.301.2.451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.301.2.451%26sid%3Dliteratum%253Aachs%26aulast%3DUveges%26aufirst%3DA.%2BJ.%26aulast%3DKowal%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSpangler%26aufirst%3DT.%2BB.%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DSemus%26aufirst%3DS.%26aulast%3DPhilip%26aufirst%3DG.%2BJ.%26atitle%3DThe%2520role%2520of%2520transmembrane%2520helix%25205%2520in%2520agonist%2520binding%2520to%2520the%2520human%2520H3%2520receptor%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D301%26spage%3D451%26epage%3D458%26doi%3D10.1124%2Fjpet.301.2.451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiroishi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weyand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsujimoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abagyan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwata, S.</span></span> <span> </span><span class="NLM_article-title">Structure of the human histamine H1 receptor complex with doxepin</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>475</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1038/nature10236</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1038%2Fnature10236" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=21697825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvVekt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=475&publication_year=2011&pages=65-72&author=T.+Shimamuraauthor=M.+Shiroishiauthor=S.+Weyandauthor=H.+Tsujimotoauthor=G.+Winterauthor=V.+Katritchauthor=R.+Abagyanauthor=V.+Cherezovauthor=W.+Liuauthor=G.+W.+Hanauthor=T.+Kobayashiauthor=R.+C.+Stevensauthor=S.+Iwata&title=Structure+of+the+human+histamine+H1+receptor+complex+with+doxepin&doi=10.1038%2Fnature10236"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the human histamine H1 receptor complex with doxepin</span></div><div class="casAuthors">Shimamura, Tatsuro; Shiroishi, Mitsunori; Weyand, Simone; Tsujimoto, Hirokazu; Winter, Graeme; Katritch, Vsevolod; Abagyan, Ruben; Cherezov, Vadim; Liu, Wei; Han, Gye Won; Kobayashi, Takuya; Stevens, Raymond C.; Iwata, So</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">475</span>
        (<span class="NLM_cas:issue">7354</span>),
    <span class="NLM_cas:pages">65-70</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The biogenic amine histamine is an important pharmacol. mediator involved in pathophysiol. processes such as allergies and inflammations.  Histamine H1 receptor (H1R) antagonists are very effective drugs alleviating the symptoms of allergic reactions.  Here, we show the crystal structure of the H1R complex with doxepin, a first-generation H1R antagonist.  Doxepin sits deep in the ligand-binding pocket and directly interacts with Trp 428, a highly conserved key residue in G-protein-coupled-receptor activation.  This well-conserved pocket with mostly hydrophobic nature contributes to the low selectivity of the first-generation compds.  The pocket is assocd. with an anion-binding region occupied by a phosphate ion.  Docking of various second-generation H1R antagonists reveals that the unique carboxyl group present in this class of compds. interacts with Lys 191 and/or Lys 179ECL2, both of which form part of the anion-binding region.  This region is not conserved in other aminergic receptors, demonstrating how minor differences in receptors lead to pronounced selectivity differences with small mols.  Our study sheds light on the mol. basis of H1R antagonist specificity against H1R.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN1obci6QtYbVg90H21EOLACvtfcHk0lhefxddWB9FPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvVekt7k%253D&md5=7116228016caa1f3afbfed11468c0154</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fnature10236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10236%26sid%3Dliteratum%253Aachs%26aulast%3DShimamura%26aufirst%3DT.%26aulast%3DShiroishi%26aufirst%3DM.%26aulast%3DWeyand%26aufirst%3DS.%26aulast%3DTsujimoto%26aufirst%3DH.%26aulast%3DWinter%26aufirst%3DG.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DIwata%26aufirst%3DS.%26atitle%3DStructure%2520of%2520the%2520human%2520histamine%2520H1%2520receptor%2520complex%2520with%2520doxepin%26jtitle%3DNature%26date%3D2011%26volume%3D475%26spage%3D65%26epage%3D72%26doi%3D10.1038%2Fnature10236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morse, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laz, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, R. E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenfeder, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anthes, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umland, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hipkin, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonsiorek, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedrick, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayne, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monsma, F. J. J.</span></span> <span> </span><span class="NLM_article-title">Cloning and characterization of a novel human histamine receptor</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>269</i></span>,  <span class="NLM_fpage">1058</span>– <span class="NLM_lpage">1066</span>,</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=2001&pages=1058-1066&author=K.+L.+Morseauthor=J.+Behanauthor=T.+M.+Lazauthor=R.+E.+J.+Westauthor=S.+A.+Greenfederauthor=J.+C.+Anthesauthor=S.+Umlandauthor=Y.+Wanauthor=R.+W.+Hipkinauthor=W.+Gonsiorekauthor=N.+Shinauthor=E.+L.+Gustafsonauthor=X.+Qiaoauthor=S.+Wangauthor=J.+A.+Hedrickauthor=J.+Greeneauthor=M.+Bayneauthor=F.+J.+J.+Monsma&title=Cloning+and+characterization+of+a+novel+human+histamine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorse%26aufirst%3DK.%2BL.%26aulast%3DBehan%26aufirst%3DJ.%26aulast%3DLaz%26aufirst%3DT.%2BM.%26aulast%3DWest%26aufirst%3DR.%2BE.%2BJ.%26aulast%3DGreenfeder%26aufirst%3DS.%2BA.%26aulast%3DAnthes%26aufirst%3DJ.%2BC.%26aulast%3DUmland%26aufirst%3DS.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DHipkin%26aufirst%3DR.%2BW.%26aulast%3DGonsiorek%26aufirst%3DW.%26aulast%3DShin%26aufirst%3DN.%26aulast%3DGustafson%26aufirst%3DE.%2BL.%26aulast%3DQiao%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DHedrick%26aufirst%3DJ.%2BA.%26aulast%3DGreene%26aufirst%3DJ.%26aulast%3DBayne%26aufirst%3DM.%26aulast%3DMonsma%26aufirst%3DF.%2BJ.%2BJ.%26atitle%3DCloning%2520and%2520characterization%2520of%2520a%2520novel%2520human%2520histamine%2520receptor%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D269%26spage%3D1058%26epage%3D1066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1350</span>– <span class="NLM_lpage">1359</span>,</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10534321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADyaK1MXntFSht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=1350-1359&author=R.+S.+Obach&title=Prediction+of+human+clearance+of+twenty-nine+drugs+from+hepatic+microsomal+intrinsic+clearance+data%3A+An+examination+of+in+vitro+half-life+approach+and+nonspecific+binding+to+microsomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes</span></div><div class="casAuthors">Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1350-1359</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Twenty-nine drugs of disparate structures and physicochem. properties were used in an examn. of the capability of human liver microsomal lability data ("in vitro T1/2" approach) to be useful in the prediction of human clearance.  Addnl., the potential importance of nonspecific binding to microsomes in the in vitro incubation milieu for the accurate prediction of human clearance was investigated.  The compds. examd. demonstrated a wide range of microsomal metabolic labilities with scaled intrinsic clearance values ranging from less than 0.5 mL/min/kg to 189 mL/min/kg.  Microsomal binding was detd. at microsomal protein concns. used in the lability incubations.  For the 29 compds. studied, unbound fractions in microsomes ranged from 0.11 to 1.0.  Generally, basic compds. demonstrated the greatest extent of binding and neutral and acidic compds. the least extent of binding.  In the projection of human clearance values, basic and neutral compds. were well predicted when all binding considerations (blood and microsome) were disregarded, however, including both binding considerations also yielded reasonable predictions.  Including only blood binding yielded very poor projections of human clearance for these two types of compds.  However, for acidic compds., disregarding all binding considerations yielded poor predictions of human clearance.  It was generally most difficult to accurately predict clearance for this class of compds.; however the accuracy was best when all binding considerations were included.  Overall, inclusion of both blood and microsome binding values gave the best agreement between in vivo clearance values and clearance values projected from in vitro intrinsic clearance data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWp2hUTOxyubVg90H21EOLACvtfcHk0lhaaWDMqWOmWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFSht7c%253D&md5=7804cd4dfb131caac45aff9b7a1df901</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DPrediction%2520of%2520human%2520clearance%2520of%2520twenty-nine%2520drugs%2520from%2520hepatic%2520microsomal%2520intrinsic%2520clearance%2520data%253A%2520An%2520examination%2520of%2520in%2520vitro%2520half-life%2520approach%2520and%2520nonspecific%2520binding%2520to%2520microsomes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1999%26volume%3D27%26spage%3D1350%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, A. Y. H.</span></span> <span> </span><span class="NLM_article-title">Inhibition and induction of cytochrome P450 and the clinical implications</span>. <i>Clin. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">361</span>– <span class="NLM_lpage">390</span>, <span class="refDoi"> DOI: 10.2165/00003088-199835050-00003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.2165%2F00003088-199835050-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=9839089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADyaK1cXnvVeqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1998&pages=361-390&author=J.+H.+Linauthor=A.+Y.+H.+Lu&title=Inhibition+and+induction+of+cytochrome+P450+and+the+clinical+implications&doi=10.2165%2F00003088-199835050-00003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition and induction of cytochrome P450 and the clinical implications</span></div><div class="casAuthors">Lin, Jiunn H.; Lu, Anthony Y. H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">361-390</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review with 192 refs.  The cytochrome P450s (CYPs) constitute a superfamily of isoforms that play an important role in the oxidative metab. of drugs.  Each CYP isoform possesses a characteristic broad spectrum of catalytic activities of substrates.  Whenever 2 or more drugs are administered concurrently, the possibility of drug interactions exists.  The ability of a single CYP to metabolize multiple substrates is responsible for a large no. of documented drug interactions assocd. with CYP inhibition.  In addn., drug interactions can also occur as a result of the induction of several human CYPs following long term drug treatment.  The mechanisms of CYP inhibition can be divided into 3 categories: (a) reversible inhibition; (b) quasi-irreversible inhibition; and (c) irreversible inhibition.  In mechanistic terms, reversible interactions arise as a result of competition at the CYP active site and probably involve only the first step of the CYP catalytic cycle.  On the other hand, drugs that act during and subsequent to the oxygen transfer step are generally irreversible or quasi-irreversible inhibitors.  Irreversible and quasi-irreversible inhibition require at least one cycle of the CYP catalytic process.  Because human liver samples and recombinant human CYPs are now readily available, in vitro systems have been used as screening tools to predict the potential for in vivo drug interaction.  Although it is easy to det. in vitro metabolic drug interactions, the proper interpretation and extrapolation of in vitro interaction data to in vivo situations require a good understanding of pharmacokinetic principles.  From the viewpoint of drug therapy, to avoid potential drug-drug interactions, it is desirable to develop a new drug candidate that is not a potent CYP inhibitor or inducer and the metab. of which is not readily inhibited by other drugs.  In reality, drug interaction by mutual inhibition between drugs is almost inevitable, because CYP-mediated metab. represents a major route of elimination of many drugs, which can compete for the same CYP enzyme.  The clin. significance of a metabolic drug interaction depends on the magnitude of the change in the concn. of active species (parent drug and/or active metabolites) at the site of pharmacol. action and the therapeutic index of the drug.  The smaller the difference between toxic and effective concn., the greater the likelihood that a drug interaction will have serious clin. consequences.  Thus, careful evaluation of potential drug interactions of a new drug candidate during the early stage of drug development is essential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxdqTupUCBbLVg90H21EOLACvtfcHk0lhaaWDMqWOmWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnvVeqtLo%253D&md5=18993123e2cdad5517962664e986a5b4</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.2165%2F00003088-199835050-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-199835050-00003%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DJ.%2BH.%26aulast%3DLu%26aufirst%3DA.%2BY.%2BH.%26atitle%3DInhibition%2520and%2520induction%2520of%2520cytochrome%2520P450%2520and%2520the%2520clinical%2520implications%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D1998%26volume%3D35%26spage%3D361%26epage%3D390%26doi%3D10.2165%2F00003088-199835050-00003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Provensi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izquierdo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blandina, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passani, M. B.</span></span> <span> </span><span class="NLM_article-title">Brain histamine modulates recognition memory: possible implications in major cognitive disorders</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>, <span class="refDoi"> DOI: 10.1111/bph.14478</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1111%2Fbph.14478" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=G.+Provensiauthor=A.+Costaauthor=I.+Izquierdoauthor=P.+Blandinaauthor=M.+B.+Passani&title=Brain+histamine+modulates+recognition+memory%3A+possible+implications+in+major+cognitive+disorders&doi=10.1111%2Fbph.14478"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1111%2Fbph.14478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.14478%26sid%3Dliteratum%253Aachs%26aulast%3DProvensi%26aufirst%3DG.%26aulast%3DCosta%26aufirst%3DA.%26aulast%3DIzquierdo%26aufirst%3DI.%26aulast%3DBlandina%26aufirst%3DP.%26aulast%3DPassani%26aufirst%3DM.%2BB.%26atitle%3DBrain%2520histamine%2520modulates%2520recognition%2520memory%253A%2520possible%2520implications%2520in%2520major%2520cognitive%2520disorders%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2018%26doi%3D10.1111%2Fbph.14478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prast, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argyriou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philippu, A.</span></span> <span> </span><span class="NLM_article-title">Histaminergic neurons facilitate social memory in rats</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>734</i></span>,  <span class="NLM_fpage">316</span>– <span class="NLM_lpage">318</span>, <span class="refDoi"> DOI: 10.1016/0006-8993(96)00886-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1016%2F0006-8993%2896%2900886-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=8896839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADyaK28Xls1Knurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=734&publication_year=1996&pages=316-318&author=H.+Prastauthor=A.+Argyriouauthor=A.+Philippu&title=Histaminergic+neurons+facilitate+social+memory+in+rats&doi=10.1016%2F0006-8993%2896%2900886-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Histaminergic neurons facilitate social memory in rats</span></div><div class="casAuthors">Prast, Helmut; Argyriou, Anastasia; Philippu, Athineos</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">734</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">316-318</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The social memory test was used so as to investigate whether brain histamine is involved in short-term memory.  Histamine injected intracerebroventricularly (i.c.v.) decreased investigation time of a juvenile rat by an adult rat.  A similar effect was elicited by i.c.v. administration of histidine.  Compared with the control animals, rat pretreatment with α-fluoromethylhistidine (FMH), which inhibits neuronal synthesis of histamine, prolonged recognition time.  The H3-receptor agonist immepip also prolonged investigation time, while the H3-antagonist thioperamide exerted the opposite effect.  Treatment with histidine increased, while treatment with FMH decreased histamine levels in various brain regions.  It is concluded that histamine released from histaminergic neurons facilitates short-term memory.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1cI8SlYoJ7bVg90H21EOLACvtfcHk0lhas_y76qK-DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xls1Knurg%253D&md5=f670e83673ac4979104d422c4a213abb</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2896%2900886-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252896%252900886-4%26sid%3Dliteratum%253Aachs%26aulast%3DPrast%26aufirst%3DH.%26aulast%3DArgyriou%26aufirst%3DA.%26aulast%3DPhilippu%26aufirst%3DA.%26atitle%3DHistaminergic%2520neurons%2520facilitate%2520social%2520memory%2520in%2520rats%26jtitle%3DBrain%2520Res.%26date%3D1996%26volume%3D734%26spage%3D316%26epage%3D318%26doi%3D10.1016%2F0006-8993%2896%2900886-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Provensi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passani, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izquierdo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blandina, P.</span></span> <span> </span><span class="NLM_article-title">Neuronal histamine and the memory of emotionally salient events</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>, <span class="refDoi"> DOI: 10.1111/bph.14476</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1111%2Fbph.14476" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=G.+Provensiauthor=M.+B.+Passaniauthor=A.+Costaauthor=I.+Izquierdoauthor=P.+Blandina&title=Neuronal+histamine+and+the+memory+of+emotionally+salient+events&doi=10.1111%2Fbph.14476"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1111%2Fbph.14476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.14476%26sid%3Dliteratum%253Aachs%26aulast%3DProvensi%26aufirst%3DG.%26aulast%3DPassani%26aufirst%3DM.%2BB.%26aulast%3DCosta%26aufirst%3DA.%26aulast%3DIzquierdo%26aufirst%3DI.%26aulast%3DBlandina%26aufirst%3DP.%26atitle%3DNeuronal%2520histamine%2520and%2520the%2520memory%2520of%2520emotionally%2520salient%2520events%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2018%26doi%3D10.1111%2Fbph.14476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parmentier, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anaclet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guhennec, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brousseau, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bricout, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giboulot, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozyczko-Coyne, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiegel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohtsu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J. S.</span></span> <span> </span><span class="NLM_article-title">The brain H<sub>3</sub>-receptor as a novel therapeutic target for vigilance and sleep-wake disorders</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">1157</span>– <span class="NLM_lpage">1171</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2007.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1016%2Fj.bcp.2007.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=17288995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjt1Smtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2007&pages=1157-1171&author=R.+Parmentierauthor=C.+Anacletauthor=C.+Guhennecauthor=E.+Brousseauauthor=D.+Bricoutauthor=T.+Giboulotauthor=D.+Bozyczko-Coyneauthor=K.+Spiegelauthor=H.+Ohtsuauthor=M.+Williamsauthor=J.+S.+Lin&title=The+brain+H3-receptor+as+a+novel+therapeutic+target+for+vigilance+and+sleep-wake+disorders&doi=10.1016%2Fj.bcp.2007.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders</span></div><div class="casAuthors">Parmentier, R.; Anaclet, C.; Guhennec, C.; Brousseau, E.; Bricout, D.; Giboulot, T.; Bozyczko-Coyne, D.; Spiegel, K.; Ohtsu, H.; Williams, M.; Lin, J. S.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1157-1171</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Brain histaminergic neurons play a prominent role in arousal and maintenance of wakefulness (W).  H3-receptors control the activity of histaminergic neurons through presynaptic autoinhibition.  The role of H3-receptor antagonists/inverse agonists (H3R-antagonists) in the potential therapy of vigilance deficiency and sleep-wake disorders were studied by assessing their effects on the mouse cortical EEG and sleep-wake cycle in comparison to modafinil and classical psychostimulants.  The H3R-antagonists, thioperamide and ciproxifan increased W and cortical EEG fast rhythms and, like modafinil, but unlike amphetamine and caffeine, their waking effects were not accompanied by sleep rebound.  Conversely, imetit (H3R-agonist) enhanced slow wave sleep and dose-dependently attenuated ciproxifan-induced W, indicating that the effects of both ligands involve H3-receptor mechanisms.  Addnl. studies using knockout (KO) mice confirmed the essential role of H3-receptors and histamine-mediated transmission in the wake properties of H3R-antagonists.  Thus ciproxifan produced no increase in W in either histidine-decarboxylase (HDC, histamine-synthesizing enzyme) or H1- or H3-receptor KO-mice whereas its waking effects persisted in H2-receptor KO-mice.  These data validate the hypothesis that H3R-antagonists, through disinhibition of H3-autoreceptors, enhancing synaptic histamine that in turn activates postsynaptic H1-receptors promoting W. Interestingly amphetamine and modafinil, despite their potent arousal effects, appear unlikely to depend on histaminergic mechanism as their effects still occurred in HDC KO-mice.  The present study thus distinguishes two classes of wake-improving agents: the first acting through non-histaminergic mechanisms and the second acting via histamine and supports brain H3-receptors as potentially novel therapeutic targets for vigilance and sleep-wake disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6KuDbNsgWqLVg90H21EOLACvtfcHk0lhas_y76qK-DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjt1Smtrw%253D&md5=ca0be091b58cfcd2879030ce54683a7a</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2007.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2007.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DParmentier%26aufirst%3DR.%26aulast%3DAnaclet%26aufirst%3DC.%26aulast%3DGuhennec%26aufirst%3DC.%26aulast%3DBrousseau%26aufirst%3DE.%26aulast%3DBricout%26aufirst%3DD.%26aulast%3DGiboulot%26aufirst%3DT.%26aulast%3DBozyczko-Coyne%26aufirst%3DD.%26aulast%3DSpiegel%26aufirst%3DK.%26aulast%3DOhtsu%26aufirst%3DH.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DJ.%2BS.%26atitle%3DThe%2520brain%2520H3-receptor%2520as%2520a%2520novel%2520therapeutic%2520target%2520for%2520vigilance%2520and%2520sleep-wake%2520disorders%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2007%26volume%3D73%26spage%3D1157%26epage%3D1171%26doi%3D10.1016%2Fj.bcp.2007.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamauchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuma, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onozawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagayama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinei, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakui, N.</span></span> <span> </span><span class="NLM_article-title">Anxiolytic-like profiles of histamine H<sub>3</sub> receptor agonists in animal models of anxiety: a comparative study with antidepressants and benzodiazepine anxiolytic</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>205</i></span>,  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">187</span>, <span class="refDoi"> DOI: 10.1007/s00213-009-1528-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1007%2Fs00213-009-1528-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=19357839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkt1ymsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=2009&pages=177-187&author=F.+Yokoyamaauthor=M.+Yamauchiauthor=M.+Oyamaauthor=K.+Okumaauthor=K.+Onozawaauthor=T.+Nagayamaauthor=R.+Shineiauthor=M.+Ishikawaauthor=Y.+Satoauthor=N.+Kakui&title=Anxiolytic-like+profiles+of+histamine+H3+receptor+agonists+in+animal+models+of+anxiety%3A+a+comparative+study+with+antidepressants+and+benzodiazepine+anxiolytic&doi=10.1007%2Fs00213-009-1528-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Anxiolytic-like profiles of histamine H3 receptor agonists in animal models of anxiety: a comparative study with antidepressants and benzodiazepine anxiolytic</span></div><div class="casAuthors">Yokoyama, Fumikazu; Yamauchi, Miki; Oyama, Masayo; Okuma, Kunihiro; Onozawa, Kaname; Nagayama, Takako; Shinei, Rie; Ishikawa, Makoto; Sato, Yasuo; Kakui, Nobukazu</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">205</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">177-187</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Rationale: Histamine H3 receptor functions as a presynaptic auto- and hetero-receptor on histaminergic and non-histaminergic neurons in the brain regulating the synaptic release of numerous neurotransmitters.  Therefore, the ligands for this receptor have been proposed to be of therapeutic interest for the treatment of various neuropsychiatric disorders.  At present, however, the psychopharmacol. profiles of H3 ligands, particularly H3 agonists, have not been extensively studied.  Objective: The present study investigated the anxiolytic-like profiles of H3-selective agonists in a variety of classical (benzodiazepine-sensitive) and atypical (antidepressant-effective) animal models of anxiety.  Comparator drugs used were diazepam and both fluvoxamine and desipramine in the former and latter models, resp.  Results: H3 agonist R-α-methylhistamine and immepip were inactive in rat elevated plus maze test and Vogel type conflict test where diazepam (5 mg/kg) produced significant anxiolytic-like effects.  Meanwhile, these H3 agonists (10-30 mg/kg) significantly reduced isolation-induced vocalizations in guinea pig pups and isolation-induced aggressive behavior in mouse resident-intruder test.  Moreover, in rat conditioned fear stress test, R-α-methylhistamine (30 mg/kg) and immepip (10 mg/kg) significantly decreased freezing time, which were completely reversed by concomitant treatment with H3 antagonist, thioperamide (10 mg/kg).  In contrast to the limited efficacy obtained with desipramine (30 mg/kg), fluvoxamine (20-60 mg/kg) exhibited anxiolytic-like effects in all the latter three atypical models.  Conclusions: These data suggest that the H3 agonists may have anxiolytic-like effects similar to those of selective serotonin reuptake inhibitors but not benzodiazepine anxiolytics and represent a novel strategy for the treatment of some anxiety disorders in which selective serotonin reuptake inhibitors are prescribed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqw1xYcgPBQLVg90H21EOLACvtfcHk0lhas_y76qK-DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkt1ymsb8%253D&md5=0e028fa8871e4a74d3b82a40ef081dbb</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1007%2Fs00213-009-1528-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-009-1528-1%26sid%3Dliteratum%253Aachs%26aulast%3DYokoyama%26aufirst%3DF.%26aulast%3DYamauchi%26aufirst%3DM.%26aulast%3DOyama%26aufirst%3DM.%26aulast%3DOkuma%26aufirst%3DK.%26aulast%3DOnozawa%26aufirst%3DK.%26aulast%3DNagayama%26aufirst%3DT.%26aulast%3DShinei%26aufirst%3DR.%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DKakui%26aufirst%3DN.%26atitle%3DAnxiolytic-like%2520profiles%2520of%2520histamine%2520H3%2520receptor%2520agonists%2520in%2520animal%2520models%2520of%2520anxiety%253A%2520a%2520comparative%2520study%2520with%2520antidepressants%2520and%2520benzodiazepine%2520anxiolytic%26jtitle%3DPsychopharmacology%26date%3D2009%26volume%3D205%26spage%3D177%26epage%3D187%26doi%3D10.1007%2Fs00213-009-1528-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seifert, R.</span></span> <span> </span><span class="NLM_article-title">Histamine H<sub>4</sub>-receptor expression in the brain?</span>. <i>Naunyn-Schmiedeberg’s Arch. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>388</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1007/s00210-014-1067-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1007%2Fs00210-014-1067-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=25420523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFOisbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2015&pages=5-9&author=E.+H.+Schneiderauthor=D.+Neumannauthor=R.+Seifert&title=Histamine+H4-receptor+expression+in+the+brain%3F&doi=10.1007%2Fs00210-014-1067-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Histamine H4-receptor expression in the brain?</span></div><div class="casAuthors">Schneider, Erich H.; Neumann, Detlef; Seifert, Roland</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-9</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkoUhOx9zItLVg90H21EOLACvtfcHk0ljLNNbp0E1XaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFOisbbI&md5=e8f833c2ffd94a42f4bcda573b1aa526</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1007%2Fs00210-014-1067-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00210-014-1067-0%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DE.%2BH.%26aulast%3DNeumann%26aufirst%3DD.%26aulast%3DSeifert%26aufirst%3DR.%26atitle%3DHistamine%2520H4-receptor%2520expression%2520in%2520the%2520brain%253F%26jtitle%3DNaunyn-Schmiedeberg%25E2%2580%2599s%2520Arch.%2520Pharmacol.%26date%3D2015%26volume%3D388%26spage%3D5%26epage%3D9%26doi%3D10.1007%2Fs00210-014-1067-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanna, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghelardini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thurmond, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galeotti, N.</span></span> <span> </span><span class="NLM_article-title">Behavioural phenotype of histamine H<sub>4</sub> receptor knockout mice: Focus on central neuronal functions</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">57</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2016.11.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1016%2Fj.neuropharm.2016.11.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=27899280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFOgt77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=48-57&author=M.+D.+Sannaauthor=C.+Ghelardiniauthor=R.+L.+Thurmondauthor=E.+Masiniauthor=N.+Galeotti&title=Behavioural+phenotype+of+histamine+H4+receptor+knockout+mice%3A+Focus+on+central+neuronal+functions&doi=10.1016%2Fj.neuropharm.2016.11.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioural phenotype of histamine H4 receptor knockout mice: Focus on central neuronal functions</span></div><div class="casAuthors">Sanna, Maria Domenica; Ghelardini, Carla; Thurmond, Robin L.; Masini, Emanuela; Galeotti, Nicoletta</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">48-57</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The functional expression of H4 receptors (H4R) within neurons of the central nervous system has been recently reported, but their role is poorly understood.  The present study aims to elucidate the role of neuronal H4R by providing the first description of the behavioral phenotype of H4R-deficient (H4R knockout, H4R-KO) mice.  Mice lacking H4R underwent behavioral studies to evaluate locomotor activity, pain perception, anxiety, depression, memory and feeding behavior.  H4R-KO mice showed a significant increase in ambulation in an open field as well as in exploratory activity in the absence of any modification of motor coordination.  The sensitivity of mutant mice to a thermal or a mech. stimulus was identical to that of the wild type mice, but H4R-KO showed sensory hypersensitivity toward a condition of neuropathic pain.  The lack of H4R is assocd. with the promotion of anxiety in the light-dark box test.  H4R-KO mice showed an increased immobility time in the tail suspension test, exptl. procedure used to evaluate the response of H4R deficient mice to a behavioral despair paradigm.  Cognitive function parameters of H4R deficient mice, examd. using the passive avoidance and the novel object recognition tests, were unaltered showing the lack of influence of H4R on working and recognition memory.  Finally, H4R-deficient mice showed an orectic phenotype.  These results illustrate that H4R modulates various neurophysiol. functions such as locomotor activity, anxiety, nociception and feeding behavior, confirming the importance of the integrity and functionality of neuronal H4R in the histaminergic regulation of neuronal functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAFDqmPUBeiLVg90H21EOLACvtfcHk0ljLNNbp0E1XaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFOgt77I&md5=b4aa07a338c707e82eaf3e1fdeccddcd</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2016.11.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2016.11.023%26sid%3Dliteratum%253Aachs%26aulast%3DSanna%26aufirst%3DM.%2BD.%26aulast%3DGhelardini%26aufirst%3DC.%26aulast%3DThurmond%26aufirst%3DR.%2BL.%26aulast%3DMasini%26aufirst%3DE.%26aulast%3DGaleotti%26aufirst%3DN.%26atitle%3DBehavioural%2520phenotype%2520of%2520histamine%2520H4%2520receptor%2520knockout%2520mice%253A%2520Focus%2520on%2520central%2520neuronal%2520functions%26jtitle%3DNeuropharmacology%26date%3D2017%26volume%3D114%26spage%3D48%26epage%3D57%26doi%3D10.1016%2Fj.neuropharm.2016.11.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blandina, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giorgetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pepeu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giovannini, M. G.</span></span> <span> </span><span class="NLM_article-title">Inhibition of cortical acetylcholine release and cognitive performance by histamine H<sub>3</sub> receptor activation in rats</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">1656</span>– <span class="NLM_lpage">1664</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.1996.tb16086.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1111%2Fj.1476-5381.1996.tb16086.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=8982515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADyaK2sXktlWrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1996&pages=1656-1664&author=P.+Blandinaauthor=M.+Giorgettiauthor=L.+Bartoliniauthor=M.+Cecchiauthor=H.+Timmermanauthor=R.+Leursauthor=G.+Pepeuauthor=M.+G.+Giovannini&title=Inhibition+of+cortical+acetylcholine+release+and+cognitive+performance+by+histamine+H3+receptor+activation+in+rats&doi=10.1111%2Fj.1476-5381.1996.tb16086.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of cortical acetylcholine release and cognitive performance by histamine H3 receptor activation in rats</span></div><div class="casAuthors">Blandina, P.; Giorgetti, M.; Bartolini, L.; Cecchi, M.; Timmerman, H.; Leurs, R.; Pepeu, G.; Giovannini, M. G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1656-1664</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">The effects of histamine and agents acting at histamine receptors on spontaneous and 100 mM K+-evoked release of acetylcholine, measured by microdialysis from the cortex of freely moving rats, and on cognitive tests are described.  Local administration of histamine (0.1-100 μM) failed to affect spontaneous but inhibited 100 mM K+-stimulated release of acetylcholine up to about 50%.  The H3 receptor agonists (R)-α-methylhistamine (RAMH) (0.1-10 μM) imetit (0.01-10 μM) and immepip (0.01-10 μM) mimicked the effect of histamine.  Neither 2-thiazolylethylamine (TEA), an agonist showing some selectivity for H1 receptors, nor the H2 receptor agonist, dimaprit, modified 100 mM K+-evoked release of acetylcholine.  The inhibitory effect of 100 μM histamine was completely prevented by the highly selective histamine H3 receptor antagonist, clobenpropit but was resistant to antagonism by triprolidine and cimetidine, antagonists at histamine H1 and H2 but not H3 receptors.  The H3 receptor-induced inhibition of K+-evoked release of acetylcholine was fully sensitive to tetrodotoxin (TTX).  The effects of i.p. injection of imetit (5 mg kg-1) and RAMH (5 mg kg-1) were tested on acetylcholine release and short term memory paradigms.  Both drugs reduced 100 mM K+-evoked release of cortical acetylcholine, and impaired object recognition and a passive avoidance response.  These observations provide the first evidence of a regulatory role of histamine H3 receptors on cortical acetylcholine release in vivo.  Moreover, they suggest a role for histamine in learning and memory and may have implications for the treatment of degenerative disorders assocd. with impaired cholinergic function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpRWbp6n09nLVg90H21EOLACvtfcHk0ljLNNbp0E1XaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlWrsw%253D%253D&md5=4b8e769a808bf1d1ffb1d61970b14ba2</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1996.tb16086.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1996.tb16086.x%26sid%3Dliteratum%253Aachs%26aulast%3DBlandina%26aufirst%3DP.%26aulast%3DGiorgetti%26aufirst%3DM.%26aulast%3DBartolini%26aufirst%3DL.%26aulast%3DCecchi%26aufirst%3DM.%26aulast%3DTimmerman%26aufirst%3DH.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DPepeu%26aufirst%3DG.%26aulast%3DGiovannini%26aufirst%3DM.%2BG.%26atitle%3DInhibition%2520of%2520cortical%2520acetylcholine%2520release%2520and%2520cognitive%2520performance%2520by%2520histamine%2520H3%2520receptor%2520activation%2520in%2520rats%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D119%26spage%3D1656%26epage%3D1664%26doi%3D10.1111%2Fj.1476-5381.1996.tb16086.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nijmeijer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelhardt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de Stolpe, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lusink, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Graaf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wijtmans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haaksma, E. E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Esch, I. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stachurski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vischer, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span> <span> </span><span class="NLM_article-title">Design and pharmacological characterization of VUF14480, a covalent partial agonist that interacts with cysteine 98<sup>3.36</sup> of the human histamine H<sub>4</sub> receptor</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>170</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1111/bph.12113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1111%2Fbph.12113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=23347159" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlSgtbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2013&pages=89-100&author=S.+Nijmeijerauthor=H.+Engelhardtauthor=S.+Schultesauthor=A.+C.+van+de+Stolpeauthor=V.+Lusinkauthor=C.+de+Graafauthor=M.+Wijtmansauthor=E.+E.+J.+Haaksmaauthor=I.+J.+P.+de+Eschauthor=K.+Stachurskiauthor=H.+F.+Vischerauthor=R.+Leurs&title=Design+and+pharmacological+characterization+of+VUF14480%2C+a+covalent+partial+agonist+that+interacts+with+cysteine+983.36+of+the+human+histamine+H4+receptor&doi=10.1111%2Fbph.12113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Design and pharmacological characterization of VUF14480, a covalent partial agonist that interacts with cysteine 983.36 of the human histamine H4 receptor</span></div><div class="casAuthors">Nijmeijer, S.; Engelhardt, H.; Schultes, S.; van de Stolpe, A. C.; Lusink, V.; de Graaf, C.; Wijtmans, M.; Haaksma, E. E. J.; de Esch, I. J. P.; Stachurski, K.; Vischer, H. F.; Leurs, R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-100</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose The recently proposed binding mode of 2-aminopyrimidines to the human (h) histamine H4 receptor suggests that the 2-amino group of these ligands interacts with glutamic acid residue E1825.46 in the transmembrane (TM) helix 5 of this receptor.  Interestingly, substituents at the 2-position of this pyrimidine are also in close proximity to the cysteine residue C983.36 in TM3.  We hypothesized that an ethenyl group at this position will form a covalent bond with C983.36 by functioning as a Michael acceptor.  A covalent pyrimidine analog will not only prove this proposed binding mode, but will also provide a valuable tool for H4 receptor research.  Exptl. Approach We designed and synthesized VUF14480, and pharmacol. characterized this compd. in hH4 receptor radioligand binding, G protein activation and β-arrestin2 recruitment expts.  The ability of VUF14480 to act as a covalent binder was assessed both chem. and pharmacol.  Key Results VUF14480 was shown to be a partial agonist of hH4 receptor-mediated G protein signalling and β-arrestin2 recruitment.  VUF14480 bound covalently to the hH4 receptor with submicromolar affinity.  Serine substitution of C983.36 prevented this covalent interaction.  Conclusion and Implications VUF14480 is thought to bind covalently to the hH4 receptor-C983.36 residue and partially induce hH4 receptor-mediated G protein activation and β-arrestin2 recruitment.  Moreover, these observations confirm our previously proposed binding mode of 2-aminopyrimidines.  VUF14480 will be a useful tool to stabilize the receptor into an active confirmation and further investigate the structure of the active hH4 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbemtwmb5BDbVg90H21EOLACvtfcHk0ljqfPoG885-ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlSgtbnK&md5=dbaa12c47194793907c66f94dfcbe5fd</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1111%2Fbph.12113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12113%26sid%3Dliteratum%253Aachs%26aulast%3DNijmeijer%26aufirst%3DS.%26aulast%3DEngelhardt%26aufirst%3DH.%26aulast%3DSchultes%26aufirst%3DS.%26aulast%3Dvan%2Bde%2BStolpe%26aufirst%3DA.%2BC.%26aulast%3DLusink%26aufirst%3DV.%26aulast%3Dde%2BGraaf%26aufirst%3DC.%26aulast%3DWijtmans%26aufirst%3DM.%26aulast%3DHaaksma%26aufirst%3DE.%2BE.%2BJ.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3DStachurski%26aufirst%3DK.%26aulast%3DVischer%26aufirst%3DH.%2BF.%26aulast%3DLeurs%26aufirst%3DR.%26atitle%3DDesign%2520and%2520pharmacological%2520characterization%2520of%2520VUF14480%252C%2520a%2520covalent%2520partial%2520agonist%2520that%2520interacts%2520with%2520cysteine%2520983.36%2520of%2520the%2520human%2520histamine%2520H4%2520receptor%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D170%26spage%3D89%26epage%3D100%26doi%3D10.1111%2Fbph.12113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mocking, T. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verweij, E. W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vischer, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span> <span> </span><span class="NLM_article-title">Homogeneous, real-time NanoBRET binding assays for the histamine H<sub>3</sub> and H<sub>4</sub> receptors on living cells</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">1371</span>– <span class="NLM_lpage">1381</span>, <span class="refDoi"> DOI: 10.1124/mol.118.113373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1124%2Fmol.118.113373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=30249614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlKhu7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2018&pages=1371-1381&author=T.+A.+M.+Mockingauthor=E.+W.+E.+Verweijauthor=H.+F.+Vischerauthor=R.+Leurs&title=Homogeneous%2C+real-time+NanoBRET+binding+assays+for+the+histamine+H3+and+H4+receptors+on+living+cells&doi=10.1124%2Fmol.118.113373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Homogeneous, real-time NanoBRET binding assays for the histamine H3 and H4 receptors on living cells</span></div><div class="casAuthors">Mocking, Tamara A. M.; Verweij, Eleonore W. E.; Vischer, Henry F.; Leurs, Rob</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1371-1381</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Receptor-binding affinity and ligand-receptor residence time are key parameters for the selection of drug candidates and are routinely detd. using radioligand competition-binding assays.  Recently, a novel bioluminescence resonance energy transfer (BRET) method utilizing a NanoLuc-fused receptor was introduced to detect fluorescent ligand binding.  Moreover, this NanoBRET method gives the opportunity to follow fluorescent ligand binding on intact cells in real time, and therefore, results might better reflect in vivo conditions as compared with the routinely used cell homogenates or purified membrane fractions.  In this study, a real-time NanoBRET-based binding assay was established and validated to detect binding of unlabeled ligands to the histamine H3 receptor (H3R) and histamine H4 receptor on intact cells.  Obtained residence times of clin. tested H3R antagonists were reflected by their duration of H3R antagonism in a functional receptor recovery assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7ZL7LtRBR1bVg90H21EOLACvtfcHk0ljqfPoG885-ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlKhu7rK&md5=ff558b89fd3748aaafb307468b3ccc28</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1124%2Fmol.118.113373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.118.113373%26sid%3Dliteratum%253Aachs%26aulast%3DMocking%26aufirst%3DT.%2BA.%2BM.%26aulast%3DVerweij%26aufirst%3DE.%2BW.%2BE.%26aulast%3DVischer%26aufirst%3DH.%2BF.%26aulast%3DLeurs%26aufirst%3DR.%26atitle%3DHomogeneous%252C%2520real-time%2520NanoBRET%2520binding%2520assays%2520for%2520the%2520histamine%2520H3%2520and%2520H4%2520receptors%2520on%2520living%2520cells%26jtitle%3DMol.%2520Pharmacol.%26date%3D2018%26volume%3D94%26spage%3D1371%26epage%3D1381%26doi%3D10.1124%2Fmol.118.113373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hauwert, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mocking, T. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da
Costa Pereira, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lion, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huppelschoten, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vischer, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Esch, I. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wijtmans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span> <span> </span><span class="NLM_article-title">A photoswitchable agonist for the histamine H<sub>3</sub> receptor, a prototypic family a G-protein-coupled receptor</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">4531</span>– <span class="NLM_lpage">4535</span>, <span class="refDoi"> DOI: 10.1002/anie.201813110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1002%2Fanie.201813110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjvFGjsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2019&pages=4531-4535&author=N.+J.+Hauwertauthor=T.+A.+M.+Mockingauthor=D.+Da%0ACosta+Pereiraauthor=K.+Lionauthor=Y.+Huppelschotenauthor=H.+F.+Vischerauthor=I.+J.+P.+de+Eschauthor=M.+Wijtmansauthor=R.+Leurs&title=A+photoswitchable+agonist+for+the+histamine+H3+receptor%2C+a+prototypic+family+a+G-protein-coupled+receptor&doi=10.1002%2Fanie.201813110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">A Photoswitchable Agonist for the Histamine H3 Receptor, a Prototypic Family A G-Protein-Coupled Receptor</span></div><div class="casAuthors">Hauwert, Niels J.; Mocking, Tamara A. M.; Da Costa Pereira, Daniel; Lion, Ken; Huppelschoten, Yara; Vischer, Henry F.; De Esch, Iwan J. P.; Wijtmans, Maikel; Leurs, Rob</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4531-4535</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Spatiotemporal control over biochem. signaling processes involving G protein-coupled receptors (GPCRs) is highly desired for dissecting their complex intracellular signaling.  We developed sixteen photoswitchable ligands for the human histamine H3 receptor (hH3R).  Upon illumination, key compd. 65 decreases its affinity for the hH3R by 8.5-fold and its potency in hH3R-mediated Gi protein activation by over 20-fold, with the trans and cis isomer both acting as full agonist.  In real-time two-electrode voltage clamp expts. in Xenopus oocytes, 65 shows rapid light-induced modulation of hH3R activity.  Ligand 65 shows good binding selectivity amongst the histamine receptor subfamily and has good photolytic stability.  In all, 65 (VUF15000) is the first photoswitchable GPCR agonist confirmed to be modulated through its affinity and potency upon photoswitching while maintaining its intrinsic activity, rendering it a new chem. biol. tool for spatiotemporal control of GPCR activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ0V367pAvQLVg90H21EOLACvtfcHk0ljqfPoG885-ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjvFGjsLc%253D&md5=c917858deb942375ff4d970aea993326</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1002%2Fanie.201813110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201813110%26sid%3Dliteratum%253Aachs%26aulast%3DHauwert%26aufirst%3DN.%2BJ.%26aulast%3DMocking%26aufirst%3DT.%2BA.%2BM.%26aulast%3DDa%2BCosta%2BPereira%26aufirst%3DD.%26aulast%3DLion%26aufirst%3DK.%26aulast%3DHuppelschoten%26aufirst%3DY.%26aulast%3DVischer%26aufirst%3DH.%2BF.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3DWijtmans%26aufirst%3DM.%26aulast%3DLeurs%26aufirst%3DR.%26atitle%3DA%2520photoswitchable%2520agonist%2520for%2520the%2520histamine%2520H3%2520receptor%252C%2520a%2520prototypic%2520family%2520a%2520G-protein-coupled%2520receptor%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2019%26volume%3D58%26spage%3D4531%26epage%3D4535%26doi%3D10.1002%2Fanie.201813110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prusoff, W. H.</span></span> <span> </span><span class="NLM_article-title">Relation between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibiton (IC50) of an enzymatic reaction</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3099</span>– <span class="NLM_lpage">3108</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=4202581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.-C.+Chengauthor=W.+H.+Prusoff&title=Relation+between+the+inhibition+constant+%28Ki%29+and+the+concentration+of+inhibitor+which+causes+50+percent+inhibiton+%28IC50%29+of+an+enzymatic+reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Relation between the inhibition constant K1) and the concentration of inhibitor which causes fifty per cent inhibition (I50) of an enzymic reaction</span></div><div class="casAuthors">Cheng, Yung-Chi; Prusoff, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3099-108</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The Ki and I50 values are equal where the kinetics are non- or uncompetitive, but not where they are competitive.  The relation between the 2 values was analyzed for non- and uncompetitive bi- and monosubstrate reactions and for competitive bisubstrate reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqodFY_8msz57Vg90H21EOLACvtfcHk0liUvtHNN_I1sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D&md5=fe7175ca300d8f4085df87af37f8656c</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.-C.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelation%2520between%2520the%2520inhibition%2520constant%2520%2528Ki%2529%2520and%2520the%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2520percent%2520inhibiton%2520%2528IC50%2529%2520of%2520an%2520enzymatic%2520reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span> <span> </span><span class="NLM_article-title">Characterization of preclinical in vitro and in vivo pharmacokinetics properties for KBP-7018, a new tyrosine kinase inhibitor candidate for treatment of idiopathic pulmonary fibrosis</span>. <i>Drug Des., Dev. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">4319</span>– <span class="NLM_lpage">4328</span>, <span class="refDoi"> DOI: 10.2147/dddt.s83055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.2147%2Fdddt.s83055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=26273193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsVOitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=4319-4328&author=Z.+Huangauthor=H.+Liauthor=Q.+Zhangauthor=X.+Tanauthor=F.+Luauthor=H.+Liuauthor=S.+Li&title=Characterization+of+preclinical+in+vitro+and+in+vivo+pharmacokinetics+properties+for+KBP-7018%2C+a+new+tyrosine+kinase+inhibitor+candidate+for+treatment+of+idiopathic+pulmonary+fibrosis&doi=10.2147%2Fdddt.s83055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of preclinical in vitro and in vivo pharmacokinetics properties for KBP-7018, a new tyrosine kinase inhibitor candidate for treatment of idiopathic pulmonary fibrosis</span></div><div class="casAuthors">Huang, Zhenhua; Li, Heran; Zhang, Qian; Tan, Xiaojuan; Lu, Fangzheng; Liu, Hongzhuo; Li, Sanming</div><div class="citationInfo"><span class="NLM_cas:title">Drug Design, Development and Therapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4319-4328</span>CODEN:
                <span class="NLM_cas:coden">DDDTAQ</span>;
        ISSN:<span class="NLM_cas:issn">1177-8881</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">KBP-7018 is a novel selective tyrosine kinase inhibitor with potential for the treatment of idiopathic pulmonary fibrosis.  The objective of this study was to characterize the preclin. pharmacokinetics of KBP-7018 in vitro and in vivo, and then to assess the likelihood of developing KBP-7018 as a clin. candidate.  The systemic clearance (CL) of KBP-7018 was relatively low in rodents and monkeys with a value of less than 30% of hepatic blood flow, while it was high in dogs.  The steady-state vol. of distribution (Vss) ranged from 1.51 L/kg to 4.65 L/kg across the species tested.  The max. concn. (Cmax) of KBP-7018 occurred at 0.25-6 h after oral dosing, and the bioavailability was moderate (21%-68%).  The human CL (∼20% of hepatic blood flow) and Vss (1.6-5.3 L/kg) were predicted by allometric scaling method and together with the other modeling methods indicated low metab. and acceptable half-time (4.8-19.3 h) in vivo.  Overall, the preclin. data make it amenable to further oral solid dosage from design for the upcoming Phase I trials in human.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPIv5wrbFKCrVg90H21EOLACvtfcHk0liUvtHNN_I1sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsVOitbs%253D&md5=71c3e026e232f685a9c9186707d5720e</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.2147%2Fdddt.s83055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252Fdddt.s83055%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DTan%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DS.%26atitle%3DCharacterization%2520of%2520preclinical%2520in%2520vitro%2520and%2520in%2520vivo%2520pharmacokinetics%2520properties%2520for%2520KBP-7018%252C%2520a%2520new%2520tyrosine%2520kinase%2520inhibitor%2520candidate%2520for%2520treatment%2520of%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DDrug%2520Des.%252C%2520Dev.%2520Ther.%26date%3D2015%26volume%3D9%26spage%3D4319%26epage%3D4328%26doi%3D10.2147%2Fdddt.s83055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths, H. H.</span></span> <span> </span><span class="NLM_article-title">Determination of microsome and hepatocyte scaling factors for in vitro/in vivo extrapolation in the rat and dog</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1386</span>– <span class="NLM_lpage">1398</span>, <span class="refDoi"> DOI: 10.1080/00498250802491662</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1080%2F00498250802491662" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=18988082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlens7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2008&pages=1386-1398&author=R.+Smithauthor=R.+D.+O.+Jonesauthor=P.+G.+Ballardauthor=H.+H.+Griffiths&title=Determination+of+microsome+and+hepatocyte+scaling+factors+for+in+vitro%2Fin+vivo+extrapolation+in+the+rat+and+dog&doi=10.1080%2F00498250802491662"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of microsome and hepatocyte scaling factors for in vitro/in vivo extrapolation in the rat and dog</span></div><div class="casAuthors">Smith, R.; Jones, R. D. O.; Ballard, P. G.; Griffiths, H. H.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1386-1398</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">In vivo clearance predictions from in vitro assays require scaling factors to relate the concns. of hepatocytes or microsomal protein to the intact liver.  The aims were to measure the variability in scaling factors for Wistar rat and beagle dog for which the literature is particularly scarce and det. any sex differences.  Scaling factors were detd. by comparing the cytochrome P 450 (P 450) content in hepatocytes or microsomes against the P 450 content of fresh liver homogenate.  The use of fresh homogenate is recommended as freezing can increase contamination and affect the P 450 assay.  Meangeo hepatic microsomal concns. in Wistar rats were 61 mg/g liver (95% confidence interval (CI); 47-75 mg/g liver) and in beagle dogs 55 mg/g liver (95% CI = 48-62 mg/g liver).  Meangeo hepatocellularity was 163 × 106 cells/g liver for Wistar rats (95% CI = 127-199 × 106 cells/g liver) and 169 × 106 cells/g liver (95% CI = 131-207 × 106 cells/g liver) for beagle dogs.  The data generated in this study indicate a consistency in scaling factors between rat and dog.  No sex differences were obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUaQwY_CMkBbVg90H21EOLACvtfcHk0liUvtHNN_I1sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlens7vM&md5=67f11c3d42fd45eda1787bd1f9f3e045</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1080%2F00498250802491662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498250802491662%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DJones%26aufirst%3DR.%2BD.%2BO.%26aulast%3DBallard%26aufirst%3DP.%2BG.%26aulast%3DGriffiths%26aufirst%3DH.%2BH.%26atitle%3DDetermination%2520of%2520microsome%2520and%2520hepatocyte%2520scaling%2520factors%2520for%2520in%2520vitro%252Fin%2520vivo%2520extrapolation%2520in%2520the%2520rat%2520and%2520dog%26jtitle%3DXenobiotica%26date%3D2008%26volume%3D38%26spage%3D1386%26epage%3D1398%26doi%3D10.1080%2F00498250802491662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Isberg, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Graaf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bortolato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mordalski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pin, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vriend, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gloriam, D. E.</span></span> <span> </span><span class="NLM_article-title">Generic GPCR residue numbers - aligning topology maps minding the gaps</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">31</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2014.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1016%2Fj.tips.2014.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=25541108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVSgu7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=22-31&author=V.+Isbergauthor=C.+de+Graafauthor=A.+Bortolatoauthor=V.+Cherezovauthor=V.+Katritchauthor=F.+H.+Marshallauthor=S.+Mordalskiauthor=J.-P.+Pinauthor=R.+C.+Stevensauthor=G.+Vriendauthor=D.+E.+Gloriam&title=Generic+GPCR+residue+numbers+-+aligning+topology+maps+minding+the+gaps&doi=10.1016%2Fj.tips.2014.11.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Generic GPCR residue numbers - aligning topology maps while minding the gaps</span></div><div class="casAuthors">Isberg, Vignir; de Graaf, Chris; Bortolato, Andrea; Cherezov, Vadim; Katritch, Vsevolod; Marshall, Fiona H.; Mordalski, Stefan; Pin, Jean-Philippe; Stevens, Raymond C.; Vriend, Gerrit; Gloriam, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-31</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Generic residue nos. facilitate comparisons of, for example, mutational effects, ligand interactions, and structural motifs.  The numbering scheme by Ballesteros and Weinstein for residues within the class A GPCRs (G protein-coupled receptors) has more than 1100 citations, and the recent crystal structures for classes B, C, and F now call for a community consensus in residue numbering within and across these classes.  Furthermore, the structural era has uncovered helix bulges and constrictions that offset the generic residue nos.  The use of generic residue nos. depends on convenient access by pharmacologists, chemists, and structural biologists.  We review the generic residue numbering schemes for each GPCR class, as well as a complementary structure-based scheme, and provide illustrative examples and GPCR database (GPCRDB) web tools to no. any receptor sequence or structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLIeBaLTmUebVg90H21EOLACvtfcHk0lh7NLalCtPsuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVSgu7rK&md5=31e18cc8196fb05a12d04dd0402b2338</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2014.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2014.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DIsberg%26aufirst%3DV.%26aulast%3Dde%2BGraaf%26aufirst%3DC.%26aulast%3DBortolato%26aufirst%3DA.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26aulast%3DMordalski%26aufirst%3DS.%26aulast%3DPin%26aufirst%3DJ.-P.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DVriend%26aufirst%3DG.%26aulast%3DGloriam%26aufirst%3DD.%2BE.%26atitle%3DGeneric%2520GPCR%2520residue%2520numbers%2520-%2520aligning%2520topology%2520maps%2520minding%2520the%2520gaps%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D36%26spage%3D22%26epage%3D31%26doi%3D10.1016%2Fj.tips.2014.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sali, A.</span></span> <span> </span><span class="NLM_article-title">Comparative protein modeling by satisfaction of spatial restraints</span>. <i>Mol. Med. Today</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">270</span>– <span class="NLM_lpage">277</span>, <span class="refDoi"> DOI: 10.1016/S1357-4310(95)91170-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1016%2FS1357-4310%2895%2991170-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=9415161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADyaK2MXptV2rtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1995&pages=270-277&author=A.+Sali&title=Comparative+protein+modeling+by+satisfaction+of+spatial+restraints&doi=10.1016%2FS1357-4310%2895%2991170-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative protein modeling by satisfaction of spatial restraints</span></div><div class="casAuthors">Sali, Andrej</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Today</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">270-7</span>CODEN:
                <span class="NLM_cas:coden">MMTOFK</span>;
        ISSN:<span class="NLM_cas:issn">1357-4310</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Trends Journals</span>)
        </div><div class="casAbstract">Approx. one third of known protein sequences are related to at least one known protein structure.  As a result, an order of magnitude more sequences can be modeled by comparative modeling than there are exptl. detd. protein structures.  A large fraction of these models has an accuracy approaching that of a low resoln. x-ray structure or a medium resoln. NMR structure.  The no. of applications where homol. modeling has been proven useful is growing rapidly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZyLUK-sQY6LVg90H21EOLACvtfcHk0lh7NLalCtPsuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXptV2rtL8%253D&md5=a3aeffed0badbd7922b1db433babd3ec</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2FS1357-4310%2895%2991170-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1357-4310%252895%252991170-7%26sid%3Dliteratum%253Aachs%26aulast%3DSali%26aufirst%3DA.%26atitle%3DComparative%2520protein%2520modeling%2520by%2520satisfaction%2520of%2520spatial%2520restraints%26jtitle%3DMol.%2520Med.%2520Today%26date%3D1995%26volume%3D1%26spage%3D270%26epage%3D277%26doi%3D10.1016%2FS1357-4310%2895%2991170-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bateman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donovan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magrane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alpi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antunes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bely, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bingley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonilla, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Britto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bursteinas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bye-AJee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowley, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da Silva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Giorgi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dogan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazzini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figueira, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garmiri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georghiou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatton-Ellis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lussi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDougall, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nightingale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palka, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pichler, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poggioli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pundir, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pureza, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosanoff, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saidi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawford, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shypitsyna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speretta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyagi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volynkin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wardell, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watkins, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaru, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zellner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xenarios, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bougueleret, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bridge, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poux, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redaschi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aimo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">ArgoudPuy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auchincloss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Axelsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baratin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blatter, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boeckmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolleman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boutet, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breuza, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casal-Casas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Castro, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coudert, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuche, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doche, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dornevil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duvaud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estreicher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Famiglietti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feuermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasteiger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehant, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerritsen, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruaz-Gumowski, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinz, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jungo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lara, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemercier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieberherr, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardot, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nouspikel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paesano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedruzzi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilbout, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozzato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pruess, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivoire, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roechert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigrist, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonesson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staehli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundaram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tognolli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verbregue, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veuthey, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arighi, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arminski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garavelli, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laiho, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGarvey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natale, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinayaka, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span> <span> </span><span class="NLM_article-title">UniProt: The universal protein knowledgebase</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">D158</span>– <span class="NLM_lpage">D169</span>, <span class="refDoi"> DOI: 10.1093/nar/gkw1099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1093%2Fnar%2Fgkw1099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=27899622" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslWgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2017&pages=D158-D169&author=A.+Batemanauthor=M.+J.+Martinauthor=C.+O%E2%80%99Donovanauthor=M.+Magraneauthor=E.+Alpiauthor=R.+Antunesauthor=B.+Belyauthor=M.+Bingleyauthor=C.+Bonillaauthor=R.+Brittoauthor=B.+Bursteinasauthor=H.+Bye-AJeeauthor=A.+Cowleyauthor=A.+Da+Silvaauthor=M.+De+Giorgiauthor=T.+Doganauthor=F.+Fazziniauthor=L.+G.+Castroauthor=L.+Figueiraauthor=P.+Garmiriauthor=G.+Georghiouauthor=D.+Gonzalezauthor=E.+Hatton-Ellisauthor=W.+Liauthor=W.+Liuauthor=R.+Lopezauthor=J.+Luoauthor=Y.+Lussiauthor=A.+MacDougallauthor=A.+Nightingaleauthor=B.+Palkaauthor=K.+Pichlerauthor=D.+Poggioliauthor=S.+Pundirauthor=L.+Purezaauthor=G.+Qiauthor=S.+Rosanoffauthor=R.+Saidiauthor=T.+Sawfordauthor=A.+Shypitsynaauthor=E.+Sperettaauthor=E.+Turnerauthor=N.+Tyagiauthor=V.+Volynkinauthor=T.+Wardellauthor=K.+Warnerauthor=X.+Watkinsauthor=R.+Zaruauthor=H.+Zellnerauthor=I.+Xenariosauthor=L.+Bougueleretauthor=A.+Bridgeauthor=S.+Pouxauthor=N.+Redaschiauthor=L.+Aimoauthor=G.+ArgoudPuyauthor=A.+Auchinclossauthor=K.+Axelsenauthor=P.+Bansalauthor=D.+Baratinauthor=M.+C.+Blatterauthor=B.+Boeckmannauthor=J.+Bollemanauthor=E.+Boutetauthor=L.+Breuzaauthor=C.+Casal-Casasauthor=E.+De+Castroauthor=E.+Coudertauthor=B.+Cucheauthor=M.+Docheauthor=D.+Dornevilauthor=S.+Duvaudauthor=A.+Estreicherauthor=L.+Famigliettiauthor=M.+Feuermannauthor=E.+Gasteigerauthor=S.+Gehantauthor=V.+Gerritsenauthor=A.+Gosauthor=N.+Gruaz-Gumowskiauthor=U.+Hinzauthor=C.+Huloauthor=F.+Jungoauthor=G.+Kellerauthor=V.+Laraauthor=P.+Lemercierauthor=D.+Lieberherrauthor=T.+Lombardotauthor=X.+Martinauthor=P.+Massonauthor=A.+Morgatauthor=T.+Netoauthor=N.+Nouspikelauthor=S.+Paesanoauthor=I.+Pedruzziauthor=S.+Pilboutauthor=M.+Pozzatoauthor=M.+Pruessauthor=C.+Rivoireauthor=B.+Roechertauthor=M.+Schneiderauthor=C.+Sigristauthor=K.+Sonessonauthor=S.+Staehliauthor=A.+Stutzauthor=S.+Sundaramauthor=M.+Tognolliauthor=L.+Verbregueauthor=A.+L.+Veutheyauthor=C.+H.+Wuauthor=C.+N.+Arighiauthor=L.+Arminskiauthor=C.+Chenauthor=Y.+Chenauthor=J.+S.+Garavelliauthor=H.+Huangauthor=K.+Laihoauthor=P.+McGarveyauthor=D.+A.+Nataleauthor=K.+Rossauthor=C.+R.+Vinayakaauthor=Q.+Wangauthor=Y.+Wangauthor=L.+S.+Yehauthor=J.+Zhang&title=UniProt%3A+The+universal+protein+knowledgebase&doi=10.1093%2Fnar%2Fgkw1099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">UniProt: the universal protein knowledgebase</span></div><div class="casAuthors">Bateman, Alex; Martin, Maria Jesus; O'Donovan, Claire; Magrane, Michele; Alpi, Emanuele; Antunes, Ricardo; Bely, Benoit; Bingley, Mark; Bonilla, Carlos; Britto, Ramona; Bursteinas, Borisas; Bye-A-Jee, Hema; Cowley, Andrew; Da Silva, Alan; De Giorgi, Maurizio; Dogan, Tunca; Fazzini, Francesco; Castro, Leyla Garcia; Figueira, Luis; Garmiri, Penelope; Georghiou, George; Gonzalez, Daniel; Hatton-Ellis, Emma; Li, Weizhong; Liu, Wudong; Lopez, Rodrigo; Luo, Jie; Lussi, Yvonne; MacDougall, Alistair; Nightingale, Andrew; Palka, Barbara; Pichler, Klemens; Poggioli, Diego; Pundir, Sangya; Pureza, Luis; Qi, Guoying; Rosanoff, Steven; Saidi, Rabie; Sawford, Tony; Shypitsyna, Aleksandra; Speretta, Elena; Turner, Edward; Tyagi, Nidhi; Volynkin, Vladimir; Wardell, Tony; Warner, Kate; Watkins, Xavier; Zaru, Rossana; Zellner, Hermann; Xenarios, Ioannis; Bougueleret, Lydie; Bridge, Alan; Poux, Sylvain; Redaschi, Nicole; Aimo, Lucila; Argoud-Puy, Ghislaine; Auchincloss, Andrea; Axelsen, Kristian; Bansal, Parit; Baratin, Delphine; Blatter, Marie-Claude; Boeckmann, Brigitte; Bolleman, Jerven; Boutet, Emmanuel; Breuza, Lionel; Casal-Casas, Cristina; de Castro, Edouard; Coudert, Elisabeth; Cuche, Beatrice; Doche, Mikael; Dornevil, Dolnide; Duvaud, Severine; Estreicher, Anne; Famiglietti, Livia; Feuermann, Marc; Gasteiger, Elisabeth; Gehant, Sebastien; Gerritsen, Vivienne; Gos, Arnaud; Gruaz-Gumowski, Nadine; Hinz, Ursula; Hulo, Chantal; Jungo, Florence; Keller, Guillaume; Lara, Vicente; Lemercier, Philippe; Lieberherr, Damien; Lombardot, Thierry; Martin, Xavier; Masson, Patrick; Morgat, Anne; Neto, Teresa; Nouspikel, Nevila; Paesano, Salvo; Pedruzzi, Ivo; Pilbout, Sandrine; Pozzato, Monica; Pruess, Manuela; Rivoire, Catherine; Roechert, Bernd; Schneider, Michel; Sigrist, Christian; Sonesson, Karin; Staehli, Sylvie; Stutz, Andre; Sundaram, Shyamala; Tognolli, Michael; Verbregue, Laure; Veuthey, Anne-Lise; Wu, Cathy H.; Arighi, Cecilia N.; Arminski, Leslie; Chen, Chuming; Chen, Yongxing; Garavelli, John S.; Huang, Hongzhan; Laiho, Kati; McGarvey, Peter; Natale, Darren A.; Ross, Karen; Vinayaka, C. R.; Wang, Qinghua; Wang, Yuqi; Yeh, Lai-Su; Zhang, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D158-D169</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">1362-4962</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The UniProt knowledgebase is a large resource of protein sequences and assocd. detailed annotation.  The database contains over 60 million sequences, of which over half a million sequences have been curated by experts who critically review exptl. and predicted data for each protein.  The remainder are automatically annotated based on rule systems that rely on the expert curated knowledge.  Since our last update in 2014, we have more than doubled the no. of ref. proteomes to 5631, giving a greater coverage of taxonomic diversity.  We implemented a pipeline to remove redundant highly similar proteomes that were causing excessive redundancy in UniProt.  The initial run of this pipeline reduced the no. of sequences in UniProt by 47 million.  For our users interested in the accessory proteomes, we have made available sets of pan proteome sequences that cover the diversity of sequences for each species that is found in its strains and sub-strains.  To help interpretation of genomic variants, we provide tracks of detailed protein information for the major genome browsers.  We provide a SPARQL endpoint that allows complex queries of the more than 22 billion triples of data in UniProt (http://sparql.uniprot.org/).  UniProt resources can be accessed via the website at http://www.uniprot.org/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8jvkS3iPadrVg90H21EOLACvtfcHk0lgVpe_14kUxjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslWgs7c%253D&md5=fd093400ec0075c76f8fc4351e3b2cde</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkw1099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkw1099%26sid%3Dliteratum%253Aachs%26aulast%3DBateman%26aufirst%3DA.%26aulast%3DMartin%26aufirst%3DM.%2BJ.%26aulast%3DO%25E2%2580%2599Donovan%26aufirst%3DC.%26aulast%3DMagrane%26aufirst%3DM.%26aulast%3DAlpi%26aufirst%3DE.%26aulast%3DAntunes%26aufirst%3DR.%26aulast%3DBely%26aufirst%3DB.%26aulast%3DBingley%26aufirst%3DM.%26aulast%3DBonilla%26aufirst%3DC.%26aulast%3DBritto%26aufirst%3DR.%26aulast%3DBursteinas%26aufirst%3DB.%26aulast%3DBye-AJee%26aufirst%3DH.%26aulast%3DCowley%26aufirst%3DA.%26aulast%3DDa%2BSilva%26aufirst%3DA.%26aulast%3DDe%2BGiorgi%26aufirst%3DM.%26aulast%3DDogan%26aufirst%3DT.%26aulast%3DFazzini%26aufirst%3DF.%26aulast%3DCastro%26aufirst%3DL.%2BG.%26aulast%3DFigueira%26aufirst%3DL.%26aulast%3DGarmiri%26aufirst%3DP.%26aulast%3DGeorghiou%26aufirst%3DG.%26aulast%3DGonzalez%26aufirst%3DD.%26aulast%3DHatton-Ellis%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLopez%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DLussi%26aufirst%3DY.%26aulast%3DMacDougall%26aufirst%3DA.%26aulast%3DNightingale%26aufirst%3DA.%26aulast%3DPalka%26aufirst%3DB.%26aulast%3DPichler%26aufirst%3DK.%26aulast%3DPoggioli%26aufirst%3DD.%26aulast%3DPundir%26aufirst%3DS.%26aulast%3DPureza%26aufirst%3DL.%26aulast%3DQi%26aufirst%3DG.%26aulast%3DRosanoff%26aufirst%3DS.%26aulast%3DSaidi%26aufirst%3DR.%26aulast%3DSawford%26aufirst%3DT.%26aulast%3DShypitsyna%26aufirst%3DA.%26aulast%3DSperetta%26aufirst%3DE.%26aulast%3DTurner%26aufirst%3DE.%26aulast%3DTyagi%26aufirst%3DN.%26aulast%3DVolynkin%26aufirst%3DV.%26aulast%3DWardell%26aufirst%3DT.%26aulast%3DWarner%26aufirst%3DK.%26aulast%3DWatkins%26aufirst%3DX.%26aulast%3DZaru%26aufirst%3DR.%26aulast%3DZellner%26aufirst%3DH.%26aulast%3DXenarios%26aufirst%3DI.%26aulast%3DBougueleret%26aufirst%3DL.%26aulast%3DBridge%26aufirst%3DA.%26aulast%3DPoux%26aufirst%3DS.%26aulast%3DRedaschi%26aufirst%3DN.%26aulast%3DAimo%26aufirst%3DL.%26aulast%3DArgoudPuy%26aufirst%3DG.%26aulast%3DAuchincloss%26aufirst%3DA.%26aulast%3DAxelsen%26aufirst%3DK.%26aulast%3DBansal%26aufirst%3DP.%26aulast%3DBaratin%26aufirst%3DD.%26aulast%3DBlatter%26aufirst%3DM.%2BC.%26aulast%3DBoeckmann%26aufirst%3DB.%26aulast%3DBolleman%26aufirst%3DJ.%26aulast%3DBoutet%26aufirst%3DE.%26aulast%3DBreuza%26aufirst%3DL.%26aulast%3DCasal-Casas%26aufirst%3DC.%26aulast%3DDe%2BCastro%26aufirst%3DE.%26aulast%3DCoudert%26aufirst%3DE.%26aulast%3DCuche%26aufirst%3DB.%26aulast%3DDoche%26aufirst%3DM.%26aulast%3DDornevil%26aufirst%3DD.%26aulast%3DDuvaud%26aufirst%3DS.%26aulast%3DEstreicher%26aufirst%3DA.%26aulast%3DFamiglietti%26aufirst%3DL.%26aulast%3DFeuermann%26aufirst%3DM.%26aulast%3DGasteiger%26aufirst%3DE.%26aulast%3DGehant%26aufirst%3DS.%26aulast%3DGerritsen%26aufirst%3DV.%26aulast%3DGos%26aufirst%3DA.%26aulast%3DGruaz-Gumowski%26aufirst%3DN.%26aulast%3DHinz%26aufirst%3DU.%26aulast%3DHulo%26aufirst%3DC.%26aulast%3DJungo%26aufirst%3DF.%26aulast%3DKeller%26aufirst%3DG.%26aulast%3DLara%26aufirst%3DV.%26aulast%3DLemercier%26aufirst%3DP.%26aulast%3DLieberherr%26aufirst%3DD.%26aulast%3DLombardot%26aufirst%3DT.%26aulast%3DMartin%26aufirst%3DX.%26aulast%3DMasson%26aufirst%3DP.%26aulast%3DMorgat%26aufirst%3DA.%26aulast%3DNeto%26aufirst%3DT.%26aulast%3DNouspikel%26aufirst%3DN.%26aulast%3DPaesano%26aufirst%3DS.%26aulast%3DPedruzzi%26aufirst%3DI.%26aulast%3DPilbout%26aufirst%3DS.%26aulast%3DPozzato%26aufirst%3DM.%26aulast%3DPruess%26aufirst%3DM.%26aulast%3DRivoire%26aufirst%3DC.%26aulast%3DRoechert%26aufirst%3DB.%26aulast%3DSchneider%26aufirst%3DM.%26aulast%3DSigrist%26aufirst%3DC.%26aulast%3DSonesson%26aufirst%3DK.%26aulast%3DStaehli%26aufirst%3DS.%26aulast%3DStutz%26aufirst%3DA.%26aulast%3DSundaram%26aufirst%3DS.%26aulast%3DTognolli%26aufirst%3DM.%26aulast%3DVerbregue%26aufirst%3DL.%26aulast%3DVeuthey%26aufirst%3DA.%2BL.%26aulast%3DWu%26aufirst%3DC.%2BH.%26aulast%3DArighi%26aufirst%3DC.%2BN.%26aulast%3DArminski%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DGaravelli%26aufirst%3DJ.%2BS.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DLaiho%26aufirst%3DK.%26aulast%3DMcGarvey%26aufirst%3DP.%26aulast%3DNatale%26aufirst%3DD.%2BA.%26aulast%3DRoss%26aufirst%3DK.%26aulast%3DVinayaka%26aufirst%3DC.%2BR.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYeh%26aufirst%3DL.%2BS.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DUniProt%253A%2520The%2520universal%2520protein%2520knowledgebase%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2017%26volume%3D45%26spage%3DD158%26epage%3DD169%26doi%3D10.1093%2Fnar%2Fgkw1099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sadowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasteiger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klebe, G.</span></span> <span> </span><span class="NLM_article-title">Comparison of automatic three-dimensional model builders using 639 X-ray structures</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1000</span>– <span class="NLM_lpage">1008</span>, <span class="refDoi"> DOI: 10.1021/ci00020a039</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci00020a039" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADyaK2cXkvVajsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1994&pages=1000-1008&author=J.+Sadowskiauthor=J.+Gasteigerauthor=G.+Klebe&title=Comparison+of+automatic+three-dimensional+model+builders+using+639+X-ray+structures&doi=10.1021%2Fci00020a039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of Automatic Three-Dimensional Model Builders Using 639 X-ray Structures</span></div><div class="casAuthors">Sadowski, Jens; Gasteiger, Johann; Klebe, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1000-8</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    </div><div class="casAbstract">Several criteria were defined to select a dataset of high-quality x-ray structures from the Cambridge file resulting in 639 mols.  Six currently available programs for automatic 3D structure generation were compared by converting the connectivity tables, including appropriate stereodescriptors from this dataset of 639 mol. structures into 3D geometries: CONCORD, ALCOGEN, Chem-X, MOLGEO, COBRA, and CORINA.  The geometries produced by the different programs were evaluated in terms of several quality criteria and discussed in detail.  These criteria measure how well the different programs reproduce the x-ray geometries of the 639 input structures.  Accordingly, the major strengths and weaknesses of the programs are indicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8vEtyDrrlq7Vg90H21EOLACvtfcHk0liETXBbW7RH5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkvVajsbY%253D&md5=246e4d66f11178a18daad2563c48331c</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fci00020a039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci00020a039%26sid%3Dliteratum%253Aachs%26aulast%3DSadowski%26aufirst%3DJ.%26aulast%3DGasteiger%26aufirst%3DJ.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DComparison%2520of%2520automatic%2520three-dimensional%2520model%2520builders%2520using%2520639%2520X-ray%2520structures%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D1994%26volume%3D34%26spage%3D1000%26epage%3D1008%26doi%3D10.1021%2Fci00020a039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">ChemAxon, L.</span></span>.  <i>Calculator</i>; <span class="NLM_publisher-name">ChemAxon</span>: <span class="NLM_publisher-loc">Budapest, Hungary</span>, <span class="NLM_year">1998–2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998%E2%80%932018&author=L.+ChemAxon&title=Calculator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DChemAxon%26aufirst%3DL.%26jtitle%3DCalculator%26pub%3DChemAxon%26date%3D1998%25E2%2580%25932018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korb, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stützle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Exner, T. E.</span></span> <span> </span><span class="NLM_article-title">An ant colony optimization approach to flexible protein–ligand docking</span>. <i>Swarm Intell.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.1007/s11721-007-0006-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1007%2Fs11721-007-0006-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2007&pages=115-134&author=O.+Korbauthor=T.+St%C3%BCtzleauthor=T.+E.+Exner&title=An+ant+colony+optimization+approach+to+flexible+protein%E2%80%93ligand+docking&doi=10.1007%2Fs11721-007-0006-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1007%2Fs11721-007-0006-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11721-007-0006-9%26sid%3Dliteratum%253Aachs%26aulast%3DKorb%26aufirst%3DO.%26aulast%3DSt%25C3%25BCtzle%26aufirst%3DT.%26aulast%3DExner%26aufirst%3DT.%2BE.%26atitle%3DAn%2520ant%2520colony%2520optimization%2520approach%2520to%2520flexible%2520protein%25E2%2580%2593ligand%2520docking%26jtitle%3DSwarm%2520Intell.%26date%3D2007%26volume%3D1%26spage%3D115%26epage%3D134%26doi%3D10.1007%2Fs11721-007-0006-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marcou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rognan, D.</span></span> <span> </span><span class="NLM_article-title">Optimizing fragment and scaffold docking by use of molecular interaction fingerprints</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">195</span>– <span class="NLM_lpage">207</span>, <span class="refDoi"> DOI: 10.1021/ci600342e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci600342e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12iurzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=195-207&author=G.+Marcouauthor=D.+Rognan&title=Optimizing+fragment+and+scaffold+docking+by+use+of+molecular+interaction+fingerprints&doi=10.1021%2Fci600342e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Optimizing Fragment and Scaffold Docking by Use of Molecular Interaction Fingerprints</span></div><div class="casAuthors">Marcou, Gilles; Rognan, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">195-207</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein-ligand interaction fingerprints have been used to postprocess docking poses of three ligand data sets: a set of 40 low-mol.-wt. compds. from the Protein Data Bank, a collection of 40 scaffolds from pharmaceutically relevant protein ligands, and a database of 19 scaffolds extd. from true cdk2 inhibitors seeded in 2230 scaffold decoys.  Four popular docking tools (FlexX, Glide, Gold, and Surflex) were used to generate poses for ligands of the three data sets.  In all cases, scoring by the similarity of interaction fingerprints to a given ref. was statistically superior to conventional scoring functions in posing low-mol.-wt. fragments, predicting protein-bound scaffold coordinates according to the known binding mode of related ligands, and screening a scaffold library to enrich a hit list in true cdk2-targeted scaffolds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHLbVKxK-BfLVg90H21EOLACvtfcHk0liETXBbW7RH5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12iurzL&md5=0c9137a39d40fbcc83546aec17b595ba</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fci600342e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci600342e%26sid%3Dliteratum%253Aachs%26aulast%3DMarcou%26aufirst%3DG.%26aulast%3DRognan%26aufirst%3DD.%26atitle%3DOptimizing%2520fragment%2520and%2520scaffold%2520docking%2520by%2520use%2520of%2520molecular%2520interaction%2520fingerprints%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2007%26volume%3D47%26spage%3D195%26epage%3D207%26doi%3D10.1021%2Fci600342e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Graaf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kooistra, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vischer, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuijer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiroishi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Esch, I. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span> <span> </span><span class="NLM_article-title">Crystal structure-based virtual screening for fragment-like ligands of the human histamine H<sub>1</sub> receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">8195</span>– <span class="NLM_lpage">8206</span>, <span class="refDoi"> DOI: 10.1021/jm2011589</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2011589" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlaltbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8195-8206&author=C.+de%0AGraafauthor=A.+J.+Kooistraauthor=H.+F.+Vischerauthor=V.+Katritchauthor=M.+Kuijerauthor=M.+Shiroishiauthor=S.+Iwataauthor=T.+Shimamuraauthor=R.+C.+Stevensauthor=I.+J.+P.+de+Eschauthor=R.+Leurs&title=Crystal+structure-based+virtual+screening+for+fragment-like+ligands+of+the+human+histamine+H1+receptor&doi=10.1021%2Fjm2011589"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure-Based Virtual Screening for Fragment-like Ligands of the Human Histamine H1 Receptor</span></div><div class="casAuthors">de Graaf, Chris; Kooistra, Albert J.; Vischer, Henry F.; Katritch, Vsevolod; Kuijer, Martien; Shiroishi, Mitsunori; Iwata, So; Shimamura, Tatsuro; Stevens, Raymond C.; de Esch, Iwan J. P.; Leurs, Rob</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8195-8206</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The recent crystal structure detns. of druggable class A G protein-coupled receptors (GPCRs) have opened up excellent opportunities in structure-based ligand discovery for this pharmaceutically important protein family.  We have developed and validated a customized structure-based virtual fragment screening protocol against the recently detd. human histamine H1 receptor (H1R) crystal structure.  The method combines mol. docking simulations with a protein-ligand interaction fingerprint (IFP) scoring method.  The optimized in silico screening approach was successfully applied to identify a chem. diverse set of novel fragment-like (≤22 heavy atoms) H1R ligands with an exceptionally high hit rate of 73%.  Of the 26 tested fragments, 19 compds. had affinities ranging from 10 μM to 6 nM.  The current study shows the potential of in silico screening against GPCR crystal structures to explore novel, fragment-like GPCR ligand space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbwo3rozOuPbVg90H21EOLACvtfcHk0lhCaYK1ed9RUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlaltbnL&md5=e45d22d293667ff443f6d62ecef90f9d</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fjm2011589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2011589%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BGraaf%26aufirst%3DC.%26aulast%3DKooistra%26aufirst%3DA.%2BJ.%26aulast%3DVischer%26aufirst%3DH.%2BF.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DKuijer%26aufirst%3DM.%26aulast%3DShiroishi%26aufirst%3DM.%26aulast%3DIwata%26aufirst%3DS.%26aulast%3DShimamura%26aufirst%3DT.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3DLeurs%26aufirst%3DR.%26atitle%3DCrystal%2520structure-based%2520virtual%2520screening%2520for%2520fragment-like%2520ligands%2520of%2520the%2520human%2520histamine%2520H1%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8195%26epage%3D8206%26doi%3D10.1021%2Fjm2011589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jakalian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jack, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayly, C. I.</span></span> <span> </span><span class="NLM_article-title">Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1623</span>– <span class="NLM_lpage">1641</span>, <span class="refDoi"> DOI: 10.1002/jcc.10128</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1002%2Fjcc.10128" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=12395429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD38XosF2rt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=1623-1641&author=A.+Jakalianauthor=D.+B.+Jackauthor=C.+I.+Bayly&title=Fast%2C+efficient+generation+of+high-quality+atomic+charges.+AM1-BCC+model%3A+II.+Parameterization+and+validation&doi=10.1002%2Fjcc.10128"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. parameterization and validation</span></div><div class="casAuthors">Jakalian, Araz; Jack, David B.; Bayly, Christopher I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1623-1641</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We present the first global parameterization and validation of a novel charge model, called AM1-BCC, which quickly and efficiently generates high-quality at. charges for computer simulations of org. mols. in polar media.  The goal of the charge model is to produce at. charges that emulate the HF/6-31G* electrostatic potential (ESP) of a mol.  Underlying electronic structure features, including formal charge and electron delocalization, are first captured by AM1 population charges; simple additive bond charge corrections (BCCs) are then applied to these AM1 at. charges to produce the AM1-BCC charges.  The parameterization of BCCs was carried out by fitting to the HF/6-31G* ESP of a training set of >2700 mols.  Most org. functional groups and their combinations were sampled, as well as an extensive variety of cyclic and fused bicyclic heteroaryl systems.  The resulting BCC parameters allow the AM1-BCC charging scheme to handle virtually all types of org. compds. listed in The Merck Index and the NCI Database.  Validation of the model was done through comparisons of hydrogen-bonded dimer energies and relative free energies of solvation using AM1-BCC charges in conjunction with the 1994 Cornell et al. forcefield for AMBER.  Homo-dimer and hetero-dimer hydrogen-bond energies of a diverse set of org. mols. were reproduced to within 0.95 kcal/mol RMS deviation from the ab initio values, and for DNA dimers the energies were within 0.9 kcal/mol RMS deviation from ab initio values.  The calcd. relative free energies of solvation for a diverse set of monofunctional isosteres were reproduced to within 0.69 kcal/mol of expt.  In all these validation tests, AMBER with the AM1-BCC charge model maintained a correlation coeff. above 0.96.  Thus, the parameters presented here for use with the AM1-BCC method present a fast, accurate, and robust alternative to HF/6-31G* ESP-fit charges for general use with the AMBER force field in computer simulations involving org. small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn9DkJ_gMzA7Vg90H21EOLACvtfcHk0lhCaYK1ed9RUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosF2rt74%253D&md5=3f2b738617bb17b2898f7ac4d751d7ec</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1002%2Fjcc.10128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.10128%26sid%3Dliteratum%253Aachs%26aulast%3DJakalian%26aufirst%3DA.%26aulast%3DJack%26aufirst%3DD.%2BB.%26aulast%3DBayly%26aufirst%3DC.%2BI.%26atitle%3DFast%252C%2520efficient%2520generation%2520of%2520high-quality%2520atomic%2520charges.%2520AM1-BCC%2520model%253A%2520II.%2520Parameterization%2520and%2520validation%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2002%26volume%3D23%26spage%3D1623%26epage%3D1641%26doi%3D10.1002%2Fjcc.10128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berendsen, H. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van
der Spoel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Drunen, R.</span></span> <span> </span><span class="NLM_article-title">GROMACS: A message-passing parallel molecular dynamics implementation</span>. <i>Comput. Phys. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1016/0010-4655(95)00042-E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1016%2F0010-4655%2895%2900042-E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADyaK2MXps1Wrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1995&pages=43-56&author=H.+J.+C.+Berendsenauthor=D.+van%0Ader+Spoelauthor=R.+van+Drunen&title=GROMACS%3A+A+message-passing+parallel+molecular+dynamics+implementation&doi=10.1016%2F0010-4655%2895%2900042-E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">GROMACS: A message-passing parallel molecular dynamics implementation</span></div><div class="casAuthors">Berendsen, H. J. C.; van der Spoel, D.; van Drunen, R.</div><div class="citationInfo"><span class="NLM_cas:title">Computer Physics Communications</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">43-56</span>CODEN:
                <span class="NLM_cas:coden">CPHCBZ</span>;
        ISSN:<span class="NLM_cas:issn">0010-4655</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A parallel message-passing implementation of a mol. dynamics (MD) program that is useful for bio(macro)mols. in aq. environment is described.  The software has been developed for a custom-designed 32-processor ring GROMACS (Groningen MAchine for Chem. Simulation) with communication to and from left and right neighbors, but can run on any parallel system onto which a a ring of processors can be mapped and which supports PVM-like block send and receive calls.  The GROMACS software consists of a preprocessor, a parallel MD and energy minimization program that can use an arbitrary no. of processors (including one), an optional monitor, and several anal. tools.  The programs are written in ANSI C and available by ftp (information: <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="f69184999b979585b6959e939bd8848391d8989a">[email protected]</a>).  The functionality is based on the GROMOS (Groningen Mol. Simulation) package (van Gunsteren and Berendsen, 1987; BIOMOS B.V., Nijenborgh 4, 9747 AG Groningen).  Conversion programs between GROMOS and GROMACS formats are included.The MD program can handle rectangular periodic boundary conditions with temp. and pressure scaling.  The interactions that can be handled without modification are variable non-bonded pair interactions with Coulomb and Lennard-Jones or Buckingham potentials, using a twin-range cut-off based on charge groups, and fixed bonded interactions of either harmonic or constraint type for bonds and bond angles and either periodic or cosine power series interactions for dihedral angles.  Special forces can be added to groups of particles (for non-equil. dynamics or for position restraining) or between particles (for distance restraints).  The parallelism is based on particle decompn.  Interprocessor communication is largely limited to position and force distribution over the ring once per time step.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovcOlT-z9eKLVg90H21EOLACvtfcHk0lhCaYK1ed9RUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXps1Wrtr0%253D&md5=04d823aeab28ca374efb86839c705179</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2F0010-4655%2895%2900042-E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0010-4655%252895%252900042-E%26sid%3Dliteratum%253Aachs%26aulast%3DBerendsen%26aufirst%3DH.%2BJ.%2BC.%26aulast%3Dvan%2Bder%2BSpoel%26aufirst%3DD.%26aulast%3Dvan%2BDrunen%26aufirst%3DR.%26atitle%3DGROMACS%253A%2520A%2520message-passing%2520parallel%2520molecular%2520dynamics%2520implementation%26jtitle%3DComput.%2520Phys.%2520Commun.%26date%3D1995%26volume%3D91%26spage%3D43%26epage%3D56%26doi%3D10.1016%2F0010-4655%2895%2900042-E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cordomí, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caltabiano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardo, L.</span></span> <span> </span><span class="NLM_article-title">Membrane protein simulations using AMBER force field and Berger lipid parameters</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">948</span>– <span class="NLM_lpage">958</span>, <span class="refDoi"> DOI: 10.1021/ct200491c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct200491c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVSqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=948-958&author=A.+Cordom%C3%ADauthor=G.+Caltabianoauthor=L.+Pardo&title=Membrane+protein+simulations+using+AMBER+force+field+and+Berger+lipid+parameters&doi=10.1021%2Fct200491c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane Protein Simulations Using AMBER Force Field and Berger Lipid Parameters</span></div><div class="casAuthors">Cordomi, Arnau; Caltabiano, Gianluigi; Pardo, Leonardo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">948-958</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">AMBER force fields are among the most commonly used in mol. dynamics (MD) simulations of proteins.  Unfortunately, they lack a specific set of lipid parameters, thus limiting its use in membrane protein simulations.  To overcome this limitation the authors assessed whether the widely used united-atom lipid parameters described by O. Berger (1997)and co-workers could be used in conjunction with AMBER force fields in simulations of membrane proteins.  Thus, free energies of solvation in water and in cyclohexane, and free energies of water to cyclohexane transfer, were computed by thermodn. integration procedures for neutral amino acid side-chains employing AMBER99, AMBER03, and OPLS-AA amino acid force fields.  In addn., MD simulations of three membrane proteins in a POPC lipid bilayer, the β2 adrenergic G protein-coupled receptor, Aquaporin-1, and the outer membrane protein Omp32, were performed with the aim of comparing the AMBER99SB/Berger combination of force fields with the OPLS-AA/Berger combination.  The authors have shown that AMBER99SB and Berger force fields are compatible, they provide reliable free energy estns. relative to exptl. values, and their combination properly describes both membrane and protein structural properties.  The authors then suggest that the AMBER99SB/Berger combination is a reliable choice for the simulation of membrane proteins, which links the easiness of ligand parametrization and the ability to reproduce secondary structure of AMBER99SB force field with the largely validated Berger lipid parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-gBrwCxhd_7Vg90H21EOLACvtfcHk0lhP8YBiCUJrOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVSqtr4%253D&md5=0a46710c03ba644a33e92b15b87ccc1c</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fct200491c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct200491c%26sid%3Dliteratum%253Aachs%26aulast%3DCordom%25C3%25AD%26aufirst%3DA.%26aulast%3DCaltabiano%26aufirst%3DG.%26aulast%3DPardo%26aufirst%3DL.%26atitle%3DMembrane%2520protein%2520simulations%2520using%2520AMBER%2520force%2520field%2520and%2520Berger%2520lipid%2520parameters%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2012%26volume%3D8%26spage%3D948%26epage%3D958%26doi%3D10.1021%2Fct200491c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roessler, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brewer, C. R.</span></span> <span> </span><span class="NLM_article-title">Permanent turbidity standards</span>. <i>Appl. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1967</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1114</span>– <span class="NLM_lpage">1121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=6077410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A280%3ADyaF1c7gtVOnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1967&pages=1114-1121&author=W.+G.+Roesslerauthor=C.+R.+Brewer&title=Permanent+turbidity+standards"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Permanent turbidity standards</span></div><div class="casAuthors">Roessler W G; Brewer C R</div><div class="citationInfo"><span class="NLM_cas:title">Applied microbiology</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1114-21</span>
        ISSN:<span class="NLM_cas:issn">0003-6919</span>.
    </div><div class="casAbstract">Permanent turbidity reference standards suitable for measurement of microbial suspensions were prepared by suspending finely divided titanium dioxide in aryl sulfonamide-formaldehyde or methylstyrene resins.  Turbidities of these standards, adjusted to a useful range for microbiological and immunological studies, were compared with other reference standards in use today.  Tube holders for a Coleman Photonephelometer and a Nepho-Colorimeter were modified to eliminate the water well and to allow use of optically standardized 10-, 16-, or 18-mm test tubes.  The standards and the tube holders have been used satisfactorily for more than 12 years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkWsOrKFyCG2hHGZei4OW9fW6udTcc2eZ7YEnFl7AcRLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF1c7gtVOnsA%253D%253D&md5=3bc55d13abc8f04cca3b29d671d025f6</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoessler%26aufirst%3DW.%2BG.%26aulast%3DBrewer%26aufirst%3DC.%2BR.%26atitle%3DPermanent%2520turbidity%2520standards%26jtitle%3DAppl.%2520Microbiol.%26date%3D1967%26volume%3D15%26spage%3D1114%26epage%3D1121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, G. A.</span></span> <span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2719</span>– <span class="NLM_lpage">2740</span>, <span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lhP8YBiCUJrOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 4 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Hannes Schihada, Xiaoyuan Ma, Ulrike Zabel, Henry F. Vischer, Gunnar Schulte, Rob Leurs, Steffen Pockes, <span class="NLM_string-name hlFld-ContribAuthor">Martin J. Lohse</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a Conformational Histamine H3 Receptor Biosensor for the Synchronous Screening of Agonists and Inverse Agonists. </span><span class="cited-content_cbyCitation_journal-name">ACS Sensors</span><span> <strong>2020,</strong> <em>5 </em>
                                    (6)
                                     , 1734-1742. <a href="https://doi.org/10.1021/acssensors.0c00397" title="DOI URL">https://doi.org/10.1021/acssensors.0c00397</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acssensors.0c00397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facssensors.0c00397%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Sensors%26atitle%3DDevelopment%252Bof%252Ba%252BConformational%252BHistamine%252BH3%252BReceptor%252BBiosensor%252Bfor%252Bthe%252BSynchronous%252BScreening%252Bof%252BAgonists%252Band%252BInverse%252BAgonists%26aulast%3DSchihada%26aufirst%3DHannes%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D29022020%26date%3D13052020%26date%3D28052020%26date%3D13052020%26volume%3D5%26issue%3D6%26spage%3D1734%26epage%3D1742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara  Rani</span>, <span class="hlFld-ContribAuthor ">Bruna  Silva-Marques</span>, <span class="hlFld-ContribAuthor ">Rob  Leurs</span>, <span class="hlFld-ContribAuthor ">Maria Beatrice  Passani</span>, <span class="hlFld-ContribAuthor ">Patrizio  Blandina</span>, <span class="hlFld-ContribAuthor ">Gustavo  Provensi</span>. </span><span class="cited-content_cbyCitation_article-title">Short- and Long-Term Social Recognition Memory Are Differentially Modulated by Neuronal Histamine. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2021,</strong> <em>11 </em>
                                    (4)
                                     , 555. <a href="https://doi.org/10.3390/biom11040555" title="DOI URL">https://doi.org/10.3390/biom11040555</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom11040555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom11040555%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DShort-%252Band%252BLong-Term%252BSocial%252BRecognition%252BMemory%252BAre%252BDifferentially%252BModulated%252Bby%252BNeuronal%252BHistamine%26aulast%3DRani%26aufirst%3DBarbara%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D4%26spage%3D555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pakhuri  Mehta</span>, <span class="hlFld-ContribAuthor ">Przemysław  Miszta</span>, <span class="hlFld-ContribAuthor ">Sławomir  Filipek</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Modeling of Histamine Receptors—Recent Advances in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (6)
                                     , 1778. <a href="https://doi.org/10.3390/molecules26061778" title="DOI URL">https://doi.org/10.3390/molecules26061778</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26061778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26061778%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DMolecular%252BModeling%252Bof%252BHistamine%252BReceptors%2525E2%252580%252594Recent%252BAdvances%252Bin%252BDrug%252BDiscovery%26aulast%3DMehta%26aufirst%3DPakhuri%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D6%26spage%3D1778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David  Reiner</span>, <span class="hlFld-ContribAuthor ">Aleksandra  Zivkovic</span>, <span class="hlFld-ContribAuthor ">Olivier  Labeeuw</span>, <span class="hlFld-ContribAuthor ">Stéphane  Krief</span>, <span class="hlFld-ContribAuthor ">Marc  Capet</span>, <span class="hlFld-ContribAuthor ">Holger  Stark</span>. </span><span class="cited-content_cbyCitation_article-title">Novel pyrrolidinone derivative lacks claimed histamine H3 receptor stimulation in receptor binding and functional studies. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>191 </em>, 112150. <a href="https://doi.org/10.1016/j.ejmech.2020.112150" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112150</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112150%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bpyrrolidinone%252Bderivative%252Blacks%252Bclaimed%252Bhistamine%252BH3%252Breceptor%252Bstimulation%252Bin%252Breceptor%252Bbinding%252Band%252Bfunctional%252Bstudies%26aulast%3DReiner%26aufirst%3DDavid%26date%3D2020%26volume%3D191%26spage%3D112150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/medium/jm9b01462_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/large/jm9b01462_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01462&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/medium/jm9b01462_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/large/jm9b01462_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Representative imidazole H<sub>3</sub>R agonists. Activities are extracted from Igel et al.,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Govoni et al.,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and Kazuta et al.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> (B) Published non-imidazole H<sub>3</sub>R (partial) agonists.<a onclick="showRef(event, 'ref27 ref28 ref29 ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30 ref31 ref32">(27−32)</a> Unless mentioned otherwise, compounds were tested on the human receptor. α, intrinsic activity compared to histamine; β-gal, cyclic adenosine monophosphate (cAMP) response element (CRE)-β-galactosidase reporter gene assay; cAMP, forskolin-stimulated cAMP accumulation assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/large/jm9b01462_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01462&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/medium/jm9b01462_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/large/jm9b01462_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Initial functional data of compounds <b>11b</b> and <b>11i</b> compared to histamine, as obtained by ligand-induced activation of hH<sub>3</sub>R expressed on HEK293T cells measured by the CRE-luc reporter gene assay. Shown is a representative graph of at least three experiments performed in triplicate. Data are mean ± standard deviation (S.D.). (B) Structures of <b>11b</b> and <b>11i</b>, the closest relevant structure (<b>14a</b>) resulting from a subsequent extensive patent search and the compound set designed for the current study.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/large/jm9b01462_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01462&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/medium/jm9b01462_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/large/jm9b01462_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Syntheses Routes for Final Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/large/jm9b01462_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01462&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) POCl<sub>3</sub>, 110 °C, 3 h, 26–52%; (ii) <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA), dioxane or <i>N</i>-methyl-2-pyrrolidone (NMP), microwave (μW), 120–150 °C, 0.5–2 h, 27–50% (<b>a</b>, <b>b</b>) or 35–71% (<b>c</b>, <b>d</b>, <b>f</b>, two steps from benzhydryl deprotection); (iii) HCl, dichloromethane (DCM), MeOH, room temperature (rt) to 50 °C, 3 h to overnight, 10% to quant.; (iv) aldehyde/ketone, AcOH, NaHB(OAc)<sub>3</sub>, DCM, MeOH, rt, 3 h to overnight, 16–44%; or 1,4-diiodobutane, K<sub>2</sub>CO<sub>3</sub>, MeCN, reflux, 16 h, 9%; (v) <i>N</i>,<i>N</i>-dimethylazetidin-3-amine dihydrochloride, DIPEA, dioxane, μW, 150 °C, 30 min, 65%; (vi) di-<i>tert</i>-butyl dicarbonate, triethylamine (TEA), tetrahydrofuran (THF), rt, overnight, 63%; (vii) NaH, R<sup>2</sup>I, THF, 0 °C to rt, overnight, 28–58%; (viii) H<sub>2</sub>, Pd/C, MeOH, EtOH, rt to 60 °C, 1 h to overnight, not purified and used crude.</p></p></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/medium/jm9b01462_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/large/jm9b01462_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Representative structure–affinity relationship (A, C) and structure–function relationship (SFR) (B, D) effects selected from <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. (A, B) Different R<sup>1</sup> substituents with R<sup>2</sup> = Et and R<sup>3</sup> = H (<b>11c</b>, <b>12c</b>, <b>13c</b>, <b>14c</b>), (C, D) Different R<sup>2</sup> and R<sup>3</sup> substituents with R<sup>1</sup> = H (<b>14b</b>, <b>14d</b>, <b>14e</b>, <b>14f</b>, <b>14i</b>). Shown is a representative graph of at least three experiments performed in triplicate. Data are mean ± S.D.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/large/jm9b01462_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01462&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/medium/jm9b01462_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/large/jm9b01462_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Predicted binding mode of <b>14d</b>. (A) Overview of the H<sub>3</sub>R homology model based on the H<sub>1</sub>R crystal structure (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RZE">3RZE</a>).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The experimentally validated binding mode of histamine (magenta) is shown in more detail in (B), and the predicted binding mode of <b>14d</b> (green) is schematically represented in (C) and shown in more detail in (D). Interaction fingerprint representations of histamine and compound <b>14d</b> are shown in (E), where a one represents the presence of an interaction according to the color coding: blue for apolar, olive green for face-to-face aromatic, green for edge-to-face aromatic, red for protein hydrogen bond donor, purple for ligand hydrogen bond donor, gray for ligand-negative charge, and orange for protein-negative charge.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/large/jm9b01462_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01462&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/medium/jm9b01462_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/large/jm9b01462_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Dose-dependent Gα<sub>i</sub> activation by <b>14d</b> and histamine as measured by [<sup>35</sup>S]GTPγS accumulation on HEK293T cell homogenates expressing the hH<sub>3</sub>R. (B, C) Dose–response curves of <b>14d</b> and histamine for ligand-induced activation of mH<sub>3</sub>R (B) and mH<sub>4</sub>R (C) expressed on HEK293T cells as measured by the CRE-luciferase reporter gene assay. Representative graphs of at least three experiments performed in triplicate are shown. Data are mean ± S.D.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/large/jm9b01462_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01462&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/medium/jm9b01462_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/large/jm9b01462_0009.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>14d</b> impairs social recognition in mice. (A) Schematic drawings showing the sequence of procedures and treatment administrations. (B) Results are calculated as means of individual percentage of time spent exploring familiar (white columns) and novel (black columns) social stimuli. ***<i>P</i> < 0.001 vs the respective familiar subject [two-way analysis of variance (ANOVA) and Bonferroni’s MCT]. (C) Discrimination index calculated according to the formula tN – tF/tN + tF. **<i>P</i> < 0.01 vs vehicle (unpaired <i>t</i>-test). Shown are means ± S.E.M. of 10–11 animals per experimental group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01462/20191205/images/large/jm9b01462_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01462&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i82">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83218" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83218" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 76 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panula, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chazot, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowart, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutzmer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W. L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thurmond, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haas, H. L.</span></span> <span> </span><span class="NLM_article-title">International Union of Basic and <tep-common:author-query>AQ9: Please check whether the updated information in ref 1 is correct.</tep-common:author-query>Clinical Pharmacology. XCVIII. Histamine receptors</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">601</span>– <span class="NLM_lpage">655</span>, <span class="refDoi"> DOI: 10.1124/pr.114.010249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1124%2Fpr.114.010249" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2014&pages=601-655&author=P.+Panulaauthor=P.+L.+Chazotauthor=M.+Cowartauthor=R.+Gutzmerauthor=R.+Leursauthor=W.+L.+S.+Liuauthor=H.+Starkauthor=R.+L.+Thurmondauthor=H.+L.+Haas&title=International+Union+of+Basic+and+%3Ctep-common%3Aauthor-query%3EAQ9%3A+Please+check+whether+the+updated+information+in+ref+1+is+correct.%3C%2Ftep-common%3Aauthor-query%3EClinical+Pharmacology.+XCVIII.+Histamine+receptors&doi=10.1124%2Fpr.114.010249"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1124%2Fpr.114.010249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.114.010249%26sid%3Dliteratum%253Aachs%26aulast%3DPanula%26aufirst%3DP.%26aulast%3DChazot%26aufirst%3DP.%2BL.%26aulast%3DCowart%26aufirst%3DM.%26aulast%3DGutzmer%26aufirst%3DR.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DW.%2BL.%2BS.%26aulast%3DStark%26aufirst%3DH.%26aulast%3DThurmond%26aufirst%3DR.%2BL.%26aulast%3DHaas%26aufirst%3DH.%2BL.%26atitle%3DInternational%2520Union%2520of%2520Basic%2520and%2520%253Ctep-common%253Aauthor-query%253EAQ9%253A%2520Please%2520check%2520whether%2520the%2520updated%2520information%2520in%2520ref%25201%2520is%2520correct.%253C%252Ftep-common%253Aauthor-query%253EClinical%2520Pharmacology.%2520XCVIII.%2520Histamine%2520receptors%26jtitle%3DPharmacol.%2520Rev.%26date%3D2014%26volume%3D67%26spage%3D601%26epage%3D655%26doi%3D10.1124%2Fpr.114.010249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arrang, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garbarg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, J. C.</span></span> <span> </span><span class="NLM_article-title">Auto-inhibition of brain histamine release mediated by a novel class (H<sub>3</sub>) of histamine receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>302</i></span>,  <span class="NLM_fpage">832</span>– <span class="NLM_lpage">837</span>, <span class="refDoi"> DOI: 10.1038/302832a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1038%2F302832a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=6188956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADyaL3sXitFSmsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=1983&pages=832-837&author=J.+M.+Arrangauthor=M.+Garbargauthor=J.+C.+Schwartz&title=Auto-inhibition+of+brain+histamine+release+mediated+by+a+novel+class+%28H3%29+of+histamine+receptor&doi=10.1038%2F302832a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Autoinhibition of brain histamine release mediated by a novel class (H3) of histamine receptor</span></div><div class="casAuthors">Arrang, Jean Michel; Garbarg, Monique; Schwartz, Jean Charles</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">5911</span>),
    <span class="NLM_cas:pages">832-7</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The K+-induced release of 3H-labeled histamine (I)  [51-45-6] from rat cerebral cortex slices was inhibited by exogenous I, suggesting the presence of histaminic receptors by which this compd. can control its own release.  Although Nα-methylhistamine  [673-50-7] and Nα,Nα-dimethylhistamine  [673-46-1] also inhibited [3H]-I release, a no. of compds. known to exhibit agonist activities of H1 or H2 receptors had no significant effect.  Consequently, autoinhibition of I release by the brain is apparently mediated by a type of receptor (histaminic H3) that is clearly different from H1 and H2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpu3HYACgLprVg90H21EOLACvtfcHk0lhe0RXTucAKIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXitFSmsbc%253D&md5=891b1e95467aa9213317c930f12bf3b7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F302832a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F302832a0%26sid%3Dliteratum%253Aachs%26aulast%3DArrang%26aufirst%3DJ.%2BM.%26aulast%3DGarbarg%26aufirst%3DM.%26aulast%3DSchwartz%26aufirst%3DJ.%2BC.%26atitle%3DAuto-inhibition%2520of%2520brain%2520histamine%2520release%2520mediated%2520by%2520a%2520novel%2520class%2520%2528H3%2529%2520of%2520histamine%2520receptor%26jtitle%3DNature%26date%3D1983%26volume%3D302%26spage%3D832%26epage%3D837%26doi%3D10.1038%2F302832a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schlicker, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kathmann, M.</span></span> <span> </span><span class="NLM_article-title">Role of the histamine H<sub>3</sub> receptor in the central nervous system</span>. <i>Handb. Exp. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>241</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">299</span>, <span class="refDoi"> DOI: 10.1007/164_2016_12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1007%2F164_2016_12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=27787717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVGkt7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=241&publication_year=2017&pages=277-299&author=E.+Schlickerauthor=M.+Kathmann&title=Role+of+the+histamine+H3+receptor+in+the+central+nervous+system&doi=10.1007%2F164_2016_12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the histamine H3 receptor in the central nervous system</span></div><div class="casAuthors">Schlicker, Eberhard; Kathmann, Markus</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">241</span>
        (<span class="NLM_cas:issue">Histamine and Histamine Receptors in Health and Disease</span>),
    <span class="NLM_cas:pages">277-299</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">1865-0325</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">The Gi/o protein-coupled histamine H3 receptor is distributed throughout the central nervous system including areas like cerebral cortex, hippocampus and striatum with the d. being highest in the posterior hypothalamus, i.e. the area in which the histaminergic cell bodies are located.  In contrast to the other histamine receptor subtypes (H1, H2 and H4), the H3 receptor is located presynaptically and shows a constitutive activity.  In detail, H3 receptors are involved in the inhibition of histamine release (presynaptic autoreceptor), impulse flow along the histaminergic neurons (somadendritic autoreceptor) and histamine synthesis.  Moreover, they occur as inhibitory presynaptic heteroreceptors on serotoninergic, noradrenergic, dopaminergic, glutamatergic, GABAergic and perhaps cholinergic neurons.  This review shows for four functions of the brain that the H3 receptor represents a brake against the wake-promoting, anticonvulsant and anorectic effect of histamine (via postsynaptic H1 receptors) and its procognitive activity (via postsynaptic H1 and H2 receptors).  Indeed, H1 agonists and H3 inverse agonists elicit essentially the same effects, at least in rodents; these effects are opposite in direction to those elicited by brain-penetrating H1 receptor antagonists in humans.  Although the benefit for H3 inverse agonists for the symptomatic treatment of dementias is inconclusive, several members of this group have shown a marked potential for the treatment of disorders assocd. with excessive daytime sleepiness.  In March 2016, the European Commission granted a marketing authorisation for pitolisant (WakixR) (as the first representative of the H3 inverse agonists) for the treatment of narcolepsy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRxj_MzY8jbLVg90H21EOLACvtfcHk0ljjQzRN_AiELQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVGkt7vO&md5=a13d674516616afba34b4029cd4885bd</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2F164_2016_12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F164_2016_12%26sid%3Dliteratum%253Aachs%26aulast%3DSchlicker%26aufirst%3DE.%26aulast%3DKathmann%26aufirst%3DM.%26atitle%3DRole%2520of%2520the%2520histamine%2520H3%2520receptor%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2017%26volume%3D241%26spage%3D277%26epage%3D299%26doi%3D10.1007%2F164_2016_12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stark, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kathmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlicker, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schunack, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlegel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sippl, W.</span></span> <span> </span><span class="NLM_article-title">Medicinal chemical and pharmacological aspects of imidazole-containing histamine H3 receptor antagonists</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">965</span>– <span class="NLM_lpage">977</span>, <span class="refDoi"> DOI: 10.2174/1389557043403107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.2174%2F1389557043403107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=15544557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosFyhtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=965-977&author=H.+Starkauthor=M.+Kathmannauthor=E.+Schlickerauthor=W.+Schunackauthor=B.+Schlegelauthor=W.+Sippl&title=Medicinal+chemical+and+pharmacological+aspects+of+imidazole-containing+histamine+H3+receptor+antagonists&doi=10.2174%2F1389557043403107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemical and pharmacological aspects of imidazole-containing histamine H3 receptor antagonists</span></div><div class="casAuthors">Stark, Holger; Kathmann, Markus; Schlicker, Eberhard; Schunack, Walter; Schlegel, Birgit; Sippl, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">965-977</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The 1st antagonists known for the histamine H3 receptor were mono-substituted imidazole-contg. compds. like thioperamide.  Meanwhile numerous novel leads were developed possessing improved affinities, selectivities, specificities, and pharmacokinetic properties.  Scope and limitations of this promising class are discussed concerning their structure-activity relationships as well as pharmacol. and potential therapeutic aspects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBGlF2FqscGrVg90H21EOLACvtfcHk0ljjQzRN_AiELQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosFyhtLg%253D&md5=942bb2726669c4457f673ec996a88251</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F1389557043403107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557043403107%26sid%3Dliteratum%253Aachs%26aulast%3DStark%26aufirst%3DH.%26aulast%3DKathmann%26aufirst%3DM.%26aulast%3DSchlicker%26aufirst%3DE.%26aulast%3DSchunack%26aufirst%3DW.%26aulast%3DSchlegel%26aufirst%3DB.%26aulast%3DSippl%26aufirst%3DW.%26atitle%3DMedicinal%2520chemical%2520and%2520pharmacological%2520aspects%2520of%2520imidazole-containing%2520histamine%2520H3%2520receptor%2520antagonists%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2004%26volume%3D4%26spage%3D965%26epage%3D977%26doi%3D10.2174%2F1389557043403107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ganellin, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurquin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piripitsi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrang, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garbarg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligneau, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schunack, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, J.-C.</span></span> <span> </span><span class="NLM_article-title">Synthesis of potent non-imidazole histamine H<sub>3</sub>-receptor antagonists</span>. <i>Arch. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>331</i></span>,  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">404</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1521-4184(199812)331:12<395::AID-ARDP395>3.0.CO;2-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1002%2F%28SICI%291521-4184%28199812%29331%3A12%3C395%3A%3AAID-ARDP395%3E3.0.CO%3B2-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=9923195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADyaK1MXivFWkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=1998&pages=395-404&author=C.+R.+Ganellinauthor=F.+Leurquinauthor=A.+Piripitsiauthor=J.+M.+Arrangauthor=M.+Garbargauthor=X.+Ligneauauthor=W.+Schunackauthor=J.-C.+Schwartz&title=Synthesis+of+potent+non-imidazole+histamine+H3-receptor+antagonists&doi=10.1002%2F%28SICI%291521-4184%28199812%29331%3A12%3C395%3A%3AAID-ARDP395%3E3.0.CO%3B2-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of potent non-imidazole histamine H3-receptor antagonists</span></div><div class="casAuthors">Ganellin, C. Robin; Leurquin, Fabien; Piripitsi, Antonia; Arrang, Jean-Michel; Garbarg, Monique; Ligneau, Xavier; Schunack, Walter; Schwartz, Jean-Charles</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">331</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">395-404</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">Histamine was converted into a non-imidazole H3-receptor histamine antagonist by addn. of a 4-phenylbutyl group at the Nα-position followed by removal of the imidazole ring.  The resulting compd., N-ethyl-N-(4-phenylbutyl)amine, had a Ki = 1.3 μM as an H3 antagonist.  Using this as a lead compd., a series of homologous O and S isosteric tertiary amines was synthesized and structure-activity studies furnished N-(5-phenoxypentyl)pyrrolidine (Ki = 0.18 μM for [3H]histamine release from rat cerebral cortex synaptosomes) which was active in vivo.  Substitution of NO2 into the para position of the phenoxy group gave N-(5-p-nitrophenoxypentyl)pyrrolidine, UCL 1972 (Ki = 39 μM), ED50 = 1.1 mg/kg per os in mice on brain tele-methylhistamine levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNYq84DJ1FlrVg90H21EOLACvtfcHk0ljkqs7PARYEYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXivFWkuw%253D%253D&md5=849df6e056508e04d5f3c7ff02cea344</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-4184%28199812%29331%3A12%3C395%3A%3AAID-ARDP395%3E3.0.CO%3B2-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-4184%2528199812%2529331%253A12%253C395%253A%253AAID-ARDP395%253E3.0.CO%253B2-7%26sid%3Dliteratum%253Aachs%26aulast%3DGanellin%26aufirst%3DC.%2BR.%26aulast%3DLeurquin%26aufirst%3DF.%26aulast%3DPiripitsi%26aufirst%3DA.%26aulast%3DArrang%26aufirst%3DJ.%2BM.%26aulast%3DGarbarg%26aufirst%3DM.%26aulast%3DLigneau%26aufirst%3DX.%26aulast%3DSchunack%26aufirst%3DW.%26aulast%3DSchwartz%26aufirst%3DJ.-C.%26atitle%3DSynthesis%2520of%2520potent%2520non-imidazole%2520histamine%2520H3-receptor%2520antagonists%26jtitle%3DArch.%2520Pharm.%26date%3D1998%26volume%3D331%26spage%3D395%26epage%3D404%26doi%3D10.1002%2F%28SICI%291521-4184%28199812%29331%3A12%3C395%3A%3AAID-ARDP395%3E3.0.CO%3B2-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Celanire, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wijtmans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talaga, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Esch, I. J. P.</span></span> <span> </span><span class="NLM_article-title">Keynote review: Histamine H<sub>3</sub> receptor antagonists reach out for the clinic</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1613</span>– <span class="NLM_lpage">1627</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(05)03625-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1016%2FS1359-6446%2805%2903625-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=16376822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlCrtrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=1613-1627&author=S.+Celanireauthor=M.+Wijtmansauthor=P.+Talagaauthor=R.+Leursauthor=I.+J.+P.+de+Esch&title=Keynote+review%3A+Histamine+H3+receptor+antagonists+reach+out+for+the+clinic&doi=10.1016%2FS1359-6446%2805%2903625-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Keynote review: Histamine H3 receptor antagonists reach out for the clinic</span></div><div class="casAuthors">Celanire, Sylvain; Wijtmans, Maikel; Talaga, Patrice; Leurs, Rob; de Esch, Iwan J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">23/24</span>),
    <span class="NLM_cas:pages">1613-1627</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Histamine receptors represent a tried and tested target for the treatments of various conditions including allergic responses, gastric ulcers and dyspepsia.  The eagerly awaited new generation of histamine H3 antagonists looks set to represent a new class of potential blockbuster drugs.  Antagonists of the histamine H1 and H2 receptors have been successful as blockbuster drugs for treating allergic conditions and gastric ulcers, resp.  As such, histamine receptors have made a significant contribution to establishing G-Protein-coupled receptors as the favored drug targets of the industry.  In this light, it can easily be understood that the discovery of a third histamine receptor subtype (H3R) in 1983 was greeted with considerable excitement.  However, characterization of the H3R turned out to be far from trivial.  In the past five years, mol. biol. approaches have given fresh impetus to the H3R research field.  As a result, H3R ligands are where they were anticipated to be 20 years ago: at the center of attention and on the verge of an anticipated breakthrough as the next generation of histaminergic blockbuster drugs.  Here, we assess the status of the H3R medicinal chem. programs of the various players in the field, as far as can be deduced from patent applications and scientific literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUsoQNsCQFFrVg90H21EOLACvtfcHk0ljkqs7PARYEYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlCrtrjJ&md5=3d534a18de31f56df11a5dd5aaf34a66</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2805%2903625-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252805%252903625-1%26sid%3Dliteratum%253Aachs%26aulast%3DCelanire%26aufirst%3DS.%26aulast%3DWijtmans%26aufirst%3DM.%26aulast%3DTalaga%26aufirst%3DP.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26atitle%3DKeynote%2520review%253A%2520Histamine%2520H3%2520receptor%2520antagonists%2520reach%2520out%2520for%2520the%2520clinic%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2005%26volume%3D10%26spage%3D1613%26epage%3D1627%26doi%3D10.1016%2FS1359-6446%2805%2903625-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lebois, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span> <span> </span><span class="NLM_article-title">The evolution of histamine H<sub>3</sub> antagonists/inverse agonists</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">648</span>– <span class="NLM_lpage">660</span>, <span class="refDoi"> DOI: 10.2174/1568026611109060648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.2174%2F1568026611109060648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=21261594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslSmsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=648-660&author=E.+P.+Leboisauthor=C.+K.+Jonesauthor=C.+W.+Lindsley&title=The+evolution+of+histamine+H3+antagonists%2Finverse+agonists&doi=10.2174%2F1568026611109060648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of histamine H3 antagonists/inverse agonists</span></div><div class="casAuthors">Lebois, Evan P.; Jones, Carrie K.; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">648-660</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This article describes our efforts along with recent advances in the development, biol. evaluation and clin. proof of concept of small mol. histamine H3 antagonists/inverse agonists.  The H3 receptor is a presynaptic autoreceptor within the Class A GPCR family, but also functions as a heteroreceptor modulating levels of neurotransmitters such as dopamine, acetylcholine, norepinephrine, serotonin, GABA and glutamate.  Thus, H3R has garnered a great deal of interest from the pharmaceutical industry for the possible treatment of obesity, epilepsy, sleep/wake, schizophrenia, Alzheimer's disease, neuropathic pain and ADHD.  Within the two main classes of H3 ligands, both imidazole and non-imidazole derived, have shown sufficient potency and specificity which culminated with efficacy in preclin. models for various CNS disorders.  Importantly, conserved elements have been identified within the small mol. H3 ligand scaffolds that resulted in a highly predictive pharmacophore model.  Understanding of the pharmacophore model has allowed several groups to dial H3R activity into scaffolds designed for other CNS targets, and engender directed polypharmacol.  Moreover, Abbott, GSK, Pfizer and several others have reported pos. Phase I and/or Phase II data with structurally diverse H3R antagonists/inverse agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpqYa1Cbba9bVg90H21EOLACvtfcHk0li3fvZOXfqR6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslSmsr4%253D&md5=511cdab35b85a73969fecac97896c24d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2174%2F1568026611109060648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026611109060648%26sid%3Dliteratum%253Aachs%26aulast%3DLebois%26aufirst%3DE.%2BP.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DThe%2520evolution%2520of%2520histamine%2520H3%2520antagonists%252Finverse%2520agonists%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D648%26epage%3D660%26doi%3D10.2174%2F1568026611109060648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuhne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wijtmans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Esch, I. J. P.</span></span> <span> </span><span class="NLM_article-title">Several down, a few to go: histamine H<sub>3</sub> receptor ligands making the final push towards the market?</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1629</span>– <span class="NLM_lpage">1648</span>, <span class="refDoi"> DOI: 10.1517/13543784.2011.625010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1517%2F13543784.2011.625010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=21992603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVyltL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=1629-1648&author=S.+Kuhneauthor=M.+Wijtmansauthor=H.+D.+Limauthor=R.+Leursauthor=I.+J.+P.+de+Esch&title=Several+down%2C+a+few+to+go%3A+histamine+H3+receptor+ligands+making+the+final+push+towards+the+market%3F&doi=10.1517%2F13543784.2011.625010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Several down, a few to go: histamine H3 receptor ligands making the final push towards the market?</span></div><div class="casAuthors">Kuhne, Sebastiaan; Wijtmans, Maikel; Lim, Herman D.; Leurs, Rob; de Esch, Iwan J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1629-1648</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction:The histamine H3 receptor (H3R) plays a pivotal role in a plethora of therapeutic areas.  Blocking the H3R with antagonists/inverse agonists has been postulated to be of broad therapeutic use.  Indeed, H3R antagonists/inverse agonists have been extensively evaluated in the clinic.Areas covered:Here, we address new developments, insights obtained and challenges encountered in the clin. evaluations.  For recent H3R clin. candidates, the status and results of the corresponding clin. trial(s) will be discussed along with preclin. data.  Main findings: In all, it becomes evident that clin. evaluation of H3R antagonists/inverse agonists is characterized by mixed results.  On one hand, Pitolisant has successfully passed several Phase II trials and seems to be the most advanced compd. in the clinic now, being in Phase III.  On the other hand, some compds. (e.g., PF-03654647 and MK-0249) failed at Phase II clin. level for several indications.Expert opinion:A challenging feature in H3R research is the multifaceted role of the receptor at a mol./biochem. level, which can complicate targeting by small mols. at several (pre)clin. levels.  Accordingly, H3R antagonists/inverse agonists require further testing to pinpoint the determinants for clin. efficacy and to aid in the final push towards the market.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL4R4cmsASwLVg90H21EOLACvtfcHk0li3fvZOXfqR6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVyltL7N&md5=25d7e80b666a495a039011a83899e36e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1517%2F13543784.2011.625010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2011.625010%26sid%3Dliteratum%253Aachs%26aulast%3DKuhne%26aufirst%3DS.%26aulast%3DWijtmans%26aufirst%3DM.%26aulast%3DLim%26aufirst%3DH.%2BD.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26atitle%3DSeveral%2520down%252C%2520a%2520few%2520to%2520go%253A%2520histamine%2520H3%2520receptor%2520ligands%2520making%2520the%2520final%2520push%2520towards%2520the%2520market%253F%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2011%26volume%3D20%26spage%3D1629%26epage%3D1648%26doi%3D10.1517%2F13543784.2011.625010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sadek, B.</span>; <span class="NLM_string-name">Łażewska, D.</span>; <span class="NLM_string-name">Hagenow, S.</span>; <span class="NLM_string-name">Kieć-Kononowicz, K.</span>; <span class="NLM_string-name">Stark, H.</span></span> <span> </span><span class="NLM_article-title">Histamine H<sub>3</sub>R Antagonists: From Scaffold Hopping to Clinical Candidates</span>. In  <i>Histamine Receptors</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blandina, P.</span>, <span class="NLM_string-name">Passani, M.</span></span>, Eds.; <span class="NLM_series">The Receptors</span>; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">Cham</span>, <span class="NLM_year">2016</span>; Vol.  <span class="NLM_volume">28</span>, pp  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">155</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1007%2F978-3-319-40308-3_5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=109-155&author=B.+Sadek&author=D.+%C5%81a%C5%BCewska&author=S.+Hagenow&author=K.+Kie%C4%87-Kononowicz&author=H.+Starkauthor=P.+Blandina&author=M.+Passani&title=Histamine+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-40308-3_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-319-40308-3_5%26sid%3Dliteratum%253Aachs%26aulast%3DSadek%26aufirst%3DB.%26atitle%3DHistamine%2520H3R%2520Antagonists%253A%2520From%2520Scaffold%2520Hopping%2520to%2520Clinical%2520Candidates%26btitle%3DHistamine%2520Receptors%26aulast%3DBlandina%26aufirst%3DP.%26pub%3DHumana%2520Press%26date%3D2016%26volume%3D28%26spage%3D109%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kollb-Sielecka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demolis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmerich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markey, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmonson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haas, M.</span></span> <span> </span><span class="NLM_article-title">The European Medicines Agency review of pitolisant for treatment of narcolepsy: summary of the scientific assessment by the Committee for Medicinal Products for Human Use</span>. <i>Sleep Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">129</span>, <span class="refDoi"> DOI: 10.1016/j.sleep.2017.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1016%2Fj.sleep.2017.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=28449891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A280%3ADC%252BC1crhvVGnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2017&pages=125-129&author=M.+Kollb-Sieleckaauthor=P.+Demolisauthor=J.+Emmerichauthor=G.+Markeyauthor=T.+Salmonsonauthor=M.+Haas&title=The+European+Medicines+Agency+review+of+pitolisant+for+treatment+of+narcolepsy%3A+summary+of+the+scientific+assessment+by+the+Committee+for+Medicinal+Products+for+Human+Use&doi=10.1016%2Fj.sleep.2017.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The European Medicines Agency review of pitolisant for treatment of narcolepsy: summary of the scientific assessment by the Committee for Medicinal Products for Human Use</span></div><div class="casAuthors">Kollb-Sielecka Marta; Demolis Pierre; Emmerich Joseph; Markey Greg; Salmonson Tomas; Haas Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Sleep medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">125-129</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">On 31 March 2016, the European Commission issued a decision for a marketing authorisation valid throughout the European Union (EU) for pitolisant (Wakix) for the treatment of narcolepsy with or without cataplexy in adults.  Pitolisant is an antagonist/inverse agonist of the human histamine H3 receptor.  The dose should be selected using an up-titration scheme depending on individual patient response and tolerance and should not exceed 36 mg/day.  The main evidence of efficacy of pitolisant was based on two Phase III clinical trials.  The improvement on excessive daytime sleepiness was shown against placebo in the Harmony I study (-3.33 points; 95% confidence interval (CI) [-5.83; -0.83]; p = 0.024) and in Harmony CTP (-3.41 points; 95% CI [-4.95; -1.87]; p < 0.0001).  The daily cataplexy rate in Harmony I improved against placebo with a rate ratio (rR) of 0.38 whilst in the Harmony CTP the ratio of improvement on weekly cataplexy rate against placebo was 0.512.  The most commonly reported adverse reactions were headache, insomnia and nausea.  This article summarizes the scientific review leading to approval of pitolisant in the EU.  The assessment report and product information are available on the European Medicines Agency website (http://www.ema.europa.eu).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQm-VCMMXIrVkNoizSOkG_FfW6udTcc2ebzXmy244O78Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1crhvVGnsg%253D%253D&md5=2f820dc747146322af50c191bb0c0f98</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.sleep.2017.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sleep.2017.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DKollb-Sielecka%26aufirst%3DM.%26aulast%3DDemolis%26aufirst%3DP.%26aulast%3DEmmerich%26aufirst%3DJ.%26aulast%3DMarkey%26aufirst%3DG.%26aulast%3DSalmonson%26aufirst%3DT.%26aulast%3DHaas%26aufirst%3DM.%26atitle%3DThe%2520European%2520Medicines%2520Agency%2520review%2520of%2520pitolisant%2520for%2520treatment%2520of%2520narcolepsy%253A%2520summary%2520of%2520the%2520scientific%2520assessment%2520by%2520the%2520Committee%2520for%2520Medicinal%2520Products%2520for%2520Human%2520Use%26jtitle%3DSleep%2520Med.%26date%3D2017%26volume%3D33%26spage%3D125%26epage%3D129%26doi%3D10.1016%2Fj.sleep.2017.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Harmony
Biosciences LLC</span>. <a href="https://www.harmonybiosciences.com/newsroom/harmony-biosciences-announces-fda-approval-of-wakix-r-pitolisant-a-first-in/" class="extLink">https://www.harmonybiosciences.com/newsroom/harmony-biosciences-announces-fda-approval-of-wakix-r-pitolisant-a-first-in/</a> (accessed Aug 15, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Harmony%0ABiosciences+LLC.+https%3A%2F%2Fwww.harmonybiosciences.com%2Fnewsroom%2Fharmony-biosciences-announces-fda-approval-of-wakix-r-pitolisant-a-first-in%2F+%28accessed+Aug+15%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kazuta, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natsume, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furuichi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuto, S.</span></span> <span> </span><span class="NLM_article-title">Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist for the histamine H<sub>3</sub> receptor, having a cis-cyclopropane structure</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1980</span>– <span class="NLM_lpage">1988</span>, <span class="refDoi"> DOI: 10.1021/jm020415q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020415q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitF2qtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1980-1988&author=Y.+Kazutaauthor=K.+Hiranoauthor=K.+Natsumeauthor=S.+Yamadaauthor=R.+Kimuraauthor=S.+I.+Matsumotoauthor=K.+Furuichiauthor=A.+Matsudaauthor=S.+Shuto&title=Cyclopropane-based+conformational+restriction+of+histamine.+%281S%2C2S%29-2-%282-aminoethyl%29-1-%281H-imidazol-4-yl%29cyclopropane%2C+a+highly+selective+agonist+for+the+histamine+H3+receptor%2C+having+a+cis-cyclopropane+structure&doi=10.1021%2Fjm020415q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclopropane-Based Conformational Restriction of Histamine. (1S,2S)-2-(2-Aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a Highly Selective Agonist for the Histamine H3 Receptor, Having a cis-Cyclopropane Structure</span></div><div class="casAuthors">Kazuta, Yuji; Hirano, Kazufumi; Natsume, Kentaro; Yamada, Shizuo; Kimura, Ryohei; Matsumoto, Shunichiro; Furuichi, Kiyoshi; Matsuda, Akira; Shuto, Satoshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1980-1988</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of cyclopropane-based conformationally restricted analogs of histamine, the "folded" cis-analogs, i.e. I (R1 = H2N, H2NCH2, H2NCH2CH2) and their enantiomers, and the "extended" trans-analogs, i.e. II and its enantiomer, were designed as histamine H3 receptor agonists.  The compds. I and II were synthesized from the versatile chiral cyclopropane units III (R2 = H2N, H2NCH2, H2NCH2CH2).  Among the conformationally restricted analogs, the "folded" analog I (R1 = H2NCH2CH2) was identified as a potent H3 receptor agonist, which showed a significant binding affinity (Ki = 1.31 ± 0.16 nM) and had an agonist effect (EC50 value of 10 ± 3 nM) on the receptor.  This compd. owes its importance to being the first highly selective H3 receptor agonist to have virtually no effect on the H4 subtype receptor.  These studies showed that the cis-cyclopropane structure is very effective in the conformational restriction of histamine to improve the specific binding to the histamine H3 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr10ks4Q3LNlbVg90H21EOLACvtfcHk0linWDsGIqYl0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitF2qtLk%253D&md5=93b0b6f6c12157c9b1dd581f53222ff1</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm020415q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020415q%26sid%3Dliteratum%253Aachs%26aulast%3DKazuta%26aufirst%3DY.%26aulast%3DHirano%26aufirst%3DK.%26aulast%3DNatsume%26aufirst%3DK.%26aulast%3DYamada%26aufirst%3DS.%26aulast%3DKimura%26aufirst%3DR.%26aulast%3DMatsumoto%26aufirst%3DS.%2BI.%26aulast%3DFuruichi%26aufirst%3DK.%26aulast%3DMatsuda%26aufirst%3DA.%26aulast%3DShuto%26aufirst%3DS.%26atitle%3DCyclopropane-based%2520conformational%2520restriction%2520of%2520histamine.%2520%25281S%252C2S%2529-2-%25282-aminoethyl%2529-1-%25281H-imidazol-4-yl%2529cyclopropane%252C%2520a%2520highly%2520selective%2520agonist%2520for%2520the%2520histamine%2520H3%2520receptor%252C%2520having%2520a%2520cis-cyclopropane%2520structure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1980%26epage%3D1988%26doi%3D10.1021%2Fjm020415q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kitbunnadaj, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuiderveld, O. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Esch, I. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vollinga, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lutz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spek, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavoy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deltent, M.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menge, W. M. P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure–activity relationships of conformationally constrained histamine H<sub>3</sub> receptor agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">5445</span>– <span class="NLM_lpage">5457</span>, <span class="refDoi"> DOI: 10.1021/jm030905y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030905y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD3sXos1SlsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=5445-5457&author=R.+Kitbunnadajauthor=O.+P.+Zuiderveldauthor=I.+J.+P.+de+Eschauthor=R.+C.+Vollingaauthor=R.+Bakkerauthor=M.+Lutzauthor=A.+L.+Spekauthor=E.+Cavoyauthor=M.-F.+Deltentauthor=W.+M.+P.+B.+Mengeauthor=H.+Timmermanauthor=R.+Leurs&title=Synthesis+and+structure%E2%80%93activity+relationships+of+conformationally+constrained+histamine+H3+receptor+agonists&doi=10.1021%2Fjm030905y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure-Activity Relationships of Conformationally Constrained Histamine H3 Receptor Agonists</span></div><div class="casAuthors">Kitbunnadaj, Ruengwit; Zuiderveld, Obbe P.; De Esch, Iwan J. P.; Vollinga, Roeland C.; Bakker, Remko; Lutz, Martin; Spek, Anthony L.; Cavoy, Emile; Deltent, Marie-France; Menge, Wiro M. P. B.; Timmerman, Henk; Leurs, Rob</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">5445-5457</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Immepip, a conformationally constrained analog of the histamine congener imbutamine, shows high affinity and functional activity on the human H3 receptor.  Using histamine and its homologs as prototypes, other rigid analogs contg. either a piperidine or pyrrolidine ring in the side chain were synthesized and tested for their activities at the human H3 receptor and the closely related H4 receptor.  In the series of piperidine contg. analogs, immepip was found to be the most potent H3 receptor agonist, whereas a propylene analog was identified as a high-affinity neutral antagonist for the human H3 receptor.  Moreover, replacement of the piperidine ring of immepip by a pyrrolidine ring led to a pair of enantiomers that show a distinct stereoselectivity at the human H3 and H4 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAbj8TTwbU8bVg90H21EOLACvtfcHk0lhKv5yyTouGrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXos1SlsL0%253D&md5=c28c9539b49258e59427bc8f37a880b4</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm030905y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030905y%26sid%3Dliteratum%253Aachs%26aulast%3DKitbunnadaj%26aufirst%3DR.%26aulast%3DZuiderveld%26aufirst%3DO.%2BP.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3DVollinga%26aufirst%3DR.%2BC.%26aulast%3DBakker%26aufirst%3DR.%26aulast%3DLutz%26aufirst%3DM.%26aulast%3DSpek%26aufirst%3DA.%2BL.%26aulast%3DCavoy%26aufirst%3DE.%26aulast%3DDeltent%26aufirst%3DM.-F.%26aulast%3DMenge%26aufirst%3DW.%2BM.%2BP.%2BB.%26aulast%3DTimmerman%26aufirst%3DH.%26aulast%3DLeurs%26aufirst%3DR.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520conformationally%2520constrained%2520histamine%2520H3%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D5445%26epage%3D5457%26doi%3D10.1021%2Fjm030905y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kitbunnadaj, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuiderveld, O. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christophe, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulscher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menge, W. M. P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelens, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snip, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakker, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Celanire, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talaga, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span> <span> </span><span class="NLM_article-title">Identification of 4-(1H-Imidazol-4(5)-ylmethyl)pyridine (immethridine) as a novel, potent, and highly selective histamine H<sub>3</sub> receptor agonist</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2414</span>– <span class="NLM_lpage">2417</span>, <span class="refDoi"> DOI: 10.1021/jm049932u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049932u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivFSrsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2414-2417&author=R.+Kitbunnadajauthor=O.+P.+Zuiderveldauthor=B.+Christopheauthor=S.+Hulscherauthor=W.+M.+P.+B.+Mengeauthor=E.+Gelensauthor=E.+Snipauthor=R.+A.+Bakkerauthor=S.+Celanireauthor=M.+Gillardauthor=P.+Talagaauthor=H.+Timmermanauthor=R.+Leurs&title=Identification+of+4-%281H-Imidazol-4%285%29-ylmethyl%29pyridine+%28immethridine%29+as+a+novel%2C+potent%2C+and+highly+selective+histamine+H3+receptor+agonist&doi=10.1021%2Fjm049932u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of 4-(1H-Imidazol-4(5)-ylmethyl)pyridine (immethridine) as a Novel, Potent, and Highly Selective Histamine H3 Receptor Agonist</span></div><div class="casAuthors">Kitbunnadaj, Ruengwit; Zuiderveld, Obbe P.; Christophe, Bernard; Hulscher, Saskia; Menge, Wiro M. P. B.; Gelens, Edith; Snip, Erwin; Bakker, Remko A.; Celanire, Sylvain; Gillard, Michel; Talaga, Patrice; Timmerman, Henk; Leurs, Rob</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2414-2417</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this study, the piperidine ring of immepip and its analogs was replaced by a rigid heterocyclic pyridine ring.  Many compds. in the series exhibit high affinity and agonist activity at the human histamine H3 receptor.  Particularly, the 4-pyridinyl analog of immepip (immethridine) is identified as a novel potent and highly selective histamine H3 receptor agonist (pKi = 9.07, pEC50 = 9.74) with a 300-fold selectivity over the closely related H4 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSB7-YU2AxdLVg90H21EOLACvtfcHk0lhKv5yyTouGrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivFSrsrw%253D&md5=df8febb3d4f05a616aad9d95b1186a10</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm049932u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049932u%26sid%3Dliteratum%253Aachs%26aulast%3DKitbunnadaj%26aufirst%3DR.%26aulast%3DZuiderveld%26aufirst%3DO.%2BP.%26aulast%3DChristophe%26aufirst%3DB.%26aulast%3DHulscher%26aufirst%3DS.%26aulast%3DMenge%26aufirst%3DW.%2BM.%2BP.%2BB.%26aulast%3DGelens%26aufirst%3DE.%26aulast%3DSnip%26aufirst%3DE.%26aulast%3DBakker%26aufirst%3DR.%2BA.%26aulast%3DCelanire%26aufirst%3DS.%26aulast%3DGillard%26aufirst%3DM.%26aulast%3DTalaga%26aufirst%3DP.%26aulast%3DTimmerman%26aufirst%3DH.%26aulast%3DLeurs%26aufirst%3DR.%26atitle%3DIdentification%2520of%25204-%25281H-Imidazol-4%25285%2529-ylmethyl%2529pyridine%2520%2528immethridine%2529%2520as%2520a%2520novel%252C%2520potent%252C%2520and%2520highly%2520selective%2520histamine%2520H3%2520receptor%2520agonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2414%26epage%3D2417%26doi%3D10.1021%2Fjm049932u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meier, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hüls, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligneau, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertz, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrang, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganellin, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schunack, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, H.</span></span> <span> </span><span class="NLM_article-title">4-(ω-(Alkyloxy)alkyl)-1H-imidazole derivatives as histamine H<sub>3</sub> receptor antagonists/agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2678</span>– <span class="NLM_lpage">2687</span>, <span class="refDoi"> DOI: 10.1021/jm031065q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm031065q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtVSqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2678-2687&author=G.+Meierauthor=M.+Krauseauthor=A.+H%C3%BClsauthor=X.+Ligneauauthor=H.+H.+Pertzauthor=J.+M.+Arrangauthor=C.+R.+Ganellinauthor=J.+C.+Schwartzauthor=W.+Schunackauthor=H.+Stark&title=4-%28%CF%89-%28Alkyloxy%29alkyl%29-1H-imidazole+derivatives+as+histamine+H3+receptor+antagonists%2Fagonists&doi=10.1021%2Fjm031065q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">4-(ω-(Alkyloxy)alkyl)-1H-imidazole Derivatives as Histamine H3 Receptor Antagonists/Agonists</span></div><div class="casAuthors">Meier, Galina; Krause, Michael; Huels, Annette; Ligneau, Xavier; Pertz, Heinz H.; Arrang, Jean-Michel; Ganellin, C. Robin; Schwartz, Jean-Charles; Schunack, Walter; Stark, Holger</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2678-2687</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In an effort to develop new histamine H3 receptor antagonists usable as pharmacol. tools, the authors present here novel unsym. ether derivs.  Etherification of different ω-(1H-imidazol-4-yl)alkyl scaffolds led to compds. contg. alkyl chains of increasing lengths either with or without unsatd. termini, cycloalkyl or arylalkyl moieties, or addnl. heteroatoms.  When investigated in an in vitro assay on rat synaptosomes, the majority of compds. displayed potencies in the low nanomolar concn. range at the H3 receptor, e.g., 4-(3-(3-cyclopentylpropyloxy)propyl)-1H-imidazole (27, Ki = 7 nM).  FUB 465, 4-(3-(ethoxy)propyl)-1H-imidazole, a useful tool for the characterization of constitutive activity of H3 receptors in vivo in rodents, proved to be of high oral in vivo potency in mice (ED50 = 0.26 mg/kg).  Further, the influence of chosen compds. on specific [35S]GTPγS binding was assayed on HEK293 cell membranes expressing the human histamine H3 receptor revealing partial agonism of the compds. in this particular model.  These distinct responses are further hints for "protean agonism" in this class of compds.  Addnl., selected compds. were functionally investigated in vitro on isolated organs of the guinea-pig at H3, H1, and H2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwkkTfmYqSHLVg90H21EOLACvtfcHk0lhKv5yyTouGrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtVSqurc%253D&md5=351d3efdb766bc08951912ee6c9f8d89</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm031065q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm031065q%26sid%3Dliteratum%253Aachs%26aulast%3DMeier%26aufirst%3DG.%26aulast%3DKrause%26aufirst%3DM.%26aulast%3DH%25C3%25BCls%26aufirst%3DA.%26aulast%3DLigneau%26aufirst%3DX.%26aulast%3DPertz%26aufirst%3DH.%2BH.%26aulast%3DArrang%26aufirst%3DJ.%2BM.%26aulast%3DGanellin%26aufirst%3DC.%2BR.%26aulast%3DSchwartz%26aufirst%3DJ.%2BC.%26aulast%3DSchunack%26aufirst%3DW.%26aulast%3DStark%26aufirst%3DH.%26atitle%3D4-%2528%25CF%2589-%2528Alkyloxy%2529alkyl%2529-1H-imidazole%2520derivatives%2520as%2520histamine%2520H3%2520receptor%2520antagonists%252Fagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2678%26epage%3D2687%26doi%3D10.1021%2Fjm031065q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pelloux-Léon, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fkyerat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piripitsi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tertiuk, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schunack, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garbarg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligneau, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrang, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganellin, C. R.</span></span> <span> </span><span class="NLM_article-title">Meta-substituted aryl(thio)ethers as potent partial agonists (or antagonists) for the histamine H<sub>3</sub> receptor lacking a nitrogen atom in the side chain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">3264</span>– <span class="NLM_lpage">3274</span>, <span class="refDoi"> DOI: 10.1021/jm031141p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm031141p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjslOitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=3264-3274&author=N.+Pelloux-L%C3%A9onauthor=A.+Fkyeratauthor=A.+Piripitsiauthor=W.+Tertiukauthor=W.+Schunackauthor=H.+Starkauthor=M.+Garbargauthor=X.+Ligneauauthor=J.-M.+Arrangauthor=J.-C.+Schwartzauthor=C.+R.+Ganellin&title=Meta-substituted+aryl%28thio%29ethers+as+potent+partial+agonists+%28or+antagonists%29+for+the+histamine+H3+receptor+lacking+a+nitrogen+atom+in+the+side+chain&doi=10.1021%2Fjm031141p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Meta-Substituted Aryl(thio)ethers as Potent Partial Agonists (or Antagonists) for the Histamine H3 Receptor Lacking a Nitrogen Atom in the Side Chain</span></div><div class="casAuthors">Pelloux-Leon, Nadia; Fkyerat, Abdellatif; Piripitsi, Antonia; Tertiuk, Wasyl; Schunack, Walter; Stark, Holger; Garbarg, Monique; Ligneau, Xavier; Arrang, Jean-Michel; Schwartz, Jean-Charles; Ganellin, C. Robin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3264-3274</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">4-(3-Aryloxypropyl)-1H-imidazoles, which possess a meta-positioned substituent in the aryl ring, have been synthesized and tested for activity at histamine H3 receptors.  The compds. having a CN, Me, or Br substituent were found to be antagonists, whereas CF3, Et, i-Pr, t-Bu, COCH3, or NO2 substituents remarkably afforded partial agonists when tested in vitro on rat cerebral cortex synaptosomes for inhibition of [3H]histamine release.  The compds. were also active in vivo, and furthermore, the CF3-substituted compd. trifluproxim acted as a potent full agonist in vivo, having ED50 = 0.6 ± 0.3 mg/kg per os in mice for inhibition of brain Nτ-methylhistamine formation.  Related structures have also been investigated; homologs 4-[4-(3-(trifluoromethyl)phenoxy)butyl]-1H-imidazole and 4-[2-(3-(trifluoromethyl)phenylthio)ethyl]-1H-imidazole are shown to be partial agonists, whereas the O isostere 4-[2-(3-(trifluoromethyl)phenoxy)ethyl]-1H-imidazole is an antagonist as is the S homolog 4-[3-(3-(trifluoromethyl)phenylthio)propyl]-1H-imidazole and its CH2 isostere 4-[4-(3-(trifluoromethyl)phenyl)butyl]-1H-imidazole.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgZUL5F4JuELVg90H21EOLACvtfcHk0lge3rnUZLZo4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjslOitrg%253D&md5=02cf3df40ee3a3b032defa81747128cd</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm031141p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm031141p%26sid%3Dliteratum%253Aachs%26aulast%3DPelloux-L%25C3%25A9on%26aufirst%3DN.%26aulast%3DFkyerat%26aufirst%3DA.%26aulast%3DPiripitsi%26aufirst%3DA.%26aulast%3DTertiuk%26aufirst%3DW.%26aulast%3DSchunack%26aufirst%3DW.%26aulast%3DStark%26aufirst%3DH.%26aulast%3DGarbarg%26aufirst%3DM.%26aulast%3DLigneau%26aufirst%3DX.%26aulast%3DArrang%26aufirst%3DJ.-M.%26aulast%3DSchwartz%26aufirst%3DJ.-C.%26aulast%3DGanellin%26aufirst%3DC.%2BR.%26atitle%3DMeta-substituted%2520aryl%2528thio%2529ethers%2520as%2520potent%2520partial%2520agonists%2520%2528or%2520antagonists%2529%2520for%2520the%2520histamine%2520H3%2520receptor%2520lacking%2520a%2520nitrogen%2520atom%2520in%2520the%2520side%2520chain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D3264%26epage%3D3274%26doi%3D10.1021%2Fjm031141p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kitbunnadaj, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuiderveld, O. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menozzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hidaka, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Esch, I. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakker, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menge, W. M. P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamatodani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coruzzi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span> <span> </span><span class="NLM_article-title">N-Substituted Piperidinyl Alkyl Imidazoles: Discovery of methimepip as a potent and selective histamine H<sub>3</sub> receptor agonist</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">2100</span>– <span class="NLM_lpage">2107</span>, <span class="refDoi"> DOI: 10.1021/jm049475h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049475h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVagtLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2100-2107&author=R.+Kitbunnadajauthor=T.+Hashimotoauthor=E.+Poliauthor=O.+P.+Zuiderveldauthor=A.+Menozziauthor=R.+Hidakaauthor=I.+J.+P.+de+Eschauthor=R.+A.+Bakkerauthor=W.+M.+P.+B.+Mengeauthor=A.+Yamatodaniauthor=G.+Coruzziauthor=H.+Timmermanauthor=R.+Leurs&title=N-Substituted+Piperidinyl+Alkyl+Imidazoles%3A+Discovery+of+methimepip+as+a+potent+and+selective+histamine+H3+receptor+agonist&doi=10.1021%2Fjm049475h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">N-Substituted Piperidinyl Alkyl Imidazoles: Discovery of Methimepip as a Potent and Selective Histamine H3 Receptor Agonist</span></div><div class="casAuthors">Kitbunnadaj, Ruengwit; Hashimoto, Takeshi; Poli, Enzo; Zuiderveld, Obbe P.; Menozzi, Alessandro; Hidaka, Ryoko; de Esch, Iwan J. P.; Bakker, Remko A.; Menge, Wiro M. P. B.; Yamatodani, Atsushi; Coruzzi, Gabriella; Timmerman, Henk; Leurs, Rob</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2100-2107</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this study, we continue our efforts toward the development of potent and highly selective histamine H3 receptor agonists.  We introduced various alkyl or aryl alkyl groups on the piperidine nitrogen of the known H3/H4 agonist immepip and its analogs.  We obsd. that N-methyl-substituted immepip (methimepip) exhibits high affinity and agonist activity at the human histamine H3 receptor (pKi = 9.0 and pEC50 = 9.5) with a 2000-fold selectivity at the human H3 receptor over the human H4 receptor and more than a 10000-fold selectivity over the human histamine H1 and H2 receptors.  Methimepip was also very effective as an H3 receptor agonist at the guinea pig ileum (pD2 = 8.26).  Moreover, in vivo microdialysis (in rat brain) showed that methimepip reduces the basal level of brain histamine to about 25% after a 5 mg/kg i.p. administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDAeujcwlOm7Vg90H21EOLACvtfcHk0lge3rnUZLZo4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVagtLvK&md5=587438743f4482608254162eb50da570</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm049475h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049475h%26sid%3Dliteratum%253Aachs%26aulast%3DKitbunnadaj%26aufirst%3DR.%26aulast%3DHashimoto%26aufirst%3DT.%26aulast%3DPoli%26aufirst%3DE.%26aulast%3DZuiderveld%26aufirst%3DO.%2BP.%26aulast%3DMenozzi%26aufirst%3DA.%26aulast%3DHidaka%26aufirst%3DR.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3DBakker%26aufirst%3DR.%2BA.%26aulast%3DMenge%26aufirst%3DW.%2BM.%2BP.%2BB.%26aulast%3DYamatodani%26aufirst%3DA.%26aulast%3DCoruzzi%26aufirst%3DG.%26aulast%3DTimmerman%26aufirst%3DH.%26aulast%3DLeurs%26aufirst%3DR.%26atitle%3DN-Substituted%2520Piperidinyl%2520Alkyl%2520Imidazoles%253A%2520Discovery%2520of%2520methimepip%2520as%2520a%2520potent%2520and%2520selective%2520histamine%2520H3%2520receptor%2520agonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2100%26epage%3D2107%26doi%3D10.1021%2Fjm049475h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Govoni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Atmioui, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menge, W. M. P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakker, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Esch, I. J. P.</span></span> <span> </span><span class="NLM_article-title">A chemical switch for the modulation of the functional activity of higher homologues of histamine on the human histamine H<sub>3</sub> receptor: effect of various substitutions at the primary amino function</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">2549</span>– <span class="NLM_lpage">2557</span>, <span class="refDoi"> DOI: 10.1021/jm0504353</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0504353" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1Khs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2549-2557&author=M.+Govoniauthor=H.+D.+Limauthor=D.+El-Atmiouiauthor=W.+M.+P.+B.+Mengeauthor=H.+Timmermanauthor=R.+A.+Bakkerauthor=R.+Leursauthor=I.+J.+P.+de+Esch&title=A+chemical+switch+for+the+modulation+of+the+functional+activity+of+higher+homologues+of+histamine+on+the+human+histamine+H3+receptor%3A+effect+of+various+substitutions+at+the+primary+amino+function&doi=10.1021%2Fjm0504353"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A Chemical Switch for the Modulation of the Functional Activity of Higher Homologues of Histamine on the Human Histamine H3 Receptor: Effect of Various Substitutions at the Primary Amino Function</span></div><div class="casAuthors">Govoni, Marinella; Lim, Herman D.; El-Atmioui, Dris; Menge, Wiro M. P. B.; Timmerman, Henk; Bakker, Remko A.; Leurs, Rob; De Esch, Iwan J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2549-2557</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In an effort to establish the structural requirements for agonism, neutral antagonism, and inverse agonism at the human histamine H3 receptor (H3R) we have prepd. a series of higher homologs of histamine in which the terminal nitrogen of the side chain has been either mono- or disubstituted with several aliph., alicyclic, and arom. moieties or incorporated in cyclic systems.  The novel ligands have been pharmacol. investigated in vitro for their affinities on the human H3R and H4R subtypes by radioligand displacement expts. and for their intrinsic H3R activities via a CRE-mediated β-galactosidase reporter gene assay.  Subtle changes of the substitution pattern at the side chain nitrogen alter enormously the pharmacol. activity of the ligands, resulting in a series of compds. with a wide spectrum of pharmacol. activities.  Among the several neutral H3R antagonists identified within this series, aminoalkylimidazoles I (n = 5, R1 = H, R2 = Et; n = 5, R1 = H, R2 = cyclopentyl), display an H3R affinity in the low nanomolar concn. range (pKi values of 8.1 and 8.4, resp.).  A very potent and selective H3R agonist I (n = 4, R1 = R2 = Me) with pEC50 = 8.9, α = 0.94, and a very potent, though not highly selective, H3R inverse agonist I (n = 5, R1 = H, R2 = CH2C6H4Cl-4) with pIC50 = 8.9, α = -0.97 have been identified as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3uk9mr0H8e7Vg90H21EOLACvtfcHk0lge3rnUZLZo4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1Khs7s%253D&md5=92d454d4de364b332b53c10f9d0b9ef2</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm0504353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0504353%26sid%3Dliteratum%253Aachs%26aulast%3DGovoni%26aufirst%3DM.%26aulast%3DLim%26aufirst%3DH.%2BD.%26aulast%3DEl-Atmioui%26aufirst%3DD.%26aulast%3DMenge%26aufirst%3DW.%2BM.%2BP.%2BB.%26aulast%3DTimmerman%26aufirst%3DH.%26aulast%3DBakker%26aufirst%3DR.%2BA.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26atitle%3DA%2520chemical%2520switch%2520for%2520the%2520modulation%2520of%2520the%2520functional%2520activity%2520of%2520higher%2520homologues%2520of%2520histamine%2520on%2520the%2520human%2520histamine%2520H3%2520receptor%253A%2520effect%2520of%2520various%2520substitutions%2520at%2520the%2520primary%2520amino%2520function%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2549%26epage%3D2557%26doi%3D10.1021%2Fjm0504353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wijtmans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Celanire, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snip, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillard, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelens, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collart, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venhuis, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christophe, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulscher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Goot, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakker, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lallemand, B. I. L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talaga, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Esch, I. J. P.</span></span> <span> </span><span class="NLM_article-title">4-Benzyl-1H-imidazoles with oxazoline termini as histamine H<sub>3</sub> receptor agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">2944</span>– <span class="NLM_lpage">2953</span>, <span class="refDoi"> DOI: 10.1021/jm7014149</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm7014149" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvF2mu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2944-2953&author=M.+Wijtmansauthor=S.+Celanireauthor=E.+Snipauthor=M.+R.+Gillardauthor=E.+Gelensauthor=P.+P.+Collartauthor=B.+J.+Venhuisauthor=B.+Christopheauthor=S.+Hulscherauthor=H.+van+der+Gootauthor=F.+Lebonauthor=H.+Timmermanauthor=R.+A.+Bakkerauthor=B.+I.+L.+F.+Lallemandauthor=R.+Leursauthor=P.+E.+Talagaauthor=I.+J.+P.+de+Esch&title=4-Benzyl-1H-imidazoles+with+oxazoline+termini+as+histamine+H3+receptor+agonists&doi=10.1021%2Fjm7014149"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">4-Benzyl-1H-imidazoles with Oxazoline Termini as Histamine H3 Receptor Agonists</span></div><div class="casAuthors">Wijtmans, Maikel; Celanire, Sylvain; Snip, Erwin; Gillard, Michel R.; Gelens, Edith; Collart, Philippe P.; Venhuis, Bastiaan J.; Christophe, Bernard; Hulscher, Saskia; van der Goot, Henk; Lebon, Florence; Timmerman, Henk; Bakker, Remko A.; Lallemand, Benedicte I. L. F.; Leurs, Rob; Talaga, Patrice E.; de Esch, Iwan J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2944-2953</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Research on the therapeutic applications of the histamine H3 receptor (H3R) has traditionally focused on antagonists/inverse agonists.  In contrast, H3R agonists have received less attention despite their potential use in several disease areas.  The lower availability of H3R agonists not only hampers their full therapeutic exploration, it also prevents an unequivocal understanding of the structural requirements for H3R activation.  In the light of these important issues, we present our findings on 4-benzyl-1H-imidazole-based H3R agonists.  Starting from two high throughput screen hits (10 and 11), the benzyl side chain was altered with lipophilic groups using combinatorial and classical chem. approaches (compds. 12-31).  Alkyne- or oxazolino-substituents gave excellent affinities and agonist activities up to the single digit nM range.  Our findings further substantiate the growing notion that basic ligand sidechains are not necessary for H3R activation and reveal the oxazolino group as a hitherto unexplored functional group in H3R research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrL9RayBsEIiLVg90H21EOLACvtfcHk0lg3rYY-MRZjyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvF2mu7g%253D&md5=5e18898562a1eeb50921ff5e17270ded</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm7014149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7014149%26sid%3Dliteratum%253Aachs%26aulast%3DWijtmans%26aufirst%3DM.%26aulast%3DCelanire%26aufirst%3DS.%26aulast%3DSnip%26aufirst%3DE.%26aulast%3DGillard%26aufirst%3DM.%2BR.%26aulast%3DGelens%26aufirst%3DE.%26aulast%3DCollart%26aufirst%3DP.%2BP.%26aulast%3DVenhuis%26aufirst%3DB.%2BJ.%26aulast%3DChristophe%26aufirst%3DB.%26aulast%3DHulscher%26aufirst%3DS.%26aulast%3Dvan%2Bder%2BGoot%26aufirst%3DH.%26aulast%3DLebon%26aufirst%3DF.%26aulast%3DTimmerman%26aufirst%3DH.%26aulast%3DBakker%26aufirst%3DR.%2BA.%26aulast%3DLallemand%26aufirst%3DB.%2BI.%2BL.%2BF.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DTalaga%26aufirst%3DP.%2BE.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26atitle%3D4-Benzyl-1H-imidazoles%2520with%2520oxazoline%2520termini%2520as%2520histamine%2520H3%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2944%26epage%3D2953%26doi%3D10.1021%2Fjm7014149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furuuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamauchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakui, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships of N-aryl-piperidine derivatives as potent (partial) agonists for human histamine H<sub>3</sub> receptor</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">5441</span>– <span class="NLM_lpage">5448</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.04.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1016%2Fj.bmc.2010.04.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=20541426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC3cXoslans70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=5441-5448&author=M.+Ishikawaauthor=T.+Furuuchiauthor=M.+Yamauchiauthor=F.+Yokoyamaauthor=N.+Kakuiauthor=Y.+Sato&title=Synthesis+and+structure-activity+relationships+of+N-aryl-piperidine+derivatives+as+potent+%28partial%29+agonists+for+human+histamine+H3+receptor&doi=10.1016%2Fj.bmc.2010.04.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and structure-activity relationships of N-aryl-piperidine derivatives as potent (partial) agonists for human histamine H3 receptor</span></div><div class="casAuthors">Ishikawa, Makoto; Furuuchi, Takeshi; Yamauchi, Miki; Yokoyama, Fumikazu; Kakui, Nobukazu; Sato, Yasuo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5441-5448</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">4-((1H-Imidazol-4-yl)methyl)-1-aryl-piperazine and piperidine derivs. were designed and synthesized as candidate human histamine type 3 agonists.  The piperazine derivs. were found to have low (or no) affinity for human histamine H3 receptor, whereas the piperidine derivs. showed moderate to high affinity, and their agonistic activity was greatly influenced by substituents on the arom. ring.  Among the piperidine-contg. compds., 17d (I) and 17h (II) were potent human histamine H3 receptor agonists with high selectivity over the closely related human H4 receptor.  Our results indicate that appropriate conformational restriction, i.e., by the piperidine spacer moiety, favors specific binding to the human histamine H3 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTot9cyE1ZdbVg90H21EOLACvtfcHk0lg3rYY-MRZjyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXoslans70%253D&md5=f261ddec809b349032e3a09d8ea725a5</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.04.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.04.052%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DFuruuchi%26aufirst%3DT.%26aulast%3DYamauchi%26aufirst%3DM.%26aulast%3DYokoyama%26aufirst%3DF.%26aulast%3DKakui%26aufirst%3DN.%26aulast%3DSato%26aufirst%3DY.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520of%2520N-aryl-piperidine%2520derivatives%2520as%2520potent%2520%2528partial%2529%2520agonists%2520for%2520human%2520histamine%2520H3%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D5441%26epage%3D5448%26doi%3D10.1016%2Fj.bmc.2010.04.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinei, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamauchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuma, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagayama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakui, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, Y.</span></span> <span> </span><span class="NLM_article-title">Role of hydrophobic substituents on the terminal nitrogen of histamine in receptor binding and agonist activity: development of an orally active histamine type 3 receptor agonist and evaluation of its antistress activity in mice</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3840</span>– <span class="NLM_lpage">3844</span>, <span class="refDoi"> DOI: 10.1021/jm901890s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901890s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksF2ls70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3840-3844&author=M.+Ishikawaauthor=R.+Shineiauthor=F.+Yokoyamaauthor=M.+Yamauchiauthor=M.+Oyamaauthor=K.+Okumaauthor=T.+Nagayamaauthor=K.+Katoauthor=N.+Kakuiauthor=Y.+Sato&title=Role+of+hydrophobic+substituents+on+the+terminal+nitrogen+of+histamine+in+receptor+binding+and+agonist+activity%3A+development+of+an+orally+active+histamine+type+3+receptor+agonist+and+evaluation+of+its+antistress+activity+in+mice&doi=10.1021%2Fjm901890s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Hydrophobic Substituents on the Terminal Nitrogen of Histamine in Receptor Binding and Agonist Activity: Development of an Orally Active Histamine Type 3 Receptor Agonist and Evaluation of Its Antistress Activity in Mice</span></div><div class="casAuthors">Ishikawa, Makoto; Shinei, Rie; Yokoyama, Fumikazu; Yamauchi, Miki; Oyama, Masayo; Okuma, Kunihiro; Nagayama, Takako; Kato, Kazuhiko; Kakui, Nobukazu; Sato, Yasuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3840-3844</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The terminal nitrogen atom of histamine was modified with lipophilic substituents to investigate the structure-activity relationship of histamine type 3 receptor (H3R) agonists.  The introduction of an alkylated benzene rings maintained or increased the H3R binding affinity.  The most potent compd., 4-(2-(4-tert-butylphenylthio)ethyl)-1H-imidazole (I), possessed in vivo agonistic activity, decreasing brain Nτ-methylhistamine levels in mice after oral administration.  It also exhibited antistress activity in the mouse resident-intruder test.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs9ig3rdlsc7Vg90H21EOLACvtfcHk0liB_G-1_VLqsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksF2ls70%253D&md5=d3d868bf617fa577565b9be9b48a1155</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm901890s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901890s%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DShinei%26aufirst%3DR.%26aulast%3DYokoyama%26aufirst%3DF.%26aulast%3DYamauchi%26aufirst%3DM.%26aulast%3DOyama%26aufirst%3DM.%26aulast%3DOkuma%26aufirst%3DK.%26aulast%3DNagayama%26aufirst%3DT.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DKakui%26aufirst%3DN.%26aulast%3DSato%26aufirst%3DY.%26atitle%3DRole%2520of%2520hydrophobic%2520substituents%2520on%2520the%2520terminal%2520nitrogen%2520of%2520histamine%2520in%2520receptor%2520binding%2520and%2520agonist%2520activity%253A%2520development%2520of%2520an%2520orally%2520active%2520histamine%2520type%25203%2520receptor%2520agonist%2520and%2520evaluation%2520of%2520its%2520antistress%2520activity%2520in%2520mice%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3840%26epage%3D3844%26doi%3D10.1021%2Fjm901890s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamauchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kudo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakui, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span> <span> </span><span class="NLM_article-title">Investigation of the histamine H<sub>3</sub> receptor binding site. Design and synthesis of hybrid agonists with a lipophilic side chain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">6445</span>– <span class="NLM_lpage">6456</span>, <span class="refDoi"> DOI: 10.1021/jm100643t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100643t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvVaru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6445-6456&author=M.+Ishikawaauthor=M.+Yamauchiauthor=F.+Yokoyamaauthor=T.+Kudoauthor=Y.+Satoauthor=N.+Kakuiauthor=K.+Katoauthor=T.+Watanabe&title=Investigation+of+the+histamine+H3+receptor+binding+site.+Design+and+synthesis+of+hybrid+agonists+with+a+lipophilic+side+chain&doi=10.1021%2Fjm100643t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of the Histamine H3 Receptor Binding Site. Design and Synthesis of Hybrid Agonists with a Lipophilic Side Chain</span></div><div class="casAuthors">Ishikawa, Makoto; Watanabe, Takashi; Kudo, Toshiaki; Yokoyama, Fumikazu; Yamauchi, Miki; Kato, Kazuhiko; Kakui, Nobukazu; Sato, Yasuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6445-6456</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As a part of our search for novel histamine H3 receptor agonists, we designed and synthesized hybrid compds. in which the lipophilic (4'-alkylphenylthio)ethyl moiety of a novel H3 receptor agonist, 4-(2-(4'-tert-butylphenylthio)ethyl)-1H-imidazole (I), was incorporated into Nα-methylhistamine, immepip, and immethridine derivs.  These hybrid compds. were expected to interact concurrently with the histamine-binding site and a putative hydrophobic region in the H3 receptor.  Among them, piperidine- and pyridine-type derivs. displayed partial agonist activity, and (S)-4-(1-(1H-imidazol-4-yl)-2-(4-(trifluoromethyl)phenylthio)ethyl)piperidine (II) was identified as a potent H3 agonist.  We performed computational docking studies to examine the binding mode of the agonists.  The results indicated that immepip interacts with the key residues, Asp114 and Glu206, in a different manner from histamine.  The binding mode of II to these residues is similar to that of immepip, and the lipophilic tail of II has an addnl. interaction with a hydrophobic region in transmembrane helix 6 of the receptor.  These results indicated that II served as a useful tool for studies on receptor-agonist interactions and drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCmdYERfiu-LVg90H21EOLACvtfcHk0liB_G-1_VLqsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvVaru7k%253D&md5=3c7dd7af7ff0535517015ed33ac07700</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm100643t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100643t%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DYamauchi%26aufirst%3DM.%26aulast%3DYokoyama%26aufirst%3DF.%26aulast%3DKudo%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DKakui%26aufirst%3DN.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DWatanabe%26aufirst%3DT.%26atitle%3DInvestigation%2520of%2520the%2520histamine%2520H3%2520receptor%2520binding%2520site.%2520Design%2520and%2520synthesis%2520of%2520hybrid%2520agonists%2520with%2520a%2520lipophilic%2520side%2520chain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6445%26epage%3D6456%26doi%3D10.1021%2Fjm100643t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cannon, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nalwalk, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stadel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silos-Santiago, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hough, L. B.</span></span> <span> </span><span class="NLM_article-title">Activation of spinal histamine H<sub>3</sub> receptors inhibits mechanical nociception</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>470</i></span>,  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1016/S0014-2999(03)01737-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1016%2FS0014-2999%2803%2901737-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=12798951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksVegsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=470&publication_year=2003&pages=139-147&author=K.+E.+Cannonauthor=J.+W.+Nalwalkauthor=R.+Stadelauthor=P.+Geauthor=D.+Lawsonauthor=I.+Silos-Santiagoauthor=L.+B.+Hough&title=Activation+of+spinal+histamine+H3+receptors+inhibits+mechanical+nociception&doi=10.1016%2FS0014-2999%2803%2901737-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of spinal histamine H3 receptors inhibits mechanical nociception</span></div><div class="casAuthors">Cannon, Keri E.; Nalwalk, Julia W.; Stadel, Rebecca; Ge, P.; Lawson, D.; Silos-Santiago, I.; Hough, Lindsay B.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">470</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">139-147</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Previous studies have suggested a possible pain-modulatory role for histamine H3 receptors, but the localization of these receptors and nature of this modulation is not clear.  To explore the role of spinal histamine H3 receptors in the inhibition of nociception, the effects of systemically (s.c.) and intrathecally (i.t.) administered histamine H3 receptor agonists were studied in rats and mice.  Immepip (5 mg/kg, s.c.) produced robust antinociception in rats on a mech. (tail pinch) test but did not alter nociceptive responses on a thermal (tail flick) test.  In contrast, this treatment in mice (immepip, 5 and 30 mg/kg, s.c.) did not change either mech. or thermally evoked nociceptive responses.  When administered directly into the spinal subarachnoid space, immepip (15-50 μg, i.t.) and R-α-methylhistamine (50 μg, i.t.) had no effect in rats on the tail flick and hot plate tests, but produced a dose- and time-dependent inhibition (90-100%) of nociceptive responses on the tail pinch test.  This attenuation was blocked by administration of thioperamide (10 mg/kg, s.c.), a histamine H3 receptor antagonist.  Intrathecally administered thioperamide also reversed antinociceptive responses induced by systemically administered immepip, which demonstrates a spinal site of action for the histamine H3 receptor agonist.  In addn., intrathecally administered immepip (25 μg) produced maximal antinociception on the tail pinch test in wild type, but not in histamine H3 receptor knockout (H3KO) mice.  These findings demonstrate an antinociceptive role for spinal histamine H3 receptors.  Further studies are needed to confirm the existence of modality-specific (i.e., mech. vs. thermal) inhibition of nociception by these receptors, and to assess the efficacy of spinally delivered histamine H3 receptor agonists for the treatment for pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphNOgDFX3yIrVg90H21EOLACvtfcHk0liB_G-1_VLqsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksVegsbs%253D&md5=e6e518b53e8cbabdfecbe1b1f6082193</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2803%2901737-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252803%252901737-0%26sid%3Dliteratum%253Aachs%26aulast%3DCannon%26aufirst%3DK.%2BE.%26aulast%3DNalwalk%26aufirst%3DJ.%2BW.%26aulast%3DStadel%26aufirst%3DR.%26aulast%3DGe%26aufirst%3DP.%26aulast%3DLawson%26aufirst%3DD.%26aulast%3DSilos-Santiago%26aufirst%3DI.%26aulast%3DHough%26aufirst%3DL.%2BB.%26atitle%3DActivation%2520of%2520spinal%2520histamine%2520H3%2520receptors%2520inhibits%2520mechanical%2520nociception%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D470%26spage%3D139%26epage%3D147%26doi%3D10.1016%2FS0014-2999%2803%2901737-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishihara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacNeil, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanatani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokita, S.</span></span> <span> </span><span class="NLM_article-title">Therapeutic potential of histamine H<sub>3</sub> receptor agonist for the treatment of obesity and diabetes mellitus</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">13866</span>– <span class="NLM_lpage">13871</span>, <span class="refDoi"> DOI: 10.1073/pnas.0506104103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1073%2Fpnas.0506104103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=16954192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvFSkt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=13866-13871&author=R.+Yoshimotoauthor=Y.+Miyamotoauthor=K.+Shimamuraauthor=A.+Ishiharaauthor=K.+Takahashiauthor=H.+Kotaniauthor=A.+S.+Chenauthor=H.+Y.+Chenauthor=D.+J.+MacNeilauthor=A.+Kanataniauthor=S.+Tokita&title=Therapeutic+potential+of+histamine+H3+receptor+agonist+for+the+treatment+of+obesity+and+diabetes+mellitus&doi=10.1073%2Fpnas.0506104103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of histamine H3 receptor agonist for the treatment of obesity and diabetes mellitus</span></div><div class="casAuthors">Yoshimoto, Ryo; Miyamoto, Yasuhisa; Shimamura, Ken; Ishihara, Akane; Takahashi, Kazuhiko; Kotani, Hidehito; Chen, Airu S.; Chen, Howard Y.; MacNeil, Douglas J.; Kanatani, Akio; Tokita, Shigeru</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">13866-13871</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Histamine H3 receptors (H3Rs) are located on the presynaptic membranes and cell soma of histamine neurons, where they neg. regulate the synthesis and release of histamine.  In addn., H3Rs are also located on nonhistaminergic neurons, acting as heteroreceptors to regulate the releases of other amines such as dopamine, serotonin, and norepinephrine.  The present study investigated the effects of H3R ligands on appetite and body-wt. regulation by using WT and H3R-deficient mice (H3RKO), because brain histamine plays a pivotal role in energy homeostasis.  The results showed that thioperamide, an H3R inverse agonist, increases, whereas imetit, an H3R agonist, decreases appetite and body wt. in diet-induced obese (DiO) WT mice.  Moreover, in DiO WT mice, but not in DiO H3RKO mice, imetit reduced fat mass, plasma concns. of leptin and insulin, and hepatic triglyceride content.  The anorexigenic effects of imetit were assocd. with a redn. in histamine release, but a comparable redn. in histamine release with α-fluoromethylhistidine, an inhibitor of histamine synthesis, increased appetite.  Moreover, the anorexigenic effects of imetit were independent of the melanocortin system, because imetit comparably reduced appetite in melanocortin 3 and 4 receptor-deficient mice.  The results provide roles of H3Rs in energy homeostasis and suggest a therapeutic potential for H3R agonists in the treatment of obesity and diabetes mellitus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofkNzoZkv1HrVg90H21EOLACvtfcHk0lgDR4yscsklmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvFSkt74%253D&md5=b47c382e0252442f05001a839d6e6577</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0506104103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0506104103%26sid%3Dliteratum%253Aachs%26aulast%3DYoshimoto%26aufirst%3DR.%26aulast%3DMiyamoto%26aufirst%3DY.%26aulast%3DShimamura%26aufirst%3DK.%26aulast%3DIshihara%26aufirst%3DA.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DKotani%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DA.%2BS.%26aulast%3DChen%26aufirst%3DH.%2BY.%26aulast%3DMacNeil%26aufirst%3DD.%2BJ.%26aulast%3DKanatani%26aufirst%3DA.%26aulast%3DTokita%26aufirst%3DS.%26atitle%3DTherapeutic%2520potential%2520of%2520histamine%2520H3%2520receptor%2520agonist%2520for%2520the%2520treatment%2520of%2520obesity%2520and%2520diabetes%2520mellitus%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D13866%26epage%3D13871%26doi%3D10.1073%2Fpnas.0506104103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reid, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brazin, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrey, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silver, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levi, R.</span></span> <span> </span><span class="NLM_article-title">Targeting Cardiac Mast Cells: Pharmacological modulation of the local renin-angiotensin system</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3744</span>– <span class="NLM_lpage">3752</span>, <span class="refDoi"> DOI: 10.2174/138161211798357908</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.2174%2F138161211798357908" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=22103845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC38XovVyrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=3744-3752&author=A.+C.+Reidauthor=J.+A.+Brazinauthor=C.+Morreyauthor=R.+B.+Silverauthor=R.+Levi&title=Targeting+Cardiac+Mast+Cells%3A+Pharmacological+modulation+of+the+local+renin-angiotensin+system&doi=10.2174%2F138161211798357908"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cardiac mast cells: pharmacological modulation of the local renin-angiotensin system</span></div><div class="casAuthors">Reid, Alicia C.; Brazin, Jacqueline A.; Morrey, Christopher; Silver, Randi B.; Levi, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">3744-3752</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Enhanced prodn. of angiotensin II and excessive release of norepinephrine in the ischemic heart are major causes of arrhythmias and sudden cardiac death.  Mast cell-dependent mechanisms are pivotal in the local formation of angiotensin II and modulation of norepinephrine release in cardiac pathophysiol.  Cardiac mast cells increase in no. in myocardial ischemia and are located in close proximity to sympathetic neurons expressing angiotensin AT1- and histamine H3-receptors.  Once activated, cardiac mast cells release a host of potent pro-inflammatory and pro-fibrotic cytokines, chemokines, preformed mediators (e.g., histamine) and proteases (e.g., renin).  In myocardial ischemia, angiotensin II (formed locally from mast cell-derived renin) and histamine (also released from local mast cells) resp. activate AT1- and H3-receptors on sympathetic nerve endings.  Stimulation of angiotensin AT1-receptors is arrhythmogenic whereas H3-receptor activation is cardioprotective.  It is likely that in ischemia/reperfusion the balance may be tipped toward the deleterious effects of mast cell renin, as demonstrated in mast cell-deficient mice, lacking mast cell renin and histamine in the heart.  In these mice, no ventricular fibrillation occurs at reperfusion following ischemia, as opposed to wild-type hearts which all fibrillate.  Preventing mast cell degranulation in the heart and inhibiting the activation of a local renin-angiotensin system, hence abolishing its detrimental effects on cardiac rhythmicity, appears to be more significant than the loss of histamine-induced cardioprotection.  This suggests that therapeutic targets in the treatment of myocardial ischemia, and potentially congestive heart failure and hypertension, should include prevention of mast cell degranulation, mast cell renin inhibition, local ACE inhibition, ANG II antagonism and H3-receptor activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSYFqvdj1nm7Vg90H21EOLACvtfcHk0lgDR4yscsklmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovVyrtw%253D%253D&md5=6e0851d9351bd6ffc09ba1fac67977c6</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.2174%2F138161211798357908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161211798357908%26sid%3Dliteratum%253Aachs%26aulast%3DReid%26aufirst%3DA.%2BC.%26aulast%3DBrazin%26aufirst%3DJ.%2BA.%26aulast%3DMorrey%26aufirst%3DC.%26aulast%3DSilver%26aufirst%3DR.%2BB.%26aulast%3DLevi%26aufirst%3DR.%26atitle%3DTargeting%2520Cardiac%2520Mast%2520Cells%253A%2520Pharmacological%2520modulation%2520of%2520the%2520local%2520renin-angiotensin%2520system%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2011%26volume%3D17%26spage%3D3744%26epage%3D3752%26doi%3D10.2174%2F138161211798357908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hashikawa-Hobara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, N. Y.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levi, R.</span></span> <span> </span><span class="NLM_article-title">Histamine 3 receptor activation reduces the expression of neuronal angiotensin II type 1 receptors in the heart</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>340</i></span>,  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.1124/jpet.111.187765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1124%2Fjpet.111.187765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=22011436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtVSlsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=2012&pages=185-191&author=N.+Hashikawa-Hobaraauthor=N.+Y.-K.+Chanauthor=R.+Levi&title=Histamine+3+receptor+activation+reduces+the+expression+of+neuronal+angiotensin+II+type+1+receptors+in+the+heart&doi=10.1124%2Fjpet.111.187765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Histamine 3 receptor activation reduces the expression of neuronal angiotensin II type 1 receptors in the heart</span></div><div class="casAuthors">Hashikawa-Hobara, Narumi; Chan, Noel Yan-Ki; Levi, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">185-191</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">In severe myocardial ischemia, histamine 3 (H3) receptor activation affords cardioprotection by preventing excessive norepinephrine release and arrhythmias; pivotal to this action is the inhibition of neuronal Na+/H+ exchanger (NHE).  Conversely, angiotensin II, formed locally by mast cell-derived renin, stimulates NHE via angiotensin II type 1 (AT1) receptors, facilitating norepinephrine release and arrhythmias.  Thus, ischemic dysfunction may depend on a balance between the NHE-modulating effects of H3 receptors and AT1 receptors.  The purpose of this investigation was therefore to elucidate the H3/AT1 receptor interaction in myocardial ischemia/reperfusion.  We found that H3 receptor blockade with clobenpropit increased norepinephrine overflow and arrhythmias in Langendorff-perfused guinea pig hearts subjected to ischemia/reperfusion.  This coincided with increased neuronal AT1 receptor expression.  NHE inhibition with cariporide prevented both increases in norepinephrine release and AT1 receptor expression.  Moreover, norepinephrine release and AT1 receptor expression were increased by the nitric oxide (NO) synthase inhibitor NG-methyl-L-arginine and the protein kinase C activator phorbol myristate acetate.  H3 receptor activation in differentiated sympathetic neuron-like PC12 cells permanently transfected with H3 receptor cDNA caused a decrease in protein kinase C activity and AT1 receptor protein abundance.  Collectively, our findings suggest that neuronal H3 receptor activation inhibits NHE by diminishing protein kinase C activity.  Reduced NHE activity sequentially causes intracellular acidification, increased NO synthesis, and diminished AT1 receptor expression.  Thus, H3 receptor-mediated NHE inhibition in ischemia/reperfusion not only opposes the angiotensin II-induced stimulation of NHE in cardiac sympathetic neurons, but also down-regulates AT1 receptor expression.  Cardioprotection ultimately results from the combined attenuation of angiotensin II and norepinephrine effects and alleviation of arrhythmias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvf26mG2Ts2rVg90H21EOLACvtfcHk0lgDR4yscsklmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtVSlsb8%253D&md5=3d2452ae305ff804015fce1eb131ebd1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.187765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.187765%26sid%3Dliteratum%253Aachs%26aulast%3DHashikawa-Hobara%26aufirst%3DN.%26aulast%3DChan%26aufirst%3DN.%2BY.-K.%26aulast%3DLevi%26aufirst%3DR.%26atitle%3DHistamine%25203%2520receptor%2520activation%2520reduces%2520the%2520expression%2520of%2520neuronal%2520angiotensin%2520II%2520type%25201%2520receptors%2520in%2520the%2520heart%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D340%26spage%3D185%26epage%3D191%26doi%3D10.1124%2Fjpet.111.187765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smits, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakker, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Dam, C. M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de
Esch, I. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span> <span> </span><span class="NLM_article-title">Discovery of S-(2-Guanidylethyl)-isothiourea (VUF 8430) as a potent nonimidazole histamine H4 receptor agonist</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6650</span>– <span class="NLM_lpage">6651</span>, <span class="refDoi"> DOI: 10.1021/jm060880d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060880d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFeltrbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6650-6651&author=H.+D.+Limauthor=R.+A.+Smitsauthor=R.+A.+Bakkerauthor=C.+M.+E.+van+Damauthor=I.+J.+P.+de%0AEschauthor=R.+Leurs&title=Discovery+of+S-%282-Guanidylethyl%29-isothiourea+%28VUF+8430%29+as+a+potent+nonimidazole+histamine+H4+receptor+agonist&doi=10.1021%2Fjm060880d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of S-(2-Guanidylethyl)-isothiourea (VUF 8430) as a Potent Nonimidazole Histamine H4 Receptor Agonist</span></div><div class="casAuthors">Lim, Herman D.; Smits, Rogier A.; Bakker, Remko A.; van Dam, Cindy M. E.; de Esch, Iwan J. P.; Leurs, Rob</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6650-6651</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">During an inhouse database screen, the authors identified S-(2-guanidylethyl)-isothiourea as a high affinity agonist for the histamine H4 receptor, with a 33-fold selectivity over the histamine H3 receptor and negligible affinity for the other histamine receptor subtypes.  This nonimidazole ligand is introduced as a useful and complementary pharmacol. tool that enables further unraveling of the physiol. roles of the H4 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6omakaVFWBbVg90H21EOLACvtfcHk0lgen-4hrMKk7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFeltrbK&md5=90e02342cb4d1814907a6a5f523ccef2</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm060880d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060880d%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DH.%2BD.%26aulast%3DSmits%26aufirst%3DR.%2BA.%26aulast%3DBakker%26aufirst%3DR.%2BA.%26aulast%3Dvan%2BDam%26aufirst%3DC.%2BM.%2BE.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3DLeurs%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520S-%25282-Guanidylethyl%2529-isothiourea%2520%2528VUF%25208430%2529%2520as%2520a%2520potent%2520nonimidazole%2520histamine%2520H4%2520receptor%2520agonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6650%26epage%3D6651%26doi%3D10.1021%2Fjm060880d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smit, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, H.</span></span> <span> </span><span class="NLM_article-title">Molecular Pharmacological Aspects of Histamine Receptors</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">413</span>– <span class="NLM_lpage">463</span>, <span class="refDoi"> DOI: 10.1016/0163-7258(95)00006-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1016%2F0163-7258%2895%2900006-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=7494855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADyaK2MXnt1alsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1995&pages=413-463&author=R.+Leursauthor=M.+J.+Smitauthor=H.+Timmerman&title=Molecular+Pharmacological+Aspects+of+Histamine+Receptors&doi=10.1016%2F0163-7258%2895%2900006-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular pharmacological aspects of histamine receptors</span></div><div class="casAuthors">Leurs, R.; Smit, M. J.; Timmerman, H.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">413-63</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review, with 375 refs., on the recent developments in the field of histamine research.  Besides the description of pharmacol. tools for the H1, H2 and H3 receptors, specific attention is paid to both the mol. aspects of the receptor proteins, including the recent cloning of the receptor genes, and their resp. signal transduction mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW6tWKRg5EybVg90H21EOLACvtfcHk0lgen-4hrMKk7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnt1alsLg%253D&md5=edff7f323b90872c084fdcd9139b53f9</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2F0163-7258%2895%2900006-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0163-7258%252895%252900006-3%26sid%3Dliteratum%253Aachs%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DSmit%26aufirst%3DM.%2BJ.%26aulast%3DTimmerman%26aufirst%3DH.%26atitle%3DMolecular%2520Pharmacological%2520Aspects%2520of%2520Histamine%2520Receptors%26jtitle%3DPharmacol.%2520Ther.%26date%3D1995%26volume%3D66%26spage%3D413%26epage%3D463%26doi%3D10.1016%2F0163-7258%2895%2900006-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
der Goot, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriks, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, H.</span></span> <span> </span><span class="NLM_article-title">Amselamine, a new selective histamine H<sub>2</sub>-receptor agonist</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1913</span>– <span class="NLM_lpage">1916</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(01)80533-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1016%2FS0960-894X%2801%2980533-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1994&pages=1913-1916&author=H.+van%0Ader+Gootauthor=J.+C.+Eriksauthor=R.+Leursauthor=H.+Timmerman&title=Amselamine%2C+a+new+selective+histamine+H2-receptor+agonist&doi=10.1016%2FS0960-894X%2801%2980533-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2801%2980533-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252801%252980533-3%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BGoot%26aufirst%3DH.%26aulast%3DEriks%26aufirst%3DJ.%2BC.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DTimmerman%26aufirst%3DH.%26atitle%3DAmselamine%252C%2520a%2520new%2520selective%2520histamine%2520H2-receptor%2520agonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1994%26volume%3D4%26spage%3D1913%26epage%3D1916%26doi%3D10.1016%2FS0960-894X%2801%2980533-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kushida, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gyobu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaguchi, T.</span></span> <span> </span><span class="NLM_article-title">PF1270A, B and C, novel histamine H3 receptor ligands produced by <i>Penicillium waksmanii</i> PF1270</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">667</span>– <span class="NLM_lpage">673</span>, <span class="refDoi"> DOI: 10.1038/ja.2007.85</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1038%2Fja.2007.85" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=18057695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVWitL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2007&pages=667-673&author=N.+Kushidaauthor=N.+Watanabeauthor=T.+Okudaauthor=F.+Yokoyamaauthor=Y.+Gyobuauthor=T.+Yaguchi&title=PF1270A%2C+B+and+C%2C+novel+histamine+H3+receptor+ligands+produced+by+Penicillium+waksmanii+PF1270&doi=10.1038%2Fja.2007.85"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">PF1270A, B and C, novel histamine H3 receptor ligands produced by Penicillium waksmanii PF1270</span></div><div class="casAuthors">Kushida, Nobuaki; Watanabe, Naoko; Okuda, Takako; Yokoyama, Fumikazu; Gyobu, Yasuhiro; Yaguchi, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">667-673</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    
            (<span class="NLM_cas:orgname">Japan Antibiotics Research Association</span>)
        </div><div class="casAbstract">Three novel histamine H3 receptor (H3R) ligands, PF1270A, PF1270B, and PF1270C were isolated from the culture broth of the fungal strain PF1270.  The strain was identified as Penicillium waksmanii on the basis of morphol. characteristics.  These compds. were obtained from the culture broth by solvent extn. and chromatog. purifn.  Their structures were established by spectroscopic methods and x-ray crystallog. anal.  They possess pentacyclic spiroindolinone skeletons.  PF1270A, B and C displayed high affinity for the rat H3R (Ki = 0.058, 0.17 and 0.19 μM, resp.) and human H3R (Ki = 0.047, 0.12 and 0.22 μM, resp.).  Moreover, PF1270A, B and C acted as potent agonists with the EC50 values of 0.12, 0.15 and 0.20 μM, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0vhpWIoKJHLVg90H21EOLACvtfcHk0lgen-4hrMKk7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVWitL%252FK&md5=60478c33c1872826274b4ba0b0acbb84</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fja.2007.85&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fja.2007.85%26sid%3Dliteratum%253Aachs%26aulast%3DKushida%26aufirst%3DN.%26aulast%3DWatanabe%26aufirst%3DN.%26aulast%3DOkuda%26aufirst%3DT.%26aulast%3DYokoyama%26aufirst%3DF.%26aulast%3DGyobu%26aufirst%3DY.%26aulast%3DYaguchi%26aufirst%3DT.%26atitle%3DPF1270A%252C%2520B%2520and%2520C%252C%2520novel%2520histamine%2520H3%2520receptor%2520ligands%2520produced%2520by%2520Penicillium%2520waksmanii%2520PF1270%26jtitle%3DJ.%2520Antibiot.%26date%3D2007%26volume%3D60%26spage%3D667%26epage%3D673%26doi%3D10.1038%2Fja.2007.85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, N.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of ZEL-H16 as a novel agonist of the histamine H<sub>3</sub> receptor</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e42185</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0042185</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1371%2Fjournal.pone.0042185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=22870296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFKhtrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=Y.+Shiauthor=R.+Shengauthor=T.+Zhongauthor=Y.+Xuauthor=X.+Chenauthor=D.+Yangauthor=Y.+Sunauthor=F.+Yangauthor=Y.+Huauthor=N.+Zhou&title=Identification+and+characterization+of+ZEL-H16+as+a+novel+agonist+of+the+histamine+H3+receptor&doi=10.1371%2Fjournal.pone.0042185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of ZEL-H16 as a novel agonist of the histamine H3 receptor</span></div><div class="casAuthors">Shi, Ying; Sheng, Rong; Zhong, Tingting; Xu, Yu; Chen, Xiaopan; Yang, Dong; Sun, Yi; Yang, Fenyan; Hu, Yongzhou; Zhou, Naiming</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e42185</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The histamine H3 receptor (H3R) has been recognized as a promising target for the treatment of various central and peripheral nervous system diseases.  In this study, a non-imidazole compd., ZEL-H16, was identified as a novel histamine H3 receptor agonist.  ZEL-H16 was found to bind to human H3R with a Ki value of approx. 2.07 nM and 4.36 nM to rat H3R.  Further characterization indicated that ZEL-H16 behaved as a partial agonist on the inhibition of forskolin-stimulated cAMP accumulation (the efficacy was 60% of that of histamine) and activation of ERK1/2 signaling (the efficacy was 50% of that of histamine) at H3 receptors, but acted as a full agonist just like histamin in the guinea-pig ileum contraction assay.  These effects were blocked by pertussis toxin and H3 receptor specific antagonist thioperamide.  ZEL-H16 showed no agonist or antagonist activities at the cloned human histamine H1, H2, and H4 receptors and other biogenic amine GPCRs in the CRE-driven reporter assay.  Furthermore, our present data demonstrated that treatment of ZEL-H16 resulted in intensive H3 receptor internalization and delayed recycling to the cell surface as compared to that of control with treatment of histamine.  Thus, ZEL-H16 is a novel and potent nonimidazole agonist of H3R, which might serve as a pharmacol. tool for future investigations or as possible therapeutic agent of H3R.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVABJX6rPEbbVg90H21EOLACvtfcHk0lic7fDELAgjDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFKhtrbI&md5=b2372e83fabf74b00466450061446dee</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0042185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0042185%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DY.%26aulast%3DSheng%26aufirst%3DR.%26aulast%3DZhong%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DN.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520ZEL-H16%2520as%2520a%2520novel%2520agonist%2520of%2520the%2520histamine%2520H3%2520receptor%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0042185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghoshal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yugandhar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sona, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuriakose, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagesh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rashid, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahajuddin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, A. K.</span></span> <span> </span><span class="NLM_article-title">Identification of novel β-lactams and pyrrolidinone derivatives as selective histamine-3 receptor (H3R) modulators as possible anti-obesity agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>152</i></span>,  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.04.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1016%2Fj.ejmech.2018.04.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=29704723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosFyhsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2018&pages=148-159&author=A.+Ghoshalauthor=A.+Kumarauthor=D.+Yugandharauthor=C.+Sonaauthor=S.+Kuriakoseauthor=K.+Nageshauthor=M.+Rashidauthor=S.+K.+Singhauthor=M.+Wahajuddinauthor=P.+N.+Yadavauthor=A.+K.+Srivastava&title=Identification+of+novel+%CE%B2-lactams+and+pyrrolidinone+derivatives+as+selective+histamine-3+receptor+%28H3R%29+modulators+as+possible+anti-obesity+agents&doi=10.1016%2Fj.ejmech.2018.04.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel β-lactams and pyrrolidinone derivatives as selective Histamine-3 receptor (H3R) modulators as possible anti-obesity agents</span></div><div class="casAuthors">Ghoshal, Anirban; Kumar, Ajeet; Yugandhar, Doddapaneni; Sona, Chandan; Kuriakose, Sunu; Nagesh, Kommu; Rashid, Mamunur; Singh, Sandeep K.; Wahajuddin, Muhammad; Yadav, Prem N.; Srivastava, Ajay K.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">148-159</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Four series of structurally related β-lactams, 2,5-pyrrolidinediones, azaspirodecatrienediones (ASDT) and dihydropyrroloquinoxalinetriones (DPQT) were synthesized by utilizing post-Ugi modifications in one-pot, and their activity towards human histamine-3 receptor (H3R) was evaluated.  Out of 94 compds., screened against histamine-3 receptor (H3R), 21 compds. showed high H3R selective agonist property with EC50 values ranging from 187 nM to 0.1 nM, whereas none of the compd. was found to have the affinity towards other receptors of histamine family such as histamine H1, H2, and H4 receptor.  All active compds. have no assay interference activity as detd. by in-silico anal. and receptor independent luciferase assay and cell cytotoxicity assay.  Given the important role of H3R in hypophagia, we also evaluated the in vivo effect of the representative compd., (E)-4-benzylidene-1-(tert-butyl)-3-(3-chlorophenyl)-3-((3,4,5-trimethoxyphenyl)amino)pyrrolidine-2,5-dione (6k) on the cumulative food intake in diet induce obese C57BL6/J mice.  Interestingly, it was obsd. that single dose administration (20 mg/kg, i.p. injection) of 6k significantly suppressed cumulative food intake, while no significant effect was obsd. at 10 mg/kg.  These results suggest that β-lactams, 2,5-pyrrolidinediones, azaspirodecatrienediones (ASDT) and dihydropyrroloquinoxalinetriones (DPQT) could be useful for the development of anti-obesity candidate drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqTTE9adXDOrVg90H21EOLACvtfcHk0lic7fDELAgjDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosFyhsbg%253D&md5=ad56433384f969c238dff5d81eb65e44</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.04.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.04.020%26sid%3Dliteratum%253Aachs%26aulast%3DGhoshal%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DYugandhar%26aufirst%3DD.%26aulast%3DSona%26aufirst%3DC.%26aulast%3DKuriakose%26aufirst%3DS.%26aulast%3DNagesh%26aufirst%3DK.%26aulast%3DRashid%26aufirst%3DM.%26aulast%3DSingh%26aufirst%3DS.%2BK.%26aulast%3DWahajuddin%26aufirst%3DM.%26aulast%3DYadav%26aufirst%3DP.%2BN.%26aulast%3DSrivastava%26aufirst%3DA.%2BK.%26atitle%3DIdentification%2520of%2520novel%2520%25CE%25B2-lactams%2520and%2520pyrrolidinone%2520derivatives%2520as%2520selective%2520histamine-3%2520receptor%2520%2528H3R%2529%2520modulators%2520as%2520possible%2520anti-obesity%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D152%26spage%3D148%26epage%3D159%26doi%3D10.1016%2Fj.ejmech.2018.04.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Igel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dove, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschauer, A.</span></span> <span> </span><span class="NLM_article-title">Histamine H<sub>4</sub> receptor agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">7191</span>– <span class="NLM_lpage">7199</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.10.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1016%2Fj.bmcl.2010.10.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=21044842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVKjtLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=7191-7199&author=P.+Igelauthor=S.+Doveauthor=A.+Buschauer&title=Histamine+H4+receptor+agonists&doi=10.1016%2Fj.bmcl.2010.10.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Histamine H4 receptor agonists</span></div><div class="casAuthors">Igel, Patrick; Dove, Stefan; Buschauer, Armin</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7191-7199</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Since its discovery 10 years ago the histamine H4 receptor (H4R) has attracted attention as a potential drug target, for instance, for the treatment of inflammatory and allergic diseases.  Potent and selective ligands including agonists are required as pharmacol. tools to study the role of the H4R in vitro and in vivo.  Many H4R agonists, which were identified among already known histamine receptor ligands, show only low or insufficient H4R selectivity.  In addn., the investigation of numerous H4R agonists in animal models is hampered by species-dependent discrepancies regarding potencies and histamine receptor selectivities of the available compds., esp. when comparing human and rodent receptors.  This article gives an overview about structures, potencies, and selectivities of various compds. showing H4R agonistic activity and summarizes the structure-activity relationships of selected compd. classes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq21SpHt6eblLVg90H21EOLACvtfcHk0ljRY24hemCErQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVKjtLbI&md5=038181dce07ea1dc83eebd9d55e12283</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.10.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.10.041%26sid%3Dliteratum%253Aachs%26aulast%3DIgel%26aufirst%3DP.%26aulast%3DDove%26aufirst%3DS.%26aulast%3DBuschauer%26aufirst%3DA.%26atitle%3DHistamine%2520H4%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D7191%26epage%3D7199%26doi%3D10.1016%2Fj.bmcl.2010.10.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geyer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaske, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumeister, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschauer, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and functional characterization of imbutamine analogs as histamine H<sub>3</sub> and H<sub>4</sub> receptor ligands</span>. <i>Arch. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>347</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1002/ardp.201300316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1002%2Fardp.201300316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=24493592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCrtbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2014&pages=77-88&author=R.+Geyerauthor=M.+Kaskeauthor=P.+Baumeisterauthor=A.+Buschauer&title=Synthesis+and+functional+characterization+of+imbutamine+analogs+as+histamine+H3+and+H4+receptor+ligands&doi=10.1002%2Fardp.201300316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Functional Characterization of Imbutamine Analogs as Histamine H3 and H4 Receptor Ligands</span></div><div class="casAuthors">Geyer, Roland; Kaske, Melanie; Baumeister, Paul; Buschauer, Armin</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">77-88</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Imbutamine (4-(1H-imidazol-4-yl)butanamine) is a potent histamine H3 (H3R) and H4 receptor (H4R) agonist (EC50 values: 3 and 66 nM, resp.).  Aiming at improved selectivity for the H4R, the imidazole ring in imbutamine was methyl-substituted or replaced by various differently substituted heterocycles (1,2,3-triazoles, 1,2,4-triazoles, pyridines, pyrimidines) as potential bioisosteres.  Investigations in [35S]GTPγS binding assays using membranes of Sf9 insect cells expressing the resp. human histamine receptor subtype revealed only very weak activity of most of the synthesized hetarylalkylamines at both receptors.  By contrast, the introduction of substituents at the 4-imidazolyl ring was most effective regarding H4R selectivity.  This holds for Me substitution in position 2 and, esp., in position 5.  5-Methylimbutamine (I, H4R: EC50 = 59 nM, α = 0.8) was equipotent with imbutamine at the hH4R, but revealed about 16-fold selectivity for the hH4R compared to the hH3R (EC50 980 nM, α = 0.36), whereas imbutamine preferred the hH3R.  The functional activities were in agreement with radioligand binding data.  The results support the hypothesis that, by analogy with histamine, Me substitution in histamine homologs offers a way to shift the selectivity in favor of the H4R.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxc6e4wvJQi7Vg90H21EOLACvtfcHk0ljRY24hemCErQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCrtbvM&md5=d28791867ecc1367a61f6b9614a318bc</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fardp.201300316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.201300316%26sid%3Dliteratum%253Aachs%26aulast%3DGeyer%26aufirst%3DR.%26aulast%3DKaske%26aufirst%3DM.%26aulast%3DBaumeister%26aufirst%3DP.%26aulast%3DBuschauer%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520functional%2520characterization%2520of%2520imbutamine%2520analogs%2520as%2520histamine%2520H3%2520and%2520H4%2520receptor%2520ligands%26jtitle%3DArch.%2520Pharm.%26date%3D2014%26volume%3D347%26spage%3D77%26epage%3D88%26doi%3D10.1002%2Fardp.201300316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keseru, G. M.</span></span> <span> </span><span class="NLM_article-title">Novel histamine H4 receptor ligands and their potential therapeutic applications: an update</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1517/13543776.2014.959494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1517%2F13543776.2014.959494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=24206261" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=1-13&author=R.+Kissauthor=G.+M.+Keseru&title=Novel+histamine+H4+receptor+ligands+and+their+potential+therapeutic+applications%3A+an+update&doi=10.1517%2F13543776.2014.959494"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1517%2F13543776.2014.959494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2014.959494%26sid%3Dliteratum%253Aachs%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26atitle%3DNovel%2520histamine%2520H4%2520receptor%2520ligands%2520and%2520their%2520potential%2520therapeutic%2520applications%253A%2520an%2520update%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2014%26volume%3D24%26spage%3D1%26epage%3D13%26doi%3D10.1517%2F13543776.2014.959494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Black, L. A.</span>; <span class="NLM_string-name">Gfesser, G. A.</span>; <span class="NLM_string-name">Cowart, M. D.</span></span> <span> </span><span class="NLM_article-title">4-Substituted-2-amino-pyrimidine Derivatives</span>. <span class="NLM_patent">US20100331294</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=L.+A.+Black&author=G.+A.+Gfesser&author=M.+D.+Cowart&title=4-Substituted-2-amino-pyrimidine+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DL.%2BA.%26atitle%3D4-Substituted-2-amino-pyrimidine%2520Derivatives%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carceller
González, E.</span>; <span class="NLM_string-name">Medina Fuentes, E. M.</span>; <span class="NLM_string-name">Martí
Via, J.</span>; <span class="NLM_string-name">Virgili
Barnardó, M.</span></span> <span> </span><span class="NLM_article-title">2-Amino-pyrimidine Derivatives as Histamine H<sub>4</sub> Antagonists</span>. <span class="NLM_patent">WO2009068512</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=E.+Carceller%0AGonz%C3%A1lez&author=E.+M.+Medina+Fuentes&author=J.+Mart%C3%AD%0AVia&author=M.+Virgili%0ABarnard%C3%B3&title=2-Amino-pyrimidine+Derivatives+as+Histamine+H4+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCarceller%2BGonz%25C3%25A1lez%26aufirst%3DE.%26atitle%3D2-Amino-pyrimidine%2520Derivatives%2520as%2520Histamine%2520H4%2520Antagonists%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, H.</span>; <span class="NLM_string-name">Chavez, F.</span>; <span class="NLM_string-name">Edwards, J. P.</span>; <span class="NLM_string-name">Fitzgerald, A. E.</span>; <span class="NLM_string-name">Liu, J.</span>; <span class="NLM_string-name">Mani, N. S.</span>; <span class="NLM_string-name">Neff, D. K.</span>; <span class="NLM_string-name">Rizzolio, M. C.</span>; <span class="NLM_string-name">Savall, B. M.</span>; <span class="NLM_string-name">Smith, D. M.</span>; <span class="NLM_string-name">Venable, J. D.</span>; <span class="NLM_string-name">Jianmei, W.</span>; <span class="NLM_string-name">Wolin, R.</span></span> <span> </span><span class="NLM_article-title">2-Aminopyrimidine Modulators of the Histamine H<sub>4</sub> Receptor</span>. <span class="NLM_patent">WO2008100565</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=H.+Cai&author=F.+Chavez&author=J.+P.+Edwards&author=A.+E.+Fitzgerald&author=J.+Liu&author=N.+S.+Mani&author=D.+K.+Neff&author=M.+C.+Rizzolio&author=B.+M.+Savall&author=D.+M.+Smith&author=J.+D.+Venable&author=W.+Jianmei&author=R.+Wolin&title=2-Aminopyrimidine+Modulators+of+the+Histamine+H4+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DH.%26atitle%3D2-Aminopyrimidine%2520Modulators%2520of%2520the%2520Histamine%2520H4%2520Receptor%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doak, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span> <span> </span><span class="NLM_article-title">Colloidal aggregation causes inhibition of G protein-coupled receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">2406</span>– <span class="NLM_lpage">2414</span>, <span class="refDoi"> DOI: 10.1021/jm301749y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301749y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVCgt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2406-2414&author=M.+F.+Sassanoauthor=A.+K.+Doakauthor=B.+L.+Rothauthor=B.+K.+Shoichet&title=Colloidal+aggregation+causes+inhibition+of+G+protein-coupled+receptors&doi=10.1021%2Fjm301749y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Colloidal aggregation causes inhibition of G protein-coupled receptors</span></div><div class="casAuthors">Sassano, Maria F.; Doak, Allison K.; Roth, Bryan L.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2406-2414</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Colloidal aggregation is the dominant mechanism for artifactual inhibition of sol. proteins, and controls against it are now widely deployed.  Conversely, investigating this mechanism for membrane-bound receptors has proven difficult.  Here, the authors investigated the activity of 4 well-characterized aggregators against 3 G protein-coupled receptors (GPCRs) recognizing peptide and protein ligands.  Each of the aggregators was active at micromolar concns. against the 3 GPCRs in cell-based assays.  This activity could be attenuated by either centrifugation of the inhibitor stock soln. or by the addn. of Tween-80 detergent.  In the absence of agonist, the aggregators acted as inverse agonists, consistent with a direct receptor interaction.  Meanwhile, several literature GPCR ligands that resembled aggregators themselves formed colloids, by both phys. and enzymol. tests.  These observations suggest that some GPCRs may be artifactually antagonized by colloidal aggregates, an effect that merits the attention of investigators in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojG9CcuOYoXrVg90H21EOLACvtfcHk0lhspS8NXmgHMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVCgt7s%253D&md5=84fa59f9635330739bf836f8085be5e0</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm301749y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301749y%26sid%3Dliteratum%253Aachs%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DDoak%26aufirst%3DA.%2BK.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DColloidal%2520aggregation%2520causes%2520inhibition%2520of%2520G%2520protein-coupled%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2406%26epage%3D2414%26doi%3D10.1021%2Fjm301749y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sirci, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Istyastono, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vischer, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kooistra, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nijmeijer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuijer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wijtmans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannhold, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Esch, I. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Graaf, C.</span></span> <span> </span><span class="NLM_article-title">Virtual fragment screening: Discovery of histamine H<sub>3</sub> receptor ligands using ligand-based and protein-based molecular fingerprints</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">3308</span>– <span class="NLM_lpage">3324</span>, <span class="refDoi"> DOI: 10.1021/ci3004094</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci3004094" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1ekt7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=3308-3324&author=F.+Sirciauthor=E.+P.+Istyastonoauthor=H.+F.+Vischerauthor=A.+J.+Kooistraauthor=S.+Nijmeijerauthor=M.+Kuijerauthor=M.+Wijtmansauthor=R.+Mannholdauthor=R.+Leursauthor=I.+J.+P.+de+Eschauthor=C.+de+Graaf&title=Virtual+fragment+screening%3A+Discovery+of+histamine+H3+receptor+ligands+using+ligand-based+and+protein-based+molecular+fingerprints&doi=10.1021%2Fci3004094"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual Fragment Screening: Discovery of Histamine H3 Receptor Ligands Using Ligand-Based and Protein-Based Molecular Fingerprints</span></div><div class="casAuthors">Sirci, Francesco; Istyastono, Enade P.; Vischer, Henry F.; Kooistra, Albert J.; Nijmeijer, Saskia; Kuijer, Martien; Wijtmans, Maikel; Mannhold, Raimund; Leurs, Rob; de Esch, Iwan J. P.; de Graaf, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3308-3324</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Virtual fragment screening (VFS) is a promising new method that uses computer models to identify small, fragment-like biol. active mols. as useful starting points for fragment-based drug discovery (FBDD).  Training sets of true active and inactive fragment-like mols. to construct and validate target customized VFS methods are however lacking.  The authors have for the first time explored the possibilities and challenges of VFS using mol. fingerprints derived from a unique set of fragment affinity data for the histamine H3 receptor (H3R), a pharmaceutically relevant G protein-coupled receptor (GPCR).  Optimized FLAP (Fingerprints of Ligands and Proteins) models contg. essential mol. interaction fields that discriminate known H3R binders from inactive mols. were successfully used for the identification of new H3R ligands.  Prospective virtual screening of 156 090 mols. yielded a high hit rate of 62% (18 of the 29 tested) exptl. confirmed novel fragment-like H3R ligands that offer new potential starting points for the design of H3R targeting drugs.  The first construction and application of customized FLAP models for the discovery of fragment-like biol. active mols. demonstrates that VFS is an efficient way to explore protein-fragment interaction space in silico.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-rcV1LwQDR7Vg90H21EOLACvtfcHk0lhspS8NXmgHMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1ekt7fM&md5=14a4c7d26dd1ba29903259d450f355df</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fci3004094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci3004094%26sid%3Dliteratum%253Aachs%26aulast%3DSirci%26aufirst%3DF.%26aulast%3DIstyastono%26aufirst%3DE.%2BP.%26aulast%3DVischer%26aufirst%3DH.%2BF.%26aulast%3DKooistra%26aufirst%3DA.%2BJ.%26aulast%3DNijmeijer%26aufirst%3DS.%26aulast%3DKuijer%26aufirst%3DM.%26aulast%3DWijtmans%26aufirst%3DM.%26aulast%3DMannhold%26aufirst%3DR.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3Dde%2BGraaf%26aufirst%3DC.%26atitle%3DVirtual%2520fragment%2520screening%253A%2520Discovery%2520of%2520histamine%2520H3%2520receptor%2520ligands%2520using%2520ligand-based%2520and%2520protein-based%2520molecular%2520fingerprints%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D3308%26epage%3D3324%26doi%3D10.1021%2Fci3004094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kooistra, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Esch, I. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Graaf, C.</span></span> <span> </span><span class="NLM_article-title">A structural chemogenomics analysis of aminergic GPCRs: Lessons for histamine receptor ligand design</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>170</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.1111/bph.12248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1111%2Fbph.12248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=23713847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlSgtbnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2013&pages=101-126&author=A.+J.+Kooistraauthor=S.+Kuhneauthor=I.+J.+P.+de+Eschauthor=R.+Leursauthor=C.+de+Graaf&title=A+structural+chemogenomics+analysis+of+aminergic+GPCRs%3A+Lessons+for+histamine+receptor+ligand+design&doi=10.1111%2Fbph.12248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design</span></div><div class="casAuthors">Kooistra, A. J.; Kuhne, S.; de Esch, I. J. P.; Leurs, R.; de Graaf, C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-126</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose Chemogenomics focuses on the discovery of new connections between chem. and biol. space leading to the discovery of new protein targets and biol. active mols.  G-protein coupled receptors (GPCRs) are a particularly interesting protein family for chemogenomics studies because there is an overwhelming amt. of ligand binding affinity data available.  The increasing no. of aminergic GPCR crystal structures now for the first time allows the integration of chemogenomics studies with high-resoln. structural analyses of GPCR-ligand complexes.  Exptl. Approach In this study, we have combined ligand affinity data, receptor mutagenesis studies, and amino acid sequence analyses to high-resoln. structural analyses of (hist)aminergic GPCR-ligand interactions.  This integrated structural chemogenomics anal. is used to more accurately describe the mol. and structural determinants of ligand affinity and selectivity in different key binding regions of the crystd. aminergic GPCRs, and histamine receptors in particular.  Key Results Our investigations highlight interesting correlations and differences between ligand similarity and ligand binding site similarity of different aminergic receptors.  Apparent discrepancies can be explained by combining detailed anal. of crystd. or predicted protein-ligand binding modes, receptor mutation studies, and ligand structure-selectivity relationships that identify local differences in essential pharmacophore features in the ligand binding sites of different receptors.  Conclusions and Implications We have performed structural chemogenomics studies that identify links between (hist)aminergic receptor ligands and their binding sites and binding modes.  This knowledge can be used to identify structure-selectivity relationships that increase our understanding of ligand binding to (hist)aminergic receptors and hence can be used in future GPCR ligand discovery and design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxr6kq48O11rVg90H21EOLACvtfcHk0lhspS8NXmgHMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlSgtbnE&md5=08ae55b9565885165e76d98e2db1befa</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1111%2Fbph.12248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12248%26sid%3Dliteratum%253Aachs%26aulast%3DKooistra%26aufirst%3DA.%2BJ.%26aulast%3DKuhne%26aufirst%3DS.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3Dde%2BGraaf%26aufirst%3DC.%26atitle%3DA%2520structural%2520chemogenomics%2520analysis%2520of%2520aminergic%2520GPCRs%253A%2520Lessons%2520for%2520histamine%2520receptor%2520ligand%2520design%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D170%26spage%3D101%26epage%3D126%26doi%3D10.1111%2Fbph.12248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jongejan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smits, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Esch, I. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haaksma, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span> <span> </span><span class="NLM_article-title">Delineation of agonist binding to the human histamine H<sub>4</sub> receptor using mutational analysis, homology modeling, and ab initio calculations</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1455</span>– <span class="NLM_lpage">1463</span>, <span class="refDoi"> DOI: 10.1021/ci700474a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci700474a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntF2rs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=1455-1463&author=A.+Jongejanauthor=H.+D.+Limauthor=R.+A.+Smitsauthor=I.+J.+P.+de+Eschauthor=E.+Haaksmaauthor=R.+Leurs&title=Delineation+of+agonist+binding+to+the+human+histamine+H4+receptor+using+mutational+analysis%2C+homology+modeling%2C+and+ab+initio+calculations&doi=10.1021%2Fci700474a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Delineation of Agonist Binding to the Human Histamine H4 Receptor Using Mutational Analysis, Homology Modeling, and ab Initio Calculations</span></div><div class="casAuthors">Jongejan, Aldo; Lim, Herman D.; Smits, Rogier A.; de Esch, Iwan J. P.; Haaksma, Eric; Leurs, Rob</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1455-1463</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A three-dimensional homol. model of the human histamine H4 receptor was developed to investigate the binding mode of a series of structurally diverse H4-agonists, i.e.  Histamine, clozapine, and the recently described selective, nonimidazole agonist VUF 8430.  Mutagenesis studies and docking of these ligands in a rhodopsin-based homol. model revealed two essential points of interactions in the binding pocket, i.e. Asp3.32 and Glu5.46 (Ballesteros-Weinstein numbering system).  It is postulated that Asp3.32 interacts in its anionic state, whereas Glu5.46 interacts in its neutral form.  The hypothesis was tested with the point mutations D3.32N and E5.46Q.  For the D3.32N no binding affinity toward any of the ligands could be detected.  This is in sharp contrast to the E5.46Q mutant, which discriminates between various ligands.  The affinity of histamine-like ligands was decreased approx. a 1000-fold, whereas the affinity of all other ligands remained virtually unchanged.  The proposed model for agonist binding as well as ab initio calcns. for histamine and VUF 8430 explain the obsd. differences in binding to the H4R mutants.  These studies provide a mol. understanding for the action of a variety of H4 receptor-ligands.  The resulting H4 receptor model will be the basis for the development of new H4 receptor-ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfm0Zxd6C6ArVg90H21EOLACvtfcHk0liOkgMutkWbPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntF2rs7g%253D&md5=28f7e8b852b66da6a537438a905c825d</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fci700474a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci700474a%26sid%3Dliteratum%253Aachs%26aulast%3DJongejan%26aufirst%3DA.%26aulast%3DLim%26aufirst%3DH.%2BD.%26aulast%3DSmits%26aufirst%3DR.%2BA.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3DHaaksma%26aufirst%3DE.%26aulast%3DLeurs%26aufirst%3DR.%26atitle%3DDelineation%2520of%2520agonist%2520binding%2520to%2520the%2520human%2520histamine%2520H4%2520receptor%2520using%2520mutational%2520analysis%252C%2520homology%2520modeling%252C%2520and%2520ab%2520initio%2520calculations%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2008%26volume%3D48%26spage%3D1455%26epage%3D1463%26doi%3D10.1021%2Fci700474a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coates, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murgolo, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morse, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayne, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strader, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monsma, F. J.</span></span> <span> </span><span class="NLM_article-title">Molecular modeling and site-specific mutagenesis of the histamine-binding site of the histamine H<sub>4</sub> receptor</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">38</span>– <span class="NLM_lpage">47</span>, <span class="refDoi"> DOI: 10.1124/mol.62.1.38</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1124%2Fmol.62.1.38" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=12065753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD38Xlt1KqtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=38-47&author=N.+Shinauthor=E.+Coatesauthor=N.+J.+Murgoloauthor=K.+L.+Morseauthor=M.+Bayneauthor=C.+D.+Straderauthor=F.+J.+Monsma&title=Molecular+modeling+and+site-specific+mutagenesis+of+the+histamine-binding+site+of+the+histamine+H4+receptor&doi=10.1124%2Fmol.62.1.38"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular modeling and site-specific mutagenesis of the histamine-binding site of the histamine H4 receptor</span></div><div class="casAuthors">Shin, Niu; Coates, Elizabeth; Murgolo, Nicholas J.; Morse, Kelley L.; Bayne, Marvin; Strader, Catherine D.; Monsma, Frederick J., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-47</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The histamine H4 receptor is a novel G-protein-coupled receptor with a unique pharmacol. profile.  The distribution of H4 mRNA suggests that it may play a role in the regulation of immune function, particularly with respect to allergy and asthma.  To define the histamine-binding site of this receptor, mol. modeling and site-directed mutagenesis were used to predict and alter amino acids residing in the histamine-binding pocket.  The effects of these alterations on histamine binding and receptor activation were then assessed.  The authors' results indicate that Asp94 (3.32) in transmembrane region (TM) 3 and Glu182 (5.46) in TM5 are critically involved in histamine binding.  Asp94 probably serves as a counter-anion to the cationic amino group of histamine, whereas Glu182 (5.46) interacts with the Nτ nitrogen atom of the histamine imidazole ring via an ion pair.  In contrast, Thr178 (5.42) and Ser179 (5.43) in TM5 are not significantly involved in either histamine binding or receptor activation.  These results resemble those for the analogous residues in the H1 histamine receptor but contrast with findings regarding the H2 histamine receptor.  The authors' results also demonstrate that Asn147 (4.57) in TM4 and Ser320 (6.52) in TM6 play a role in receptor activation but are not involved in histamine binding.  Taken together, these data indicate that although histamine seems to bind to the H4 receptor in a fashion similar to that predicted for the other histamine receptor subtypes, there are also important differences that can probably be exploited for the discovery of novel H4-selective compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp04y1YiSqFS7Vg90H21EOLACvtfcHk0liOkgMutkWbPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xlt1KqtLk%253D&md5=13f386f22254209e61e858b14a2f89e6</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1124%2Fmol.62.1.38&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.62.1.38%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DN.%26aulast%3DCoates%26aufirst%3DE.%26aulast%3DMurgolo%26aufirst%3DN.%2BJ.%26aulast%3DMorse%26aufirst%3DK.%2BL.%26aulast%3DBayne%26aufirst%3DM.%26aulast%3DStrader%26aufirst%3DC.%2BD.%26aulast%3DMonsma%26aufirst%3DF.%2BJ.%26atitle%3DMolecular%2520modeling%2520and%2520site-specific%2520mutagenesis%2520of%2520the%2520histamine-binding%2520site%2520of%2520the%2520histamine%2520H4%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2002%26volume%3D62%26spage%3D38%26epage%3D47%26doi%3D10.1124%2Fmol.62.1.38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Istyastono, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nijmeijer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stolpe van de, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roumen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kooistra, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vischer, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Esch, I. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Graaf, C.</span></span> <span> </span><span class="NLM_article-title">Molecular determinants of ligand binding modes in the histamine H<sub>4</sub> receptor: linking ligand-based three-dimensional quantitative structure–activity relationship (3D-QSAR) models to in silico guided receptor mutagenesis studies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">8136</span>– <span class="NLM_lpage">8147</span>, <span class="refDoi"> DOI: 10.1021/jm201042n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201042n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlaksrjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8136-8147&author=E.+P.+Istyastonoauthor=S.+Nijmeijerauthor=H.+D.+Limauthor=A.+Stolpe+van+deauthor=L.+Roumenauthor=A.+J.+Kooistraauthor=H.+F.+Vischerauthor=I.+J.+P.+de+Eschauthor=R.+Leursauthor=C.+de+Graaf&title=Molecular+determinants+of+ligand+binding+modes+in+the+histamine+H4+receptor%3A+linking+ligand-based+three-dimensional+quantitative+structure%E2%80%93activity+relationship+%283D-QSAR%29+models+to+in+silico+guided+receptor+mutagenesis+studies&doi=10.1021%2Fjm201042n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Determinants of Ligand Binding Modes in the Histamine H4 Receptor: Linking Ligand-Based Three-Dimensional Quantitative Structure-Activity Relationship (3D-QSAR) Models to in Silico Guided Receptor Mutagenesis Studies</span></div><div class="casAuthors">Istyastono, Enade P.; Nijmeijer, Saskia; Lim, Herman D.; van de Stolpe, Andrea; Roumen, Luc; Kooistra, Albert J.; Vischer, Henry F.; de Esch, Iwan J. P.; Leurs, Rob; de Graaf, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8136-8147</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The histamine H4 receptor (H4R) is a G protein-coupled receptor (GPCR) that plays an important role in inflammation.  Similar to the homologous histamine H3 receptor (H3R), two acidic residues in the H4R binding pocket, D3.32 and E5.46, act as essential hydrogen bond acceptors of pos. ionizable hydrogen bond donors in H4R ligands.  Given the sym. distribution of these complementary pharmacophore features in H4R and its ligands, different alternative ligand binding mode hypotheses have been proposed.  The current study focuses on the elucidation of the mol. determinants of H4R-ligand binding modes by combining (3D) quant. structure-activity relationship (QSAR), protein homol. modeling, mol. dynamics simulations, and site-directed mutagenesis studies.  We have designed and synthesized a series of clobenpropit (N-(4-chlorobenzyl)-S-[3-(4(5)-imidazolyl)propyl]isothiourea) derivs. to investigate H4R-ligand interactions and ligand binding orientations.  Interestingly, our studies indicate that clobenpropit (2) itself can bind to H4R in two distinct binding modes, while the addn. of a cyclohexyl group to the clobenpropit isothiourea moiety allows VUF5228 (5) to adopt only one specific binding mode in the H4R binding pocket.  Our ligand-steered, exptl. supported protein modeling method gives new insights into ligand recognition by H4R and can be used as a general approach to elucidate the structure of protein-ligand complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhhoHc4I5Ya7Vg90H21EOLACvtfcHk0liOkgMutkWbPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlaksrjO&md5=f4adb3a9dfd4cefaba2ea1cdc56c7e1f</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm201042n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201042n%26sid%3Dliteratum%253Aachs%26aulast%3DIstyastono%26aufirst%3DE.%2BP.%26aulast%3DNijmeijer%26aufirst%3DS.%26aulast%3DLim%26aufirst%3DH.%2BD.%26aulast%3DStolpe%2Bvan%2Bde%26aufirst%3DA.%26aulast%3DRoumen%26aufirst%3DL.%26aulast%3DKooistra%26aufirst%3DA.%2BJ.%26aulast%3DVischer%26aufirst%3DH.%2BF.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3Dde%2BGraaf%26aufirst%3DC.%26atitle%3DMolecular%2520determinants%2520of%2520ligand%2520binding%2520modes%2520in%2520the%2520histamine%2520H4%2520receptor%253A%2520linking%2520ligand-based%2520three-dimensional%2520quantitative%2520structure%25E2%2580%2593activity%2520relationship%2520%25283D-QSAR%2529%2520models%2520to%2520in%2520silico%2520guided%2520receptor%2520mutagenesis%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8136%26epage%3D8147%26doi%3D10.1021%2Fjm201042n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uveges, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spangler, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunlop, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philip, G. J.</span></span> <span> </span><span class="NLM_article-title">The role of transmembrane helix 5 in agonist binding to the human H<sub>3</sub> receptor</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>301</i></span>,  <span class="NLM_fpage">451</span>– <span class="NLM_lpage">458</span>, <span class="refDoi"> DOI: 10.1124/jpet.301.2.451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1124%2Fjpet.301.2.451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=11961043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtlKjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2002&pages=451-458&author=A.+J.+Uvegesauthor=D.+Kowalauthor=Y.+Zhangauthor=T.+B.+Spanglerauthor=J.+Dunlopauthor=S.+Semusauthor=G.+J.+Philip&title=The+role+of+transmembrane+helix+5+in+agonist+binding+to+the+human+H3+receptor&doi=10.1124%2Fjpet.301.2.451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The role of transmembrane helix 5 in agonist binding to the human H3 receptor</span></div><div class="casAuthors">Uveges, Albert J.; Kowal, Dianne; Zhang, Yingxin; Spangler, Taylor B.; Dunlop, John; Semus, Simon; Jones, Philip G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">301</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">451-458</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We have used alanine scanning mutagenesis to identify residues in transmembrane domain 5 of the histamine H3 receptor that are important for agonist binding.  All of the mutants generated were functionally expressed as demonstrated by their ability to bind [125I]iodoproxyfan with comparable affinity to the wild-type receptor and their ability to inhibit forskolin-stimulated cAMP formation when activated by histamine.  Many mutations produced small changes in the potency of histamine, but the most pronounced redn. in potency and affinity of the agonists, histamine, R-α-methylhistamine, imetit, and impentamine, was seen with mutation of glutamate 206.  Our modeling suggests that this residue plays a key role in ligand binding by interacting with the imidazole ring of histamine.  Interestingly, L199A greatly reduced agonist potency in functional assays but had only minor effects on agonist affinity, implicating a role for this residue in the mechanism of receptor activation.  We also studied the functional effects of the mutations by linking the receptor to calcium signaling using a chimeric G protein.  A comparison of the two functional assays demonstrated contrasting effects on agonist activity.  Histamine, imetit, and impentamine were full agonists in the cAMP assay, but imetit exhibited only partial agonist activity through the chimeric G protein.  Furthermore, impentamine, another potent agonist in the cAMP assay, was only able to activate the E206A mutant in the calcium assay despite being inactive at the wild-type receptor.  These observations suggest that the agonist receptor complexes formed by these three different H3 agonists are not conformationally equiv.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQYuVf-QZSLrVg90H21EOLACvtfcHk0liugNOqMxAhkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtlKjurg%253D&md5=1a47a766511d1c6170ca31e5a31dc598</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1124%2Fjpet.301.2.451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.301.2.451%26sid%3Dliteratum%253Aachs%26aulast%3DUveges%26aufirst%3DA.%2BJ.%26aulast%3DKowal%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSpangler%26aufirst%3DT.%2BB.%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DSemus%26aufirst%3DS.%26aulast%3DPhilip%26aufirst%3DG.%2BJ.%26atitle%3DThe%2520role%2520of%2520transmembrane%2520helix%25205%2520in%2520agonist%2520binding%2520to%2520the%2520human%2520H3%2520receptor%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D301%26spage%3D451%26epage%3D458%26doi%3D10.1124%2Fjpet.301.2.451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiroishi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weyand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsujimoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abagyan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwata, S.</span></span> <span> </span><span class="NLM_article-title">Structure of the human histamine H1 receptor complex with doxepin</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>475</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1038/nature10236</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1038%2Fnature10236" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=21697825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvVekt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=475&publication_year=2011&pages=65-72&author=T.+Shimamuraauthor=M.+Shiroishiauthor=S.+Weyandauthor=H.+Tsujimotoauthor=G.+Winterauthor=V.+Katritchauthor=R.+Abagyanauthor=V.+Cherezovauthor=W.+Liuauthor=G.+W.+Hanauthor=T.+Kobayashiauthor=R.+C.+Stevensauthor=S.+Iwata&title=Structure+of+the+human+histamine+H1+receptor+complex+with+doxepin&doi=10.1038%2Fnature10236"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the human histamine H1 receptor complex with doxepin</span></div><div class="casAuthors">Shimamura, Tatsuro; Shiroishi, Mitsunori; Weyand, Simone; Tsujimoto, Hirokazu; Winter, Graeme; Katritch, Vsevolod; Abagyan, Ruben; Cherezov, Vadim; Liu, Wei; Han, Gye Won; Kobayashi, Takuya; Stevens, Raymond C.; Iwata, So</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">475</span>
        (<span class="NLM_cas:issue">7354</span>),
    <span class="NLM_cas:pages">65-70</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The biogenic amine histamine is an important pharmacol. mediator involved in pathophysiol. processes such as allergies and inflammations.  Histamine H1 receptor (H1R) antagonists are very effective drugs alleviating the symptoms of allergic reactions.  Here, we show the crystal structure of the H1R complex with doxepin, a first-generation H1R antagonist.  Doxepin sits deep in the ligand-binding pocket and directly interacts with Trp 428, a highly conserved key residue in G-protein-coupled-receptor activation.  This well-conserved pocket with mostly hydrophobic nature contributes to the low selectivity of the first-generation compds.  The pocket is assocd. with an anion-binding region occupied by a phosphate ion.  Docking of various second-generation H1R antagonists reveals that the unique carboxyl group present in this class of compds. interacts with Lys 191 and/or Lys 179ECL2, both of which form part of the anion-binding region.  This region is not conserved in other aminergic receptors, demonstrating how minor differences in receptors lead to pronounced selectivity differences with small mols.  Our study sheds light on the mol. basis of H1R antagonist specificity against H1R.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN1obci6QtYbVg90H21EOLACvtfcHk0liugNOqMxAhkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvVekt7k%253D&md5=7116228016caa1f3afbfed11468c0154</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fnature10236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10236%26sid%3Dliteratum%253Aachs%26aulast%3DShimamura%26aufirst%3DT.%26aulast%3DShiroishi%26aufirst%3DM.%26aulast%3DWeyand%26aufirst%3DS.%26aulast%3DTsujimoto%26aufirst%3DH.%26aulast%3DWinter%26aufirst%3DG.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DIwata%26aufirst%3DS.%26atitle%3DStructure%2520of%2520the%2520human%2520histamine%2520H1%2520receptor%2520complex%2520with%2520doxepin%26jtitle%3DNature%26date%3D2011%26volume%3D475%26spage%3D65%26epage%3D72%26doi%3D10.1038%2Fnature10236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morse, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laz, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, R. E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenfeder, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anthes, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umland, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hipkin, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonsiorek, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedrick, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayne, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monsma, F. J. J.</span></span> <span> </span><span class="NLM_article-title">Cloning and characterization of a novel human histamine receptor</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>269</i></span>,  <span class="NLM_fpage">1058</span>– <span class="NLM_lpage">1066</span>,</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=2001&pages=1058-1066&author=K.+L.+Morseauthor=J.+Behanauthor=T.+M.+Lazauthor=R.+E.+J.+Westauthor=S.+A.+Greenfederauthor=J.+C.+Anthesauthor=S.+Umlandauthor=Y.+Wanauthor=R.+W.+Hipkinauthor=W.+Gonsiorekauthor=N.+Shinauthor=E.+L.+Gustafsonauthor=X.+Qiaoauthor=S.+Wangauthor=J.+A.+Hedrickauthor=J.+Greeneauthor=M.+Bayneauthor=F.+J.+J.+Monsma&title=Cloning+and+characterization+of+a+novel+human+histamine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorse%26aufirst%3DK.%2BL.%26aulast%3DBehan%26aufirst%3DJ.%26aulast%3DLaz%26aufirst%3DT.%2BM.%26aulast%3DWest%26aufirst%3DR.%2BE.%2BJ.%26aulast%3DGreenfeder%26aufirst%3DS.%2BA.%26aulast%3DAnthes%26aufirst%3DJ.%2BC.%26aulast%3DUmland%26aufirst%3DS.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DHipkin%26aufirst%3DR.%2BW.%26aulast%3DGonsiorek%26aufirst%3DW.%26aulast%3DShin%26aufirst%3DN.%26aulast%3DGustafson%26aufirst%3DE.%2BL.%26aulast%3DQiao%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DHedrick%26aufirst%3DJ.%2BA.%26aulast%3DGreene%26aufirst%3DJ.%26aulast%3DBayne%26aufirst%3DM.%26aulast%3DMonsma%26aufirst%3DF.%2BJ.%2BJ.%26atitle%3DCloning%2520and%2520characterization%2520of%2520a%2520novel%2520human%2520histamine%2520receptor%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D269%26spage%3D1058%26epage%3D1066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1350</span>– <span class="NLM_lpage">1359</span>,</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10534321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADyaK1MXntFSht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=1350-1359&author=R.+S.+Obach&title=Prediction+of+human+clearance+of+twenty-nine+drugs+from+hepatic+microsomal+intrinsic+clearance+data%3A+An+examination+of+in+vitro+half-life+approach+and+nonspecific+binding+to+microsomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes</span></div><div class="casAuthors">Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1350-1359</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Twenty-nine drugs of disparate structures and physicochem. properties were used in an examn. of the capability of human liver microsomal lability data ("in vitro T1/2" approach) to be useful in the prediction of human clearance.  Addnl., the potential importance of nonspecific binding to microsomes in the in vitro incubation milieu for the accurate prediction of human clearance was investigated.  The compds. examd. demonstrated a wide range of microsomal metabolic labilities with scaled intrinsic clearance values ranging from less than 0.5 mL/min/kg to 189 mL/min/kg.  Microsomal binding was detd. at microsomal protein concns. used in the lability incubations.  For the 29 compds. studied, unbound fractions in microsomes ranged from 0.11 to 1.0.  Generally, basic compds. demonstrated the greatest extent of binding and neutral and acidic compds. the least extent of binding.  In the projection of human clearance values, basic and neutral compds. were well predicted when all binding considerations (blood and microsome) were disregarded, however, including both binding considerations also yielded reasonable predictions.  Including only blood binding yielded very poor projections of human clearance for these two types of compds.  However, for acidic compds., disregarding all binding considerations yielded poor predictions of human clearance.  It was generally most difficult to accurately predict clearance for this class of compds.; however the accuracy was best when all binding considerations were included.  Overall, inclusion of both blood and microsome binding values gave the best agreement between in vivo clearance values and clearance values projected from in vitro intrinsic clearance data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWp2hUTOxyubVg90H21EOLACvtfcHk0liJ3arF8d_b1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFSht7c%253D&md5=7804cd4dfb131caac45aff9b7a1df901</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DPrediction%2520of%2520human%2520clearance%2520of%2520twenty-nine%2520drugs%2520from%2520hepatic%2520microsomal%2520intrinsic%2520clearance%2520data%253A%2520An%2520examination%2520of%2520in%2520vitro%2520half-life%2520approach%2520and%2520nonspecific%2520binding%2520to%2520microsomes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1999%26volume%3D27%26spage%3D1350%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, A. Y. H.</span></span> <span> </span><span class="NLM_article-title">Inhibition and induction of cytochrome P450 and the clinical implications</span>. <i>Clin. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">361</span>– <span class="NLM_lpage">390</span>, <span class="refDoi"> DOI: 10.2165/00003088-199835050-00003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.2165%2F00003088-199835050-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=9839089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADyaK1cXnvVeqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1998&pages=361-390&author=J.+H.+Linauthor=A.+Y.+H.+Lu&title=Inhibition+and+induction+of+cytochrome+P450+and+the+clinical+implications&doi=10.2165%2F00003088-199835050-00003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition and induction of cytochrome P450 and the clinical implications</span></div><div class="casAuthors">Lin, Jiunn H.; Lu, Anthony Y. H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">361-390</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review with 192 refs.  The cytochrome P450s (CYPs) constitute a superfamily of isoforms that play an important role in the oxidative metab. of drugs.  Each CYP isoform possesses a characteristic broad spectrum of catalytic activities of substrates.  Whenever 2 or more drugs are administered concurrently, the possibility of drug interactions exists.  The ability of a single CYP to metabolize multiple substrates is responsible for a large no. of documented drug interactions assocd. with CYP inhibition.  In addn., drug interactions can also occur as a result of the induction of several human CYPs following long term drug treatment.  The mechanisms of CYP inhibition can be divided into 3 categories: (a) reversible inhibition; (b) quasi-irreversible inhibition; and (c) irreversible inhibition.  In mechanistic terms, reversible interactions arise as a result of competition at the CYP active site and probably involve only the first step of the CYP catalytic cycle.  On the other hand, drugs that act during and subsequent to the oxygen transfer step are generally irreversible or quasi-irreversible inhibitors.  Irreversible and quasi-irreversible inhibition require at least one cycle of the CYP catalytic process.  Because human liver samples and recombinant human CYPs are now readily available, in vitro systems have been used as screening tools to predict the potential for in vivo drug interaction.  Although it is easy to det. in vitro metabolic drug interactions, the proper interpretation and extrapolation of in vitro interaction data to in vivo situations require a good understanding of pharmacokinetic principles.  From the viewpoint of drug therapy, to avoid potential drug-drug interactions, it is desirable to develop a new drug candidate that is not a potent CYP inhibitor or inducer and the metab. of which is not readily inhibited by other drugs.  In reality, drug interaction by mutual inhibition between drugs is almost inevitable, because CYP-mediated metab. represents a major route of elimination of many drugs, which can compete for the same CYP enzyme.  The clin. significance of a metabolic drug interaction depends on the magnitude of the change in the concn. of active species (parent drug and/or active metabolites) at the site of pharmacol. action and the therapeutic index of the drug.  The smaller the difference between toxic and effective concn., the greater the likelihood that a drug interaction will have serious clin. consequences.  Thus, careful evaluation of potential drug interactions of a new drug candidate during the early stage of drug development is essential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxdqTupUCBbLVg90H21EOLACvtfcHk0liJ3arF8d_b1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnvVeqtLo%253D&md5=18993123e2cdad5517962664e986a5b4</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.2165%2F00003088-199835050-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-199835050-00003%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DJ.%2BH.%26aulast%3DLu%26aufirst%3DA.%2BY.%2BH.%26atitle%3DInhibition%2520and%2520induction%2520of%2520cytochrome%2520P450%2520and%2520the%2520clinical%2520implications%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D1998%26volume%3D35%26spage%3D361%26epage%3D390%26doi%3D10.2165%2F00003088-199835050-00003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Provensi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izquierdo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blandina, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passani, M. B.</span></span> <span> </span><span class="NLM_article-title">Brain histamine modulates recognition memory: possible implications in major cognitive disorders</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>, <span class="refDoi"> DOI: 10.1111/bph.14478</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1111%2Fbph.14478" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=G.+Provensiauthor=A.+Costaauthor=I.+Izquierdoauthor=P.+Blandinaauthor=M.+B.+Passani&title=Brain+histamine+modulates+recognition+memory%3A+possible+implications+in+major+cognitive+disorders&doi=10.1111%2Fbph.14478"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1111%2Fbph.14478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.14478%26sid%3Dliteratum%253Aachs%26aulast%3DProvensi%26aufirst%3DG.%26aulast%3DCosta%26aufirst%3DA.%26aulast%3DIzquierdo%26aufirst%3DI.%26aulast%3DBlandina%26aufirst%3DP.%26aulast%3DPassani%26aufirst%3DM.%2BB.%26atitle%3DBrain%2520histamine%2520modulates%2520recognition%2520memory%253A%2520possible%2520implications%2520in%2520major%2520cognitive%2520disorders%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2018%26doi%3D10.1111%2Fbph.14478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prast, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argyriou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philippu, A.</span></span> <span> </span><span class="NLM_article-title">Histaminergic neurons facilitate social memory in rats</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>734</i></span>,  <span class="NLM_fpage">316</span>– <span class="NLM_lpage">318</span>, <span class="refDoi"> DOI: 10.1016/0006-8993(96)00886-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1016%2F0006-8993%2896%2900886-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=8896839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADyaK28Xls1Knurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=734&publication_year=1996&pages=316-318&author=H.+Prastauthor=A.+Argyriouauthor=A.+Philippu&title=Histaminergic+neurons+facilitate+social+memory+in+rats&doi=10.1016%2F0006-8993%2896%2900886-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Histaminergic neurons facilitate social memory in rats</span></div><div class="casAuthors">Prast, Helmut; Argyriou, Anastasia; Philippu, Athineos</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">734</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">316-318</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The social memory test was used so as to investigate whether brain histamine is involved in short-term memory.  Histamine injected intracerebroventricularly (i.c.v.) decreased investigation time of a juvenile rat by an adult rat.  A similar effect was elicited by i.c.v. administration of histidine.  Compared with the control animals, rat pretreatment with α-fluoromethylhistidine (FMH), which inhibits neuronal synthesis of histamine, prolonged recognition time.  The H3-receptor agonist immepip also prolonged investigation time, while the H3-antagonist thioperamide exerted the opposite effect.  Treatment with histidine increased, while treatment with FMH decreased histamine levels in various brain regions.  It is concluded that histamine released from histaminergic neurons facilitates short-term memory.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1cI8SlYoJ7bVg90H21EOLACvtfcHk0liJ3arF8d_b1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xls1Knurg%253D&md5=f670e83673ac4979104d422c4a213abb</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2896%2900886-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252896%252900886-4%26sid%3Dliteratum%253Aachs%26aulast%3DPrast%26aufirst%3DH.%26aulast%3DArgyriou%26aufirst%3DA.%26aulast%3DPhilippu%26aufirst%3DA.%26atitle%3DHistaminergic%2520neurons%2520facilitate%2520social%2520memory%2520in%2520rats%26jtitle%3DBrain%2520Res.%26date%3D1996%26volume%3D734%26spage%3D316%26epage%3D318%26doi%3D10.1016%2F0006-8993%2896%2900886-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Provensi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passani, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izquierdo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blandina, P.</span></span> <span> </span><span class="NLM_article-title">Neuronal histamine and the memory of emotionally salient events</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>, <span class="refDoi"> DOI: 10.1111/bph.14476</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1111%2Fbph.14476" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=G.+Provensiauthor=M.+B.+Passaniauthor=A.+Costaauthor=I.+Izquierdoauthor=P.+Blandina&title=Neuronal+histamine+and+the+memory+of+emotionally+salient+events&doi=10.1111%2Fbph.14476"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1111%2Fbph.14476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.14476%26sid%3Dliteratum%253Aachs%26aulast%3DProvensi%26aufirst%3DG.%26aulast%3DPassani%26aufirst%3DM.%2BB.%26aulast%3DCosta%26aufirst%3DA.%26aulast%3DIzquierdo%26aufirst%3DI.%26aulast%3DBlandina%26aufirst%3DP.%26atitle%3DNeuronal%2520histamine%2520and%2520the%2520memory%2520of%2520emotionally%2520salient%2520events%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2018%26doi%3D10.1111%2Fbph.14476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parmentier, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anaclet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guhennec, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brousseau, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bricout, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giboulot, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozyczko-Coyne, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiegel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohtsu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J. S.</span></span> <span> </span><span class="NLM_article-title">The brain H<sub>3</sub>-receptor as a novel therapeutic target for vigilance and sleep-wake disorders</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">1157</span>– <span class="NLM_lpage">1171</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2007.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1016%2Fj.bcp.2007.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=17288995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjt1Smtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2007&pages=1157-1171&author=R.+Parmentierauthor=C.+Anacletauthor=C.+Guhennecauthor=E.+Brousseauauthor=D.+Bricoutauthor=T.+Giboulotauthor=D.+Bozyczko-Coyneauthor=K.+Spiegelauthor=H.+Ohtsuauthor=M.+Williamsauthor=J.+S.+Lin&title=The+brain+H3-receptor+as+a+novel+therapeutic+target+for+vigilance+and+sleep-wake+disorders&doi=10.1016%2Fj.bcp.2007.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders</span></div><div class="casAuthors">Parmentier, R.; Anaclet, C.; Guhennec, C.; Brousseau, E.; Bricout, D.; Giboulot, T.; Bozyczko-Coyne, D.; Spiegel, K.; Ohtsu, H.; Williams, M.; Lin, J. S.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1157-1171</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Brain histaminergic neurons play a prominent role in arousal and maintenance of wakefulness (W).  H3-receptors control the activity of histaminergic neurons through presynaptic autoinhibition.  The role of H3-receptor antagonists/inverse agonists (H3R-antagonists) in the potential therapy of vigilance deficiency and sleep-wake disorders were studied by assessing their effects on the mouse cortical EEG and sleep-wake cycle in comparison to modafinil and classical psychostimulants.  The H3R-antagonists, thioperamide and ciproxifan increased W and cortical EEG fast rhythms and, like modafinil, but unlike amphetamine and caffeine, their waking effects were not accompanied by sleep rebound.  Conversely, imetit (H3R-agonist) enhanced slow wave sleep and dose-dependently attenuated ciproxifan-induced W, indicating that the effects of both ligands involve H3-receptor mechanisms.  Addnl. studies using knockout (KO) mice confirmed the essential role of H3-receptors and histamine-mediated transmission in the wake properties of H3R-antagonists.  Thus ciproxifan produced no increase in W in either histidine-decarboxylase (HDC, histamine-synthesizing enzyme) or H1- or H3-receptor KO-mice whereas its waking effects persisted in H2-receptor KO-mice.  These data validate the hypothesis that H3R-antagonists, through disinhibition of H3-autoreceptors, enhancing synaptic histamine that in turn activates postsynaptic H1-receptors promoting W. Interestingly amphetamine and modafinil, despite their potent arousal effects, appear unlikely to depend on histaminergic mechanism as their effects still occurred in HDC KO-mice.  The present study thus distinguishes two classes of wake-improving agents: the first acting through non-histaminergic mechanisms and the second acting via histamine and supports brain H3-receptors as potentially novel therapeutic targets for vigilance and sleep-wake disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6KuDbNsgWqLVg90H21EOLACvtfcHk0lgDlJg3Kr2BSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjt1Smtrw%253D&md5=ca0be091b58cfcd2879030ce54683a7a</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2007.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2007.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DParmentier%26aufirst%3DR.%26aulast%3DAnaclet%26aufirst%3DC.%26aulast%3DGuhennec%26aufirst%3DC.%26aulast%3DBrousseau%26aufirst%3DE.%26aulast%3DBricout%26aufirst%3DD.%26aulast%3DGiboulot%26aufirst%3DT.%26aulast%3DBozyczko-Coyne%26aufirst%3DD.%26aulast%3DSpiegel%26aufirst%3DK.%26aulast%3DOhtsu%26aufirst%3DH.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DJ.%2BS.%26atitle%3DThe%2520brain%2520H3-receptor%2520as%2520a%2520novel%2520therapeutic%2520target%2520for%2520vigilance%2520and%2520sleep-wake%2520disorders%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2007%26volume%3D73%26spage%3D1157%26epage%3D1171%26doi%3D10.1016%2Fj.bcp.2007.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamauchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuma, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onozawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagayama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinei, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakui, N.</span></span> <span> </span><span class="NLM_article-title">Anxiolytic-like profiles of histamine H<sub>3</sub> receptor agonists in animal models of anxiety: a comparative study with antidepressants and benzodiazepine anxiolytic</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>205</i></span>,  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">187</span>, <span class="refDoi"> DOI: 10.1007/s00213-009-1528-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1007%2Fs00213-009-1528-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=19357839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkt1ymsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=2009&pages=177-187&author=F.+Yokoyamaauthor=M.+Yamauchiauthor=M.+Oyamaauthor=K.+Okumaauthor=K.+Onozawaauthor=T.+Nagayamaauthor=R.+Shineiauthor=M.+Ishikawaauthor=Y.+Satoauthor=N.+Kakui&title=Anxiolytic-like+profiles+of+histamine+H3+receptor+agonists+in+animal+models+of+anxiety%3A+a+comparative+study+with+antidepressants+and+benzodiazepine+anxiolytic&doi=10.1007%2Fs00213-009-1528-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Anxiolytic-like profiles of histamine H3 receptor agonists in animal models of anxiety: a comparative study with antidepressants and benzodiazepine anxiolytic</span></div><div class="casAuthors">Yokoyama, Fumikazu; Yamauchi, Miki; Oyama, Masayo; Okuma, Kunihiro; Onozawa, Kaname; Nagayama, Takako; Shinei, Rie; Ishikawa, Makoto; Sato, Yasuo; Kakui, Nobukazu</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">205</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">177-187</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Rationale: Histamine H3 receptor functions as a presynaptic auto- and hetero-receptor on histaminergic and non-histaminergic neurons in the brain regulating the synaptic release of numerous neurotransmitters.  Therefore, the ligands for this receptor have been proposed to be of therapeutic interest for the treatment of various neuropsychiatric disorders.  At present, however, the psychopharmacol. profiles of H3 ligands, particularly H3 agonists, have not been extensively studied.  Objective: The present study investigated the anxiolytic-like profiles of H3-selective agonists in a variety of classical (benzodiazepine-sensitive) and atypical (antidepressant-effective) animal models of anxiety.  Comparator drugs used were diazepam and both fluvoxamine and desipramine in the former and latter models, resp.  Results: H3 agonist R-α-methylhistamine and immepip were inactive in rat elevated plus maze test and Vogel type conflict test where diazepam (5 mg/kg) produced significant anxiolytic-like effects.  Meanwhile, these H3 agonists (10-30 mg/kg) significantly reduced isolation-induced vocalizations in guinea pig pups and isolation-induced aggressive behavior in mouse resident-intruder test.  Moreover, in rat conditioned fear stress test, R-α-methylhistamine (30 mg/kg) and immepip (10 mg/kg) significantly decreased freezing time, which were completely reversed by concomitant treatment with H3 antagonist, thioperamide (10 mg/kg).  In contrast to the limited efficacy obtained with desipramine (30 mg/kg), fluvoxamine (20-60 mg/kg) exhibited anxiolytic-like effects in all the latter three atypical models.  Conclusions: These data suggest that the H3 agonists may have anxiolytic-like effects similar to those of selective serotonin reuptake inhibitors but not benzodiazepine anxiolytics and represent a novel strategy for the treatment of some anxiety disorders in which selective serotonin reuptake inhibitors are prescribed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqw1xYcgPBQLVg90H21EOLACvtfcHk0lgDlJg3Kr2BSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkt1ymsb8%253D&md5=0e028fa8871e4a74d3b82a40ef081dbb</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1007%2Fs00213-009-1528-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-009-1528-1%26sid%3Dliteratum%253Aachs%26aulast%3DYokoyama%26aufirst%3DF.%26aulast%3DYamauchi%26aufirst%3DM.%26aulast%3DOyama%26aufirst%3DM.%26aulast%3DOkuma%26aufirst%3DK.%26aulast%3DOnozawa%26aufirst%3DK.%26aulast%3DNagayama%26aufirst%3DT.%26aulast%3DShinei%26aufirst%3DR.%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DKakui%26aufirst%3DN.%26atitle%3DAnxiolytic-like%2520profiles%2520of%2520histamine%2520H3%2520receptor%2520agonists%2520in%2520animal%2520models%2520of%2520anxiety%253A%2520a%2520comparative%2520study%2520with%2520antidepressants%2520and%2520benzodiazepine%2520anxiolytic%26jtitle%3DPsychopharmacology%26date%3D2009%26volume%3D205%26spage%3D177%26epage%3D187%26doi%3D10.1007%2Fs00213-009-1528-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seifert, R.</span></span> <span> </span><span class="NLM_article-title">Histamine H<sub>4</sub>-receptor expression in the brain?</span>. <i>Naunyn-Schmiedeberg’s Arch. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>388</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1007/s00210-014-1067-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1007%2Fs00210-014-1067-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=25420523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFOisbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2015&pages=5-9&author=E.+H.+Schneiderauthor=D.+Neumannauthor=R.+Seifert&title=Histamine+H4-receptor+expression+in+the+brain%3F&doi=10.1007%2Fs00210-014-1067-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Histamine H4-receptor expression in the brain?</span></div><div class="casAuthors">Schneider, Erich H.; Neumann, Detlef; Seifert, Roland</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-9</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkoUhOx9zItLVg90H21EOLACvtfcHk0lhpNA2o9aDKbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFOisbbI&md5=e8f833c2ffd94a42f4bcda573b1aa526</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1007%2Fs00210-014-1067-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00210-014-1067-0%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DE.%2BH.%26aulast%3DNeumann%26aufirst%3DD.%26aulast%3DSeifert%26aufirst%3DR.%26atitle%3DHistamine%2520H4-receptor%2520expression%2520in%2520the%2520brain%253F%26jtitle%3DNaunyn-Schmiedeberg%25E2%2580%2599s%2520Arch.%2520Pharmacol.%26date%3D2015%26volume%3D388%26spage%3D5%26epage%3D9%26doi%3D10.1007%2Fs00210-014-1067-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanna, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghelardini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thurmond, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galeotti, N.</span></span> <span> </span><span class="NLM_article-title">Behavioural phenotype of histamine H<sub>4</sub> receptor knockout mice: Focus on central neuronal functions</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">57</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2016.11.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1016%2Fj.neuropharm.2016.11.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=27899280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFOgt77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=48-57&author=M.+D.+Sannaauthor=C.+Ghelardiniauthor=R.+L.+Thurmondauthor=E.+Masiniauthor=N.+Galeotti&title=Behavioural+phenotype+of+histamine+H4+receptor+knockout+mice%3A+Focus+on+central+neuronal+functions&doi=10.1016%2Fj.neuropharm.2016.11.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioural phenotype of histamine H4 receptor knockout mice: Focus on central neuronal functions</span></div><div class="casAuthors">Sanna, Maria Domenica; Ghelardini, Carla; Thurmond, Robin L.; Masini, Emanuela; Galeotti, Nicoletta</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">48-57</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The functional expression of H4 receptors (H4R) within neurons of the central nervous system has been recently reported, but their role is poorly understood.  The present study aims to elucidate the role of neuronal H4R by providing the first description of the behavioral phenotype of H4R-deficient (H4R knockout, H4R-KO) mice.  Mice lacking H4R underwent behavioral studies to evaluate locomotor activity, pain perception, anxiety, depression, memory and feeding behavior.  H4R-KO mice showed a significant increase in ambulation in an open field as well as in exploratory activity in the absence of any modification of motor coordination.  The sensitivity of mutant mice to a thermal or a mech. stimulus was identical to that of the wild type mice, but H4R-KO showed sensory hypersensitivity toward a condition of neuropathic pain.  The lack of H4R is assocd. with the promotion of anxiety in the light-dark box test.  H4R-KO mice showed an increased immobility time in the tail suspension test, exptl. procedure used to evaluate the response of H4R deficient mice to a behavioral despair paradigm.  Cognitive function parameters of H4R deficient mice, examd. using the passive avoidance and the novel object recognition tests, were unaltered showing the lack of influence of H4R on working and recognition memory.  Finally, H4R-deficient mice showed an orectic phenotype.  These results illustrate that H4R modulates various neurophysiol. functions such as locomotor activity, anxiety, nociception and feeding behavior, confirming the importance of the integrity and functionality of neuronal H4R in the histaminergic regulation of neuronal functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAFDqmPUBeiLVg90H21EOLACvtfcHk0lhpNA2o9aDKbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFOgt77I&md5=b4aa07a338c707e82eaf3e1fdeccddcd</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2016.11.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2016.11.023%26sid%3Dliteratum%253Aachs%26aulast%3DSanna%26aufirst%3DM.%2BD.%26aulast%3DGhelardini%26aufirst%3DC.%26aulast%3DThurmond%26aufirst%3DR.%2BL.%26aulast%3DMasini%26aufirst%3DE.%26aulast%3DGaleotti%26aufirst%3DN.%26atitle%3DBehavioural%2520phenotype%2520of%2520histamine%2520H4%2520receptor%2520knockout%2520mice%253A%2520Focus%2520on%2520central%2520neuronal%2520functions%26jtitle%3DNeuropharmacology%26date%3D2017%26volume%3D114%26spage%3D48%26epage%3D57%26doi%3D10.1016%2Fj.neuropharm.2016.11.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blandina, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giorgetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmerman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pepeu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giovannini, M. G.</span></span> <span> </span><span class="NLM_article-title">Inhibition of cortical acetylcholine release and cognitive performance by histamine H<sub>3</sub> receptor activation in rats</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">1656</span>– <span class="NLM_lpage">1664</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.1996.tb16086.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1111%2Fj.1476-5381.1996.tb16086.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=8982515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADyaK2sXktlWrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1996&pages=1656-1664&author=P.+Blandinaauthor=M.+Giorgettiauthor=L.+Bartoliniauthor=M.+Cecchiauthor=H.+Timmermanauthor=R.+Leursauthor=G.+Pepeuauthor=M.+G.+Giovannini&title=Inhibition+of+cortical+acetylcholine+release+and+cognitive+performance+by+histamine+H3+receptor+activation+in+rats&doi=10.1111%2Fj.1476-5381.1996.tb16086.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of cortical acetylcholine release and cognitive performance by histamine H3 receptor activation in rats</span></div><div class="casAuthors">Blandina, P.; Giorgetti, M.; Bartolini, L.; Cecchi, M.; Timmerman, H.; Leurs, R.; Pepeu, G.; Giovannini, M. G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1656-1664</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">The effects of histamine and agents acting at histamine receptors on spontaneous and 100 mM K+-evoked release of acetylcholine, measured by microdialysis from the cortex of freely moving rats, and on cognitive tests are described.  Local administration of histamine (0.1-100 μM) failed to affect spontaneous but inhibited 100 mM K+-stimulated release of acetylcholine up to about 50%.  The H3 receptor agonists (R)-α-methylhistamine (RAMH) (0.1-10 μM) imetit (0.01-10 μM) and immepip (0.01-10 μM) mimicked the effect of histamine.  Neither 2-thiazolylethylamine (TEA), an agonist showing some selectivity for H1 receptors, nor the H2 receptor agonist, dimaprit, modified 100 mM K+-evoked release of acetylcholine.  The inhibitory effect of 100 μM histamine was completely prevented by the highly selective histamine H3 receptor antagonist, clobenpropit but was resistant to antagonism by triprolidine and cimetidine, antagonists at histamine H1 and H2 but not H3 receptors.  The H3 receptor-induced inhibition of K+-evoked release of acetylcholine was fully sensitive to tetrodotoxin (TTX).  The effects of i.p. injection of imetit (5 mg kg-1) and RAMH (5 mg kg-1) were tested on acetylcholine release and short term memory paradigms.  Both drugs reduced 100 mM K+-evoked release of cortical acetylcholine, and impaired object recognition and a passive avoidance response.  These observations provide the first evidence of a regulatory role of histamine H3 receptors on cortical acetylcholine release in vivo.  Moreover, they suggest a role for histamine in learning and memory and may have implications for the treatment of degenerative disorders assocd. with impaired cholinergic function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpRWbp6n09nLVg90H21EOLACvtfcHk0lhpNA2o9aDKbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlWrsw%253D%253D&md5=4b8e769a808bf1d1ffb1d61970b14ba2</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1996.tb16086.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1996.tb16086.x%26sid%3Dliteratum%253Aachs%26aulast%3DBlandina%26aufirst%3DP.%26aulast%3DGiorgetti%26aufirst%3DM.%26aulast%3DBartolini%26aufirst%3DL.%26aulast%3DCecchi%26aufirst%3DM.%26aulast%3DTimmerman%26aufirst%3DH.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DPepeu%26aufirst%3DG.%26aulast%3DGiovannini%26aufirst%3DM.%2BG.%26atitle%3DInhibition%2520of%2520cortical%2520acetylcholine%2520release%2520and%2520cognitive%2520performance%2520by%2520histamine%2520H3%2520receptor%2520activation%2520in%2520rats%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D119%26spage%3D1656%26epage%3D1664%26doi%3D10.1111%2Fj.1476-5381.1996.tb16086.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nijmeijer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelhardt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de Stolpe, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lusink, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Graaf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wijtmans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haaksma, E. E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Esch, I. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stachurski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vischer, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span> <span> </span><span class="NLM_article-title">Design and pharmacological characterization of VUF14480, a covalent partial agonist that interacts with cysteine 98<sup>3.36</sup> of the human histamine H<sub>4</sub> receptor</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>170</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1111/bph.12113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1111%2Fbph.12113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=23347159" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlSgtbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2013&pages=89-100&author=S.+Nijmeijerauthor=H.+Engelhardtauthor=S.+Schultesauthor=A.+C.+van+de+Stolpeauthor=V.+Lusinkauthor=C.+de+Graafauthor=M.+Wijtmansauthor=E.+E.+J.+Haaksmaauthor=I.+J.+P.+de+Eschauthor=K.+Stachurskiauthor=H.+F.+Vischerauthor=R.+Leurs&title=Design+and+pharmacological+characterization+of+VUF14480%2C+a+covalent+partial+agonist+that+interacts+with+cysteine+983.36+of+the+human+histamine+H4+receptor&doi=10.1111%2Fbph.12113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Design and pharmacological characterization of VUF14480, a covalent partial agonist that interacts with cysteine 983.36 of the human histamine H4 receptor</span></div><div class="casAuthors">Nijmeijer, S.; Engelhardt, H.; Schultes, S.; van de Stolpe, A. C.; Lusink, V.; de Graaf, C.; Wijtmans, M.; Haaksma, E. E. J.; de Esch, I. J. P.; Stachurski, K.; Vischer, H. F.; Leurs, R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-100</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose The recently proposed binding mode of 2-aminopyrimidines to the human (h) histamine H4 receptor suggests that the 2-amino group of these ligands interacts with glutamic acid residue E1825.46 in the transmembrane (TM) helix 5 of this receptor.  Interestingly, substituents at the 2-position of this pyrimidine are also in close proximity to the cysteine residue C983.36 in TM3.  We hypothesized that an ethenyl group at this position will form a covalent bond with C983.36 by functioning as a Michael acceptor.  A covalent pyrimidine analog will not only prove this proposed binding mode, but will also provide a valuable tool for H4 receptor research.  Exptl. Approach We designed and synthesized VUF14480, and pharmacol. characterized this compd. in hH4 receptor radioligand binding, G protein activation and β-arrestin2 recruitment expts.  The ability of VUF14480 to act as a covalent binder was assessed both chem. and pharmacol.  Key Results VUF14480 was shown to be a partial agonist of hH4 receptor-mediated G protein signalling and β-arrestin2 recruitment.  VUF14480 bound covalently to the hH4 receptor with submicromolar affinity.  Serine substitution of C983.36 prevented this covalent interaction.  Conclusion and Implications VUF14480 is thought to bind covalently to the hH4 receptor-C983.36 residue and partially induce hH4 receptor-mediated G protein activation and β-arrestin2 recruitment.  Moreover, these observations confirm our previously proposed binding mode of 2-aminopyrimidines.  VUF14480 will be a useful tool to stabilize the receptor into an active confirmation and further investigate the structure of the active hH4 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbemtwmb5BDbVg90H21EOLACvtfcHk0lgKoc9M7vrZiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlSgtbnK&md5=dbaa12c47194793907c66f94dfcbe5fd</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1111%2Fbph.12113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12113%26sid%3Dliteratum%253Aachs%26aulast%3DNijmeijer%26aufirst%3DS.%26aulast%3DEngelhardt%26aufirst%3DH.%26aulast%3DSchultes%26aufirst%3DS.%26aulast%3Dvan%2Bde%2BStolpe%26aufirst%3DA.%2BC.%26aulast%3DLusink%26aufirst%3DV.%26aulast%3Dde%2BGraaf%26aufirst%3DC.%26aulast%3DWijtmans%26aufirst%3DM.%26aulast%3DHaaksma%26aufirst%3DE.%2BE.%2BJ.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3DStachurski%26aufirst%3DK.%26aulast%3DVischer%26aufirst%3DH.%2BF.%26aulast%3DLeurs%26aufirst%3DR.%26atitle%3DDesign%2520and%2520pharmacological%2520characterization%2520of%2520VUF14480%252C%2520a%2520covalent%2520partial%2520agonist%2520that%2520interacts%2520with%2520cysteine%2520983.36%2520of%2520the%2520human%2520histamine%2520H4%2520receptor%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D170%26spage%3D89%26epage%3D100%26doi%3D10.1111%2Fbph.12113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mocking, T. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verweij, E. W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vischer, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span> <span> </span><span class="NLM_article-title">Homogeneous, real-time NanoBRET binding assays for the histamine H<sub>3</sub> and H<sub>4</sub> receptors on living cells</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">1371</span>– <span class="NLM_lpage">1381</span>, <span class="refDoi"> DOI: 10.1124/mol.118.113373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1124%2Fmol.118.113373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=30249614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlKhu7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2018&pages=1371-1381&author=T.+A.+M.+Mockingauthor=E.+W.+E.+Verweijauthor=H.+F.+Vischerauthor=R.+Leurs&title=Homogeneous%2C+real-time+NanoBRET+binding+assays+for+the+histamine+H3+and+H4+receptors+on+living+cells&doi=10.1124%2Fmol.118.113373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Homogeneous, real-time NanoBRET binding assays for the histamine H3 and H4 receptors on living cells</span></div><div class="casAuthors">Mocking, Tamara A. M.; Verweij, Eleonore W. E.; Vischer, Henry F.; Leurs, Rob</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1371-1381</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Receptor-binding affinity and ligand-receptor residence time are key parameters for the selection of drug candidates and are routinely detd. using radioligand competition-binding assays.  Recently, a novel bioluminescence resonance energy transfer (BRET) method utilizing a NanoLuc-fused receptor was introduced to detect fluorescent ligand binding.  Moreover, this NanoBRET method gives the opportunity to follow fluorescent ligand binding on intact cells in real time, and therefore, results might better reflect in vivo conditions as compared with the routinely used cell homogenates or purified membrane fractions.  In this study, a real-time NanoBRET-based binding assay was established and validated to detect binding of unlabeled ligands to the histamine H3 receptor (H3R) and histamine H4 receptor on intact cells.  Obtained residence times of clin. tested H3R antagonists were reflected by their duration of H3R antagonism in a functional receptor recovery assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7ZL7LtRBR1bVg90H21EOLACvtfcHk0lgKoc9M7vrZiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlKhu7rK&md5=ff558b89fd3748aaafb307468b3ccc28</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1124%2Fmol.118.113373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.118.113373%26sid%3Dliteratum%253Aachs%26aulast%3DMocking%26aufirst%3DT.%2BA.%2BM.%26aulast%3DVerweij%26aufirst%3DE.%2BW.%2BE.%26aulast%3DVischer%26aufirst%3DH.%2BF.%26aulast%3DLeurs%26aufirst%3DR.%26atitle%3DHomogeneous%252C%2520real-time%2520NanoBRET%2520binding%2520assays%2520for%2520the%2520histamine%2520H3%2520and%2520H4%2520receptors%2520on%2520living%2520cells%26jtitle%3DMol.%2520Pharmacol.%26date%3D2018%26volume%3D94%26spage%3D1371%26epage%3D1381%26doi%3D10.1124%2Fmol.118.113373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hauwert, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mocking, T. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da
Costa Pereira, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lion, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huppelschoten, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vischer, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Esch, I. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wijtmans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span> <span> </span><span class="NLM_article-title">A photoswitchable agonist for the histamine H<sub>3</sub> receptor, a prototypic family a G-protein-coupled receptor</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">4531</span>– <span class="NLM_lpage">4535</span>, <span class="refDoi"> DOI: 10.1002/anie.201813110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1002%2Fanie.201813110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjvFGjsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2019&pages=4531-4535&author=N.+J.+Hauwertauthor=T.+A.+M.+Mockingauthor=D.+Da%0ACosta+Pereiraauthor=K.+Lionauthor=Y.+Huppelschotenauthor=H.+F.+Vischerauthor=I.+J.+P.+de+Eschauthor=M.+Wijtmansauthor=R.+Leurs&title=A+photoswitchable+agonist+for+the+histamine+H3+receptor%2C+a+prototypic+family+a+G-protein-coupled+receptor&doi=10.1002%2Fanie.201813110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">A Photoswitchable Agonist for the Histamine H3 Receptor, a Prototypic Family A G-Protein-Coupled Receptor</span></div><div class="casAuthors">Hauwert, Niels J.; Mocking, Tamara A. M.; Da Costa Pereira, Daniel; Lion, Ken; Huppelschoten, Yara; Vischer, Henry F.; De Esch, Iwan J. P.; Wijtmans, Maikel; Leurs, Rob</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4531-4535</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Spatiotemporal control over biochem. signaling processes involving G protein-coupled receptors (GPCRs) is highly desired for dissecting their complex intracellular signaling.  We developed sixteen photoswitchable ligands for the human histamine H3 receptor (hH3R).  Upon illumination, key compd. 65 decreases its affinity for the hH3R by 8.5-fold and its potency in hH3R-mediated Gi protein activation by over 20-fold, with the trans and cis isomer both acting as full agonist.  In real-time two-electrode voltage clamp expts. in Xenopus oocytes, 65 shows rapid light-induced modulation of hH3R activity.  Ligand 65 shows good binding selectivity amongst the histamine receptor subfamily and has good photolytic stability.  In all, 65 (VUF15000) is the first photoswitchable GPCR agonist confirmed to be modulated through its affinity and potency upon photoswitching while maintaining its intrinsic activity, rendering it a new chem. biol. tool for spatiotemporal control of GPCR activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ0V367pAvQLVg90H21EOLACvtfcHk0lgKoc9M7vrZiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjvFGjsLc%253D&md5=c917858deb942375ff4d970aea993326</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1002%2Fanie.201813110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201813110%26sid%3Dliteratum%253Aachs%26aulast%3DHauwert%26aufirst%3DN.%2BJ.%26aulast%3DMocking%26aufirst%3DT.%2BA.%2BM.%26aulast%3DDa%2BCosta%2BPereira%26aufirst%3DD.%26aulast%3DLion%26aufirst%3DK.%26aulast%3DHuppelschoten%26aufirst%3DY.%26aulast%3DVischer%26aufirst%3DH.%2BF.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3DWijtmans%26aufirst%3DM.%26aulast%3DLeurs%26aufirst%3DR.%26atitle%3DA%2520photoswitchable%2520agonist%2520for%2520the%2520histamine%2520H3%2520receptor%252C%2520a%2520prototypic%2520family%2520a%2520G-protein-coupled%2520receptor%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2019%26volume%3D58%26spage%3D4531%26epage%3D4535%26doi%3D10.1002%2Fanie.201813110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prusoff, W. H.</span></span> <span> </span><span class="NLM_article-title">Relation between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibiton (IC50) of an enzymatic reaction</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3099</span>– <span class="NLM_lpage">3108</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=4202581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.-C.+Chengauthor=W.+H.+Prusoff&title=Relation+between+the+inhibition+constant+%28Ki%29+and+the+concentration+of+inhibitor+which+causes+50+percent+inhibiton+%28IC50%29+of+an+enzymatic+reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Relation between the inhibition constant K1) and the concentration of inhibitor which causes fifty per cent inhibition (I50) of an enzymic reaction</span></div><div class="casAuthors">Cheng, Yung-Chi; Prusoff, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3099-108</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The Ki and I50 values are equal where the kinetics are non- or uncompetitive, but not where they are competitive.  The relation between the 2 values was analyzed for non- and uncompetitive bi- and monosubstrate reactions and for competitive bisubstrate reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqodFY_8msz57Vg90H21EOLACvtfcHk0ljqxK1Ojz7Odg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D&md5=fe7175ca300d8f4085df87af37f8656c</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.-C.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelation%2520between%2520the%2520inhibition%2520constant%2520%2528Ki%2529%2520and%2520the%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2520percent%2520inhibiton%2520%2528IC50%2529%2520of%2520an%2520enzymatic%2520reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span> <span> </span><span class="NLM_article-title">Characterization of preclinical in vitro and in vivo pharmacokinetics properties for KBP-7018, a new tyrosine kinase inhibitor candidate for treatment of idiopathic pulmonary fibrosis</span>. <i>Drug Des., Dev. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">4319</span>– <span class="NLM_lpage">4328</span>, <span class="refDoi"> DOI: 10.2147/dddt.s83055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.2147%2Fdddt.s83055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=26273193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsVOitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=4319-4328&author=Z.+Huangauthor=H.+Liauthor=Q.+Zhangauthor=X.+Tanauthor=F.+Luauthor=H.+Liuauthor=S.+Li&title=Characterization+of+preclinical+in+vitro+and+in+vivo+pharmacokinetics+properties+for+KBP-7018%2C+a+new+tyrosine+kinase+inhibitor+candidate+for+treatment+of+idiopathic+pulmonary+fibrosis&doi=10.2147%2Fdddt.s83055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of preclinical in vitro and in vivo pharmacokinetics properties for KBP-7018, a new tyrosine kinase inhibitor candidate for treatment of idiopathic pulmonary fibrosis</span></div><div class="casAuthors">Huang, Zhenhua; Li, Heran; Zhang, Qian; Tan, Xiaojuan; Lu, Fangzheng; Liu, Hongzhuo; Li, Sanming</div><div class="citationInfo"><span class="NLM_cas:title">Drug Design, Development and Therapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4319-4328</span>CODEN:
                <span class="NLM_cas:coden">DDDTAQ</span>;
        ISSN:<span class="NLM_cas:issn">1177-8881</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">KBP-7018 is a novel selective tyrosine kinase inhibitor with potential for the treatment of idiopathic pulmonary fibrosis.  The objective of this study was to characterize the preclin. pharmacokinetics of KBP-7018 in vitro and in vivo, and then to assess the likelihood of developing KBP-7018 as a clin. candidate.  The systemic clearance (CL) of KBP-7018 was relatively low in rodents and monkeys with a value of less than 30% of hepatic blood flow, while it was high in dogs.  The steady-state vol. of distribution (Vss) ranged from 1.51 L/kg to 4.65 L/kg across the species tested.  The max. concn. (Cmax) of KBP-7018 occurred at 0.25-6 h after oral dosing, and the bioavailability was moderate (21%-68%).  The human CL (∼20% of hepatic blood flow) and Vss (1.6-5.3 L/kg) were predicted by allometric scaling method and together with the other modeling methods indicated low metab. and acceptable half-time (4.8-19.3 h) in vivo.  Overall, the preclin. data make it amenable to further oral solid dosage from design for the upcoming Phase I trials in human.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPIv5wrbFKCrVg90H21EOLACvtfcHk0ljqxK1Ojz7Odg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsVOitbs%253D&md5=71c3e026e232f685a9c9186707d5720e</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.2147%2Fdddt.s83055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252Fdddt.s83055%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DTan%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DS.%26atitle%3DCharacterization%2520of%2520preclinical%2520in%2520vitro%2520and%2520in%2520vivo%2520pharmacokinetics%2520properties%2520for%2520KBP-7018%252C%2520a%2520new%2520tyrosine%2520kinase%2520inhibitor%2520candidate%2520for%2520treatment%2520of%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DDrug%2520Des.%252C%2520Dev.%2520Ther.%26date%3D2015%26volume%3D9%26spage%3D4319%26epage%3D4328%26doi%3D10.2147%2Fdddt.s83055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths, H. H.</span></span> <span> </span><span class="NLM_article-title">Determination of microsome and hepatocyte scaling factors for in vitro/in vivo extrapolation in the rat and dog</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1386</span>– <span class="NLM_lpage">1398</span>, <span class="refDoi"> DOI: 10.1080/00498250802491662</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1080%2F00498250802491662" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=18988082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlens7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2008&pages=1386-1398&author=R.+Smithauthor=R.+D.+O.+Jonesauthor=P.+G.+Ballardauthor=H.+H.+Griffiths&title=Determination+of+microsome+and+hepatocyte+scaling+factors+for+in+vitro%2Fin+vivo+extrapolation+in+the+rat+and+dog&doi=10.1080%2F00498250802491662"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of microsome and hepatocyte scaling factors for in vitro/in vivo extrapolation in the rat and dog</span></div><div class="casAuthors">Smith, R.; Jones, R. D. O.; Ballard, P. G.; Griffiths, H. H.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1386-1398</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">In vivo clearance predictions from in vitro assays require scaling factors to relate the concns. of hepatocytes or microsomal protein to the intact liver.  The aims were to measure the variability in scaling factors for Wistar rat and beagle dog for which the literature is particularly scarce and det. any sex differences.  Scaling factors were detd. by comparing the cytochrome P 450 (P 450) content in hepatocytes or microsomes against the P 450 content of fresh liver homogenate.  The use of fresh homogenate is recommended as freezing can increase contamination and affect the P 450 assay.  Meangeo hepatic microsomal concns. in Wistar rats were 61 mg/g liver (95% confidence interval (CI); 47-75 mg/g liver) and in beagle dogs 55 mg/g liver (95% CI = 48-62 mg/g liver).  Meangeo hepatocellularity was 163 × 106 cells/g liver for Wistar rats (95% CI = 127-199 × 106 cells/g liver) and 169 × 106 cells/g liver (95% CI = 131-207 × 106 cells/g liver) for beagle dogs.  The data generated in this study indicate a consistency in scaling factors between rat and dog.  No sex differences were obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUaQwY_CMkBbVg90H21EOLACvtfcHk0ljqxK1Ojz7Odg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlens7vM&md5=67f11c3d42fd45eda1787bd1f9f3e045</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1080%2F00498250802491662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498250802491662%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DJones%26aufirst%3DR.%2BD.%2BO.%26aulast%3DBallard%26aufirst%3DP.%2BG.%26aulast%3DGriffiths%26aufirst%3DH.%2BH.%26atitle%3DDetermination%2520of%2520microsome%2520and%2520hepatocyte%2520scaling%2520factors%2520for%2520in%2520vitro%252Fin%2520vivo%2520extrapolation%2520in%2520the%2520rat%2520and%2520dog%26jtitle%3DXenobiotica%26date%3D2008%26volume%3D38%26spage%3D1386%26epage%3D1398%26doi%3D10.1080%2F00498250802491662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Isberg, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Graaf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bortolato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mordalski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pin, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vriend, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gloriam, D. E.</span></span> <span> </span><span class="NLM_article-title">Generic GPCR residue numbers - aligning topology maps minding the gaps</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">31</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2014.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1016%2Fj.tips.2014.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=25541108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVSgu7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=22-31&author=V.+Isbergauthor=C.+de+Graafauthor=A.+Bortolatoauthor=V.+Cherezovauthor=V.+Katritchauthor=F.+H.+Marshallauthor=S.+Mordalskiauthor=J.-P.+Pinauthor=R.+C.+Stevensauthor=G.+Vriendauthor=D.+E.+Gloriam&title=Generic+GPCR+residue+numbers+-+aligning+topology+maps+minding+the+gaps&doi=10.1016%2Fj.tips.2014.11.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Generic GPCR residue numbers - aligning topology maps while minding the gaps</span></div><div class="casAuthors">Isberg, Vignir; de Graaf, Chris; Bortolato, Andrea; Cherezov, Vadim; Katritch, Vsevolod; Marshall, Fiona H.; Mordalski, Stefan; Pin, Jean-Philippe; Stevens, Raymond C.; Vriend, Gerrit; Gloriam, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-31</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Generic residue nos. facilitate comparisons of, for example, mutational effects, ligand interactions, and structural motifs.  The numbering scheme by Ballesteros and Weinstein for residues within the class A GPCRs (G protein-coupled receptors) has more than 1100 citations, and the recent crystal structures for classes B, C, and F now call for a community consensus in residue numbering within and across these classes.  Furthermore, the structural era has uncovered helix bulges and constrictions that offset the generic residue nos.  The use of generic residue nos. depends on convenient access by pharmacologists, chemists, and structural biologists.  We review the generic residue numbering schemes for each GPCR class, as well as a complementary structure-based scheme, and provide illustrative examples and GPCR database (GPCRDB) web tools to no. any receptor sequence or structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLIeBaLTmUebVg90H21EOLACvtfcHk0lh8Zw9Z4iHT_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVSgu7rK&md5=31e18cc8196fb05a12d04dd0402b2338</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2014.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2014.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DIsberg%26aufirst%3DV.%26aulast%3Dde%2BGraaf%26aufirst%3DC.%26aulast%3DBortolato%26aufirst%3DA.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26aulast%3DMordalski%26aufirst%3DS.%26aulast%3DPin%26aufirst%3DJ.-P.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DVriend%26aufirst%3DG.%26aulast%3DGloriam%26aufirst%3DD.%2BE.%26atitle%3DGeneric%2520GPCR%2520residue%2520numbers%2520-%2520aligning%2520topology%2520maps%2520minding%2520the%2520gaps%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D36%26spage%3D22%26epage%3D31%26doi%3D10.1016%2Fj.tips.2014.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sali, A.</span></span> <span> </span><span class="NLM_article-title">Comparative protein modeling by satisfaction of spatial restraints</span>. <i>Mol. Med. Today</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">270</span>– <span class="NLM_lpage">277</span>, <span class="refDoi"> DOI: 10.1016/S1357-4310(95)91170-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1016%2FS1357-4310%2895%2991170-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=9415161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADyaK2MXptV2rtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1995&pages=270-277&author=A.+Sali&title=Comparative+protein+modeling+by+satisfaction+of+spatial+restraints&doi=10.1016%2FS1357-4310%2895%2991170-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative protein modeling by satisfaction of spatial restraints</span></div><div class="casAuthors">Sali, Andrej</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Today</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">270-7</span>CODEN:
                <span class="NLM_cas:coden">MMTOFK</span>;
        ISSN:<span class="NLM_cas:issn">1357-4310</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Trends Journals</span>)
        </div><div class="casAbstract">Approx. one third of known protein sequences are related to at least one known protein structure.  As a result, an order of magnitude more sequences can be modeled by comparative modeling than there are exptl. detd. protein structures.  A large fraction of these models has an accuracy approaching that of a low resoln. x-ray structure or a medium resoln. NMR structure.  The no. of applications where homol. modeling has been proven useful is growing rapidly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZyLUK-sQY6LVg90H21EOLACvtfcHk0lh8Zw9Z4iHT_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXptV2rtL8%253D&md5=a3aeffed0badbd7922b1db433babd3ec</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2FS1357-4310%2895%2991170-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1357-4310%252895%252991170-7%26sid%3Dliteratum%253Aachs%26aulast%3DSali%26aufirst%3DA.%26atitle%3DComparative%2520protein%2520modeling%2520by%2520satisfaction%2520of%2520spatial%2520restraints%26jtitle%3DMol.%2520Med.%2520Today%26date%3D1995%26volume%3D1%26spage%3D270%26epage%3D277%26doi%3D10.1016%2FS1357-4310%2895%2991170-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bateman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donovan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magrane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alpi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antunes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bely, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bingley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonilla, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Britto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bursteinas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bye-AJee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowley, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da Silva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Giorgi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dogan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazzini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figueira, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garmiri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georghiou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatton-Ellis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lussi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDougall, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nightingale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palka, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pichler, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poggioli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pundir, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pureza, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosanoff, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saidi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawford, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shypitsyna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speretta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyagi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volynkin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wardell, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watkins, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaru, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zellner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xenarios, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bougueleret, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bridge, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poux, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redaschi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aimo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">ArgoudPuy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auchincloss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Axelsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baratin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blatter, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boeckmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolleman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boutet, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breuza, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casal-Casas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Castro, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coudert, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuche, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doche, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dornevil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duvaud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estreicher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Famiglietti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feuermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasteiger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehant, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerritsen, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruaz-Gumowski, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinz, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jungo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lara, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemercier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieberherr, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardot, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nouspikel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paesano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedruzzi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilbout, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozzato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pruess, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivoire, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roechert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigrist, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonesson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staehli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundaram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tognolli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verbregue, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veuthey, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arighi, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arminski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garavelli, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laiho, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGarvey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natale, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinayaka, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span> <span> </span><span class="NLM_article-title">UniProt: The universal protein knowledgebase</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">D158</span>– <span class="NLM_lpage">D169</span>, <span class="refDoi"> DOI: 10.1093/nar/gkw1099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1093%2Fnar%2Fgkw1099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=27899622" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslWgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2017&pages=D158-D169&author=A.+Batemanauthor=M.+J.+Martinauthor=C.+O%E2%80%99Donovanauthor=M.+Magraneauthor=E.+Alpiauthor=R.+Antunesauthor=B.+Belyauthor=M.+Bingleyauthor=C.+Bonillaauthor=R.+Brittoauthor=B.+Bursteinasauthor=H.+Bye-AJeeauthor=A.+Cowleyauthor=A.+Da+Silvaauthor=M.+De+Giorgiauthor=T.+Doganauthor=F.+Fazziniauthor=L.+G.+Castroauthor=L.+Figueiraauthor=P.+Garmiriauthor=G.+Georghiouauthor=D.+Gonzalezauthor=E.+Hatton-Ellisauthor=W.+Liauthor=W.+Liuauthor=R.+Lopezauthor=J.+Luoauthor=Y.+Lussiauthor=A.+MacDougallauthor=A.+Nightingaleauthor=B.+Palkaauthor=K.+Pichlerauthor=D.+Poggioliauthor=S.+Pundirauthor=L.+Purezaauthor=G.+Qiauthor=S.+Rosanoffauthor=R.+Saidiauthor=T.+Sawfordauthor=A.+Shypitsynaauthor=E.+Sperettaauthor=E.+Turnerauthor=N.+Tyagiauthor=V.+Volynkinauthor=T.+Wardellauthor=K.+Warnerauthor=X.+Watkinsauthor=R.+Zaruauthor=H.+Zellnerauthor=I.+Xenariosauthor=L.+Bougueleretauthor=A.+Bridgeauthor=S.+Pouxauthor=N.+Redaschiauthor=L.+Aimoauthor=G.+ArgoudPuyauthor=A.+Auchinclossauthor=K.+Axelsenauthor=P.+Bansalauthor=D.+Baratinauthor=M.+C.+Blatterauthor=B.+Boeckmannauthor=J.+Bollemanauthor=E.+Boutetauthor=L.+Breuzaauthor=C.+Casal-Casasauthor=E.+De+Castroauthor=E.+Coudertauthor=B.+Cucheauthor=M.+Docheauthor=D.+Dornevilauthor=S.+Duvaudauthor=A.+Estreicherauthor=L.+Famigliettiauthor=M.+Feuermannauthor=E.+Gasteigerauthor=S.+Gehantauthor=V.+Gerritsenauthor=A.+Gosauthor=N.+Gruaz-Gumowskiauthor=U.+Hinzauthor=C.+Huloauthor=F.+Jungoauthor=G.+Kellerauthor=V.+Laraauthor=P.+Lemercierauthor=D.+Lieberherrauthor=T.+Lombardotauthor=X.+Martinauthor=P.+Massonauthor=A.+Morgatauthor=T.+Netoauthor=N.+Nouspikelauthor=S.+Paesanoauthor=I.+Pedruzziauthor=S.+Pilboutauthor=M.+Pozzatoauthor=M.+Pruessauthor=C.+Rivoireauthor=B.+Roechertauthor=M.+Schneiderauthor=C.+Sigristauthor=K.+Sonessonauthor=S.+Staehliauthor=A.+Stutzauthor=S.+Sundaramauthor=M.+Tognolliauthor=L.+Verbregueauthor=A.+L.+Veutheyauthor=C.+H.+Wuauthor=C.+N.+Arighiauthor=L.+Arminskiauthor=C.+Chenauthor=Y.+Chenauthor=J.+S.+Garavelliauthor=H.+Huangauthor=K.+Laihoauthor=P.+McGarveyauthor=D.+A.+Nataleauthor=K.+Rossauthor=C.+R.+Vinayakaauthor=Q.+Wangauthor=Y.+Wangauthor=L.+S.+Yehauthor=J.+Zhang&title=UniProt%3A+The+universal+protein+knowledgebase&doi=10.1093%2Fnar%2Fgkw1099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">UniProt: the universal protein knowledgebase</span></div><div class="casAuthors">Bateman, Alex; Martin, Maria Jesus; O'Donovan, Claire; Magrane, Michele; Alpi, Emanuele; Antunes, Ricardo; Bely, Benoit; Bingley, Mark; Bonilla, Carlos; Britto, Ramona; Bursteinas, Borisas; Bye-A-Jee, Hema; Cowley, Andrew; Da Silva, Alan; De Giorgi, Maurizio; Dogan, Tunca; Fazzini, Francesco; Castro, Leyla Garcia; Figueira, Luis; Garmiri, Penelope; Georghiou, George; Gonzalez, Daniel; Hatton-Ellis, Emma; Li, Weizhong; Liu, Wudong; Lopez, Rodrigo; Luo, Jie; Lussi, Yvonne; MacDougall, Alistair; Nightingale, Andrew; Palka, Barbara; Pichler, Klemens; Poggioli, Diego; Pundir, Sangya; Pureza, Luis; Qi, Guoying; Rosanoff, Steven; Saidi, Rabie; Sawford, Tony; Shypitsyna, Aleksandra; Speretta, Elena; Turner, Edward; Tyagi, Nidhi; Volynkin, Vladimir; Wardell, Tony; Warner, Kate; Watkins, Xavier; Zaru, Rossana; Zellner, Hermann; Xenarios, Ioannis; Bougueleret, Lydie; Bridge, Alan; Poux, Sylvain; Redaschi, Nicole; Aimo, Lucila; Argoud-Puy, Ghislaine; Auchincloss, Andrea; Axelsen, Kristian; Bansal, Parit; Baratin, Delphine; Blatter, Marie-Claude; Boeckmann, Brigitte; Bolleman, Jerven; Boutet, Emmanuel; Breuza, Lionel; Casal-Casas, Cristina; de Castro, Edouard; Coudert, Elisabeth; Cuche, Beatrice; Doche, Mikael; Dornevil, Dolnide; Duvaud, Severine; Estreicher, Anne; Famiglietti, Livia; Feuermann, Marc; Gasteiger, Elisabeth; Gehant, Sebastien; Gerritsen, Vivienne; Gos, Arnaud; Gruaz-Gumowski, Nadine; Hinz, Ursula; Hulo, Chantal; Jungo, Florence; Keller, Guillaume; Lara, Vicente; Lemercier, Philippe; Lieberherr, Damien; Lombardot, Thierry; Martin, Xavier; Masson, Patrick; Morgat, Anne; Neto, Teresa; Nouspikel, Nevila; Paesano, Salvo; Pedruzzi, Ivo; Pilbout, Sandrine; Pozzato, Monica; Pruess, Manuela; Rivoire, Catherine; Roechert, Bernd; Schneider, Michel; Sigrist, Christian; Sonesson, Karin; Staehli, Sylvie; Stutz, Andre; Sundaram, Shyamala; Tognolli, Michael; Verbregue, Laure; Veuthey, Anne-Lise; Wu, Cathy H.; Arighi, Cecilia N.; Arminski, Leslie; Chen, Chuming; Chen, Yongxing; Garavelli, John S.; Huang, Hongzhan; Laiho, Kati; McGarvey, Peter; Natale, Darren A.; Ross, Karen; Vinayaka, C. R.; Wang, Qinghua; Wang, Yuqi; Yeh, Lai-Su; Zhang, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D158-D169</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">1362-4962</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The UniProt knowledgebase is a large resource of protein sequences and assocd. detailed annotation.  The database contains over 60 million sequences, of which over half a million sequences have been curated by experts who critically review exptl. and predicted data for each protein.  The remainder are automatically annotated based on rule systems that rely on the expert curated knowledge.  Since our last update in 2014, we have more than doubled the no. of ref. proteomes to 5631, giving a greater coverage of taxonomic diversity.  We implemented a pipeline to remove redundant highly similar proteomes that were causing excessive redundancy in UniProt.  The initial run of this pipeline reduced the no. of sequences in UniProt by 47 million.  For our users interested in the accessory proteomes, we have made available sets of pan proteome sequences that cover the diversity of sequences for each species that is found in its strains and sub-strains.  To help interpretation of genomic variants, we provide tracks of detailed protein information for the major genome browsers.  We provide a SPARQL endpoint that allows complex queries of the more than 22 billion triples of data in UniProt (http://sparql.uniprot.org/).  UniProt resources can be accessed via the website at http://www.uniprot.org/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8jvkS3iPadrVg90H21EOLACvtfcHk0lhdt-SyacJT1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslWgs7c%253D&md5=fd093400ec0075c76f8fc4351e3b2cde</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkw1099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkw1099%26sid%3Dliteratum%253Aachs%26aulast%3DBateman%26aufirst%3DA.%26aulast%3DMartin%26aufirst%3DM.%2BJ.%26aulast%3DO%25E2%2580%2599Donovan%26aufirst%3DC.%26aulast%3DMagrane%26aufirst%3DM.%26aulast%3DAlpi%26aufirst%3DE.%26aulast%3DAntunes%26aufirst%3DR.%26aulast%3DBely%26aufirst%3DB.%26aulast%3DBingley%26aufirst%3DM.%26aulast%3DBonilla%26aufirst%3DC.%26aulast%3DBritto%26aufirst%3DR.%26aulast%3DBursteinas%26aufirst%3DB.%26aulast%3DBye-AJee%26aufirst%3DH.%26aulast%3DCowley%26aufirst%3DA.%26aulast%3DDa%2BSilva%26aufirst%3DA.%26aulast%3DDe%2BGiorgi%26aufirst%3DM.%26aulast%3DDogan%26aufirst%3DT.%26aulast%3DFazzini%26aufirst%3DF.%26aulast%3DCastro%26aufirst%3DL.%2BG.%26aulast%3DFigueira%26aufirst%3DL.%26aulast%3DGarmiri%26aufirst%3DP.%26aulast%3DGeorghiou%26aufirst%3DG.%26aulast%3DGonzalez%26aufirst%3DD.%26aulast%3DHatton-Ellis%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLopez%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DLussi%26aufirst%3DY.%26aulast%3DMacDougall%26aufirst%3DA.%26aulast%3DNightingale%26aufirst%3DA.%26aulast%3DPalka%26aufirst%3DB.%26aulast%3DPichler%26aufirst%3DK.%26aulast%3DPoggioli%26aufirst%3DD.%26aulast%3DPundir%26aufirst%3DS.%26aulast%3DPureza%26aufirst%3DL.%26aulast%3DQi%26aufirst%3DG.%26aulast%3DRosanoff%26aufirst%3DS.%26aulast%3DSaidi%26aufirst%3DR.%26aulast%3DSawford%26aufirst%3DT.%26aulast%3DShypitsyna%26aufirst%3DA.%26aulast%3DSperetta%26aufirst%3DE.%26aulast%3DTurner%26aufirst%3DE.%26aulast%3DTyagi%26aufirst%3DN.%26aulast%3DVolynkin%26aufirst%3DV.%26aulast%3DWardell%26aufirst%3DT.%26aulast%3DWarner%26aufirst%3DK.%26aulast%3DWatkins%26aufirst%3DX.%26aulast%3DZaru%26aufirst%3DR.%26aulast%3DZellner%26aufirst%3DH.%26aulast%3DXenarios%26aufirst%3DI.%26aulast%3DBougueleret%26aufirst%3DL.%26aulast%3DBridge%26aufirst%3DA.%26aulast%3DPoux%26aufirst%3DS.%26aulast%3DRedaschi%26aufirst%3DN.%26aulast%3DAimo%26aufirst%3DL.%26aulast%3DArgoudPuy%26aufirst%3DG.%26aulast%3DAuchincloss%26aufirst%3DA.%26aulast%3DAxelsen%26aufirst%3DK.%26aulast%3DBansal%26aufirst%3DP.%26aulast%3DBaratin%26aufirst%3DD.%26aulast%3DBlatter%26aufirst%3DM.%2BC.%26aulast%3DBoeckmann%26aufirst%3DB.%26aulast%3DBolleman%26aufirst%3DJ.%26aulast%3DBoutet%26aufirst%3DE.%26aulast%3DBreuza%26aufirst%3DL.%26aulast%3DCasal-Casas%26aufirst%3DC.%26aulast%3DDe%2BCastro%26aufirst%3DE.%26aulast%3DCoudert%26aufirst%3DE.%26aulast%3DCuche%26aufirst%3DB.%26aulast%3DDoche%26aufirst%3DM.%26aulast%3DDornevil%26aufirst%3DD.%26aulast%3DDuvaud%26aufirst%3DS.%26aulast%3DEstreicher%26aufirst%3DA.%26aulast%3DFamiglietti%26aufirst%3DL.%26aulast%3DFeuermann%26aufirst%3DM.%26aulast%3DGasteiger%26aufirst%3DE.%26aulast%3DGehant%26aufirst%3DS.%26aulast%3DGerritsen%26aufirst%3DV.%26aulast%3DGos%26aufirst%3DA.%26aulast%3DGruaz-Gumowski%26aufirst%3DN.%26aulast%3DHinz%26aufirst%3DU.%26aulast%3DHulo%26aufirst%3DC.%26aulast%3DJungo%26aufirst%3DF.%26aulast%3DKeller%26aufirst%3DG.%26aulast%3DLara%26aufirst%3DV.%26aulast%3DLemercier%26aufirst%3DP.%26aulast%3DLieberherr%26aufirst%3DD.%26aulast%3DLombardot%26aufirst%3DT.%26aulast%3DMartin%26aufirst%3DX.%26aulast%3DMasson%26aufirst%3DP.%26aulast%3DMorgat%26aufirst%3DA.%26aulast%3DNeto%26aufirst%3DT.%26aulast%3DNouspikel%26aufirst%3DN.%26aulast%3DPaesano%26aufirst%3DS.%26aulast%3DPedruzzi%26aufirst%3DI.%26aulast%3DPilbout%26aufirst%3DS.%26aulast%3DPozzato%26aufirst%3DM.%26aulast%3DPruess%26aufirst%3DM.%26aulast%3DRivoire%26aufirst%3DC.%26aulast%3DRoechert%26aufirst%3DB.%26aulast%3DSchneider%26aufirst%3DM.%26aulast%3DSigrist%26aufirst%3DC.%26aulast%3DSonesson%26aufirst%3DK.%26aulast%3DStaehli%26aufirst%3DS.%26aulast%3DStutz%26aufirst%3DA.%26aulast%3DSundaram%26aufirst%3DS.%26aulast%3DTognolli%26aufirst%3DM.%26aulast%3DVerbregue%26aufirst%3DL.%26aulast%3DVeuthey%26aufirst%3DA.%2BL.%26aulast%3DWu%26aufirst%3DC.%2BH.%26aulast%3DArighi%26aufirst%3DC.%2BN.%26aulast%3DArminski%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DGaravelli%26aufirst%3DJ.%2BS.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DLaiho%26aufirst%3DK.%26aulast%3DMcGarvey%26aufirst%3DP.%26aulast%3DNatale%26aufirst%3DD.%2BA.%26aulast%3DRoss%26aufirst%3DK.%26aulast%3DVinayaka%26aufirst%3DC.%2BR.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYeh%26aufirst%3DL.%2BS.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DUniProt%253A%2520The%2520universal%2520protein%2520knowledgebase%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2017%26volume%3D45%26spage%3DD158%26epage%3DD169%26doi%3D10.1093%2Fnar%2Fgkw1099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sadowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasteiger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klebe, G.</span></span> <span> </span><span class="NLM_article-title">Comparison of automatic three-dimensional model builders using 639 X-ray structures</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1000</span>– <span class="NLM_lpage">1008</span>, <span class="refDoi"> DOI: 10.1021/ci00020a039</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci00020a039" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADyaK2cXkvVajsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1994&pages=1000-1008&author=J.+Sadowskiauthor=J.+Gasteigerauthor=G.+Klebe&title=Comparison+of+automatic+three-dimensional+model+builders+using+639+X-ray+structures&doi=10.1021%2Fci00020a039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of Automatic Three-Dimensional Model Builders Using 639 X-ray Structures</span></div><div class="casAuthors">Sadowski, Jens; Gasteiger, Johann; Klebe, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1000-8</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    </div><div class="casAbstract">Several criteria were defined to select a dataset of high-quality x-ray structures from the Cambridge file resulting in 639 mols.  Six currently available programs for automatic 3D structure generation were compared by converting the connectivity tables, including appropriate stereodescriptors from this dataset of 639 mol. structures into 3D geometries: CONCORD, ALCOGEN, Chem-X, MOLGEO, COBRA, and CORINA.  The geometries produced by the different programs were evaluated in terms of several quality criteria and discussed in detail.  These criteria measure how well the different programs reproduce the x-ray geometries of the 639 input structures.  Accordingly, the major strengths and weaknesses of the programs are indicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8vEtyDrrlq7Vg90H21EOLACvtfcHk0lhdt-SyacJT1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkvVajsbY%253D&md5=246e4d66f11178a18daad2563c48331c</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fci00020a039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci00020a039%26sid%3Dliteratum%253Aachs%26aulast%3DSadowski%26aufirst%3DJ.%26aulast%3DGasteiger%26aufirst%3DJ.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DComparison%2520of%2520automatic%2520three-dimensional%2520model%2520builders%2520using%2520639%2520X-ray%2520structures%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D1994%26volume%3D34%26spage%3D1000%26epage%3D1008%26doi%3D10.1021%2Fci00020a039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">ChemAxon, L.</span></span>.  <i>Calculator</i>; <span class="NLM_publisher-name">ChemAxon</span>: <span class="NLM_publisher-loc">Budapest, Hungary</span>, <span class="NLM_year">1998–2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998%E2%80%932018&author=L.+ChemAxon&title=Calculator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DChemAxon%26aufirst%3DL.%26jtitle%3DCalculator%26pub%3DChemAxon%26date%3D1998%25E2%2580%25932018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korb, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stützle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Exner, T. E.</span></span> <span> </span><span class="NLM_article-title">An ant colony optimization approach to flexible protein–ligand docking</span>. <i>Swarm Intell.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.1007/s11721-007-0006-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1007%2Fs11721-007-0006-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2007&pages=115-134&author=O.+Korbauthor=T.+St%C3%BCtzleauthor=T.+E.+Exner&title=An+ant+colony+optimization+approach+to+flexible+protein%E2%80%93ligand+docking&doi=10.1007%2Fs11721-007-0006-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1007%2Fs11721-007-0006-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11721-007-0006-9%26sid%3Dliteratum%253Aachs%26aulast%3DKorb%26aufirst%3DO.%26aulast%3DSt%25C3%25BCtzle%26aufirst%3DT.%26aulast%3DExner%26aufirst%3DT.%2BE.%26atitle%3DAn%2520ant%2520colony%2520optimization%2520approach%2520to%2520flexible%2520protein%25E2%2580%2593ligand%2520docking%26jtitle%3DSwarm%2520Intell.%26date%3D2007%26volume%3D1%26spage%3D115%26epage%3D134%26doi%3D10.1007%2Fs11721-007-0006-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marcou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rognan, D.</span></span> <span> </span><span class="NLM_article-title">Optimizing fragment and scaffold docking by use of molecular interaction fingerprints</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">195</span>– <span class="NLM_lpage">207</span>, <span class="refDoi"> DOI: 10.1021/ci600342e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci600342e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12iurzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=195-207&author=G.+Marcouauthor=D.+Rognan&title=Optimizing+fragment+and+scaffold+docking+by+use+of+molecular+interaction+fingerprints&doi=10.1021%2Fci600342e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Optimizing Fragment and Scaffold Docking by Use of Molecular Interaction Fingerprints</span></div><div class="casAuthors">Marcou, Gilles; Rognan, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">195-207</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein-ligand interaction fingerprints have been used to postprocess docking poses of three ligand data sets: a set of 40 low-mol.-wt. compds. from the Protein Data Bank, a collection of 40 scaffolds from pharmaceutically relevant protein ligands, and a database of 19 scaffolds extd. from true cdk2 inhibitors seeded in 2230 scaffold decoys.  Four popular docking tools (FlexX, Glide, Gold, and Surflex) were used to generate poses for ligands of the three data sets.  In all cases, scoring by the similarity of interaction fingerprints to a given ref. was statistically superior to conventional scoring functions in posing low-mol.-wt. fragments, predicting protein-bound scaffold coordinates according to the known binding mode of related ligands, and screening a scaffold library to enrich a hit list in true cdk2-targeted scaffolds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHLbVKxK-BfLVg90H21EOLACvtfcHk0lg7qh9tkRZeMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12iurzL&md5=0c9137a39d40fbcc83546aec17b595ba</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fci600342e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci600342e%26sid%3Dliteratum%253Aachs%26aulast%3DMarcou%26aufirst%3DG.%26aulast%3DRognan%26aufirst%3DD.%26atitle%3DOptimizing%2520fragment%2520and%2520scaffold%2520docking%2520by%2520use%2520of%2520molecular%2520interaction%2520fingerprints%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2007%26volume%3D47%26spage%3D195%26epage%3D207%26doi%3D10.1021%2Fci600342e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Graaf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kooistra, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vischer, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuijer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiroishi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Esch, I. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span> <span> </span><span class="NLM_article-title">Crystal structure-based virtual screening for fragment-like ligands of the human histamine H<sub>1</sub> receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">8195</span>– <span class="NLM_lpage">8206</span>, <span class="refDoi"> DOI: 10.1021/jm2011589</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2011589" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlaltbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8195-8206&author=C.+de%0AGraafauthor=A.+J.+Kooistraauthor=H.+F.+Vischerauthor=V.+Katritchauthor=M.+Kuijerauthor=M.+Shiroishiauthor=S.+Iwataauthor=T.+Shimamuraauthor=R.+C.+Stevensauthor=I.+J.+P.+de+Eschauthor=R.+Leurs&title=Crystal+structure-based+virtual+screening+for+fragment-like+ligands+of+the+human+histamine+H1+receptor&doi=10.1021%2Fjm2011589"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure-Based Virtual Screening for Fragment-like Ligands of the Human Histamine H1 Receptor</span></div><div class="casAuthors">de Graaf, Chris; Kooistra, Albert J.; Vischer, Henry F.; Katritch, Vsevolod; Kuijer, Martien; Shiroishi, Mitsunori; Iwata, So; Shimamura, Tatsuro; Stevens, Raymond C.; de Esch, Iwan J. P.; Leurs, Rob</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8195-8206</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The recent crystal structure detns. of druggable class A G protein-coupled receptors (GPCRs) have opened up excellent opportunities in structure-based ligand discovery for this pharmaceutically important protein family.  We have developed and validated a customized structure-based virtual fragment screening protocol against the recently detd. human histamine H1 receptor (H1R) crystal structure.  The method combines mol. docking simulations with a protein-ligand interaction fingerprint (IFP) scoring method.  The optimized in silico screening approach was successfully applied to identify a chem. diverse set of novel fragment-like (≤22 heavy atoms) H1R ligands with an exceptionally high hit rate of 73%.  Of the 26 tested fragments, 19 compds. had affinities ranging from 10 μM to 6 nM.  The current study shows the potential of in silico screening against GPCR crystal structures to explore novel, fragment-like GPCR ligand space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbwo3rozOuPbVg90H21EOLACvtfcHk0lg7qh9tkRZeMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlaltbnL&md5=e45d22d293667ff443f6d62ecef90f9d</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fjm2011589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2011589%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BGraaf%26aufirst%3DC.%26aulast%3DKooistra%26aufirst%3DA.%2BJ.%26aulast%3DVischer%26aufirst%3DH.%2BF.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DKuijer%26aufirst%3DM.%26aulast%3DShiroishi%26aufirst%3DM.%26aulast%3DIwata%26aufirst%3DS.%26aulast%3DShimamura%26aufirst%3DT.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3DLeurs%26aufirst%3DR.%26atitle%3DCrystal%2520structure-based%2520virtual%2520screening%2520for%2520fragment-like%2520ligands%2520of%2520the%2520human%2520histamine%2520H1%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8195%26epage%3D8206%26doi%3D10.1021%2Fjm2011589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jakalian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jack, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayly, C. I.</span></span> <span> </span><span class="NLM_article-title">Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1623</span>– <span class="NLM_lpage">1641</span>, <span class="refDoi"> DOI: 10.1002/jcc.10128</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1002%2Fjcc.10128" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=12395429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BD38XosF2rt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=1623-1641&author=A.+Jakalianauthor=D.+B.+Jackauthor=C.+I.+Bayly&title=Fast%2C+efficient+generation+of+high-quality+atomic+charges.+AM1-BCC+model%3A+II.+Parameterization+and+validation&doi=10.1002%2Fjcc.10128"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. parameterization and validation</span></div><div class="casAuthors">Jakalian, Araz; Jack, David B.; Bayly, Christopher I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1623-1641</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We present the first global parameterization and validation of a novel charge model, called AM1-BCC, which quickly and efficiently generates high-quality at. charges for computer simulations of org. mols. in polar media.  The goal of the charge model is to produce at. charges that emulate the HF/6-31G* electrostatic potential (ESP) of a mol.  Underlying electronic structure features, including formal charge and electron delocalization, are first captured by AM1 population charges; simple additive bond charge corrections (BCCs) are then applied to these AM1 at. charges to produce the AM1-BCC charges.  The parameterization of BCCs was carried out by fitting to the HF/6-31G* ESP of a training set of >2700 mols.  Most org. functional groups and their combinations were sampled, as well as an extensive variety of cyclic and fused bicyclic heteroaryl systems.  The resulting BCC parameters allow the AM1-BCC charging scheme to handle virtually all types of org. compds. listed in The Merck Index and the NCI Database.  Validation of the model was done through comparisons of hydrogen-bonded dimer energies and relative free energies of solvation using AM1-BCC charges in conjunction with the 1994 Cornell et al. forcefield for AMBER.  Homo-dimer and hetero-dimer hydrogen-bond energies of a diverse set of org. mols. were reproduced to within 0.95 kcal/mol RMS deviation from the ab initio values, and for DNA dimers the energies were within 0.9 kcal/mol RMS deviation from ab initio values.  The calcd. relative free energies of solvation for a diverse set of monofunctional isosteres were reproduced to within 0.69 kcal/mol of expt.  In all these validation tests, AMBER with the AM1-BCC charge model maintained a correlation coeff. above 0.96.  Thus, the parameters presented here for use with the AM1-BCC method present a fast, accurate, and robust alternative to HF/6-31G* ESP-fit charges for general use with the AMBER force field in computer simulations involving org. small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn9DkJ_gMzA7Vg90H21EOLACvtfcHk0lgWRX0lJUBxWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosF2rt74%253D&md5=3f2b738617bb17b2898f7ac4d751d7ec</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1002%2Fjcc.10128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.10128%26sid%3Dliteratum%253Aachs%26aulast%3DJakalian%26aufirst%3DA.%26aulast%3DJack%26aufirst%3DD.%2BB.%26aulast%3DBayly%26aufirst%3DC.%2BI.%26atitle%3DFast%252C%2520efficient%2520generation%2520of%2520high-quality%2520atomic%2520charges.%2520AM1-BCC%2520model%253A%2520II.%2520Parameterization%2520and%2520validation%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2002%26volume%3D23%26spage%3D1623%26epage%3D1641%26doi%3D10.1002%2Fjcc.10128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berendsen, H. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van
der Spoel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Drunen, R.</span></span> <span> </span><span class="NLM_article-title">GROMACS: A message-passing parallel molecular dynamics implementation</span>. <i>Comput. Phys. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1016/0010-4655(95)00042-E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=10.1016%2F0010-4655%2895%2900042-E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADyaK2MXps1Wrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1995&pages=43-56&author=H.+J.+C.+Berendsenauthor=D.+van%0Ader+Spoelauthor=R.+van+Drunen&title=GROMACS%3A+A+message-passing+parallel+molecular+dynamics+implementation&doi=10.1016%2F0010-4655%2895%2900042-E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">GROMACS: A message-passing parallel molecular dynamics implementation</span></div><div class="casAuthors">Berendsen, H. J. C.; van der Spoel, D.; van Drunen, R.</div><div class="citationInfo"><span class="NLM_cas:title">Computer Physics Communications</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">43-56</span>CODEN:
                <span class="NLM_cas:coden">CPHCBZ</span>;
        ISSN:<span class="NLM_cas:issn">0010-4655</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A parallel message-passing implementation of a mol. dynamics (MD) program that is useful for bio(macro)mols. in aq. environment is described.  The software has been developed for a custom-designed 32-processor ring GROMACS (Groningen MAchine for Chem. Simulation) with communication to and from left and right neighbors, but can run on any parallel system onto which a a ring of processors can be mapped and which supports PVM-like block send and receive calls.  The GROMACS software consists of a preprocessor, a parallel MD and energy minimization program that can use an arbitrary no. of processors (including one), an optional monitor, and several anal. tools.  The programs are written in ANSI C and available by ftp (information: <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="1077627f7d717363507378757d3e6265773e7e7c">[email protected]</a>).  The functionality is based on the GROMOS (Groningen Mol. Simulation) package (van Gunsteren and Berendsen, 1987; BIOMOS B.V., Nijenborgh 4, 9747 AG Groningen).  Conversion programs between GROMOS and GROMACS formats are included.The MD program can handle rectangular periodic boundary conditions with temp. and pressure scaling.  The interactions that can be handled without modification are variable non-bonded pair interactions with Coulomb and Lennard-Jones or Buckingham potentials, using a twin-range cut-off based on charge groups, and fixed bonded interactions of either harmonic or constraint type for bonds and bond angles and either periodic or cosine power series interactions for dihedral angles.  Special forces can be added to groups of particles (for non-equil. dynamics or for position restraining) or between particles (for distance restraints).  The parallelism is based on particle decompn.  Interprocessor communication is largely limited to position and force distribution over the ring once per time step.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovcOlT-z9eKLVg90H21EOLACvtfcHk0lgWRX0lJUBxWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXps1Wrtr0%253D&md5=04d823aeab28ca374efb86839c705179</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2F0010-4655%2895%2900042-E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0010-4655%252895%252900042-E%26sid%3Dliteratum%253Aachs%26aulast%3DBerendsen%26aufirst%3DH.%2BJ.%2BC.%26aulast%3Dvan%2Bder%2BSpoel%26aufirst%3DD.%26aulast%3Dvan%2BDrunen%26aufirst%3DR.%26atitle%3DGROMACS%253A%2520A%2520message-passing%2520parallel%2520molecular%2520dynamics%2520implementation%26jtitle%3DComput.%2520Phys.%2520Commun.%26date%3D1995%26volume%3D91%26spage%3D43%26epage%3D56%26doi%3D10.1016%2F0010-4655%2895%2900042-E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cordomí, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caltabiano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardo, L.</span></span> <span> </span><span class="NLM_article-title">Membrane protein simulations using AMBER force field and Berger lipid parameters</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">948</span>– <span class="NLM_lpage">958</span>, <span class="refDoi"> DOI: 10.1021/ct200491c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct200491c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVSqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=948-958&author=A.+Cordom%C3%ADauthor=G.+Caltabianoauthor=L.+Pardo&title=Membrane+protein+simulations+using+AMBER+force+field+and+Berger+lipid+parameters&doi=10.1021%2Fct200491c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane Protein Simulations Using AMBER Force Field and Berger Lipid Parameters</span></div><div class="casAuthors">Cordomi, Arnau; Caltabiano, Gianluigi; Pardo, Leonardo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">948-958</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">AMBER force fields are among the most commonly used in mol. dynamics (MD) simulations of proteins.  Unfortunately, they lack a specific set of lipid parameters, thus limiting its use in membrane protein simulations.  To overcome this limitation the authors assessed whether the widely used united-atom lipid parameters described by O. Berger (1997)and co-workers could be used in conjunction with AMBER force fields in simulations of membrane proteins.  Thus, free energies of solvation in water and in cyclohexane, and free energies of water to cyclohexane transfer, were computed by thermodn. integration procedures for neutral amino acid side-chains employing AMBER99, AMBER03, and OPLS-AA amino acid force fields.  In addn., MD simulations of three membrane proteins in a POPC lipid bilayer, the β2 adrenergic G protein-coupled receptor, Aquaporin-1, and the outer membrane protein Omp32, were performed with the aim of comparing the AMBER99SB/Berger combination of force fields with the OPLS-AA/Berger combination.  The authors have shown that AMBER99SB and Berger force fields are compatible, they provide reliable free energy estns. relative to exptl. values, and their combination properly describes both membrane and protein structural properties.  The authors then suggest that the AMBER99SB/Berger combination is a reliable choice for the simulation of membrane proteins, which links the easiness of ligand parametrization and the ability to reproduce secondary structure of AMBER99SB force field with the largely validated Berger lipid parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-gBrwCxhd_7Vg90H21EOLACvtfcHk0lgWRX0lJUBxWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVSqtr4%253D&md5=0a46710c03ba644a33e92b15b87ccc1c</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fct200491c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct200491c%26sid%3Dliteratum%253Aachs%26aulast%3DCordom%25C3%25AD%26aufirst%3DA.%26aulast%3DCaltabiano%26aufirst%3DG.%26aulast%3DPardo%26aufirst%3DL.%26atitle%3DMembrane%2520protein%2520simulations%2520using%2520AMBER%2520force%2520field%2520and%2520Berger%2520lipid%2520parameters%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2012%26volume%3D8%26spage%3D948%26epage%3D958%26doi%3D10.1021%2Fct200491c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roessler, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brewer, C. R.</span></span> <span> </span><span class="NLM_article-title">Permanent turbidity standards</span>. <i>Appl. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1967</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1114</span>– <span class="NLM_lpage">1121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=6077410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A280%3ADyaF1c7gtVOnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1967&pages=1114-1121&author=W.+G.+Roesslerauthor=C.+R.+Brewer&title=Permanent+turbidity+standards"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Permanent turbidity standards</span></div><div class="casAuthors">Roessler W G; Brewer C R</div><div class="citationInfo"><span class="NLM_cas:title">Applied microbiology</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1114-21</span>
        ISSN:<span class="NLM_cas:issn">0003-6919</span>.
    </div><div class="casAbstract">Permanent turbidity reference standards suitable for measurement of microbial suspensions were prepared by suspending finely divided titanium dioxide in aryl sulfonamide-formaldehyde or methylstyrene resins.  Turbidities of these standards, adjusted to a useful range for microbiological and immunological studies, were compared with other reference standards in use today.  Tube holders for a Coleman Photonephelometer and a Nepho-Colorimeter were modified to eliminate the water well and to allow use of optically standardized 10-, 16-, or 18-mm test tubes.  The standards and the tube holders have been used satisfactorily for more than 12 years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkWsOrKFyCG2hHGZei4OW9fW6udTcc2eZdUEyEWXiP6rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF1c7gtVOnsA%253D%253D&md5=3bc55d13abc8f04cca3b29d671d025f6</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoessler%26aufirst%3DW.%2BG.%26aulast%3DBrewer%26aufirst%3DC.%2BR.%26atitle%3DPermanent%2520turbidity%2520standards%26jtitle%3DAppl.%2520Microbiol.%26date%3D1967%26volume%3D15%26spage%3D1114%26epage%3D1121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, G. A.</span></span> <span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2719</span>– <span class="NLM_lpage">2740</span>, <span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lgruT_dtKM4pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RZE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RZE','PDB','3RZE'); return false;">PDB: 3RZE</a></li><li><a href="http://www.ncbi.nlm.nih.gov/gquery?Term=AF140538" onclick="trackOutboundLink('http://www.ncbi.nlm.nih.gov/gquery?Term=AF140538','Genbank','AF140538'); return false;">Genbank: AF140538</a></li><li><a href="http://www.ncbi.nlm.nih.gov/gquery?Term=NM_133849.3" onclick="trackOutboundLink('http://www.ncbi.nlm.nih.gov/gquery?Term=NM_133849.3','Genbank','NM_133849.3'); return false;">Genbank: NM_133849.3</a></li><li><a href="http://www.ncbi.nlm.nih.gov/gquery?Term=AY136745" onclick="trackOutboundLink('http://www.ncbi.nlm.nih.gov/gquery?Term=AY136745','Genbank','AY136745'); return false;">Genbank: AY136745</a></li><li><a href="http://www.ncbi.nlm.nih.gov/gquery?Term=NM_153087.2" onclick="trackOutboundLink('http://www.ncbi.nlm.nih.gov/gquery?Term=NM_153087.2','Genbank','NM_153087.2'); return false;">Genbank: NM_153087.2</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i79"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01462">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_51680"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b01462">10.1021/acs.jmedchem.9b01462</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Nephelometry results of <b>14d</b>; best-scored docking poses of <b>14d</b>; functional assay on H<sub>1</sub>R and H<sub>2</sub>R; effect of <b>14d</b> on CYP3A4, CYP2D6, and CYP2C9 activities; sociability effect of <b>14d</b> in the social recognition test in mice; HPLC-MS chromatogram and spectra of <b>14d</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01462/suppl_file/jm9b01462_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Biochemical data of <b>1</b>, <b>11a</b> to <b>14k</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01462/suppl_file/jm9b01462_si_003.xls">XLS</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01462/suppl_file/jm9b01462_si_004.csv">CSV</a>)</p></li><li><p class="inline">MD simulations of the model where the <i>n</i>Pr group of <b>14d</b> is pointing toward the extracellular vestibule (Movie 1) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01462/suppl_file/jm9b01462_si_005.mpg">MPG</a>)</p></li><li><p class="inline">MD simulations of the model where the <i>n</i>Pr group of <b>14d</b> is directed toward the intracellular half of the receptor (Movie 2) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01462/suppl_file/jm9b01462_si_006.mpg">MPG</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01462/suppl_file/jm9b01462_si_001.pdf">jm9b01462_si_001.pdf (1.47 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01462/suppl_file/jm9b01462_si_003.xls">jm9b01462_si_003.xls (100.0 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01462/suppl_file/jm9b01462_si_004.csv">jm9b01462_si_004.csv (1.85 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01462/suppl_file/jm9b01462_si_005.mpg">jm9b01462_si_005.mpg (2.46 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01462/suppl_file/jm9b01462_si_006.mpg">jm9b01462_si_006.mpg (2.83 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01462&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01462%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-23" class="show-recommended-placeholder"></div>




        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01462" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679980cbe8103cd6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
